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 ABSTRACT 
 
Phosphoinositide-specific phospholipase C enzymes (PLCs) cleave the plasma 
membrane phospholipid PtdIns(4,5)P2 to generate two messengers, inositol (1,4,5) 
trisphosphate [Ins(1,4,5)P3] and diacylglycerol (DAG) (Kirk 1990). Ins(1,4,5)P3 is an 
important second messenger in animal cells. It releases calcium from intracellular 
stores by opening Ins(1,4,5)P3 receptors (InsP3Rs) and is formed in response to 
activation of cell surface hormone and growth factor receptors. It is also important for 
its immediate phosphorylation to form higher phosphorylated inositol phosphates 
(InsPs) (Auesukaree et al., 2005; Perera et al., 2004; York et al., 1999), which are 
critical for various cell signaling functions.  
 
Sub-families of PLC enzymes exist in cells and the regulation of the β and γ type 
PLCs via G-protein coupled receptors and receptor tyrosine kinases respectively, is 
well understood. In contrast, the regulation of PLC-δs is still a mystery. This is 
particularly frustrating because these enzymes are the only isoforms of PLC found in 
fungi and plants, as well as animals, and thus are likely to perform an ancient and 
important function.   
 
Plc1p is the single PLC of the δ family in the budding yeast Sacchromyces cerevisiae. 
It plays a key role in generating Ins(1,4,5)P3 in this fungi in response to stress and yet 
the yeast genome encodes no Ins(1,4,5)P3 receptor. This suggests that the functions of 
PLC-δs are mediated in a novel fashion, probably occurs via the higher inositol 
phosphates that derived upon rapid phosphorylation of Ins(1,4,5)P3 by a series of 
kinases (Arg82p, Ipk1p, Kcs1p and Vip1p).  
 This study focuses on the localisation of GFP-Plc1p in order to gain insight into its 
function. Plc1p is present in both cytoplasm and nucleus. Plc1p is too large to diffuse 
through the nuclear pore complex, and thus relies on nuclear export signals (NES) and 
nuclear localisation signals (NLS) to facilitate its passage through the nuclear 
envelope. By creating mutants of Plc1p that are restricted to one of these 
compartments: GFP-Plc1pCAAX for plasma membrane localisation, GFP-Plc1pNES for 
nucleus and GFP-Plc1pPKI for cytoplasm, I investigated which defects persist in yeast 
expressing these mutants as their sole Plc1p.  
 
My data suggest that these mutants do appear to display distinct subsets of phenotypes 
consistent with the idea of separate pools of inositol phosphates. I showed that both 
cytoplasmic and nuclear pools of Plc1p are important for function as neither PLC1NES 
nor PLC1PKI rescue the stress sensitivity of plc1Δ mutants. Therefore, Plc1p are likely 
to shuttle in between different compartments to exert its diverse functions.  It will be 
instructive to characterise inositol phosphate metabolism in these mutants to 
determine in which compartments basal and stimulated rises in inositol phosphates 
occur in yeast cells.  
 
In addition, I report the novel finding that Plc1p interacts with one (or more than one) 
of its metabolites.  Plc1p appears to associate tightly with the plasma membrane in the 
absence of the inositol phosphate kinase Arg82p, most likely due to the absence of 
Arg82p-derived inositol polyphosphates, and such association is required for intact 
PH, X-Y and C2 domain – disruption in any of these domains would result in failure 
of such association. 
 
 Hence, higher phosphorylated inositol phosphates seem to influence Plc1p’s 
localisation, and a physiological feedback cycle of regulation probably exists where 
Plc1p may be regulated by the products of its own catalytic activity. Future studies 
will seek to understand the role of this feedback cycle in stress signalling and 
physiology in yeast cells. 
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Chapter 1    Introduction 
 
1.1 Discovery of Phosphoinositides and recognition of their importance 
Signaling systems translate extracellular information into chemical messages to which 
the intracellular machinery can respond (Downes and Currie, 1998). Receptor proteins 
first detect alterations in the external physical or chemical environment of the cell and 
then trigger changes in the activity of enzyme(s) or ion channels that transform and 
amplify this information. A group of molecules referred as ‘second messengers’ are 
important components of most signal transduction cascades. They are responsible for 
relaying the external signals received by receptors to intracellular target molecules, 
usually through binding to and activating effector molecules such as protein kinases, 
ion channels, and a variety of other proteins.  
 
Three major second messenger groups have been defined: hydrophilic molecules, 
including cAMP, cGMP, Ins(1,4,5)P3 and Ca2+; gases, such as nitric oxide (NO) and 
carbon monoxide (CO); and hydrophobic molecules, such as diacylglycerol and other 
lipids. 
 
Phosphoinositides (PPIn), the various inositol lipids, function as second messengers 
or the precursors to second messengers, and also fulfil a number of other regulatory 
functions (Clarke, 2003). PPIn regulatory pathways are ubiquitous in eukaryotic cells. 
They are responsible for regulating multiple responses to a wide range of external 
stimuli in diverse cells, including stress responses, mitogenesis, apoptosis, cell 
motility and membrane trafficking (Clarke, 2003). 
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Studies on phosphoinositides began around eighty years ago when myo-inositol, the  
hexahydroxycyclohexane that is the head-group of phosphatidylinositol, was 
identified as a component of the lipids of mycobacteria (Anderson, 1930). An 
understanding of the structures of inositol lipids and their metabolic turnover only 
started developing after Jordi Folch discovered an ‘inositol phospholipid fraction’ in a 
bovine brain extract in the 1940s. Folch’s compound contained phosphate and inositol 
in an approximate molar ratio of 2:1 and was named ‘diphosphoinositide’ (Folch, 
1949).  
 
During the 1950s and 1960s three major classes of inositol phospholipids were 
isolated: mono-, di-, and tri-phosphoinositide, which are now more correctly referred 
as phosphatidylinositol (PtdIns or PI), phosphatidylinositol 4-phosphate (PtdIns4P or 
PI4P), and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2 or PI(4,5)P2), 
respectively (Michell, 1986). Despite being quantitatively minor lipids, these 
phosphoinositides are widely distributed in many types of cells and tissues (Downes, 
1982; Folch, 1959; Wagner et al., 1961). Structural characterization showed that they 
all have an sn-1,2-diacylglycerol ‘backbone’, and an inositol phosphate ‘headgroup’ 
(Figure 1.1).  
 
These lipids first came to attention in 1953 when Mabel and Lowell Hokin observed 
that cell surface receptors could induce rapid turnover of “PtdIns” (Hokin and Hokin, 
1955a, b; Hokin and Hokin, 1953). In the same year, hydrolysis of phosphoinositides 
at the diester phosphate bond was described when Sloan-Stanley found that brain 
homogenates hydrolysed Folch’s ‘diphosphoinositide’ fraction more quickly than any 
other phospholipid, with inositol phosphate(s) as direct product(s) (Sloane-Stanley, 
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1953). A phospholipase C (PLC) activity was detected by several groups and a 
“PtdIns-specific PLC” was partially purified and characterized by Dawson and his 
colleagues in 1959, and then, later, by Hawthorne’s lab (Atherton and Hawthorne, 
1968; Dawson, 1959; Kemp et al., 1961). 
 
A major change occurred when a large body of evidence was interpreted by Robert 
Michell’s group as showing a direct link between cell surface receptor signaling and 
 
Fig 1.1: Structures of phosphatidylinositol, phosphatidylinositol 4-phosphate and 
phosphatidylinositol 4,5-bisphosphate 
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phospholipase C-catalyzed PtdIns hydrolysis. Michell also put forward the idea that 
PtdIns turnover might be associated with an increase of cytoplasmic [Ca2+] in 
stimulated cells (Michell, 1975). However, the fact that PLC enzymes are highly 
sensitive to Ca2+ themselves muddled the issue of whether PLC activation was a 
downstream event in response to increased intracellular Ca2+ or an initiator of this 
increase (Michell, 1982). Then, in 1981, Judith Creba and Peter Downes in Michell’s 
lab identified PtdIns(4,5)P2 and PtdIns4P as the likely in vivo substrates of receptor-
activated PLCs (Creba et al., 1983; Michell et al., 1981). These observations indicated 
that Ins(1,4,5)P3 might be an intracellular second messenger. This was soon settled 
when Ins(1,4,5)P3 stimulated release of Ca2+ from the ER membrane was discovered 
(Streb et al., 1983).  
 
These reports opened up the study of phospholinositide-specific PLC (which will 
from now on be referred to simply as PLC) as a key enzyme in agonist-stimulated 
phosphoinositide metabolism (Downes, 1985).  
 
In the late 1980s and 1990s, a new focus for inositide research emerged with the 
discovery of the novel inositol lipids PtdIns3P and PtdIns(3,4,5)P3 in 1988 (Traynor-
Kaplan et al., 1988; Whitman et al., 1988), and of PtdIns5P and PtdIns(3,5)P2 in 1997 
(Dove et al., 1997; Rameh et al., 1997). By 1996, the crystal structure of PLC-δ1 
made it clear that no PPIn with a D3-phosphate could serve as a substrate for PLC, 
and this was later confirmed by experimental work (Essen et al., 1996).   
 
There are now 7 PPIn known and their structures are shown below (Figure 1.2).  
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Fig 1.2: Structures of phosphatidylinositol and its phosphorylated derivatives 
 
 
 
 
  
         
1.2 The synthesis of phosphoinositides in eukaryotic cells 
All phosphoinositide synthesis starts with formation of myo-inositol. Myo-inositol is 
one of nine possible regio-isomers of hexahydroxycyclohexane: a group of molecules 
collectively known as the inositols. Myo-inositol (hereafter referred to as inositol) is 
of the most common naturally occuring inositol. Once its D1 hydroxyl is linked to a 
lipid, then all of the other 5 hydroxyls become stereochemically unique (Overduin et 
al., 2001). It is the only isomer used by most cells in phospholipid synthesis and has 
also been adapted to many other roles (Michell, 1997). 
 
The synthesis of inositol is catalyzed by two enzymes: an NAD+-dependent myo-
inositol-3-phosphate synthase (MIPS, called Ino1p in yeast) that converts glucose-6-
phosphate to D-myo inositol-3-phosphate (Ins3P). Ins3P then serves as the substrate 
for an inositol monophosphatase (InsPase) that releases free inositol (Michell, 2008).  
represents a monoester phosphate group P 
 6
Phosphatidylinositol (sn-1,2-diacylglycero-3-phospho-D-1-myoinositol; PtdIns) is an 
acidic diacylglycerolipid, and is generally the most abundant inositol 
glycerophospholipid, constituting ~5-20% of the total lipid in eukaryotic cells (Rameh 
and Cantley, 1999). It is synthesized from CDP-diacylglycerol (also termed CMP-
PtdOH) by PtdIns synthase at the endoplasmic reticulum, by transferring a 
phosphatidyl residue to the D1-hydroxyl of inositol (Shen and Dowhan, 1996) (Fig 
1.3).  
 
Figure 1.3: Route of synthesis of phosphatidylinositol 
 
DAG, diacylglycerol; PtdOH, phosphatidic acid or phosphatidate; CTP, cytidine trisphosphate; 
CMP, cytidine monophosphate; PtdIns, phosphatidylinositol 
  
 
Synthesis of PtdIns takes place in the ER and PtdIns turnover has a half-time in 
weeks. In contrast, the synthesis of PPIn from PtdIns is very rapid and phosphate 
group turnover occurs in seconds or minutes.  All of the PPIn are derived from the 
parent lipid phosphatidylinositol by combinatorial phosphorylation that is catalysed 
by families of lipid kinases and lipid phosphatases (Overduin et al., 2001) (Fig 1.4). 
The ATP-dependent kinase/phosphatase enzyme pairs that interconvert PtdIns, 
PtdIns4P, and PtdIns(4,5)P2 were first detected in erythrocyte ghosts, liver plasma 
membranes and brain cytosol (Hokin and Hokin, 1964; Michell and Hawthorne, 1965; 
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Kai et al., 1966). Both kinases and phosphatases tend to display specificity for a 
particular hydroxyl or phosphomonoester at the D-3-, 4-, or 5- position of the inositol 
ring and also require that certain other hydroxyls are either free or are phosphorylated. 
For example, PtdIns 4-kinases will only phosphorylate the 4-position of the inositol ring of 
PtdIns when all other hydroxyls are free and unphosphorylated (Kirk, 1990), and  
phosphatases of the myotubularin family attack the D3-posphates of PtdIns3P and 
PtdIns(3,5)P2, but not those in PtdIns(3,4,5)P3 or PtdIns(3,4)P2 (Robinson and Dixon, 
2006).   
 
Figure 1.4: The network of interconversion between PPIn (Balla, 2006) 
 
 
PPIns are phosphorylated (red arrows) by PPIn kinases and dephosphorylated (blue arrows) by PPIn 
phosphatases. Most PtdIns(4,5)P2 are formed through PtdIns4P by PtdIns 4-kinases, which remains as 
the canonical route for PtdIns(4,5)P2 synthesis (enlarged blue circles). 
 
1.3 General characteristics of acutely regulated and house-keeping PPIn 
Phosphoinositides can be grouped into two types: acutely regulated and housekeeping 
or constitutive lipids. The ‘acutely regulated phosphoinositides’ such as 
PtdIns(3,4,5)P3 tend to be second-messengers, and changes in their concentrations are 
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rapid and transient upon receptor stimulation. They initiate their effects by binding 
and allosterically regulating target proteins known as effectors. The housekeeping 
lipids are always present in cells and are generally involved in membrane trafficking 
or other constitutive functions (Overduin et al., 2001). These lipids are employed by 
cells use to mark particular compartments (Toker, 2002). For example, some PtdIns4P 
is associated with the Golgi and a number of proteins, such as the lipid-transfer 
proteins OSBP and FAPP, seem to require its presence in order to localize and 
function at this compartment (Toker, 2002).  
 
PtdIns3P is a key component in endosomal membrane trafficking and depletion of 
this lipid results in an aberrant morphology of these organelles (Corvera, 2001; 
Lemmon, 2003). PtdIns(3,5)P2 also functions in the endo-lysosomal system and 
regulates the fission/fragmentation of lysosome/vacuoles both constitutively and in 
stressed cells (Dove et al., 1997; Rudge et al., 2004).  
 
PtdIns(3,4,5)P3 has a major plasma membrane signaling role. It exists in very low 
concentrations in quiescent cells but its levels can be transiently and dramatically 
enhanced upon activation of type I PPIn 3-kinases, and PtdIns(3,4,5)P3 activates 
multiple pathways that control cell survival and growth (Di Paolo and De Camilli, 
2006). 
 
PtdIns5P has been suggested to be a regulator in some cellular processes, including 
PtdIns(3,4,5)P3 signalling and exocytosis (Morris et al., 2000; Sbrissa et al., 2004), 
but its role in these activities, if any, requires further clarification.  
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1.4 PtdIns(4,5)P2 
PtdIns(4,5)P2 is mainly concentrated at the plasma membrane (Di Paolo and De 
Camilli, 2006), but is also present in the Golgi and the nucleus (Halstead et al., 2005). 
Two consecutive phosphorylations of PtdIns by Type III PtdIns 4-kinase and Type I 
PtdIns4P 5-kinase form the main path of PtdIns(4,5)P2 synthesis (Hinchliffe et al., 
1998). However, a small fraction of PtdIns(4,5)P2 might also be made by Type II 
PtdIns5P 4-kinase from PtdIns5P (Santarius et al., 2006). 
 
PtdIns(4,5)P2 serves as the substrate for two second messenger systems: for 
generation of the survival signal PtdIns(3,4,5)P3  and as a substrate of PLCs, leading 
to production of the two second messengers InsP3 and DAG (Toker, 2002). Both of 
these systems are activated by cell surface receptors in response to a wide variety of 
physical and chemical stimuli, probably in all animals, and maybe in some other 
eukaryotes (Toker, 2002).  
 
A large body of evidence also points to regulatory roles for PtdIns(4,5)P2 itself (Insall 
and Weiner, 2001). These include the regulation of actin cytoskeletal dynamics, 
chromatin remodeling, ion channel gating, clathrin-mediated endocytosis, exocytosis, 
vesicle trafficking and focal adhesion formation (Di Paolo and De Camilli, 2006; 
Downes et al., 2005; Heilmann, 2008; Santarius et al., 2006; van Rheenen et al., 
2005).  
 
PtdIns(4,5)P2 can influence cytoskeletal organisation through regulating the 
concentration of free actin monomers in the cell as a result of its association with 
actin-binding proteins such as profilin (Lassing and Lindberg, 1985). Actin uncapping 
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can also be regulated by PtdIns(4,5)P2 through its interaction with gelsolin or CapZ-
related proteins. This allows elongation of pre-existing actin filaments (Schafer et al., 
1996). PtdIns(4,5)P2 also interacts with many cytoskeletal anchoring proteins such as 
talin, vinculin, and proteins of the ERM (Ezrin, Radixin, and Moesin) family (Barret 
et al., 2000; Hirao et al., 1996).  
 
There is evidence that the vacuolar/lysosomal fission/fusion equilibrium depends on 
proper maintenance of the traffic of plasma membrane-synthesised PtdIns(4,5)P2 
between vacuolar and plasma membranes (Mayer et al., 2000; Wiradjaja et al., 2007). 
The metabolites of PtdIns(4,5)P2 – DAG, inositol polyphosphates or both – might 
regulate vacuole fusion (Seeley et al., 2002), as evidence has recently shown that 
vacuole fusion in vitro is blocked by sequestration of DAG or by PLC inhibitors (Jun 
et al., 2004).  
 
PtdIns(4,5)P2 accumulates at the cleavage furrow of dividing cells (Emoto et al., 
2005; Field et al., 2005; Wong et al., 2005). The presence there of high concentrations 
of PtdIns(4,5)P2 and of actin binding proteins that bind PtdIns(4,5)P2 suggests a role 
for this lipid in cytokinesis (Field et al., 2005). Treatment with a PLC inhibitor 
(U73122) or sequestration of PtdIns(4,5)P2 causes an impairment in cleavage furrow 
function and a defect in cytokinesis, suggesting that hydrolysis of PtdIns(4,5)P2 is 
essential for this process, maybe because they require Ins(1,4,5)P3 stimulated release 
of intracellular Ca2+ (Wong et al., 2005). 
 
1.5 Phosphoinositide-specific Phospholipase C mediated hydrolysis of 
PtdIns(4,5)P2 and the Ins(1,4,5)P3/ DAG pathway  
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The cell-surface receptor mediated activation of phosphoinositide-specific 
phospholipase C (PLC) to hydrolyze PtdIns(4,5)P2, forms the two second messengers 
inositol 1,4,5-trisphosphate (Ins(1,4,5)P3 or InsP3) and sn-1,2-diacylglycerol (DAG) 
(Berridge, 1983). Most of the DAG derived from PPIn in animal cells has a distinctive 
fatty-acid profile: 1-stearoyl 2-arachidonyl DAG. This DAG remains in the plasma 
membrane and activates the classical isoforms of protein kinase C (cPKCs) via 
binding to their C1 domains (Rhee, 2001) (Fig 1.5). Activation of cPKCs can lead to 
diverse intracellular events in a variety of different tissues. These include regulation 
of cellular growth and proliferation, cardiac hypertrophy, smooth muscle contraction, 
mitogenesis and/or differentiation, stimulation of Na+/H+ exchange, activation of 
MAP kinases, and increased transcription of the nuclear proto-oncogenes c-myc and c-
fos (Berridge and Irvine, 1989; Grobler and Hurley, 1998).  
 
Figure 1.5: Hydrolysis of phosphatidylinositol 4,5-bisphosphate by PLC 
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PLC derived DAG also occurs in nuclei: the levels of nuclear DAG changes during 
the cell cycle, at around the G1-S transition and the G2–M boundary (Sun et al., 
1997). These two distinct pulses of DAG result in PKC activation in the nucleus, 
leading to specific cellular/nuclear activity at different cell stages. (D'Santos et al., 
1999).  
 
Budding yeast has a homolog of mammalian protein kinase C (PKC1), but its domain 
structure is different from any known mammalian PKC isotype. In addition, the 
protein kinase activity of Pkc1p does not respond to DAG, Ca2+ or the other activating 
cofactors normally required for stimulation of mammalian cPKCs in vitro (Watanabe 
et al., 1994). 
 
The other product of the PLC pathway, InsP3, is water soluble and diffuses away from 
the plasma membrane to associate with a specific InsP3 receptor, a ligand-gated Ca2+ 
channel that releases Ca2+ from the cortical endoplasmic reticulum that is closely 
apposed to the plasma membrane (Fig 1.6). As mentioned earlier (Section 1.1), this 
was first demonstrated by Streb et al. (Streb et al., 1983).   
 
Fig 1.6:  The DAG/InsP3 pathway in mammalian cells 
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InsP3 mediated elevation of cytosolic Ca2+ levels leads to the stimulation of a variety 
of calmodulin-dependent enzymes, including protein kinases and phosphoprotein 
phosphatases (Cockcroft and Stutchfield, 1988b; Kirk, 1990). Through its regulation 
of intracellular Ca2+, InsP3 regulates many cellular processes, including fertilization, 
cell growth, transformation, secretion and smooth muscle contraction (Kirk, 1990).  
This elevation of cytosolic Ca2+ also helps to activate cPKCs: the Ca2+ dependent 
phosphatidylserine-binding C2 domain of these enzymes requires low micromolar 
Ca2+ concentrations before it can associate with the plasma membrane and be 
activated by DAG (Kirk, 1990).  
 
The other pivotal role of InsP3 is as the substrate for a series of kinases that generate 
inositol polyphosphates or inositol pyrophosphates. These molecules have very 
diverse functions including regulating membrane trafficking, cytoskeletal 
organization, gene expression, and mRNA export. Highly phosphorylated inositol 
phosphates are especially important in lower organisms since only animal cells 
express classical InsP3 receptor channels. Thus InsP3 in lower organisms appears to 
be rapidly converted to form the higher inositol polyphosphates or inositol 
pyrophosphates (Tisi et al., 2004). The inositol polyphosphates and their kinases are 
important in this study and will be introduced in greater detail in a later section.  
 
1.6 Phosphoinositide-specific Phospholipase Cs  
1.6.1 PLC isoenzymes 
There are PLCs that are not inositide-specific, but they are beyond the scope of this 
study. So, the term PLC(s) in this work will refer only to the PI-PLCs.   
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The eukaryotic PLC family is a diverse group of enzymes, that share considerable 
sequence similarity within shared domains and also display a common core domain 
organization (Rhee and Bae, 1997). PLC isoforms are classified according to 
sequence similarity into six types: PLC-β (β1–β4), PLC-γ (γ1 and γ2), PLC-δ (δ1, δ3 
and δ4), PLC-ε, PLC-ζ and PLC-η (η1 and η2) (Katan, 1998; Rebecchi and Pentyala, 
2000; Rhee and Bae, 1997). Each isoform is encoded by a different gene, and further 
molecular diversity is generated by splice variants (Katan, 1998).  
 
The PLC isoforms differ in domain organization, mechanisms of receptor-regulated 
activation and size: ~85 kilodaltons (kDa) for the PLC-δ subfamily, 120-155 kDa for 
PLC-β and PLC-γ subfamilies, up to 230-260 kDa for PLC-ε. The subcellular location 
of each isoform is often determined by the non-conserved domains (Cockcroft, 2006). 
 
Among all the PLC subfamilies, PLC-δs are ubiquitously expressed in eukaryotes, 
appearing in yeasts, slime moulds, filamentous fungi, plants, and other organisms. 
DNA sequence comparisons indicate that an ancestral form of PLC-δ was likely 
present in the primordial eukaryotes that gave rise to multicellular organisms, and the 
other PLC subfamilies then evolved from this archetypal PLC-δ after the split 
between fungi, plants and animals about 940 million years ago (Koyanagi et al., 1998; 
Rhee and Bae, 1997). PLC-ε, PLC-η, and the classical PLC–β and PLC-γ isoforms 
only exist in metazoans, and PLC-ζ is found only found in sperm (Cockcroft, 2006). 
 
1.6.2 Structure of PLC isoenzymes 
PLCs are multidomain proteins. The common core structure shared by most PLC 
family enzymes is comprised of four elements: a PH domain, 2-4 EF-hands, a 
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catalytic domain (consisting of a combination of the conserved X and Y regions) and 
the C2 domain (C2) (Katan, 1998)(Fig 1.7).  
 
Figure 1.7: Domain organization of mammalian PLC isoforms (Katan,2005) 
 
 
PLC-γ, is unique in having a second PH domain, two SH2 (Src homology 2) and one SH3 (Src 
homology 3) region formed as a flexible loop in its catalytic domain. PLCε contains a guanyl-
nucleotide exchange factor activity (CDC25) at the N-terminus and two RA (Ras association) domains 
at the C-terminus. The sequences unique to PLC-η (tail) and to PLC-β, are also located at the C-
terminus.  
 
The PH domain 
Both the localization and the function of PLCs are known to be regulated through 
membrane targeting motif(s), such as the PH (Pleckstrin Homolgy) domain. Most 
PLCs contain an amino-terminal PH domain, a ~130 residue module that is also found 
in many other signalling proteins. The lack of obvious catalytic properties means that 
PH domains are largely viewed as adaptors or binding sites that tether binding 
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partners to membranes (Yagisawa et al., 1998). The sequences of PH domains are not 
well conserved among PLCs suggesting that they might bind disparate ligands, most 
often phosphoinositides and Gβγ subunits (Rhee, 2001), but the three-dimensional 
structure of the “generalized PH domain” is highly conserved (Bottomley et al., 1998; 
Lemmon and Ferguson, 2000).  
 
The binding of PLC-δ1 to PtdIns(4,5)P2, via its PH domain, is important for the 
processive catalysis of the substrate by PLC-δ1 (Cifuentes et al., 1993; Lomasney et 
al., 1996). Mutations of the PH domain yields PLC-δ1 mutants that show low rates of 
hydrolysis in vivo or in vitro in the absence of detergents (Yagisawa et al., 1998). 
Equilibrium binding measurements infer a co-distribution between PLC-δ1 and its 
substrate (Cifuentes et al., 1994). Later, a study by Ferguson and Lemmon 
demonstrated that the PH domain residues form a strong non-covalent bond with the 
4- and 5-phosphates of PtdIns(4,5)P2 (Ferguson et al., 1995) and this tethers PLC-δ1 
to the polar head of substrate at the plasma membrane (Garcia et al., 1995).  
 
PPIn 3-kinase activity is required for some PLC isoforms to be recruited to their lipid 
binding partners (Falasca et al., 1998). PLC-γ1 can be recruited by PtdIns(3,4,5)P3 
through the affinity of the NH2-terminal PH domain for this lipid (Rhee, 2001). 
Accordingly, targeting of PLC-γ1 to the plasma membrane is dependent upon type I 
PPIn 3-kinase activity. The PH domain in PLC-β1 binds to PtdIns3P and Gβγ in cells 
where PPIn 3-kinase is activated. These two components act synergistically to shift 
PLC-β1 to the membrane surface, though PLC-β1-PH was found to bind to other 
phosphoinositides as well but with lower affinity (Razzini et al., 2000).  
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The PH domain of PLC-δ1 was also reported to have a higher affinity for inositol 
phosphates than for lipids, eg, InsP3 interacts with PLC-δ1 via its PH domain with 
high affinity and thus prevents it from binding with PtdIns(4,5)P2 (Cifuentes et al., 
1994; Lemmon et al., 1995). Indeed, there is a growing body of literature suggesting 
that inositol phosphates can inhibit the interaction between many PH domains and 
phosphoinositides (Hirata et al., 1998). In this study, I present some evidence in 
support of this view. 
 
The EF-hand 
With the exception of PLC-ε, all PLC isozymes isolated to date have up to four helix-
loop-helix structured EF-hand motifs located between the PH and X domains. The 
first two EF-hands present in mammalian, yeast and Dictyostelium discoideum 
isoforms are capable of binding divalent cations (Ca2+ and Mg2+), whereas the 
remaining two EF-hands don’t (Bennett et al., 1998; Drayer et al., 1994; Payne and 
Fitzgerald-Hayes, 1993). However, PLC-δ1 crystals soaked in calcium or its analogs 
do not take up any cations (Essen et al., 1997). 
 
The role of the EF–hand domains of PLC isozymes is not clear. They may function as 
regulatory motifs and/or as a link between the PH domain and the rest of the enzyme 
thus allowing the enzyme to exert its catalytic function after binding. More recent 
evidence indicates that the EF- hand domain of PLC-δ1 might serve as a binding site 
for Ca2+ which is necessary for the efficient interaction between the PH domain and 
PtdIns(4,5)P2 (Yamamoto et al., 1999). Also, a functional Nuclear Export Signal 
(NES) sequence was located in EF-hand of PLC-δ1-4, -β1, -γ1, -ε, and ζ, suggesting it 
may have a role in interaction with exportins to allow translocation of PLC from the 
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nucleus to the cytoplasm (Yamaga et al., 1999). 
 
The catalytic domain: X-Y region 
Among all the PLC subfamilies, the sequences of the X and Y domains are highly 
conserved (~150 and ~260 amino acids, respectively) (Williams, 1999). These two 
regions constitute the catalytic core of the enzyme. This domain is formed of 
α−helices and β-strands resembling an incomplete triose phosphate isomerase (TIM), 
α/β barrel (Rebecchi and Pentyala, 2000). The sequence homology in the X and Y 
domains is ~60% amongst all the isozymes, with even greater homology within 
individual PLC subfamilies (Rhee, 2001). The X domain is involved in both substrate 
and Ca2+ binding, while the Y domain primarily interacts with the substrate (Essen et 
al., 1996). Structural analyses have also demonstrated the importance of individual 
conserved residues within the catalytic core for substrate binding, catalysis, and 
membrane interactions.  These include His-311, His-356, Glu-341, Asp-343, and Glu-
390 (Essen et al., 1996).  
 
There is also a ridge of hydrophobic residues, Leu-320, Tyr-358, Phe-360, Leu-529, 
and Trp-555, surrounding the active site known to be important for membrane 
interaction/insertion (Rebecchi and Pentyala, 2000).  
 
The intervening sequence joining the X and Y domains is highly disordered and 
contains sequences that auto-inhibit all PLCs. Most of the activation mechanisms of 
PLCs involve removal of the X-Y linker from the active site. This linker has a 
variable length that is characteristic of each family: 40 to 110 residues in the -β and -δ 
subfamilies, and 190 residues in -ε (Rhee, 2001). This intervening sequence within 
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PLC-γ family is much larger (~400 residues) and includes multiple adaptor domains, 
and is designated as the Z region (X/Y spanning polypeptide). The Z-domain of PLC-
γs contains two Src homology 2 (SH2) domains and one SH3 domain, which bind 
phosphotyrosine-containing sequences and proline-rich sequences, respectively. The 
SH2 and SH3, together with the PH domain, regulate the binding of the PLC-γ 
subfamily with their protein and lipid partners. These multiple adaptor domains are 
critical to extrinsic regulation of the -γ isoform as well as an intrinsic control of its 
catalytic activity (Rebecchi and Pentyala, 2000; Rhee, 2001). 
 
The catalytic activities of eukaryotic PLCs have many properties shared in common 
(Rhee and Choi, 1992). The general mechanism of substrate hydrolysis for these 
eukaryotic enzymes could be briefly described as acid/base catalysis leading to the 
formation of inositol 1,2-cyclic phosphate in a phosphotransfer step, followed by 
phosphohydrolysis to convert it to an acyclic inositol phosphate (Heinz et al., 1998). 
Ca2+ is required by all PLCs as an essential component of the active site (Williams, 
1999). The principle role of the metal is to facilitate the deprotonation of the attacking 
hydroxyl to greatly increase its nucleophilicity. The bound Ca2+ also functions as a 
stabilizer during the negatively charged transition state (Essen et al., 1997). PtdIns4P 
and PtdIns(4,5)P2 are the preferred substrates, and steric constrains make the enzymes 
unable to hydrolyze 3-phosphorylated phosphoinositides (Bruzik and Tsai, 1994).  
 
The C2 domain 
The C2 domain is a region found in many proteins that bind phospholipids in either a 
calcium-dependent or -independent manner. Calcium binding to the C2 domain is 
known to function as an electrostatic switch that enhances phospholipid binding 
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(Sutton et al., 1995). 
 
The C2 domains of PLC isozymes are about 120 residues long and in the δ subfamily, 
where we have structural information, consists of antiparallel β-strands arranged as a 
sandwich, with one end of the sandwich binding up to three calcium ions (Rhee, 
2001). These calcium-binding regions (CBR) of δ-isoforms are homologous from 
yeasts to humans, suggesting conservation of some important function, but do not 
share as much similarity with the CBR of the other PLC subfamilies (Rhee, 2001).  
 
A single C2 domain and short peptide cap the carboxy-terminal ends of PLCs of the -γ 
and -δ subfamilies, but PLC-βs (except for a splice variant of PLC-β4) bear long 
carboxy-terminal extensions, which are assumed to enhance membrane binding, 
nuclear localization (Rhee, 2001), and activation by G protein subunits. This C-
terminal extension and the PH domains, both interact with Gαq and Gβγ, during the 
activation of PLC-βs (Wang et al., 2000). The C2 domain of PLC-ζ interacts with 
PtdIns3P or PtdIns5P, and this seems to inhibit the PLC (Kouchi et al., 2005). 
 
1.7 Mode of regulation of PLC isoenzymes 
1.7.1 Activation of PLC-β 
A wide range of stimuli, from photons and odorant molecules to proteins, can activate 
PLC-β isozymes through transmembrane G protein-coupled receptors (GPCRs). 
Activated α subunits of the Gq subfamily or liberated Gβγ heterodimers or both, bind 
and activate various PLC-βs (Rebecchi and Pentyala, 2000; Rhee, 2001). 
 
Fig 1.8 shows the standard model for G protein activation of PLC-βs. Agonist binding 
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with the receptor triggers exchange of GTP for GDP on the α subunit of the 
heterotrimeric G-protein associated with the GPCR. The active GTP-charged α 
subunit is released from the membrane, and either this α subunit or the βγ heterodimer 
or both bind to and stimulate the PLC-β (Rebecchi and Pentyala, 2000).  
 
Fig 1.8: Regulation of PLC-β by G protein-coupled receptors (GPCRs)  
(Rebecchi and Pentyala, 2000) 
 
 
                                                                                                                 
PLC-β can be regulated by the αq subunit of Gα and βγ-subunits released from Gi/o. RGS (Regulator 
in G protein) proteins act as receptor-specific down-modulators of the Gα subunits. The continued 
receptor-catalyzed charging of αq with GTP is required for PLC-β to remain active.  
 
 
G proteins were implicated in phosphoinositide/calcium signaling even before PLC-
β isoforms were identified (Boyer et al., 1989; Cockcroft and Gomperts, 1985; 
Cockcroft and Stutchfield, 1988a, b; Fain et al., 1988). The Gq subfamily of related 
pertussis toxin (PTX)-insensitive α−subunits (αq, α11, α14, α15, and α16) were cloned 
at roughly the same time as the four PLC-β isoforms were first isolated (Strathmann 
and Simon, 1990).  The Go and Gi family of G-proteins are likely those that are 
sensitive to pertussis toxin (Cockcroft and Thomas, 1992). GPCRs that activate the 
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Gqα-PLC-β signalling pathway include those for thromboxane A2, bradykinin, 
bombesin, angiotensin II, histamine, vasopressin, acetylcholine (muscarinic m1 and 
m3), a1-adrenergic agonists, C-C and C-X-C chemokines and endothelin-1 (Rhee, 
2001). Different members of the Gq family activate PLC-β isoforms selectively: PLC-
β2 and PLC-β3 appear more sensitive to βγ stimulation than PLC-β1 (Camps et al., 
1992; Lee et al., 1994; Park et al., 1993; Smrcka and Sternweis, 1993). Gαq purified 
using a βγ-affinity gel stimulates PLC-β1 but not -β2 (Park et al., 1992; Rhee and 
Choi, 1992a), and Gα16 prefers PLC-β2 (Lee et al., 1992; Rhee and Choi, 1992a). The 
mix and match relationships between initiator G-proteins and individual PLC 
isoforms provides a versatile system to suit the disparate needs of the panoply of cell 
types in which they are found (Cockcroft and Thomas, 1992). It is not yet clear 
exactly how the individual PLC-βs couple to particular receptors in vivo.  
 
1.7.2 Activation of PLC-γ 
Receptors for polypeptide growth factors, such as platelet-derived growth factor 
(PDGF), epidermal growth factor (EGF), fibroblast growth factor (FGF) and nerve 
growth factor (NGF) can activate PLC-γs both in vivo and in vitro.  There are also 
receptors that lack intrinsic tyrosine kinase activity but which can nevertheless 
activate PLC-γs, such as the B and T-cell receptors, Fc receptor and receptors for a 
number of cytokines (Rebecchi and Pentyala, 2000).  
 
Fig 1.9 represents the general mechanism of activation of PLC-γs. The binding of 
growth factors to receptor tyrosine kinases (RTKs) triggers the dimerisation of 
receptor subunits and the stimulation of their intrinsic tyrosine kinase activity. This 
results in transphosphorylation of multiple tyrosine residues on the cytoplasmic tails 
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of the receptors. PLC-γ and the Type IA PI 3-kinases are then recruited to these 
phosphorylated Tyr residues via their high-affinity SH2 domains, and both signaling 
enzymes are subsequently tyrosine phosphorylated at specific residues by the receptor 
or its associated accessory proteins (Rebecchi and Pentyala, 2000).  
 
Fig 1.9: Regulation of PLC-γ by tyrosine protein kinases and PtdIns(3,4,5)P3 
(Rebecchi and Pentyala, 2000) 
 
 
 
 
For PLC-γ1  the sites of tyrosine phosphorylation are Tyr-783, Tyr-1254 and to a lesser 
extent, Tyr-472 (Kim et al., 1990; Wahl et al., 1990).  A single mutation at Tyr-783 or 
Tyr-1254 affects PLC-γ activation in vivo, but only decreases its catalytic activity in 
vitro when the actin binding protein profilin is included in the assay: profilin-
PtdIns(4,5)P2 complexes are inhibitory to non-phosphorylated PLC-γs  (Kim et al., 
1991). Over-expressing these mutants in fibroblasts results in different growth and 
cytoskeletal phenotypes, indicating each of these sites could have distinct functions 
(Pei and Williamson, 1998). These phosphorylations are necessary but not sufficient 
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to activate PLC-γs, and PtdIns(3,4,5)P3 is essential as a positive factor during the 
process. PtdIns(3,4,5)P3 binds the PH and SH2 domains of PLC-γs and helps to tether 
the enzyme to the membrane stably and enhances the rate of PtdIns(4,5)P2 hydrolysis 
(Bae et al., 1998). 
 
Regulation by non-receptor tyrosine kinases (nRTKs) occurs in a similar fashion. 
GPCRs can control PLC-γ function by activating nRTKs and PPIn 3-kinases. Upon 
stimulation, receptors recruit and activate nRTKs such as Src or Jak/Tyk, which 
become auto-phosphorylated and activated. The active nRTKs then recruit PLC-γs via 
their SH2 domain and tyrosine-phosphorylate and activate them (Fluckiger et al., 
1998; Gusovsky et al., 1993; Park et al., 1992; Park et al., 1991). 
 
1.7.3 Activation of PLC-ε 
PLC-ε has an amino-terminal Ras guanine nucleotide exchange factor (RasGEF/ 
CDC25) motif and two carboxy-terminal Ras-associating (RA) domains (Lopez et al., 
2001), suggesting that it might be a GDP-GTP exchange factor for, and effector of, 
Ras (Shibatohge et al., 1998).  
 
PLC-ε binds GTP-Ras with high affinity, and the association as well as co-expression 
of activated Ras with PLC-ε leads to PLC-ε activation and translocation from cytosol 
to the plasma membrane (Song et al., 2001). Once the reaction is terminated by the 
hydrolysis of Ras-bound GTP, Ras might be reloaded with GTP by the action of the 
RasGEF motif of PLC-ε, thereby prolonging the receptor-mediated activation of PLC-
ε (Rhee, 2001). For example, EGF can stimulate PLC-ε by increasing GTP-Ras 
activity and causing membrane translocation and activation of PLC-ε (Rhee, 2001; 
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Song et al., 2001).  
 
PLC-ε also appears to be activated by Gα12, and the small GTPases of the Rho family 
(Rhee, 2001).  Co-expression of a constitutively active mutant (GTPase-defective) of 
Gα12 with PLC-ε specifically increased its PLC activity, whereas none of the other 
Gα subunits had such an effect (Lopez et al., 2001). Therefore, thrombin and 
lysophosphatidic acid, whose receptors are coupled to Gα12, might be able to activate 
PLC-ε (Rhee, 2001). 
 
1.7.4 Activation of PLC-δ 
PLC-δs are the only isoforms found in eukaryotic cells other than animals (Katan, 
2005). However, despite the fact that much is known about the structure and catalytic 
mechanism of PLC-δs, their regulation is poorly understood.  
 
PLC-δ isozymes are more sensitive to Ca2+ than the other isozymes and it has 
therefore been suggested that a rise in intracellular Ca2+ might trigger PLC-δ 
activation (Rhee, 2001). Fig 1.10 shows a possible route for PLC-δ stimulation in 
animal cells via a hierarchal arrangement of PLC subtypes that sustains calcium 
signaling in response to receptor activation. Various stimuli could activate multiple 
PLC subtypes: PLC-β by GPCRs and PLC-γ by nRTKs and PI 3-kinases. PLC-δs 
might then be activated by the resulting increase in cytosolic [Ca2+], and could thus 
amplify and extend the Ca2+ signals initiated by PLC-β or PLC-γ (Rebecchi and 
Pentyala, 2000). 
 
Plc1p, a PLC-δ type enzyme that is the sole PLC in yeast, can be activated by  
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Fig 1.10: Hierarchy of PLC subtypes in cell signaling  
(Rebecchi and Pentyala, 2000) 
 
 
 
stresses, such as hypo-osmotic shock and heat (Perera et al., 2004). The molecular 
mechanism for this activation is obscure but does not involve Ca2+ influx because 
activation was not blocked by external BAPTA, a high-affinity Ca2+ chelator (Perera 
et al., 2004). 
 
Rat PLC-δ1 can be regulated, at least in vitro, by Gh (75-80 kDa), a high-molecular-
weight G protein (Rhee, 2001). Gh is a widely expressed, multidomain protein with 
tissue transglutaminase activity (Im et al., 1997). It binds to PLC-δ1 in α1-
adrenergically stimulated heart and liver cells (Chen et al., 1996; Das et al., 1993; 
Nakaoka et al., 1994) or oxytocin-stimulated myometrium (Park et al., 1998). 
Epinephrine was also found to potentiate Gh to from a complex with a 69 kDa active 
proteolytic fragment of PLC-δ1 (Das et al., 1993; Feng et al., 1996; Park et al., 1998). 
This binding leads to an increased enzyme sensitivity to Ca2+, causing its activation 
by 0.1-5 μM Ca2+ in the presence of GTP (Das et al., 1993). However, Murthy et al. 
demonstrated potential GTP inhibition of PLC-δ1 activation by showing that free or 
GDP-bound Gh, but not GTP-bound Gh, associated with PLC-δ1 in response to 
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receptor accupancy (Murthy et al., 1999). 
 
A Rho GTPase-activating protein (p122 RhoGAP) has a strong affinity for PLC-δ1 
and enhance its catalytic activity up to 10-fold at low Ca2+concentrations (~ 0.1 μM) 
and neither PLC-β1 nor PLC-γ1 responded to p122-RhoGAP (Homma and Emori, 
1995; Yamaga et al., 2008).  
 
A problem with all of these mechanisms is lack of universality. None can explain the 
activation of PLC-δs in all organisms: Gh and p122 are not present in many 
eukaryotes whose genomes encode a PLC-δ, and PLC cascade theory is also not 
relevant to organisms that lack any other PLCs.  
 
More recently, the small Ral GTPases were reported to be involved in PLC-δ 
regulation: Ral binding to PLC-δ alone is sufficient to stimulate its activity in vitro 
(Sidhu et al., 2005). Indeed, whilst this work was being prepared, a study by 
Ferguson’s group demonstrated that angiotensin II type 1 receptor AT1R-stimulated 
InsP formation was attenuated after PLC-δ1 siRNA treatment in HEK 239 cells. This 
study also provided evidence of a RalGDS (Ral guanine nucleotide dissociation 
stimulator)/Ral-mediated AT1R stimulation of PLC-δ (Godin et al., 2010). AT1R has 
traditionally been considered to be coupled to the activation of PLC-β via its 
association with Gαq/11 and also to induce tyrosine phosphorylation of PLC-γ1 
activation (Lea et al., 2002; Ochocka and Pawelczyk, 2003; Suh et al., 2008), and this 
further enhances the idea that GPCRs may be coupled to PLC-δ activation in some 
organisms.  
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1.8 Plc1p – The Phosphoinositide-specific Phospholipase C of S. cerevisiae 
1.8.1 Plc1p belongs to the PLC-δ subfamily  
The S. cerevisiae genome encodes a single PLC, Plc1p, of 100.6 kDa. The sequence 
of Plc1p is homologous to PLCs from other eukaryotes in the highly conserved X and 
Y domains, with 43-53% identity in the X domain and 18-20% identity in the Y 
domain (Yoko-o et al., 1993).  
 
The following arguments suggest that yeast Plc1p is most closely related to the PLC-δ 
subfamily: The Plc1p domain organization and sequence are closest to the -δ isoforms 
than to the larger  and more complex PLCs of the -β, -γ and -ε subfamilies (Flick and 
Thorner, 1993). The X and Y domains of Plc1p are situated near the carboxy-terminal 
end, as in PLC-δ isoforms, rather than internally as in the -β, -γ and -ε subfamilies 
(Yoko-o et al., 1993). As in the PLC-δs, ~75 amino acids separate the X and Y 
domains and this region includes a PEST motif (residues 521 to 568) (Rogers et al., 
1986). A consensus Ca2+-binding motif is present both in the EF-hand domain of 
Plc1p (residues 282 to 293) and in the corresponding region of the rat and bovine 
PLC-δs (Yoko-o et al., 1993).  
 
However, Plc1p has a 100-residue extension at its amino-terminus that the 
mammalian -δ isotypes lack. Also, Plc1p is a basic protein whereas some of the 
animal PLC-δs (e.g. rat and bovine -δ enzymes) are acidic. The functional 
significance of these differences is currently unknown (Flick and Thorner, 1993).  
 
1.8.2 Phenotypes of plc1Δ mutant 
Deletion of PLC1 has various phenotypic outcomes though the resulting plc1Δ cells 
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are viable in most strain backgrounds. Cells lacking PLC1 can grow but are fragile 
and vulnerable to environmental stresses (Flick and Thorner, 1993; Yoko-o et al., 
1993) (Figure 1.11). This reflects that fact that Plc1p and/or its products regulate the 
cytoskeleton, an important checkpoint function in the cell cycle, mRNA export, 
vacuole fusion, and presumably other regulatory pathways that control the responses 
of S. cerevisiae to changes in nutrient availability or environmental stresses (Ansari et 
al., 1999; DeLillo et al., 2003; Demczuk et al., 2008; Guha et al., 2007; Jun et al., 
2004; Rebecchi and Pentyala, 2000; York, 2006). 
 
Figure 1.11: plc1Δ phenotypes 
 
Cells depleted of PLC1 are sensitive to various sources of stresses as shown in the figure. 
 
The degree of the various stress phenotypes varies in different genetic strains and with 
different nutrients (Yoko-o et al., 1993). The growth of plc1Δ cells slows as the 
temperature increases and usually stops at around 37oC (Flick and Thorner, 1993; 
Payne and Fitzgerald-Hayes, 1993; Yoko-o et al., 1993). plc1Δ cells grown at 
restrictive temperature become larger and multi-budded, do not complete cytokinesis 
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and show chromosome mis-segregation (Flick and Thorner, 1993).  
 
Yeast lacking PLC1 also have a deficiency in growth on media with limited nutrient 
sources, possibly because of mitochondrial abnormalities caused indirectly by the 
mRNA export defect. Yeast grow best with glucose as a carbon source, and plc1Δ 
mutants grow poorly on raffinose, galactose, and other non-fermentable carbon 
sources such as glycerol (Flick and Thorner, 1993).  
 
Stationary phase cultures of wild-type and isogenic plc1Δ yeast display similar 
viability in complete medium, but viability of the plc1Δ strain drops to ~10% or less 
without a nitrogen source (Flick and Thorner, 1993). 
 
plc1Δ are sensitive to hyper-osmotic stress and in some strain backgrounds they do 
not grow (Flick and Thorner, 1993). A previous student in our lab, Dr Nevin Perera, 
made progress in understanding the regulation and function of Plc1p, including the 
discovery that Plc1p is stimulated by hypo-osmotic stress to hydrolyse a 50% of 
cellular PtdIns(4,5)P2 within two minutes (Perera et al., 2004). 
 
Phosphorylation of Ins(1,4,5)P3 to a series of ‘higher’ inositol polyphosphates (those 
with 4 or more phosphates) and inositol pyrophosphates is very rapid in yeast, so 
these accumulate fast when Plc1p is activated. This suggests that these molecules, 
rather than of accumulation of Ins(1,4,5)P3, may be the physiologically important 
consequence of Plc1p activity.  
 
Our understanding of the molecular information about the functions of Plc1p and 
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inositol phosphates and the phenotypes reported above are limited and thus there is 
much more to discover about these pathways. 
 
1.9 The ‘higher’ inositol polyphosphates (InsPs) 
1.9.1 Synthesis of the ‘higher’ inositol polyphosphates (InsPs) 
Although the importance of InsP3 has been known since 1983, roles for other inositol 
polyphosphates in cell regulation have only recently emerged. Our knowledge of the 
synthesis of the InsPs has come mainly from studies of yeast and metazoan InsPs 
kinases. Two major pathways of inositol polyphosphates synthesis are known. The 
first pathway, identified in Dictyostelium, proceeds directly from inositol via multiple 
phosphorylations (Stephens and Irvine, 1990). This pathway seems to be absent from 
many organisms, so I will not consider it further. The second pathway, begins with the 
action of Plc1p on PtdIns(4,5)P2 followed by multiple phosphorylations of the 
liberated Ins(1,4,5)P3. This latter pathway was discovered first in S. pombe and S. 
cerevisiae and completed by York et al. (York et al., 1999). InsP3 is sequentially 
phosphorylated by four kinases (Arg82p, Ipk1p, Kcs1p and Vip1p) to InsP6 and the 
pyrophosphorylated InsPs (Fig 1.12).   
 
Fig 1.12:  Synthesis of ‘higher’ InsPs in S. cerevisiae (Demczuk et al., 2008) 
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Arg82p (also called Ipk2p) is an inositol polyphosphate multikinase (IPMK). It 
phosphorylates InsP3 to Ins(1,4,5,6)P4 and then to Ins(1,3,4,5,6)P5, while Ipk1p is 
primarily a 2-kinase and converts InsP5 to InsP6. Kcs1p, an inositol diphosphate 
synthase, phosphorylates InsP6 to PP-InsP5 and some InsP5 to PP-InsP4 (Seeds et al., 
2004). A revised and more complex pathway of InsPs production in S. cerevisiae 
emerged after the discovery of a second inositol pyrophosphate synthase, Vip1p. 
Vip1p phosphorylates InsP6 at P4 or P6 to generate 4/6-[PP]-InsP5 or can 
phosphorylate InsP7 (5-[PP]-InsP5) produced by Kcs1p to form InsP8 (4,5-[PP]2-
InsP4 or 5,6-[PP]2-InsP4). Deletion of VIP1 does not cause temperature sensitivity but 
its InsP6 kinase activity is required for maintaining various cellular processes (Mulugu 
et al., 2007). A 3-kinase activity of Kcs1p and/or Arg82p/Ipk2p can compensate for 
loss of some, but not all, of the InsPs/PP-InsPs in ARG82(IPK2) deficient cells (Seeds 
et al., 2005).          
     
Deletion of the inositol phosphate kinases, ARG82(IPK2), IPK1 and KCS1 inhibit 
inositol phosphate production at various steps but the deletions are not individually 
lethal (York, 2006). These mutants exhibit subsets of the phenotypes displayed by 
plc1Δ mutants, indicating that the resulting inositol polyphosphates are responsible for 
at least part of the functions of Plc1p. Oddly, deletion of IPK1 produces very few 
phenotypes, indicating that PP-InsP4 can probably fulfill many of the functions that 
normally require InsP6, InsP7 and InsP8 (NM Perera and Sk Dove, 2002 pers. comm.). 
 
In metazoans, the synthesis of higher InsPs is similar to that in yeast except for an 
extra step: in mammals, InsP3 is rapidly phosphorylated to Ins(1,3,4,5)P4 by an InsP3 
3-kinase (Fig 1.13A). The function of Ins(1,3,4,5)P4 is thought to contribute to 
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refilling of the ER Ca2+ store. Ins(1,3,4,5)P4 is then phosphorylated by Arg82p(Ipk2p) 
(Seeds et al., 2004).  
 
The synthesis of InsP5 and InsP6 in Drosophila melanogaster is fairly similar to the 
yeast pathway, despite the presence of active InsP3 3-kinases and Ins(1,3,4,5)P4 
(Seeds et al., 2004) (Fig 1.13B).  
 
Fig 1.13 (Seeds et al., 2004): 
 
The Metazoan pathway of InsPs synthesis 
 
In metazoans, a five-step proposed pathway is initiated by Ins(1,4,5)P-3 kinase (IP3K), followed 
by 5-phosphatase attack, then turnover by the InsP3 5-/6-kinases, Ipk2 and Ipk1. 
 
 
 
Black font highlights portions of the model that are directly supported by data obtained up to 
date. Gray font indicates portions that are presumed and not yet confirmed. 
 
 
B. Drosophila InsPs synthesis 
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The gene products of these InsPs kinases and synthases are conserved throughout 
eukaryotes, from yeast to human. The ARG82(IPK2)/IPMK and IPK1 routes are the 
essential major pathway in most eukaryotic species (York, 2006), but plants and 
mammals do possess alternative pathways that involve the Ins(1,4,5)P3 3-kinase and 
Ins(1,3,4)P3 5/6-kinase (York, 2006) and synthesis by lipid-independent routes 
(Brearley and Hanke, 1996; Shi et al., 2005; Stephens and Irvine, 1990).  
 
1.9.2 Regulatory roles of inositol phosphates 
Various InsPs are associated with distinct aspects of cell regulation, and these will 
now be discussed in some detail. It is often not obvious how an individual InsP can be 
regulated independently in view of the intrinsically interconnected metabolisms of 
many InsPs. Many of the functions discussed below are constitutive, which would not 
require that some InsPs to be acutely regulated. 
 
1.9.2.1 Arg82p(Ipk2p) and InsP4 /InsP5 
Arg82p (IPMK) catalyses the first enzyme step in the pathway leading from InsP3 to 
the higher InsPs. Arg82p was discovered because of its role in regulating arginine 
metabolism which is reported to be separate from its role in inositol phosphate 
signalling, though this is an area of some controversy. The InsP3 kinase activity of 
Arg82p is involved in diverse processes including sporulation, mating, and the 
responses to stress in yeast (Dubois and Messenguy, 1994). In mice, Ipk2/IPMK is 
required for several development events: its deletion causes embryonic lethality at 
E8.5, and Ipk2/IPMK-deficient mice exhibit multiple morphological defects 
(Frederick et al., 2005).  
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Arg82p is an essential component of the ArgR-MCM1 transcription complex 
(Mcm1p, Arg80p, Arg81p and Arg82p) that binds to the ARG box in the promoters of 
arginine-regulated genes in the presence of arginine, leading to the activation or 
repression of multiple genes involved in homeostasis (Crabeel et al., 1995; El 
Bakkoury et al., 2000). Binding of Arg82p stabilizes Mcm1p/Arg80p (Cocco et al., 
1998; Dubois and Messenguy, 1994). One group claims that inositol phosphate kinase 
activity is dispensible for control of arginine metabolism (Dubois et al., 2000), but 
another asserts that it is required: Ins(1,4,5,6)P4 or Ins(1,3,4,5,6)P5 is involved since 
IPK1 deletion has no effect on arginine metabolism (Odom et al., 2000).  
 
Arg82p may facilitate the binding of Mcm1p/Arg80p to chromatin. The suggestion 
that PtdIns(4,5)P2 and maybe also inositol polyphosphates may stimulate binding of 
the chromatin-remodeling BAF complex to chromatin in mammalian cells (Zhao et 
al., 1998b) and a similar actin-containing complex called ARI in yeast (Chi and 
Crabtree, 2000),  raised the possibility that inositol polyphosphates might regulate 
chromatin remodeling with the assembly of the ArgR-MCM1 transcription complex in 
vivo. It was later claimed that Ins(1,4,5,6)P4 or Ins(1,3,4,5,6)P5 are required during 
chromatin remodeling, but this has been disputed (El Alami et al., 2003). Fig 1.14 
illustrates the proposed mechanism of nuclear InsPs in the transcriptional control. 
 
Arg82p kinase activity might also be required for other transcriptional processes (Chi 
and Crabtree, 2000), for example the activation and repression of both nitrogen-
responsive genes (El Alami et al., 2003) and for chromatin remodelling within the 
PHO5 promotor (Steger et al., 2003).  
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Fig 1.14: Nuclear inositol phosphates control transcription and mRNA export  
(Chi and Crabtree, 2000) 
 
Arginine (Arg) either induces or represses genes involved in its metabolism. Inositol signaling is 
required for induction of genes whose proteins catabolise arginine. InsP4 is likely to function in the 
binding of the ArgR-MCM1 transcription complex to gene promoters, or transcription initiation, or 
mRNA elongation. InsP6 localized at the nuclear pore, contributes to the export of mRNA. 
 
1.9.2.2 Ipk1p and InsP6 
The Arg82p(Ipk2p)/IPMK and Ipk1p route appears to be the major route to InsP6 in 
all eukaryotes (York, 2006). 
 
InsP6 has been implicated in the regulation of diverse cellular events. It is found 
localised at the nuclear pore, where it is required for efficient export of mRNA in both 
yeast and mammalian cells (Feng et al., 2001; Saiardi et al., 2000a; York et al., 1999). 
However, where InsP6 is produced does not seem that important: a plasma membrane-
localised mutant of Ipk1p has no growth defect, showing that cytoplasmic production 
of InsP6 can support mRNA export (Seeds et al., 2007) (see also section 1.10.3) 
 
Other proposed roles for InsP6 include directly interacting with synaptotagmin, a 
Ca2+-sensitive vesicle protein that regulates endo- and exocytosis (Fleischer et al., 
1994; Norris et al., 1995; Voglmaier et al., 1992), synaptic vesicle trafficking (Llinas 
et al., 1994; Niinobe et al., 1994; Schiavo et al., 1995), and receptor desensitization 
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(Palczewski et al., 1991). InsP6 production is required for the asymmetric Ca2+ flux 
during left-right heart specification (Sarmah et al., 2005). It may also play a role as an 
antioxidant through binding of Fe3+(Graf et al., 1987) and as a phosphate store, 
especially in plants (Morton and Raison, 1963).  
 
InsP6 was found bound to the Ku70/80 subunits of DNA-PK, the DNA-dependent 
protein kinase involved in DNA repair, when this enzyme was crystallized, but the 
yeast homologue of Ku70/80, yKu70/80, does not bind InsP6 (Hanakahi and West, 
2002). 
 
1.9.2.3 Kcs1p, Vip1p and inositol pyrophosphates 
S. cerevisiae has two inositol pyrophosphate synthases, Kcs1p and Vip1p. Kcs1p, the 
predominant InsP6 kinase capable of generating PP-InsP5, was discovered as a 
second-site suppressor of protein kinase C mutants (Huang and Symington, 1995; 
Saiardi et al., 1999). Kcs1p can also phosphorylate other InsPs to produce the 
pyrophosphates including PP-InsP4, PP-InsP5, (PP)2-InsP3 and (PP)2-InsP4 (Luo et 
al., 2002; Saiardi et al., 2000a; Saiardi et al., 2002; Seeds et al., 2005; York et al., 
2005), and it also phosphorylates Ins(1,4,5)P3 at the D3 position (Dubois et al., 2002; 
Seeds et al., 2005). Vip1p, the second inositol pyrophosphate synthase can synthesise 
several other pyrophosphorylated InsPs (PP-InsP4, PP-InsP5 and (PP)2-InsP4 ) (Seeds 
et al., 2005; York et al., 2005). 
 
Inositol pyrophosphates seem to be involved in diverse cellular processes, including 
endocytic trafficking (Saiardi et al., 2002), DNA recombination (Luo et al., 2002), 
vacuole morphogenesis (Saiardi et al., 2000), cell wall integrity and resistance to salt 
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stress (Dubois et al., 2002). They also seem to be essential for the expression of genes 
regulated by the quality of the nitrogen source and of phosphate-responsive genes (El 
Alami et al., 2003). How they are involved in these processes remain ill-defined. 
 
Recently, Kcs1p and its product PP-InsP4 have been shown to be necessary for 
telomere maintenance and DNA repair: Mutants of PLC1, ARG82 or KCS1 
lengthened telomere and increased levels of PP-InsP4 result in shortened telomeres as 
compared with the wild-type cells, implicating PP-InsP4 as a negative regulator of 
telomere length (York et al., 2005). How inositol pyrophosphatess regulate telomere 
length is not known, but, the PPIn 3-kinase-related protein kinase Tel1p may be 
involved (Saiardi et al., 2005). 
 
Another important finding was that InsP7 (5-PP-InsP5) phosphorylates proteins non-
enzymatically (Saiardi et al., 2004). InsP7 only phosphorylates proteins that have been 
already phosphorylated on serine residues by ATP-dependant kinases, and this 
phosphorylation forms pyrophosphorylated serine residues (Bhandari et al., 2007).  
 
1.10 Functional interactions of the Plc1p pathway with other systems 
Recent studies have implicated Plc1p in a number of other yeast regulatory systems.  
 
1.10.1 Involvement of Plc1p with nutrient modulation of growth 
Nitrogen sensing 
Plc1p was implicated in a nitrogen-sensing pathway that regulates the modulation of 
pseudohyphal differentiation (Ansari et al., 1999; Toker, 2002). According to 
Schomerus and Kuntzel, re-addition of a nitrogen source (ammonium sulphate) to 
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nitrogen-depleted media provoked a rapid increase in InsP3 and DAG generated from 
PtdIns(4,5)P2 hydrolysis by activated Plc1p in wild-type S. cerevisiae (Schomerus and 
Kuntzel, 1992). In our lab, we found addition of NH4 to nitrogen-starved yeast 
induced the formation of an unidentified InsP4 suggesting that inositol phosphate 
outputs from Plc1p activation can be modulated depending upon cell state (Perera et 
al., 2004). 
 
Another recent genetic study has provided a link between Plc1p and Gpa2p, one of the 
two heterotrimeric G protein α−subunit homologs in yeast and an element of the 
nitrogen sensing machinery that regulates pseudohyphal differentiation by modulating 
cAMP levels (Lorenz and Heitman, 1997). A putative heptahelical receptor, Gpr1p, 
coupled with Gpa2p, regulates cAMP synthesis and the protein kinase A (PKA) 
activity to control filamentation and growth (Lu and Hirsch, 2005; Trott et al., 2005).  
 
In the absence of nitrogen, cells lacking Gpr1p, Plc1p, or Gpa2p fail to form 
pseudohyphae. This defect of filamentation in plc1Δ and gpr1Δ strains can be rescued 
by over-expression of Tpk2p, one of the three catalytic subunits of PKA in 
S.cerevisiae, via the cAMP pathway (by the catalytic subunit of cAMP-dependent 
protein kinase), or via the mitogen-activated protein kinase (MAPK) pathway (by 
introduction of STE11-4, a dominant-active allele of STE11 that is a component of 
MAPK pathway).  The cAMP and MAPK pathways converge to regulate 
transcriptional control of FLO11, which encodes a cell surface protein required for 
pseudohyphal formation (Rupp et al., 1999). 
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Gpr1p acts mainly through the cAMP pathway involving Gpa2p. Physical association 
of Plc1p with Gpr1p was observed by two-hybrid and co-immunoprecipitation. This 
association is independent of Gpa2p, whereas Plc1p is required for Gpr1p/Gpa2p 
association (Ansari et al., 1999). It appears that the MAPK pathway is also dependent 
on Plc1p regardless of the presence of Gpr1p, based on analysis of transcriptional 
regulation of filamentation (Ansari et al., 1999).  
 
The genetic and physical interactions between Plc1p, Gpr1p and Gpa2p suggest 
Gpr1p and Gpa2p act in concert with Plc1p, but in parallel to the small G-protein 
Ras2p, since Ras2p suppresses gpr1Δ and gpa2Δ phenotypes yet fails to rescue PLC1 
null mutants (Ansari et al., 1999). Also, plc1Δgpa2Δ and plc1Δgpr1Δ double mutants 
grow as well as the plc1Δ single mutant, while the plc1Δras2Δ mutant displays a 
strong synthetic growth defect (Demczuk et al., 2008). Therefore, Gpr1p interacts 
with Plc1p during the pseudohyphal formation through Gpa2p, in a Ras-independent, 
cAMP-dependent pathway (Demczuk et al., 2008). 
 
The mechanism by which Plc1p regulates these interactions is unknown. As indicated 
above, Plc1p probably acts upstream of Gpa2p, possibly by hydrolysing PtdIns(4,5)P2 
locally and exposing a binding site for Gpa2p in the carboxy-terminal region of Gpr1p 
(Toker, 2002). However, since Arg82p and synthesis of InsPs are required for normal 
PKA signalling, this simple explanation seems unlikely. Indeed arg82Δ cells display 
increased transcription of Msn2p-dependent stress-responsive genes which indicates a 
decreased activity of PKA in these mutants. Thus it is not clear whether it’s the 
catalytic activity of Plc1p that is required in the regulation of cAMP synthesis and 
 41
PKA signalling or if Plc1p only serves as a scaffold protein that is essential for the 
Gpr1p-Gpa2p interaction (Demczuk et al., 2008). 
 
Phosphate accumulation 
In S. cerevisiae, the PHO pathway regulates several phosphate-responsive genes, 
including PHO5, which encodes repressible acid phosphatase. A cyclin-dependent 
kinase inhibitor (Pho81p) regulates the kinase activity of the cyclin-cyclin-dependent 
kinase complex Pho80p-Pho85p (Kaffman et al., 1994). Pho81p forms a stable 
complex with Pho80p-Pho85p regardless of the cellular phosphate level, but inhibits 
the kinase activity of Pho85p only under low phosphate conditions. The Pho80p-
Pho85p complex regulates PHO5 expression by controlling the activity and 
localisation of the transcription factor Pho4p through phosphorylation in response to 
intracellular phosphate levels (Kaffman et al., 1994; Kaffman et al., 1998; Ogawa et 
al., 1995; Schneider et al., 1994).  
 
plc1Δ, arg82Δ and kcs1Δ cells have significantly reduced intracellular polyphosphate 
levels and PHO5 is constitutively expressed in these mutants, suggesting that the 
inositol pyrophospate products of these enzymes are required for polyphosphate 
accumulation (Auesukaree et al., 2005). 
 
Recently work by the York and O’Shea labs has highlighted the role of the InsP6 
kinase Vip1p in the regulation of phosphate homeostasis. Vip1p pyrophosphorylates 
InsP6 at the 4- or 6- position and the resulting 4/6-[PP]-InsP5 modifies the interactions 
between Pho81p and Pho80p-Pho85p: elevated levels of 4/6-[PP]-InsP5 appear to 
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inhibit Pho85p kinase activity, but 5-[PP]-InsP5 does not have this effect (Lee et al., 
2008; Lee et al., 2007). 
 
1.10.2 Role(s) of Plc1p in stress responses 
Yeast cells lacking PLC1 display defects in their responses to various stresses. Plc1p 
contributes to the regulation of approximately 2% of yeast genes in cells grown in rich 
medium. Most of these genes are required under limited nutrient or stressed 
environment and are derepressed in plc1Δ cells (Demczuk et al., 2008). 
 
Plc1p participates in stress responses via regulating the transcription of Msn2p-
dependent genes. Msn2p is a zinc finger transcription factor that plays an important 
role in transcriptional responses to starvation and other forms of environmental stress 
(Estruch, 2000; Estruch and Carlson, 1993; Martinez-Pastor et al., 1996). PKA, which 
is Plc1p-regulated (see earlier), negatively regulates transcription of Msn2p-dependent 
genes by phosphorylating Msn2p, preventing its nuclear translocation (Beck and Hall, 
1999; Chi et al., 2001; Gorner et al., 1998; Gorner et al., 2002) or its binding to the 
STRE elements in the promoters of stress-responsive genes (Hirata et al., 2003).  
 
Osmotic stress 
In S. cerevisiae, two protein kinase pathways are known to regulate the response to 
osmolarity changes in the media: the high osmolarity glycerol (HOG) response 
pathway (Hohmann, 2002) and the protein kinase C (Pkc1p) pathway (Gustin et al., 
1998). There is no convincing evidence for a link between Plc1p and either of these 
pathways, despite the fact that Pkc1p is a homolog of mammalian protein kinase Cs. 
However, several sequence differences between the C1 domains of Pkc1p and of 
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classical PKCs make Pkc1p unresponsive to DAG and Pkc1p also fails to respond to 
Ca2+(Watanabe et al., 1994). 
 
However, PLC1 mutants are osmosensitive, so Plc1p has some roles in maintaining 
osmotic homeostasis (Flick and Thorner, 1993). Plc1p is required for expression of 
the osmo-inducible GPD1 gene and for intracellular accumulation of glycerol but its 
effect is much less important than the role played by Hog1p (Lin et al., 2002). A strain 
with both PLC1 and HOG1 deleted expressed lower levels of a GPD1-lacZ fusion and 
synthesized less glycerol than strains with either single deletion (Lin et al., 2002). 
 
Plc1p has also been reported to interact physically with Sgd1p (Lin et al., 2002), a 
nuclear protein which is known as a suppressor of the osmo-sensitivity. SGD1 is an 
essential gene which was initially isolated by complementation of the osmo-sensitive 
and glycerol-defective phenotype of the S. cerevisiae hog1 mutant (Akhtar et al., 
2000). SGD1 displays genetic interactions with HOG1 -- overexpression of Sgd1p 
suppresses the osmo-sensitivity of hog1Δ and pbs2Δ strains. Thus, Sgd1p probably 
operates downstream of Hog1p. It is still not clear how the association of Plc1p with 
Sgd1p could affect Sgd1p during stress responses, and it is speculated that it has 
something to do with Plc1p’s function in kinetochore activity. Sgd1p could serve as 
the targeting component when Plc1p localises to specific chromosomal loci and 
modifies chromatin structure at these loci (Lin et al., 2000). 
 
Another clue to the role of Plc1p in osmo-regulation comes from the fact that deleting 
PHO81 or SPL2, another inhibitor of Pho85p activity, allows plc1Δ mutants to grow 
in high salt media (Flick and Thorner, 1998), suggesting that one of the roles of Plc1p 
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during growth in high salt conditions is to activate Pho85p, probably through InsPs 
and PP-InsPs (Lee et al., 2008; Steger et al., 2003).  
 
Growth at high temperature 
The PLC1 promoter region contains a consensus element for binding of heat shock 
transcription factor and growth of plc1Δ cells ceases at elevated temperatures (37ºC or 
above)(Flick and Thorner, 1993). Hence, survival of yeast cells at higher temperatures 
may require increased expression of PLC1 by heat shock induction (Flick and 
Thorner, 1993). Our lab has observed that yeast cells produce increased amounts of 
inositol phosphates, particularly InsP6, in a Plc1p dependent manner when they are 
grown at elevated temperatures (NM Perera and SK Dove 2002, pers. comm.): The 
reason for this is unknown but levels of InsP6 can increase almost 10-fold over basal 
when cells are grown at 37ºC.  
 
Plc1p is also associated with regulation of Ume3p, a cyclin-type protein. When yeast 
cells are stressed in a variety of ways, they respond by inducing several highly 
conserved gene families that express cytoprotective heat shock proteins (Craig et al., 
1993). Ume3p represses the transcription of the HSP70 family member SSA1. 
Downregulation of this cyclin is part of the normal cellular response to stress: Ume3p 
is rapidly destroyed when cells are exposed to elevated temperatures to relieve 
repression of SSA1 (Cooper et al., 1997; Cooper et al., 1999). An UME3 null allele 
also suppresses the hypersensitivity of PLC1 mutant at elevated temperature (Cooper 
et al., 1999). These results indicate that the growth defects observed in PLC1 mutants 
under heat stress could be due to a failure to downregulate Ume3p.  
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1.10.3 Plc1p and the inositol phosphates it generates are needed for mRNA 
export from the nucleus 
Eukaryotic mRNA undergoes a series of molecular events, including transcription, 
processing, export, translation and degradation. A key step is mRNA export from the 
nucleus, the outward translocation of mRNA-protein complex (mRNPs) complexes 
through nuclear pore complexes (NPCs). Functional connections between mRNA 
export and translation have been suggested (Culjkovic et al., 2006; Gross et al., 2007; 
Jin et al., 2003; Rosenwald et al., 1995), but these molecular mechanisms are less 
well defined.  
 
GLE1 encodes Gle1p, a cytoplasmically-oriented nuclear-pore complex associated 
factor (York et al., 1999). It is an essential mRNA export protein that is conserved 
from yeast to human cells (Murphy and Wente, 1996; Watkins et al., 1998). InsP6 
generated via sequential phosphorylation by the inositol phosphate kinases Arg82p 
and Ipk1p is required to support mRNA export: Plc1p was discovered to be involved 
in modulating the nuclear export of mRNA via the Gle1p-dependent β-exportin 
pathway when it was found that plc1Δ, arg82Δ and ipk1Δ but not kcs1Δ cells have a 
defect in mRNA export (York et al., 1999). Deletions of all these genes are 
synthetically lethal with a conditional allele of GLE1 or various mRNA export factors 
(Weirich et al., 2006; York et al., 1999).  
 
InsP6 is directly required for mRNA export and the export function of Gle1p is 
dependent on InsP6 (Bolger et al., 2008).  InsP6 directly binds to Gle1p (Weirich et al., 
2006) and they act together to stimulate the RNA-dependent ATPase activity of the 
DEAD-box protein Dbp5p (Alcazar-Roman et al., 2006). Dbp5p is essential for 
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mRNA export: It is recruited to the cytoplasmic fibrils of the NPC via interaction with 
the nucleoporins CAN/Nup159p and participates in the export of mRNAs out of the 
nucleus (Schmitt et al., 1999).  
 
Ins(1,3,4,5,6)P5 can also activate Dbp5p and hence can partially compensate for loss 
of InsP6 in vitro but is less efficient and requires a much higher concentrations of 
Ins(1,3,4,5,6)P5 for this process to proceed at a normal rate (Weirich et al., 2006). 
Cells devoid of Plc1p or Arg82p normally display more severe phenotypes than those 
lacking the Ins(1,3,4,5,6)P5-kinase Ipk1p, probably because ipk1Δ cells accumulate 
significantly increased levels of the direct InsP6-precursor, Ins(1,3,4,5,6)P5 and 
possibly also because Kcs1p can phosphorylate Ins(1,3,4,5,6)P5 to produce PP-InsP4 
(Weirich et al., 2006). 
 
There is also evidence that InsP6-dependent mRNA export might be a feature of 
mammalian cells: when the InsP6 levels in tissue culture cells were suppressed by 
expressing SopB, a Salmonella Dublin virulence factor that is relatively unspecific 
inositol polyphosphate phosphatase, mRNA accumulates in the nucleus (Feng et al., 
2001). 
 
Since mRNA export is a fundamental cellular process, a number of the plc1Δ 
phenotypes may be secondary consequences of this central defect.  
 
One recent study has expanded the functions of InsP6 to now include translation 
termination in S. cerevisiae, showing that Gle1p functions in termination via an InsP6-
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dependent activation of Dbp5 but InsP6 is not involved in the initiation (Bolger et al., 
2008). 
 
1.11 Nuclear inositide signalling 
Recent evidence has suggested the existence of nuclear specific pathways of inositide 
metabolism, though understanding of these processes remains incomplete (Irvine, 
2003). One stumbling block to widespread acceptance of nuclear inositide signalling 
is the fact that most researchers cannot agree on whether the nucleus and the 
cytoplasm are insulated from one to another so that inositol phosphates generated in 
one compartment would not diffuse into the other compartment through nuclear pores. 
One important milestone in showing that inositol phosphates could be spatially 
restricted was a study that showed that many phosphorylated molecules, including 
higher inositol phosphates, are unable to pass through the pores of dialysis tubing, 
even when the molecular weight cutoff of the pores is 50 kD (Van der Kaay and Van 
Haastert, 1995). The explanation for this observation is still lacking but is thought to 
be a consequence of the high charge density and ordering of water into a hydration 
shell around these molecules. In any case, the 50 kD pore in these membranes is much 
larger than the 30 kD cutoff that characterises the nuclear pore complex (Van der 
Kaay and Van Haastert, 1995). 
 
Whatever the details, much of the machinery for inositide signaling is present in the 
nucleus. Nuclear localisation has been observed for several PLCs, including PLC-β1 
and PLC-δ4, in animal cells (D'Santos et al., 1998; Divecha et al., 1997; Liu et al., 
1996; Martelli et al., 1992). In some cases, there are data that demonstrate that these 
enzymes are performing a real signaling function: insulin-like growth factor I (IGF-I) 
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activates nuclear PLC-β1 and causes changes in nuclear phosphoinositides in Swiss 
3T3 cells. IGF-1 activates only the nuclear pool of this enzyme and only nuclear 
PtdIns(4,5)P2 is attacked during signaling. This process is both necessary and 
sufficient to drive IGF-1-induced cell division (Manzoli et al., 1997). Exactly how 
extracellular stimuli such as IGF-1 elicit selective nuclear inositide turnover is still 
obscure.  
 
One surprising finding is that nuclear PtdIns(4,5)P2 is present not only in the nuclear 
membrane, but also in ill-defined non-membranous complexes with protein that are 
completely resistant to extraction with detergents (Yagisawa et al., 2002). Some 
researchers have suggested that PtdIns(4,5)P2 is bound to chromatin covalently, but 
how this could occur and why are not well understood (Yagisawa et al., 2002). 
 
The outcomes of nuclear inositide signalling are equally ill-defined. InsP3 receptors 
have been found localised to the inner nuclear membrane and could mediate nuclear 
calcium release (Gerasimenko and Gerasimenko, 2004). However, the above studies 
were all done at a time when the phosphorylation of InsP3 was not well understood 
and hence it is possible that ‘higher’ inositol phosphates are involved. Indeed, since 
many of the known functions of InsP6, InsP7 and InsP8 are nuclear, it is tempting to 
speculate that they mediate at least some of the effects of agonists, like IGF-1, on cell 
physiology. 
 
1.12 Nucleo-cytoplasmic shuttling of PLCs 
Most of the PLCs that have been observed in the nucleus, do not permanently reside 
there, at least in animal cells: they undergo some form of nucleo-cytoplasmic shuttling 
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(Faenza et al., 2005; Topham and Prescott, 2002; Yagisawa, 2006). Some enzymes 
that have traditionally been regarded as exclusively cytoplasmic have recently been 
found to maintain their steady-state localisation as a result of dynamic shuttling. PLC-
δ1 once thought of as a plasma membrane-localised enzyme in intact mammalian 
cells, is now known to be distributed between cytoplasm, nucleus and plasma 
membrane (Yagisawa et al., 2002). PLC-δ1 enters the nucleus upon stimulation and 
undergoes continuous nuclear/cytoplasmic shuttling even under unstimulated 
conditions (Diakonova et al., 1997; Yagisawa et al., 2002). Its translocation is also 
linked with cell cycle progression as it shifts localization to the nucleus at certain 
stages (Okada et al., 2002; Yagisawa et al., 2006).  
 
1.12.1 Nuclear export and import of PLCs 
Once we concede that PLCs can show dynamic localisation behaviour, it becomes 
important to know how nucleo-cytoplasmic shuttling of PLCs is regulated. It was 
originally suggested that nascent PLC enzymes, newly translated from RNA in the 
cytoplasm, depend on some extracellular stimuli or cell cycle-dependent signal to get 
imported into the nucleus (Yagisawa et al., 2006). In general, molecules as large as 
PLCs cannot freely diffuse through the nuclear pore complex, and so rely on nuclear 
localization signals (NLS) and nuclear export signals (NES) to enter and leave this 
compartment. The intracellular distribution of a given protein is the result of the 
balance of the strength of these two signals (Yagisawa et al., 2006).  
 
Fig 1.15 illustrates a schematic representation for conventional nucleo-cytoplasmic 
shuttling. Briefly, binding of cargo protein to an adaptor called importin-α occurs via 
the NLS in the cargo, and this initiates the association with the carrier protein, 
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importin-β. This trimer can be recognized by the nuclear pore complex (NPC) and 
transported into the nucleus. Once in the nucleus, the complex dissociates, and the 
importins are transported back to the cytoplasm by a small G protein, Ran. For export, 
the cargo protein must bind to CRM1 (known as Crm1p or Xpo1p in S. cerevisiae), an 
exportin-1, through its NES and is then transported out of the nucleus. Leptomycin B, 
a specific inhibitor of Crm1p forms a covalent bond with CRM1 and blocks nuclear 
export, resulting in the accumulation of cargo proteins in the nucleus (Yoneda, 2000). 
 
 
Fig1.15: Nuclear import and export machineries (Yoneda, 2000)  
 
 
 
 
The first observation that suggested the presence of a functional NES in any PLC was 
an experiment in which Leptomycin B was used to treat MDCK cells expressing a 
GFP-tagged PLC-δ1. The PLC accumulated in the nuclei of these cells, indicating 
nucleo-cytoplasmic shuttling of this enzyme and export via CRM1 (Kudo et al., 1998; 
Yoshida et al., 1990). 
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The canonical NES consensus sequence is a short leucine-rich motif. In mammalian 
PLC-δ1, amino acid residues 164-177 of the EF-hand domain perform this function 
(Yamaga et al., 1999). There is an NES sequence in this region in the following 
enzymes: PLC-β1, -δ3, -γ1, -ε , -ζ (Yamaga et al., 1999). The observed sequence 
variation probably reflects the differing strength of the NES in various isoforms (Fig 
1.16). 
 
Fig 1.16: The putative NES sequence of PLC-δ1 and canonical NES sequences 
(Yamaga et al., 1999) 
 
 
 
Schematic representation of PLC-δ type NES sequences in the EF-hand domain. The numbers above 
the structure refer to the amino-acids in rat PLC-δ1. The NES sequences of mitogen-activated protein 
kinase kinase (MAPKK), protein kinase inhibitor (PKI) and Rev are also aligned as typical leucine-rich 
NES sequences. “X” denotes any amino acid, and important hydrophobic residues in the sequences are 
boxed. Note, the bovine PLC-δ2 is actually a homolog of human and mouse PLC-δ4. 
 
Nuclear import is mediated by NLS sequences. They serve as the docking sites to bind 
to the carrier proteins for nuclear import. The necessary sequence elements for a 
functional NLS are less well defined than for the NES. They are usually short 
stretches of 5-10 basic amino acids, but some of the sequences that confer NLS 
function, particularly in viral proteins, have no obvious similarity to the suggested 
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canonical consensus. 
 
For most animal PLCs, the functional NLS sequence is in the vicinity of the XY-linker 
(Yagisawa et al., 2006). Fig 1.17 shows NLS sequences from a number of PLC 
isoforms from different species - but note that the sequences from non-animal species 
have not been tested as being functional. S. cerevisiae Plc1p has such a NLS 
consensus sequence in its X-Y linker, but deletion of this motif has no effect on the 
localisation of this protein (SK Dove 2005, pers. comm.).  
 
Fig 1.17: Sequence resembling classical NLS in the X domain and in the XY-linker 
region of the PLC isoforms (Okada et al., 2002) 
 
 
Sequence alignment of the C-terminus of the X domain and XY-linker in various PLCs. A schematic 
structure of PLC-δ1 with the sequence resembling a classical NLS in this region is shown. The NLS 
sequence of nucleoplasmin is aligned as a typical bipartite NLS sequence.  
 
In PLC-δ1 two lysine residues (K432 and K434) are critical for the import signal but 
local secondary structure was also important for NLS function (Okada et al., 2002).  
 
In addition, Corbett’s group recently concluded that a ‘classic’ monopartite NLS was 
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formed by a loose consensus sequence of K(K/R)X(K/R) requiring a lysine in the 
position 1, followed by 2 basic residues at postion 2 and 4(Leung et al., 2003). 
 
1.12.2 Signals that trigger PLCs to translocate 
The steady-state localisation of a dynamically shuttling PLC depends upon the 
relative activities of the import and export machineries, so a shift in the equilibrium of 
the strengths of these two signals will cause a change in localisation. Many factors are 
now known to regulate this equilibrium, including receptor activation, stresses, and 
cell cycle progression (Yagisawa et al., 2006).  
 
PLC-δ1 accumulates in nuclei at the G1/S phase boundary in NIH-3T3 cells 
(Yagisawa et al., 2006), and nuclear translocation of PLC-ζ occurs during early 
embryonic development of mice (Larman et al., 2004; Sone et al., 2005). Both growth 
factor receptor activation (Bertagnolo et al., 1995) and cell cycle progression (Faenza 
et al., 2000) can cause PLC-β1 to relocate to the nucleus and this shift is critical for 
erythroid cell survival and differentiation (Faenza et al., 2002). Also, changes in a 
cell’s PtdIns(4,5)P2 complement can affect PLC-δ1 localisation (Yagisawa et al., 
2006). However, the mechanisms mediating these localisation shifts are poorly 
understood. 
 
An increase in intracellular Ca2+ also seems to be important for nuclear localization: 
mechanisms that increase Ca2+ seem to facilitate PLC-δ1 import and impede its export 
(Okada et al., 2005). Three possible explanations of how Ca2+ might regulate the 
localization of PLC-δ1 are illustrated in Fig 1.18 (Okada et al., 2005).  
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Fig 1.18: Possible mechanisms for the Ca2+-dependent regulation of nuclear 
transport of PLC-δ1 (Yagisawa, 2006) 
 
 
             
 
The proposed mechanisms by which Ca2+ might regulate PLC-δ1 translocation: A. altering the structure 
of the NPC; B. down-regulating the formation of nuclear export complex; C. enhancing the formation 
of import carrier complex by changing the structure of PLC-δ1 and/or increasing availability of PLC-δ1 
in the cytoplasm by dissociation of PLC-δ1 from the plasma membrane.
A. 
B. 
      un
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1.13 Aim of this work 
In contrast to PLC-β and PLC-γ, the regulation of PLC-δs is still largely a mystery. 
This is particularly frustrating because PLC-δs are the only PLCs in fungi, plants, and 
often non-animal eukaryotes, and are likely to perform an ancient and important 
function(s).   
 
The budding yeast S. cerevisiae encodes a single PLC gene, Plc1p, which is an 
orthologue of mammalian PLC-δ. Plc1p generates InsP3 in response to stress, but the 
yeast genome encodes no InsP3 receptor. This suggests that the functions of PLC-δs 
are mediated in a novel fashion, probably involving ‘higher’ inositol phosphates 
(InsPs) and pyrophosphorylated inositol phosphates (PP-InsPs) that are generated 
from InsP3 by inositol polyphosphate kinases.  
 
Deleting or disrupting any of these genes in yeast results in defective InsPs/PP-InsPs 
synthesis. Accordingly, mutants in any of the genes encoding these proteins share a 
number of common defects. Yeast is therefore a powerful model in studying the InsPs 
and PP-InsPs derived from the PLC signalling pathway.  
 
The aim of this work is to understand how yeast PLC-δ localisation is regulated, in 
order to gain insight into its function. Plc1p is present in both nucleus and cytoplasm 
in normal growing cells. I take advantage of its nuclear export signals (NES) and 
nuclear localization signals (NLS) to manipulate Plc1p’s intracellular distribution by 
creating mutants that are restricted to nuclear or cytoplasmic compartments. The 
overall aim was to investigate which defects of plc1Δ cells would persist in yeast 
expressing Plc1p mutants restricted to only one compartment. I reasoned that this 
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would allow us to see if any of these mutants would only rescue subsets of the many 
stress-related phenotypes that are characteristic of cells lacking Plc1p, and so help us 
understand whether distinct pools of phosphoinositide signals might function 
independently in each of the two compartments. 
 
I also focussed on the regulation of Plc1p by endogenous inositides and by possible 
interactions with other proteins. Mammalian PLC-δ1 is known to interact with InsP3 
through its PH domain. I looked into the interaction of the yeast PLC-δ with the 
inositol phosphates it derives. This probably works as a feedback signal in PLC 
activation, and highlights the fact that PLCs can be regulated by the products of their 
own catalytic activity.  
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Chapter 2    Materials and Methods 
 
2.1 Strains, Plasmids, Media and Reagents  
Wild type S. cerevisiae FY833 was purchased from ATCC (Manassas, USA). BY4742 
and some deletion strains bearing KANMX4 deletion cassettes were purchased from 
EUROSCARF (Germany). The remaining deletion strains were either from the Dove 
lab yeast strain collection or else were made in this study. S. cerevisiae strains were 
grown in standard Yeast extract-Peptone-Dextrose (YPD) or Synthetic Complete (SC) 
minimal media supplemented with essential amino acids. The budding yeast strains 
used in this study are listed in Table 2.1. 
 
E.coli TOP10 competent cells were used for all sub-cloning and were made competent 
as described below. BL21-star (DE3)-RIL cells were obtained from the Dove lab 
E.coli strain collection and were used to express GST (glutathione-S-transferase)-
Plc1p fusion proteins. E.coli strains were propagated in LB broth or LB plates 
(containing appropriate antibiotics for plasmid retention) following routine 
manipulation. 
 
Plasmid pUG36 and pUG34 were gifts from Dr. J. H. Hegemann (Institut für 
Mikrobiologie, Germany). Plasmid pGEX-6P-K-1 was obtained from Dr Dove who 
modified the commercially available vector pGEX-6P-1 (G.E Biotech) by inserting 
sequences that encode a protein kinase A phosphorylation consensus motif between 
the GST and the protein of interest. pUR34NLS was a gift from Dr. F. Rodrigues 
(Universidade do Minho, Portugal). pGEM-T Easy Vector System was purchased 
from Promega (Promega#A1360). pYcPlac111 was obtained from ATCC (#87587, 
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Table 2.1: S. cerevisiae strains used in this study 
Strain Genotype Source 
BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Euroscarf 
BY4742 plc1Δ MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 plc1::kanMX4 Euroscarf 
BY4742 arg82Δ MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 arg82::kanMX4 Euroscarf 
BY4742 arg82Δplc1Δ MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 arg82::kanMX4 plc1::HIS3 This study 
BY4742 ipk1Δ MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 ipk1::kanMX4 Euroscarf 
BY4742 kcs1Δ MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 kcs1::kanMX4 Euroscarf 
BY4742 vip1Δ MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 vip1::kanMX4 Euroscarf 
BY4742 kcs1Δvip1Δ MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 kcs1::kanMX4 vip1::LEU2 Dove lab 
BY4742 arg82Δvps41Δ MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 arg82::kanMX4 vps41::HIS3 This study 
FY833 MATa ade2 his3 leu2 trp1 ura3  Euroscarf 
FY833 (PLC1-3HA) MATa ade2 his3 leu2 trp1 ura3 plc1::PLC1-3xHA-His3 This study 
FY833 (PLC1-3HA; ARG82-9Myc ) MATa ade2 his3 leu2 trp1 ura3 plc1::PLC1-3xHA-His3 arg82::ARG82-9xMyc-Trp1 This study 
FY833 (PLC1-GFP; ARG82-9Myc ) MATa ade2 his3 leu2 trp1 ura3 arg82::ARG82-9xMyc-Trp1 [pUG36-PLC1] This study 
KWY120 MATα xpo1::LEU2 ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 [pKW440-XPO1-HIS3]  Dove lab  
KWY121 MATα xpo1::LEU2 ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 [pKW457-xpo1-1-HIS3] Dove lab  
BY4742 gpr1Δ MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 gpr1::LEU2 This study 
BY4742 gpr1Δarg82Δ MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 arg82::kanMX4 gpr1::LEU2 This study 
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Manassas, USA). pFA6a-His3MX6 was obtained from Dr Bill Parrish (UCSD, 
California). 
 
Plasmid pUG34 used in this study is a low copy centromeric yeast expression vector 
and was modified by Dr. Hegemann so that GFP is expressed as a C-terminal fusion 
to any gene cloned into the multiple cloning site (Niedenthal et al., 1996).  
 
Plasmid pUG36 (YCp, URA3, PMET25-yEGFP3-MCS-TCYC1 (Niedenthal et al., 1996) 
was used as the vector to express green fluorescent protein (GFP) fusion proteins (Fig 
2.1). Proper cloning of an insert into the multiple cloning sites (MCS) of pUG36 
allows the expression of yEGFP N-terminal fusion proteins under the control of 
methionine-regulated MET25 promoter(Mumberg et al., 1994). Plasmids pUG36-
PLC1, pUG36-CAAX and pUG36-ARG82 were obtained from the Dove lab plasmid 
collection. PCR products encoding PLC1 or ARG82 were cloned into the BamHI-
HindIII sites of pUG36. 
 
Media for growth of yeast strains: yeast extract, bacto-peptone, bacto-agar, bacto-
tryptone, yeast nitrogen base without amino acids or ammonium sulphate were from 
Difco Laboratories (Detroit, MI).  
 
2-O-Butyryl-Ins(1,3,4,5,6)P5/PM, Membrane permeant Ins(1,3,4,5,6)P5 was from 
Echelon (#Q-M1396).   
 
All other biochemical reagents were from Sigma-Aldrich (St. Louis, MI) except as 
indicated, and were of Biotechnological grade or better. U73122 (#U6756) and its  
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Fig 2.1: pUG36 map 
 
 
 
 
 
inactive analog U73433 (#U6881) were purchased from Sigma. 
 
2.2 Media composition and solutions 
All media were autoclaved for 15 mins at 121°C, cooled and glucose was then added 
to a final concentration of 2% (from a 40% w/v stock) prior to use. 
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Yeast extract Peptone Dextrose (YPD) (1L): 
Glucose (2.0% w:v), Bactopeptone (2.0% w:v), Yeast extract (1.0% w:v), Adenine 
(100 mg), Uracil (100 mg) 
 
Yeast extract Tryptone Dextrose (YTD) (1L): 
Glucose (2.0% w:v), Bacto-tryptone (2.0% w:v), Yeast extract (1.0% w:v), Adenine 
(100 mg), Uracil (100 mg). 
 
Luria Broth (LB) (1L): 
Tryptone (1.0% w:v), Yeast Extract (0.5% w:v), NaCl (1.0% w:v)  
 
LB + 100 μg/ml Ampicillin (1L): 
LB, Ampicillin (100 μg/ml) 
 
LB + 100 μg/ml Ampicillin + 50 μgml-1 Chloramphenicol (1L): 
LB, Ampicillin (100 μg/ml), Chloramphenicol (50 μg/ml) 
 
To prepare agar plates for YPD, YTD or LB media, Bacto agar (2.0% w:v) was added 
before autoclaving. Media was cooled to 50ºC and then glucose and/or antibiotics or 
salt were added.  
 
Amino acid (AA) mix stock: 
Adenine (2 g), Arginine (2 g), Tyrosine (30 mg), Isoleucine (2g), Phenylalanine (2.06 
g), Glutamic acid (2 g), Aspartic acid (2 g), Valine (2 g), Threonine (2 g), Serine (2 g), 
Glycine (2 g), Proline (2 g), Alanine (2 g). Powder was milled in the IKA for 1 minute 
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and then stored at 4°C. 
 
Synthetic Complete (SC) (1L): 
Glucose (2.0% w:v), Yeast Nitrogen Base without Amino Acids & Ammonium  
 
Sulfate (1.7 g), Ammonium Sulfate (3 g), Glutamine (100 mg), AA mix stock (1g), 
100 mg leucine, lysine, tryptophan, histidine, methionine, uracil; pH 5.7 
 
For selective SC medium, the corresponding amino acid was omitted. For example, to 
make SC-Ura, 100mg Uracil was left out.    
 
To prepare agar plates for SC media, the pH of SC was adjusted to 5.7 with 5M 
NaOH prior to the addition of Bacto agar (2.0% w:v). Media was then autoclaved, 
cooled and then glucose was added before use.  
 
SC-Ura+Met (0.2g/L) agar (1L) : 
SC-Ura, Methionine (100mg), Bacto agar (2.0% w:v) 
 
SOC medium (1L): 
Tryptone (2.0% w:v), Yeast Extract (0.5% w:v), NaCl (0.05% w:v), KCl (2.55 mM), 
adjust pH to 7 with NaOH. After autoclaving, sterile solution of MgCl2 (10 μM) and 
Glucose (20 μM) were added. 
 
× 50 Tris-Acetate-EDTA buffer (TAE):  
Tris (2.0 M), Glacial acetic acid (0.94 M), 0.05 M EDTA (pH 8.0) 
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× 6 DNA gel electrophoresis sample buffer:  
Tris.HCl (10 mM), Glycerol (50% v:v), Bromophenol blue (0.2% w:v) 
 
× 5 SDS-PAGE sample buffer: 
Tris.HCl (250 mM, pH 6.8), Glycerol (50% v:v), SDS (10% w:v), Bromophenol blue 
(0.5%, w:v). DTT (100 mM) was added fresh (from a 1M stock) before use.  
 
× 10 SDS-PAGE running buffer: 
Tris-Base(250 mM), Glycine (2.5 M), SDS (1% w:v) 
 
× 10 transferring buffer for Western blotting: 
Tris-Base(250 mM), Glycine (1.87 M)  
 
PBST buffer (Phosphate buffered saline + Tween 20) 
Sterile PBS (8.2 mM Na2HPO4, 1.5 mM KH2PO4, 139 mM NaCl, 3 mM KCl) was 
prepared using PBS tablets (Oxoid) and filter sterilised using a 0.22 μM filter or 
autoclaved.  Tween 20 (0.1%) was added before use.   
 
MES buffer  
MES (10 mM), glucose (2.0% w:v) 
 
TBST buffer (Tris-buffered saline + Tween 20). 
Tris.HCl (50 mM, pH 7.5), NaCl (150 mM). Tween 20 (0.1%) was added before use. 
 
2.3 Polymerase chain reaction (PCR) 
All PCRs were performed with Expand High Fidelity PCR system (Roche) except as 
in indicated, in a TECHNE TC-3000 (Staffordshire, UK) thermal block cycler. Two 
reaction mixes were prepared according to manufacturers instructions as follows: 
Master mix 1: Deoxyribonucleotide mix (200 μM of each dNTP, Bioline#39025), 
upstream primer (300 nM), downstream primer (300 nM), and target DNA were 
mixed in one “master mix” made up to 50 μl  total volume with ice-cold ddH2O. 
Master mix 2: 10x buffer (5 μl) and Expand enzyme (0.75 ul) were made up to 50 μl 
total volume with ddH2O and mixed. 
 
The two master mixes were then thoroughly mixed again. All PCRs were then 
aliquoted into 50 μl reactions, since this was the volume that the thermal cycler 
temperature program was designed to control. The cycling profile was as follows: 
94°C 94°C Tmi-5°C 68°C 94°C Tm-5°C 68°C 68°C 4°C 
4 min 0.5min 1min 2min/1kb 0.5min 1min 2min/1kb 10min 12hrs 
1 cyc 15 cycs 25 cycs 1 cyc 1 cyc 
* Tmi is the Tm with only the initial matching region. 
 
2.4 Site-specific mutagenesis: Splicing by Overlapping Extension PCR (SOE-
PCR) 
The following method was modified from Molecular Cloning: A laboratory manual, 
third edition (Sambrook J & Russell DW, eds), Cold Spring Harbour Laboratory 
Press, Cold Spring Harbour, New York, USA, 2001, Volume 2: 13.36.  
 
Four primers were used to introduce a site-specific mutation by overlap extension. 
The first pair of primers (A & B) was used to amplify the DNA that contained the 
mutation site together with upstream sequences. Of which, Primer A harboured a 
wild-type sequence whereas primer B contained the mutation(s) to be introduced. 
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Similarly, the second pair of primers (C & D) was used to amplify the DNA that 
contained the mutation sites with downstream sequences. Of which, Primer D 
included a wild-type sequence whereas primer C harboured the mutation(s) to be 
introduced.  
 
The two sets of primers were used in two separate amplification reactions to amplify 
over-lapping DNA fragments (fragment AB and CD). The mutation(s) of interest was 
located in the region of overlap and therefore in both sets of resulting amplified 
fragments. The overlapping fragments were mixed, denatured and annealed to 
generate heteroduplexes that could be extended via ‘megapriming’ and, in a third 
PCR, amplified into a full-length DNA using two primers that bound to the extremes 
of the two initial fragments (The overall strategy is sketched in Fig. 2.2).    
 
Figure 2.2: Site-directed Mutagenesis by Overlap Extension 
(Sambrook, 2001) 
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2.5 DNA sequencing 
DNA sequencing was performed by the Functional Genomics and Proteomics Unit, 
University of Birmingham (Birmingham, UK). A reaction mix was prepared for each 
template to be sequenced, as follows: template (100 ~ 500 ng), primer (3.2 pmol), and 
ddH2O were added to total volume of 10μl. The Genomics facility then added a 
Terminator Reaction Mix to each primer/DNA mix so supplied to give a final volume 
of 20μl. The reaction mixes were then amplified via PCR and the resulting chain-
termination reaction resolved using an ABI sequencing device that separated the dye 
labelled fragments by capillary electrophoresis. The sequencing data were then 
analyzed in Chromas (version 1.45). 
 
2.6 Plasmid construction  
All DNA restriction enzymes and T4 DNA ligase were obtained from New England 
Biolabs, Inc (Beverly, MA). Standard molecular biology techniques were used for 
DNA manipulations. PCR products were purified by Qiagen II resin. Plasmids were 
purified by mini/midi/maxi prep kits obtained from Qiagen Ltd. All constructs were 
generated by transforming into E. coli TOP10 competent cells and confirmed by DNA 
sequencing. All oligos were synthesized by Alta Biosciences, University of 
Birmingham, UK and are listed in Table 2.2.  
 
pUG36–PLC11-110 
PLC11-110 was amplified from original pUG36-PLC1 using oligonucleotides pUG36-
SOEA1 and pUG36-SOED3 that incorporated unique BamHI and HindIII restriction 
enzyme sites at the 5’ and 3’ ends respectively. The PCR product was digested with 
BamHI and HindIII, then sub-cloned into BamHI/HindIII-digested pUG36 vector. 
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Table 2.2:  Oligos used in this study 
 
Name  Sequence (5’ to 3’) 
pUG36-SOEA1 GTGTGTGTGTCTTGTTACCAGACAACCATTACTTAT 
pUG36-SOEA2  TTTTTTTTGGATCCATGGAAAGCATACTTTTGCCTG 
pUG36-SOED1 GTTTGTTTTTGTTTGATTAAGTTGGGTAACGCCAGG 
pUG36-SOED2  TTTTGGAAGCTTTCATTGCTCATGCTGCTCTGTAAT 
pUG36-SOED3 TTTTTGAAGCTTCTATTGCAATACGCGACATAGCGT 
PLC1-330Top TTTGGATCCAGAGGAATCAGGATGATTAGGATG 
PLC1-1000Top TTTTTGGATCCAGCAGCATGAGCAAGTGGATC 
PLC1Trunc1 GTTTTAAGCTTTCACAGGCAAAAGTATGCTTTCCAT 
PLC1_NES_f                          AACAAAGCTAAAGCGGCTCACGTAGTTGCTTTGAAT 
PLC1_NES_r       TACGTGAGCCGCTTTAGCTTTGTTGGAAACCTTATA 
PLC1-ORF5 TGTGTGAAGCTTTAAAATTTGTGTATGAATAAATAAAGTGCAAAATAT  
pUG36CAAX_f AGCTTGGATCGGGTGGCTGTTGTATTATAAGTTAAGAGCTCC 
pUG36CAAX_r TCGAGGAGCTCTTAACTTATAATACAACAGCCA CCCGATCCA 
PLC1NLS_KKLRK_f TTAACGCTGCTTTAGCTAAAGACTGTGATCTCAGCA  
PLC1NLS_KKLRK_r CAGTCTTTAGCTAAAGCAGCGTTAACAAGCTCATTTAT  
PLC1NLS_KRLR_f  ATCCGGCTGCTTTGGCTTCGGACAGTAAACTTT 
PLC1NLS_KRLR_r  AAGCCAAAGCAGCCGGATCTACTTCCTCTTGAT 
PLC1NLS-C1                         AATTGGGAATCAGGATGATTTCTATGACAAGAAGAAGAAGGAA  
PLC1NLS-B1   ATAGAAATCATCCTGATTCCCAATTGCAATACGCGACATA 
PLC1NLS-C2   GACATCTAGAAGAGAAAAGTTCTATGAATTTAAATTAATCAATAACAACG 
PLC1NLS-B2  TTTTCTCTTCTAGATGTCATCCTAATCATCCTGATTCC 
PKI(2x)BamHI/SacI_f GATCCTTGGCTTTGAAATTGGCTGGTTTGGATATTGAGCTCTTGGCTTTGAAATTGGCTGGTTTGG 
ATATTG       
PKI(2x)BamHI/SacI_r GATCCAATATCCAAACCAGCCAATTTCAAAGCCAAGAGCTCAATATCCAAACCAGCAATTTCAAA 
GCCAAG 
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PKI(2x)HindIII/XhoI_f AGCTTTTGGCTTTGAAATTGGCTGGTTTGGATATTCTCGAGTTGGCTTTGAAATTGGCTGGTTTGGA 
TATTA       
PKI(2x)HindIII/XhoI_r AGCTTAATATCCAAACCAGCCAATTTCAAAGCCAACTCGAGAATATCCAAACCAGCCAATTTCAAA 
GCCAAA 
PLC1_HindIII_f TATATGAATGAAGCTTACTGAAAGTGCTATAGATGAC 
LEU2_KpnI_r CTTTGGTACCCCATTTAGGACCACC 
pGEasy_SacI_f CTTTGAGCTCCCAACGCGTTGGAT 
PLC1_HindIII_r TTTCAGTAAGCTTCATTCATATACACTGCGTGAAT 
PLC1_R117S/R120S_f CAGGATGATTTCTATGACATCTAGAAGAAGGAAGTTCTA   
PLC1_R117S/R120S_r CTTCTTCTAGATGTCATAGAAATCATCCTGATTCCTCT 
PLC1_R117S/R123E_f CAGGATGATTTCTATGACAAGAAGAAGAGAAAAGTTCTATG 
PLC1_R117S/R123E_r GAACTTTTCTCTTCTTCTTGTCATAGAAATCATCCTGATTC 
PLC1_R111L_f CGTATTGCAATTGGGAATCAGGATGATTAGGATGACAA 
PLC1_R111L_r ATCCTGATTCCCAATTGCAATACGCGACATAGC 
PLC11-999nt(no stop)_HindIII_r GGGAAGCTTTTGCTCATGCTGCTCTGTAATTAAAA   
PLC1end_XhoI_r TTTCTCGAGCTATAAAATTTGTGTATGAATAAATAAAGTGCAAAATATG 
PLC1C2_HindIII_f AAAAGCTTATGTTAGATCACCAACCTGATGGAAGT   
D56677DL GAGAAGGGCGTTTAGATAAAACCCCAACTT 
D56678DL TTTTTTGATGGTGATATCATCTTTCAGTGTCTC 
ClaI_A TCGAATTTTATCTACACAGTTATTGCCCAGATTG 
XhoI_B CGCCTACTCGAGTAAAATTTGTGTATGAATAAATAAAGTGCAAAATATG  
XhoI_C CAAATTTTACTCGAGTAGGCGATCTTTTTCCGGCCAAA 
BamHI_D AATACTCAAGCTATGCATCCAACGCGTT 
LEU2TAG1  TTTTTGGATCCAGATGCAAGAGTTCGAATCTCTTA 
LEU2TAG2 GTTTTGGATCCTTCCATTTTGTAATTTCGTGTCGT 
PLC1_pFA6aHis3_f1 TAAACGTACAACGGTAAGGTCATTCACGCAGTGTATATGACGGATCCCCGGGTTAATTAA 
PLC1_pFA6aHis3_r1 GTACGTATTTATGAATATGTGTATTTGGCCGGAAAAAGATCGCGAATTCGAGCTCGTTTAAAC   
VPS41_pFA6aHis3_f1 AGCATTTTAACGAAGAGTATATACCTACTATTAGACATTACGGATCCCCGGGTTAATTAA 
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VPS41_pFA6aHis3_r1 AAGTGTACACTTGCCTTGTGTATTAAATGATGATTCGATAGAATTCGAGCTCGTTTAAAC 
PLC1-S3_f GAACAATACATATTTTGCACTTTATTTATTCATACACAAATTTTACGTACGCTGCAGGTCGAC 
PLC1-S2_r ATGTACGTATTTATGAATATGTGTATTTGGCCGGAAAAAGATCGCATCGATGAATTCGAGCTCG  
ARG82-S3_f GTGATTGAAGGAGTTGAAACCTTGCTAGATATTTTTATGAAATTCCGTACGCTGCAGGTCGAC  
ARG82-S2_r TGTACCATATACCATAAACAAGGTAAACTTCACCTCTCAATATATATCGATGAATTCGAGCTCG 
ARG82_XbaI_f GAAAATCTAGAATGGATACGGTAAACAATTATAGGGT 
ARG82_XhoI_r TTTCTCGAGCTAGAATTTCATAAAAATATCTAGCAAGGT 
ARG82_BamHI_f TTTTGGATCCCCACAATAGCAATTGGTAAAATTGTTAAAATTGC                                                                    
ARG82_PstI_f AAAACTGCAGCTTCAATTTGACAGAAGGATCTGTAGTCAT         
BamHI-PLC1 GCGCGAGGGGATCCATGACTGAAAGTGCTATAGATGAC 
PLC1-HindIII GGCGGCAGCGGCGAAGCTTCTATAAAATTTGTGTATGAATAAATAAAGTGC 
PLC1_H439L_f ATGGTGAAAATGGGCCAGTGGTATGCCTAGGATTTTTAACGTCAGCTATTCC 
PLC1_H439L_r GCTGACGTTAAAAATCCTAGGCATACCACTGGCCCATTTTCAC 
PLC1_E425G_f GTAGGTGCGTAGGTATTGATATATGGGATGGTGAAAATGGGCC 
PLC1_E425G_r ACTGGCCCATTTTCACCATCCCATATATCAATACCTACGCACCTACAACCTTGTT 
Gpr1_LEU2_f AAGTGATCCGAAGTGTGACGAATAAAGCAAACTCTCCAACTCAAAAGATGCAAGAGTTCGAATCTCTTA 
Gpr1_LEU2_r GTATTACGTTCCTTACTTTCCATTTTCAAACATCGCGATACAAAAACTTTCCATTTTGTAATTTCGTGTCGT  
 
 
[The italic font indicates the restriction sites incorporated; bold font indicates the mutation made; and the smaller-sized font indicates the 
beginning of the sequence homologous to the auxotrophic marker gene to be amplified.] 
 
 
 
 
 
 pUG36–PLC11-220 
pUG36–PLC11-220 was constructed in the same way as pUG36–PLC11-110 but with 
PLC1Trunc1 as the 3’ oligonucleotide. 
 
pUG36–PLC11-333  
pUG36–PLC11-333 was constructed in the same way as pUG36– pUG36–PLC11-110 but 
with pUG36-SOED2 as the 3’ oligonucleotide. 
 
pUG36–PLC1110-220 
PLC1110-220 was amplified from original pUG36-PLC1 using oligonucleotides PLC1-
330Top and PLC1Trunc1 that incorporated unique BamHI and HindIII restriction 
enzyme sites at the 5’ and 3’, respectively. The PCR product was digested with 
BamHI and HindIII, then sub-cloned into BamHI/HindIII-digested pUG36 vector.  
 
pUG36–PLC1220-333  
PLC1220-333 was amplified from original pUG36-PLC1 using oligonucleotides 
pUG36-SOEA2 and pUG36-SOED2 that incorporated unique BamHI and HindIII 
restriction enzyme sites at the 5’ and 3’, respectively. The PCR product was digested 
with BamHI and HindIII, then sub-cloned into BamHI/HindIII-digested pUG36 
vector. 
 
pUG36–PLC1110-end 
PLC1110-end was amplified from original pUG36-PLC1 using oligonucleotides PLC1-
330Top and pUG36-SOED1 that incorporated unique BamHI and HindIII restriction 
enzyme sites at the 5’ and 3’ ends respectively. The PCR product was digested with 
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BamHI and HindIII, then sub-cloned into BamHI/HindIII-digested pUG36 vector. 
 
pUG36–PLC1220-end 
pUG36–PLC1220-end was constructed in the same way as pUG36–PLC1110-end but with 
pUG36-SOEA2 as the 5’ oligonucleotide. 
 
pUG36–PLC1333-end 
pUG36–PLC1333-end was constructed in the same way as pUG36–PLC1110-end but with 
PLC1-1000Top as the 5’ oligonucleotide. 
 
pUG36–PLC1NES 
PLC1NES (PLC1L190A/L193A) was constructed by SOE-PCR amplification of pUG36–
PLC1 using oligonucleotides: PLC1_NES_f and PLC1_NES_r. The whole PLC1 gene 
with the NES being mutated was then amplified with pUG36SOEA1 and 
pUG36SOED1. The PCR product was digested with BamHI and HindIII, then sub-
cloned into BamHI/HindIII-digested pUG36 vector.  
 
pUG36–PLC1CAAX  
PLC1no stop (with stop codon removed) was amplified by PCR pUG36–PLC1 using 
oligonucleotides: pUG36SOEA1 and PLC1ORF5 (this pair of oligos amplified the 
whole PLC1 gene only without the last stop codon), and digested with BamHI and 
HindIII, then sub-cloned into BamHI/HindIII-digested pUG36 vector. 
The CAAX motif sequence was synthesized as follows: pUG36CAAX_f and 
pUG36CAAX_r, 25 μl of each (20 pmol), were mixed and annealed using PCR block 
programmed as 94oC for 5 min, 59oC for 1 hour and quick cooled to 10oC for 10 min. 
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Plasmid pUG36–PLC1CAAX was created by cloning the annealed double stranded 
CAAX oligonucleotides into the HindIII/XhoI sites of pUG36– PLC1no stop. 
 
pUG36–PLC1PKI  
PKI(2x) motif sequence was synthesized as follows: PKI(2x)BamHI/SacI_f and 
PKI(2x)BamHI/SacI_r, 25 μl of each (20 pmol), were mixed and annealed using a 
PCR block programmed as follows: 94oC for 5 min, 66oC for 1 hour and quick cooled 
at 10oC for 10 min.  
pUG36–PLC1PKI was created by cloning the BamHI digested double strand PKI(2x) 
oligonucleotides into the BamHI site of pUG36– PLC1. 
 
pUG36–PLC1NES/CAAX  
PLC1NES/no stop (with stop codon removed) was amplified by PCR pUG36–PLC1NES  
using oligonucleotides: pUG36SOEA1 and PLC1ORF5 (this pair of oligos amplified 
the whole PLC1 gene save for the stop codon). PLC1NES/no stop was digested with 
BamHI and HindIII, and exchanged with the BamHI and HindIII digested PLC1 
fragment of pUG36–PLC1CAAX construct to generate pUG36–PLC1NES/CAAX. 
 
pUG36–PLC1NES/PKI  
pUG36–PLC1NES/PKI was created by cloning the BamHI digested double strand 
PKI(2x) oligosnucleotides into BamHI site of pUG36– PLC1NES. 
 
pUG36-PLC1KKLRK  
pUG36-PLC1KKLRK (PLC1K94A/K95A/R97A)  was constructed by SOE-PCR amplification 
of pUG36–PLC1 using oligonucleotides: PLC1NLS_KKLRK_f and 
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PLC1NLS_KKLRK_r. The whole PLC1 gene with the K94A/K95A/R97A mutations 
was then amplified with pUG36SOEA1 and pUG36SOED1. The PCR product was 
digested with BamHI and HindIII, then sub-cloned into BamHI/HindIII-digested 
pUG36 vector.  
 
pUG36-PLC1KRLR  
pUG36-PLC1KRLR (PLC1K170A/R171A/R173A) was constructed in the same way as pUG36–
PLC1K94A/K95A/R97A but using PLC1NLS_KRLR_f and PLC1NLS_KRLR_r 
oligonucleotides. 
 
pUG36-PLC14R  
pUG36-PLC14R (PLC1R111L/R117S/R120S/R123E) was constructed in two steps: 
 PLC1R111L/R117S was amplified by SOE-PCR of pUG36–PLC1 using oligonucleotides: 
PLC1NLS-C1 and PLC1NLS-B1. The whole PLC1 gene with the R111L/R117S 
mutations was then amplified with pUG36SOEA1 and pUG36SOED1. 
PLC1R111L/R117S was then further amplified by SOE-PCR using oligonucleotides: 
PLC1NLS-C2 and PLC1NLS-B2 to introduce two further mutations. The whole 
PLC1 gene with the R111L/R117S/R120S/R123E mutations was then created by a 
second PCR step using oligos pUG36SOEA1 and pUG36SOED1. Finally, PLC14R 
was digested with BamHI and HindIII, then sub-cloned into BamHI/HindIII-digested 
pUG36 vector.  
 
pUG36-PLC1R2/3  
pUG36-PLC1R2/3 (PLC1R117S/R120S)  was constructed by SOE-PCR amplification of 
pUG36–PLC1 using oligonucleotides: PLC1_R117S/R120S_f and 
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PLC1_R117S/R120S_r. The whole PLC1 gene with the R117S/R120S mutations was 
then created by a second round of PCR utilising oligos pUG36SOEA1 and 
pUG36SOED1. The PCR product was digested with BamHI and HindIII, then sub-
cloned into BamHI/HindIII-digested pUG36 vector.  
 
pUG36-PLC1R2/4 
pUG36-PLC1R2/4 (PLC1R117S/R123E) was constructed in the same way as pUG36–
PLC1R2/3 but using PLC1_R117S/R123E_f and PLC1_R117S/R123E _r 
oligonucleotides. 
 
pUG36-PLC1R3/4 
pUG36-PLC1R3/4 (PLC1R120S/R123E) was constructed in the same way as pUG36–
PLC1R2/3  but using PLC1NLS-C2 and PLC1NLS-B2 oligonucleotides. 
 
pUG36-PLC1R1 
pUG36-PLC1R1 (PLC1R111L) was constructed in the same way as pUG36–PLC1R2/3 but 
using PLC1_R111L_f and PLC1_R111L _r oligonucleotides. 
 
pUG36-PLC1(1-333)+C2 
PLC11-333(no stop) (with stop codon removed) was amplified by PCR pUG36–PLC11-333 
using oligonucleotides: pUG36SOEA1 and PLC11-999nt(no stop)_HindIII_r (this pair of 
oligos amplified the whole PLC11-333 gene only without the last stop codon). pUG36-
PLC11-333(no stop)  was created by digesting PCR of PLC11-333(no stop)  with BamHI and 
HindIII, then sub-cloned into BamHI/HindIII-digested pUG36 vector. 
PLC1C2 was amplified by PCR using pUG36–PLC1 as target DNA and 
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oligonucleotides: PLC1C2_HindIII_f and PLC1end_XhoI_r. 
pUG36-PLC1(1-333)+C2 was then created by cloning the HindIII/XhoI digested PLC1C2  
into the HindIII/XhoI sites of pUG36-PLC11-333(no stop). 
 
pUG36-PLC1H439L 
PLCH439L was constructed by SOE-PCR amplification of pUG36–PLC1 using 
oligonucleotides: PLC1_H439L_f and PLC1_H439L_r. The whole PLC1 gene with 
the H439L mutation was then amplified with BamHI-PLC1 and PLC1-HindIII. The 
PCR product was digested with BamHI and HindIII, then sub-cloned into 
BamHI/HindIII-digested pUG36 vector.  
 
pUG36-PLC1E425G 
pUG36-PLC1E425G was constructed in the same way as pUG36–PLC1H439L but using 
PLC1_E425G_f and PLC1_E425G_r oligonucleotides  
 
pUG36-PLC14R/E425G  
pUG36-PLC14R/E425G (PLC1 R111L/R117S/R120S/R123E/E425G) was constructed by SOE-PCR 
amplification of pUG36-PLC14R using oligonucleotides: PLC1_E425G_f and 
PLC1_E425G_r. The whole PLC1 gene with the combined mutations was then 
created by  PCR using oligos BamHI-PLC1 and PLC1-HindIII. The PCR product was 
digested with BamHI and HindIII, then sub-cloned into BamHI/HindIII-digested 
pUG36 vector.  
 
pYcplac111-ARG82 
pYcplac111-ARG82 was constructed by PCR amplification of the ARG82 ORF from 
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yeast genomic DNA using ARG82_BamHI_f and ARG82_PstI_f oligonucleotides. 
The PCR product was digested with BamHI and PstI, then sub-cloned into BamHI/ 
PstI -digested pYcplac111 vector.  
 
pYcplac111-ARG82D131A  
pYcplac111-ARG82D131A was constructed by inserting the BamHI digested 
ARG82D131A fragment from pFV-ARG82D131A(a gift from Dr. Evelyne Dubois, 
Brussels) to BamHI digested pYcplac111 vector. 
 
pYcplac111-Arg82Δasp 
pYcplac111-ARG82Δasp (ARG82Δ(283-308)) was constructed by inserting the BamHI 
digested ARG82Δasp fragment from pFV-ARG82Δ(283-308) (a gift from Dr. Evelyne 
Dubois, Brussels) to BamHI digested pYcplac111 vector. 
 
pUG34-ARG82  
pUG34–ARG82 was constructed by PCR amplification of the ARG82 ORF from yeast 
genomic DNA using ARG82_XbaI_f and ARG82_XhoI_r oligonucleotides. The PCR 
product was digested with XbaI and XhoI, then sub-cloned into XbaI/XhoI -digested 
pUG34 vector.  
 
pUG34-ARG82G344R 
ARG82G344R was constructed by PCR amplification of pRS314-ARG82G344R (a gift 
from Dr John York, Durham, USA) using ARG82_XbaI_f and ARG82_XhoI_r 
oligonucleotides. The PCR product was digested with XbaI and XhoI, then sub-cloned 
into XbaI/XhoI -digested pUG34 vector.  
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pUG36-ARG82D131A 
ARG82D131A was constructed by PCR amplification of pYcPlac111-ARG82D131A using 
oligonucleotides: Arg82_BamHI_f and Arg82_XhoI_r. The PCR product was digested 
with BamHI and XhoI, then sub-cloned into BamHI/XhoI -digested pUG36 vector.  
 
pGEX6PK1–PLC1 and pGEX6PK1–PLC1E425G  
PLC1 fragements of BamHI and XhoI digested pUG36-PLC1 and pUG36-PLC1E425G, 
were inserted into the BamHI/XhoI site of pGEX6PK1, respectively.  
 
2.7 Yeast knock out & knock in 
Deletion or knock in strain creation was accomplished via high efficiency 
transformation of the appropriate PCR construct into the correct competent S. 
cerevisiae strain.  
 
2.7.1 Knock out 
For deletion of certain (open reading frames) ORFs, an auxotrophic marker was 
amplified from a “knock-out plasmid” (all plasmids based on pRS416 or on pFA-
KANMX4) by PCR using primers that contained sequences for annealing to the 
template plasmid, flanked by sequences that encode regions immediately before the 
start codon and after the stop codon of the corresponding ORFs. PCR products were 
used to transform yeast strains and putative knock-out strains were confirmed by 
sequencing the genomic DNA recovered from transformed cells. 
 
BY4742 plc1Δarg82Δ 
BY4742 plc1Δarg82Δ (plc1::HIS3 arg82::KanMX4) was created by PCR using the 
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knock-out plasmid pFA6a-HIS3MX6 (Longtine et al., 1998) using 
PLC1_pFA6aHis3_f1 and PLC1_pFA6aHis3_r1 oligonucleotides, followed by high 
efficiency yeast transformation to BY4742 arg82::KanMX4 (EUROSCARF). 
Colonies were grown at 25 oC and selected on SC-His plates. 
 
BY4742 vps41Δarg82Δ 
BY4742 vps41Δarg82Δ (vps41::HIS3 arg82::KanMX4) was made in the same way as 
BY4742 plc1Δarg82Δ but using VPS41_pFA6aHis3_f1 and VPS41_pFA6aHis3_r1 
oligonucleotides. Colonies were grown at 25 oC and selected on SC-His. 
 
BY4742 gpr1Δ 
BY4742 gpr1Δ (gpr1::LEU2) was created by PCR plasmid pYcPlac111(cen-ARS, 
LEU2, amp) (Gietz and Sugino, 1988) using Gpr1_LEU2_f and Gpr1_LEU2_r 
oligonucleotides, followed by high efficiency yeast transformation to wild-type 
BY4742 (Euroscarf). Colonies were grown at 25 oC and selected on SC-Leu. 
 
BY4742 gpr1Δarg82Δ 
BY4742 gpr1Δarg82Δ (gpr1::LEU2 arg82::KanMX4) was made in the same as 
BY4742 gpr1Δ but PCR product was transformed to BY4742 arg82::KanMX4 
(Euroscarf). Colonies were grown at 25 oC and selected on SC-Leu. 
 
2.7.2 PLC1 knock in mutant 
To express PLC1 mutants at endogenous levels, PLC1 knock-in strains were 
constructed in pGEM -T -Easy with a LEU2 gene inserted 3’ to the PLC1 gene to act 
as a selective marker (Fig 2.3).  
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PLC1 (wild type) knock in  
A fragment encoding the whole PLC1 ORF, including the promoter region and all 
intergenic sequences between PLC1 and the adjacent two genes (KAR9 and ACM1) 
was amplified by PCR. The template for this reaction was genomic DNA from wild 
type yeast BY4742 genomic DNA using D56677DL and D56678DL oligonucleotides. 
PCR product was TA coloned into the pGEM-T Easy (Promega#A1360) to create 
pGEM-T Easy-PLC1.  
For construction of pGEM-T Easy-PLC1-LEU2, DNA encoding the selective marker 
LEU2 was obtained by PCR from plasmid pYcPlac111 using LEU2TAG1 and  
 
Fig 2.3: PLC1 mutant knock in 
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LEU2TAG2 oligos, followed by digestion with BamHI and insertion into the BamHI 
site of pGEM-T Easy-PLC1.  
The resulting PLC1-LEU2 fragment was amplified by PCR with D56677DL and 
D56678DL oligonucleotides. Reactions were conducted using Long Template 
Polymerase (Roche). The whole fragment was then transformed to competent wild-
type BY4742. Colonies were recovered at 25 oC and selected on SC-Leu. 
 
PLC1NES knock in 
pUG36-PLC1NES was digested with HpaI and ClaI, and exchanged with the HpaI and 
ClaI digested PLC1 fragment of pGEM-T Easy-PLC1-LEU2 to create pGEM-T Easy- 
PLC1NES-LEU2. PLC1NES-LEU2 was amplified and transformed to wild-type BY4742 
as above. Colonies were grown at 25 oC and selected on SC-Leu. 
 
PLC1CAAX knock in 
A XhoI site was created in pGEM-T Easy-PLC1-LEU2 right before the PLC1 stop 
codon, via SOE-PCR using two pairs of oligonucleotides: (i) ClaI_A and XhoI_B,  (ii) 
XhoI_C and BamHI_D, followed by PCR with ClaI_A and BamHI_D to produce a 
fragment with a unique XhoI. This fragment was then digested with ClaI and BamHI 
and exchanged with the ClaI/BamHI fragment of pGEM-T Easy-PLC1-LEU2 to 
create a pGEM-T Easy-PLC1XhoI-LEU2. 
The CAAX sequence was then incorporated to pGEM-T Easy-PLC1XhoI-LEU2 by digesting 
pUG36-PLC1CAAX with ClaI and XhoI, and exchanging the resulting fragment with the 
ClaI/XhoI fragment of pGEM-T Easy-PLC1XhoI-LEU2. 
PLC1CAAX-LEU2 was amplified and transformed to wild-type BY4742. Colonies were grown 
at 25 oC and selected on SC-Leu. 
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PLC1PKI knock in 
A HindIII site was first inserted into pGEM-T Easy-PLC1-LEU2 right before the 
PLC1 start codon, by SOE-PCR conducted using two pairs of oligonucleotides: (i) 
PLC1_HindIII_f and LEU2_KpnI_r, (ii) pGEasy_SacI_f and PLC1_HindIII_r, then 
followed by PCR with pGEM-T-Easy_SacI_f and LEU2_KpnI_r to produce a 
fragment with the unique HindIII site. This fragment was then digested with SacI and 
KpnI and exchanged with the SacI/KpnI fragment of pGEM-T Easy-PLC1-LEU2 to 
create a pGEM-T Easy-PLC1HindIII-LEU2. 
The PKI(2x) sequence was created as follows: PKI(2x)HindIII/XhoI_f and 
PKI(2x)HindIII/XhoI_r, 25 μl of each (20 pmol), were mixed and annealed using a 
PCR block programmed as follows: 94oC for 5 min, 65oC for 1 hour and quick cooled 
at 10oC for 10 min. pGEM-T Easy-PLC1PKI-LEU2 was created by cloning the double-
stranded, annealed PKI(2x) oligonucleotides into the HindIII site of pGEM-T Easy-
PLC1HindIII-LEU2. Orientation was determined by sequencing a number of correct 
plasmids, selected by creation of a new XhoI site. 
PLC1PKI-LEU2 was amplified and transformed to wild-type BY4742. Colonies were 
grown at 25 oC and selected on SC-Leu. 
 
2.8 High efficiency transformation of competent E. coli cells  
Competent E.coli cells were prepared in the lab: Supercomp medium (60 ml: BIO101) 
was inoculated with an appropriate E. coli strain (200 μl of an overnight culture) and 
incubated at 37oC until the A660 was ~0.3. 10 ml aliquots were then incubated on ice 
for 10 min and cells were collected through centrifugation at 3000 g for 5 min at 4oC. 
Each cell pellet was resuspended in ice-cold 1 x Rubidium-CaCl2 mixture (2.0 ml: 
BIO101). The cell suspensions were combined and incubated on ice for a further 20 
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min. Cells were collected as above, resuspended in ice-cold x 1 Rubidium-CaCl2 
mixture (4 ml: BIO101) containing 20% (w:v) glycerol, separated into 100 μl aliquots 
and stored at -80oC. On some occasions, E.coli were left over-night in the x 1 
Rubidium-CaCl2 mixture as this is reported to increase competency. 
 
Transformation was carried out as follows: Plasmid DNA (0.1-10 μg) was added to an 
aliquot of competent E. coli cells (100 μl), incubated on ice for 30 min and heat 
shocked at 42oC for 90 seconds. SOC medium (1.0 ml) was immediately added to the 
cell suspension, mixed gently and incubated at 37oC for 60 min. Cells were collected 
through centrifugation at 6000 rpm for 10 seconds, resuspended in 100 μl of fresh 
SOC medium and plated onto a LB + 100 μg/ml Ampicillin agar plate. Plates were 
incubated at 37oC for 16-20 h. 
 
2.9 High efficiency transformation of yeast 
Polyethylene glycol (PEG), lithium acetate and single-stranded salmon testis DNA 
were obtained from Sigma Chemical Company. 
 
The following method was adapted from Methods in Yeast Genetics (Adam, A., 
Goccschling, D.E., Kaiser, C.A., and Sterns T., eds), Cold Springs Harbour 
Laboratory Manual, 1997.  
 
Cells were sub-cultured to 5 x 106 cells/ml in YPD+ 2.0% glucose medium (2 ml) and 
grown on at 30oC to 1~2 x 107 cells/ml. Cells were collected, resuspended in H2O (1 
ml), and centrifuged at 3000 x g for 1 min at 30oC. Cells were again collected, 
resuspended in 1ml of 100 mM lithium acetate (LiAc). The cell suspension was 
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centrifuged at 6000 x g for 15 seconds and the supernatant was removed. Single-
stranded salmon testis DNA, ssDNA (carrier DNA; 2mg/ml in dH20) was boiled for 5 
min and chilled on ice. The following solutions were then added to the cell pellet in 
the this order: 240 μl of 50% PEG, 36 μl of 1.0M LiAc, 50 μl of boiled ssDNA, 25 μl 
of ddH2O containing the DNA (0.1~ 10 μg) to be transformed, and the resulting 
mixtures were mixed by vortexing vigorously until the cells were completely 
resuspended. Cells were then incubated at 30°C for 30 min followed by heat shock at 
42°C for 25 min. Cells were collected by centrifugation at 6000 x g for 15 seconds, 
the supernatant was discarded and the cells were resuspended (very gently) in 200 μl 
of ddH2O, plated out onto selective agar plates and incubated at 30°C.  
 
2.10 Genomic DNA purification from budding yeast 
The following method is from Gentra Puregene Handbook, second edition, Qiagen, 
p47~ 48, 09/2007.  
 
2 ml of exponentially growing cells were collected and resuspended in 300 μl of Cell 
Suspension Solution (provided by the kit) with 1.5 μl of Lytic Enzyme Solution, the 
resulting mixture was incubated at 37°C for 30 min. Cells were pelleted by 
centrifugation at 16,000g for 1 min and resuspended in 300 μl of Cell Lysis Solution 
plus 100 μl of Protein Precipitation Solution, and vortexed vigorously for 20 s at high 
speed, then centrifuged at 16,000g for 3 min. The supernatant (approx. 400 μl) was 
decanted into a fresh tube containing 300 μl of isopropanol, mixed well and 
centrifuged at 16,000g for 1 min. The supernatant was carefully discarded and the 
tube drained by inverting it on a clean piece of absorbent paper. Then the DNA pellet 
was washed once with 300 μl of 70% ethanol and air dried for up to 10 min. The DNA 
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pellet was resuspended in 50 μl of DNA Hydration Solution plus 1.5 μl of RNase A 
Solution and incubated at 37°C for 30 min, then incubated at 65°C for 1 hour to 
dissolve the DNA.         
 
2.11 SDS-PAGE (Sodium Dodecyl Sulphate-polyacrylamide Gel Electrophoresis)  
5 x SDS sample buffer was added to protein samples to a final concentration of 1 x. 
Samples were then vortexed and incubated at 100°C for 5 min. Proteins were 
separated by a 10% (w:v) acrylamide resolving gel and separated in a Bio-Rad Mini-
Protean II xi Cell at 100V for approximately 1.5 hour until the bromophenol blue dye-
front reached the end of the gel or until the desired separation of the prestained 
molecular weight markers was achieved. Electrophoresis reagents and molecular 
weight markers were obtained from Bio-Rad. 
 
2.12 Western blotting 
Proteins separated by SDS-PAGE were transferred to a Hybond-ECL nitrocellulose 
membrane (Amersham Biosciences) for further analysis. The nitrocellulose membrane 
and two pieces of 3MM filter paper (Whatman) were cut to the size of the separating 
gel and pre-soaked in the blotting buffer. The gel was removed from the cassette and 
put into the blotting buffer. A blotting cassette was assembled according to the 
manufacturer's instructions, as follows: a sponge, two filter papers, gel (rinsed with 
blotting buffer), a nitrocellulose membrane, two filter papers and another sponge, 
from black (cathode) to the white (anode). The assembled blotting cassette and an ice 
block for cooling were inserted into the transfer tank with blotting buffer, and the 
transfer performed at 400 mA for 1 hour, followed by milk blocking (5% skimmed 
milk powder dissolved in PBST) for at least 1 hour. A specific antibody was added for 
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each experiment (in PBST) for an appropriate incubation time, then a 2nd antibody (in 
PBST) was incubated with the blot for at least 1 hour. Blots were then washed for 15 
minutes (x 3) after each incubation with antibodies. The immunoreactive proteins 
were visualized by a chemi-luminescense detection system as follows: Solution A 
(100mM glycine, pH 10(with NaOH), 0.4mM luminol (Sigma#A-8511), 8mM 4-
iodophenol (Aldrich#l1,020-1)) and Solution B ( 0.12% (w/w) hydrogen peroxide in 
water) were mixed in equal volumes just prior to use, and the resulting working 
solution incubated with the blot for 1 minute before exposure to film or CCD camera. 
 
Chemiluminescence was detected by a Fluor-STM Multimager (Bio-Rad) Gel 
Documentation System. Different exposure times were used depending on the 
intensity of the protein bands. 
 
2.13 GFP-Plc1p mutant construct stability test 
To analyze the stability of GFP Plc1p fusions, yeast whole-cell extracts were prepared 
as follows: 5 ml of exponentially growing cells were harvested by centrifugation at 
3000 x g for 0.5 minutes, re-suspended in 200 μl of 0.1M NaOH, and incubated at 
room temperature (RT) for 5 minutes. The cells were again centrifuged and the 
supernatant was discarded. The cell pellet was then resuspended in 50 μl of 1x SDS-
PAGE loading buffer and boiled for 3 minutes. Centrifugation was then carried out at 
maximum speed (13,000 x g) for 1 minute to remove the debris. The supernatant, 
containing the extracted total protein lysate, were loaded for Western analysis.  
 
After SDS-PAGE, proteins were transferred to a nitrocellulose membrane and the 
immunoblots were probed with anti-GFP antibodies (anti-GFP mouse monoclonal 
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IgG2a, Santa Cruz#SC-9996, B0507) (1:1000 dilution) and then secondary antibody 
(HRP-Goat anti-mouse IgG (H+L, Zymed Laboratory Ltd, #274061) at a 1:2000 
dilution following the routine immunoblotting protocol described above. For each 
experiment, equal equivalents of cells were analysed.  
 
2.14 Expression of GST-Plc1p and GST-Plc1pE425G 
pGEX6PK1-PLC1 and pGEX6PK1-PLC1E425G were transformed to BL21-star (DE3)-
RIL competent E. coli cells. Transformants were selected on LB + 100 μg/ml 
Ampicillin + 50 μg/ml Chloramphenicol agar plates. Plc1p and Plc1pE425G were 
expressed as a GST-tagged full-length fusion proteins. 
 
The transformed E. coli strains were grown to an A600 of ~ 0.8 at 37oC and induced by 
IPTG (0.1 mM) (Bio-Rad) with PMSF (0.4 mM) at 20oC overnight ( ~ 12 hours). 
Cells were collected (8000 g for 5 min at 4oC) and ‘washed’ in 40 ml ice-cold 
Breakage buffer (100mM Hepes-KOH, 150 mM NaCl, 5mM Benzamidine and 10mM 
EDTA, pH 7.5). All subsequent procedures were carried out at 4oC. Cells were 
resuspended in 40 ml of Breakage buffer containing 1mg/ml lysozyme and 200 μl of 
bacterial protease inhibitor cocktail (Sigma, P8465 added immediately prior to use) 
and incubated, with stirring, on ice for 30 min. Inhibitor cocktail was included in all 
subsequent breakage buffers.  The E. coli cells were disrupted using a sonicator by 10 
x 5 s pulses at maximum intensity level. The final volume of lysis was adjusted to 45 
ml with breakage buffer and 5 ml 10% (v:v) Triton X-100 was added, and incubated 
on ice with stirring for 30 min. Following homogenisation, the cells were centrifuged 
at 8000 rpm (Beckman J2-MC, rotor JA18) for 10 min at 4oC and the supernatant was 
further centrifuged at 50,000g (Beckman L-70 ultracentrifuge, rotor Type 70 Ti) for 
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20 min at 4oC. This supernatant was filtered using 0.22 μm polyethylene sulphate 
(PES) filter discs (Millipore Ltd). Glutathione-Sepharose 4B resin (GE Healthcare) 
(1.33 ml of a 75% slurry) was equilibrated in breakage buffer containing 1% (v:v) 
Triton X-100 and 100 μl protease inhibitor cocktail for 30 min and washed 2 times in 
the same buffer. The filtered supernatant was added to the pre-swollen beads and 
rotated for 1 hour at 4oC to allow binding. Beads were recovered in a centrifuge at 200 
g for 5 min at 4oC, followed by two washes with breakage buffer containing 0.1% 
(v:v) Triton X-100 and protease inhibitor cocktail, then another two washes with 
detergent-free breakage buffer, and a final wash in washing buffer (100mM Hepes-
KOH, 150 mM NaCl, 5mM Benzamidine, pH 7.5) with protease inhibitor cocktail (all 
washing steps including recovery by centrifugation at 200 g for 5 min at 4oC). The 
beads were resuspended in 5 ml of washing buffer with protease inhibitor cocktail and 
poured into a poly-prep chromatography column (Bio-Rad,#731-1550) allowed to 
settle and the buffer drained out. GST-tagged proteins were then eluted in 3 ml (0.5 ml 
for each collected fraction) of detergent-free elution buffer (50 mM Tris, 150 mM 
NaCl, 5 mM Benzamidine, 20 mM Glutathione, pH 8.5).  
 
Fractions containing protein were identified by protein assay (BioRad), made up to 
50% (v:v) glycerol by adding pure, cooled, molecular biology grade glycerol to them 
on ice, whereupon they were gently mixed by pipetting up and down and stored at -
80oC.  
 
16 μl of purified GST-tagged protein from each fraction collected was loaded for 
SDS-PAGE analysis. Proteins were visualised with Coomassie brillant blue R250 
(Sigma) in 50% (v:v) methanol and 7% (v:v) acetic acid (Fig 2.4). 
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Fig 2.4: SDS-PAGE of GST-tagged protein expression 
1L of BL21-star (DE3)-RIL cells expressing each GST-tagged protein as indicated was expressed as 
described above. The gel pictures shows resolution of 16μl from each 500μl fraction of eluted 
recombinant protein. 1μl of BSA (1mg/mg) was loaded as control. L indicates total lysate (after bead 
binding). M1 stands for Precision Plus Protein Standards (Bio-Rad,#161-0374) and M2 stands for SDS-
PAGE high range standards (Bio-Rad,#161-0303).  
 
 
2.15 Co-immunoprecipitation for putative binding of Arg82p and Plc1p 
Epitope tagging of PLC1 and ARG82 in FY833 was conducted using Schiebel’s S2/S3 
genomic tagging primers (Knop et al., 1999). 
 
ARG82::ARG82-9Myc-TRP1 was constructed by PCR using the pYM6 plasmid as 
template (obtained from Dr Elmar Schiebel, University of Heidelberg) with 
oligonucleotides ARG82-S3_f and ARG82-S2_r, which included the sequences for 
annealing to the template plasmid, flanked by sequences complementary to the 40 
nucleotides immediately before and after the stop codon of ARG82. A PCR fragment 
encoding this fragment was transformed into wild type FY833 cells, grown and 
selected on SC-Trp plates. Putative knock-in strains were confirmed by sequencing 
genomic DNA of TRP1 clones. 
 
plc1::PLC1-3HA-HIS3 was constructed in the  same way but using pYM2 as a 
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template (obtained from Dr Elmar Schiebel, University of Heidelberg) and 
oligonucleotides PLC1-S3_f and PLC1-S2_r. A PCR fragment obtained as above was 
transformed into wild type FY833 and FY833 ARG82::ARG82-9Myc cells. Correct 
colonies were selected on an SC-His plate and confirmed by sequencing the target 
fragment of genomic DNA. 
 
Cells (100ml) were grown till OD A600 ~1.0. and collected (1000g, 4ºC, 5 min) and 
washed in 20 ml of ice-cold extraction buffer (200mM Tris-HCl pH8.0, 150mM 
Ammonium Sulfate, 10% Glycerol, 5mM EDTA, 150mM NaCl and 1mM PMSF, 
yeast protease inhibitor cocktail were added freshly before use.). Cells were then re-
suspended in 600μl of the same extraction buffer and transferred to clean eppendorf 
tubes, containing 400 μl glass beads (Sigma). Cells were then broken in a Yeast Bead-
beater by vigorous agitation for 1 min, followed by at least 1 min on ice: this was 
repeated 5 times. Centrifugation was then carried out (16,000g ~3 min, 4ºC) to 
remove all the beads and collect the total lysate. 
 
Note, 5mM DSP (in DMSO) (Pierce, #22585) was added to each cell culture in 500μl 
extraction buffer before cell breakage. Meanwhile, 100 μl Protein G sepharose (GE 
Healthcare) (133 μl of a 75% slurry) was pre-washed in Breakage buffer (the same 
buffer as described in 2.14, protease inhibitor cocktail and 1mM PMSF were added 
before use) and collected at 500g for 5 min (x 3 times). anti-HA(BAbCO, # MMS-
101R, 16B12)(1:2000), anti-cMyc(Santa Cruz,#SC-40, 9E10) (1:2000) and washed 
Protein G sepharose were together added to 500 μl breakage buffer, and incubated on 
a rotating wheel for 2 hours at 4oC, then washed as above and the supernatant 
discarded. The total lysate was added to the beads, and incubated on a rotating wheel 
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for 2 hours/overnight at 4oC. Supernatant and pellet were separated by centrifugation 
at 500g for 5 min and washed as above before adding SDS-PAGE loading buffer to 
the beads. Proteins bound to the beads were then resolved by SDS-PAGE and 
analyzed by western blotting.  
 
2.16 Spot dilution assay 
Exponentially growing cells (~ 1 x 107cells/ml) were harvested and the cell density 
were adjusted to exactly 1 x 107cells/ml first by counting the cells using a 
haemocytometer and then adjusting the cell suspensions by dilution. Then 5-fold 
serial dilutions of each cell suspension were made and 5 μl of each dilution spotted 
onto YTD or SC-Ura+Met (0.2g/L) (for various plasmid transformed constructs 
derived from pUG36) incubated at 37oC for heat stress, or YTD/SC-Ura+Met (0.2g/L) 
plates containing 0.7 M NaCl at 23oC for the salt sensitivity assay. Control plates were 
grown at 23oC. Cells were grown under stress till colonies of wild-type cell were fully 
formed, normally 2 days for heat stress and 6 days for salt stress.  
 
YTD plates were used in this assay because variations in batches of peptone caused 
variable and inconsistent results whereas tryptone proved to be a much more 
consistent product in our hands. 
 
2.17 Hypo-osmotic shock and vacuole staining with the lipophilic dye FM4-64  
The following method was adapted from Vida and Emr, 1995.  
 
Strains were grown in YPD at 23°C to early exponential phase (no more than 1x107 
cells/ml). 5 ml cells for each strain were harvested and resuspended in 200 μl of YPD 
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media. FM 4-64 (Molecular Probes, #T13320) was added to 40 μM from a stock 
solution of 16 mM in DMSO. The cells were then incubated with shaking for 10-15 
min at 23°C. After this preliminary labelling step, the cells were harvested at 200 g for 
3 min at room temperature. Cells were then resuspended in 400μl of fresh YPD 
media, and incubated with shaking for 60 min to allow vacuole staining. After this 
"chase" period, Cells were again harvested at 200 g for 3 min, resuspended in a 
suitable volume of fresh YPD media and visualised by light/fluorescence microscopy. 
For salt stress experiments, NaCl was added to YPD media to a final concentration of 
0.6 M for 10 min and visualised. For hypo-osmotic shock, cells in YPD + 0.6M NaCl 
were diluted with 9 volumes of YPD, and incubated with shaking for 60 min, before 
being visualised. 
 
2.18 Fluorescence microscopy 
Yeast strains were cultured to 0.6 ~ 1 x 107 cells/ml in appropriate media, washed with 
MES buffer (2-(N-morpholino) ethanesulfonic acid buffer) or MES with an 
appropriate concentration of NaCl for hyper- or hypo- osmotic treated cells.  
 
Slides and cover-slips were prewashed with 70% ethanol and ddH2O. Cover-slips 
were further processed by coating with poly-lysine (10mg/ml), followed by washing 
in ddH2O. Slides and cover-slips were quick dried with streams of N2. 
 
Cells were dispersed thoroughly to achieve a ‘homogenous’ distribution, and were 
then visualized on a Nikon Eclipse E600 microscope with an XF100-3 filter cube 
(Omega Optical) and projector used was a Nikon Plan Apo (100×/1.40 oil DIC H). 
Images were acquired with an ORCA digital camera (Hamamatsu, Japan) and 
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processed in Adobe Photoshop. Figures showed representative fields from multiple 
experiments.   
 
2.19 Statistical analysis 
Plasma membrane, cytosolic and nuclear GFP fluorescence images were false-
coloured in the programme Simple PCI and exported. The fluorescence intensity was 
then measured in Adobe Photoshop using the eyedropper tool. No cell was analysed 
where any part of the cell had the maximum fluorescence reading of 255, to avoid 
problems of saturation. All cells analysed were those that were representative of the 
population of cells from which they were derived. For each cell, 6 spots on each of the 
three localizations were randomly selected and measured (only cytosolic and nuclear 
readings were taken for chapter 3). Ten cells were examined for each genotype.  
 
Sample mean and standard error of the mean (SEM) were calculated in Excel using 
the following formula: AVERAGE() and STDEV()/SQRT(COUNT()). Cells from 
different genotypes were compared by an unpaired Student's t test. Treated and 
untreated cells from same genotype were compared by paired t test.  
 
2.20 Lipid Western/dot-blot assay  
PtdIns3P, PtdIns(3,5)P2 and PtdIns(4,5)P2 were obtained from Prof. Andrew Holmes 
(The University of Melbourne) or Dr Gavin Painter (IRL, New Zealand). The lipid 
dot blot assay method was adapted from the work published by Lemmon group 
(Narayan and Lemmon 2006). 
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1 nmole (in chloroform:methanol:ddH2O (400:56:4)) of each phosphoinositide was 
spotted onto a strip of Hybond C+ supported nitrocellulose membrane (Amersham 
Biosciences). All lipid manipulations were performed in clear glass vials (Supelco, 
#27134), and lipid solutions are stored at -80oC under nitrogen. After spotting lipids 
onto nitrocellulose, the strips were dried for ~ 1 h at RT.  Strips were then stored at -
20ºC in a container with dry silica gel inside to provide a water free atmosphere until 
use. 
 
Each strip was blocked for at least 1 h at 4oC in TBST containing 3% (w/v) fatty-acid 
free bovine serum albumin (BSA). After blocking, the strip was incubated with 
purified GST-Plc1p or GST-Plc1pE425G in TBST at a concentration of 2.5 μg/ml 
protein at RT for 2 hrs. The strip was then washed 5 times with TBST (5 min each), 
followed by routine immunoblotting protocol with mouse monoclonal anti-
GST(sigma, #G-1160)(1;1000), and HRP-Goat anti-mouse IgG(H+L) (Zymed 
Laboratory Ltd, #274061)(1:2000). 
 
2.21 Synchronizing yeast cells 
To synchronize the yeast cell cultures, exponentially growing cells (0.6 ~ 1 x 107 
cells/ml) were treated with: 200 ng/ml rapamycin (Alexix Biochemicals, #380-004-
M001)(2.5mg/ml in DMSO) for ~ 6 hours to arrest cells at G1 phase, or 15μg/ml 
nocodazole (Sigma, #M1404) (10mg/ml in DMSO) for ~ 4 hours to arrest cells at M 
phase or 100 mM hydroxyurea (Sigma, #H8627)(2 M in ddH2O) for ~ 4 hours to 
arrest cells at S phase. Equal amounts of DMSO were added to control cells to test for 
vehicle effects. 
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The duration for drug treatment was based on those employed in previous studies 
(Heitman et al., 1991; Iwaki et al., 2007). Indeed, after each treatment, most cells 
appeared to show the typical characteristics for the cell stage they were arrested at. 
Cells then were subjected to microscopy. 
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                Chapter 3    Plc1p localisation and function 
 
3.1 Introduction 
The function of PLC-δs in eukaryotes is not well understood, even though the δ-
family is likely to be the closest in domain structure to the original, ancestral form of 
these enzymes (Koyanagi et al., 1998; Rhee and Bae, 1997). PLC-δs are the only 
PLCs found in plants and fungi (Rhee, 2001), yet the regulation of these enzymes has 
never been resolved, as the proposed mechanisms require at least one protein 
component that is absent from some of the groups of organisms in which PLC-δs are 
found (Rebecchi and Pentyala, 2000). The fact that PLC-δs are present in lower 
organisms that lack InsP3 receptors suggested that the functions of PLC-δs might be 
fundamentally different from the signalling processes that are initiated by the other, 
better characterized, families such as the PLC-βs and PLC-γs.  
 
The discovery of yeast InsP3 kinases was a first step in unravelling this mystery (York 
et al., 1999). This lead to the realisation that ‘higher’ inositol phosphates, such as 
InsP6 and the inositol pyrophosphates, InsP7 and InsP8, might be derived from PLC-
generated InsP3 through the action of inositol phosphate kinases, at least in some 
organisms. This implied that PLC-δs might indirectly generate InsP6, InsP7 and InsP8 
in cells and that study of these might reveal major, and maybe ancestral, functions of 
PLC-δs. 
 
Many of the most penetrative insights relating to PLC-δs and the higher inositol 
phosphates have come from studies of Plc1p, the δ-type PLC of S. cerevisiae. 
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Deletion of the PLC1 gene gives rise to a pleiotrophic phenotype that includes 
sensitivity to heat and osmotic stresses, inability to grow on non-fermentable carbon 
sources and defects in vacuole and nuclear morphology (Flick and Thorner, 1993; 
Rebecchi and Pentyala, 2000; Yoko-o et al., 1993).  
 
A number of proteins have been identified that bind ‘higher’ inositol phosphates. 
Unexpectedly, most of these proteins are nuclear and catalyze functions that are 
constitutive and would not be expected to be grossly regulated by the kind of 
signalling with which animal PLCs are usually associated (El Alami et al., 2003; Feng 
et al., 2001; Saiardi et al., 2000a; Seeds et al., 2007; Steger et al., 2003; Weirich et 
al., 2006; York et al., 1999). Most animal PLC-δs are mainly cytoplasmic and seem to 
signal from the plasma membrane (Faenza et al., 2005; Topham and Prescott, 2002; 
Yagisawa, 2006). Many of the functions mediated by these inositol phosphate binding 
proteins do not seem to be obviously connected to processes that would explain the 
phenotypes of cells in which the PLC1 gene has been deleted (plc1Δ). 
 
The aim of this part of my work was to try and understand where Plc1p is inside yeast 
cells under a variety of conditions and to determine whether any treatment(s) would 
provoke movement of Plc1p between nucleus and cytoplasm. Underlying our initial 
thinking about Plc1p was the desire to investigate if there might exist separate pools 
of nuclear and cytoplasmic ‘higher’ inositol phosphates that might be regulated and 
function separately. Although the presence of nuclear pores would seem to preclude 
this, the inability of these highly charged molecules to pass through the pores of 
dialysis tubing with a 50 kD molecular cutoff suggests that higher inositol phosphates 
might not be as mobile as is commonly supposed (Van der Kaay and Van Haastert,  
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1995).  
 
Some animals PLCs are constitutively nuclear: e.g. PLC-β1 and PLC-δ4 (Martelli et 
al. 1992; Liu et al. 1996; Divecha et al. 1997; D'Santos et al. 1998). Although the 
steady-state localisation of most mammalian PLC-δ1 is at the plasma membrane and in 
the cytoplasm of normal growing cells, it constantly shuttles between the nucleus and 
cytoplasm (Yagisawa et al., 2002). 
 
This and other evidence has lead to many suggestions of a nuclear inositol phosphate 
signalling system separate from the ‘classical’ plasma membrane signaling pathway 
(Divecha et al., 1991; Irvine, 2000; Martelli et al., 1992).  
 
3.2 Plc1p abundance is very low in wild-type yeast 
Plc1p is the sole PLC in yeast, and appears to play crucial roles in a number of ill-
defined cellular events. Despite controlling several apparently disparate processes, 
Plc1p is reported to be expressed at very low levels from its native promoter in 
exponentially growing cells at 30ºC (Flick and Thorner, 1993; Fratti et al. 2004). To 
confirm this, I examined the expression of Plc1p by tagging it with three copies of the 
HA epitope at the C-terminus. Plc1p-3HA was not detected by western blot, which 
confirmed its low abundance in vivo (Fig 3.1 A).    
 
I therefore decided to use the system developed by (Perera 2002, p.111) to detect 
Plc1p. The complete open reading frame of the PLC1 gene was inserted into the yeast 
single-copy shuttle vector, pUG36 (YCp, URA3, PMET25-yEGFP3-MCS-TCYC1) 
(Niedenthal et al. 1996) such that Plc1p was expressed as an N-terminal GFP fusion. 
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Expression of GFP-Plc1p was under the control of the methionine-repressable MET25 
promoter. Maximal expression of GFP-Plc1p from this promoter, to about ten times 
the levels found in wild-type cells was possible in the absence of methionine whilst 
increasing concentrations of this amino acid could be used to progressively lower its 
expression (NM Perera and SK Dove 2002, unpublished). Although completely 
deregulated expression from pMET25 results in substantial over-expression of Plc1p, 
our lab has previously shown that inositol phosphate metabolism is not significantly 
perturbed in cells under these conditions (NM Perera and SK Dove 2002, 
unpublished). Using this system, GFP-Plc1p ( ~130 kDa) could be detected by 
immunoblotting with an anti-GFP antibody and was found to be largely stable (Fig 
3.1 B and APPX. Fig A). 
 
Fig 3.1:  Western blot for detecting the expression of Plc1p 
                                        
5ml of FY833 (plc1::PLC1-3HA-HIS3) cultured in YPD (2% glu), for A, or BY4742 + pUG36-PLC1 
cultured in SC-Ura-Met (2% glu) for B, were grown to OD600 ~0.7 (1x 107 cells/ml). After cell 
breakage, 32μl (~ 40%) total lysates were resolved by SDS-PAGE followed by western blotting. 
Samples were then electrophoretically transferred to nitrocellulose followed by incubation with anti-
HA (1:2000) for A, or anti-GFP (1:1000) for B, respectively. 
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3.3 Intracellular localisation of GFP-Plc1p 
To visualize the intracellular localization of Plc1p, I used the pUG36-PLC1 construct 
to enhance the expression level of Plc1p. Plc1p tagged with green fluorescent protein 
(GFP-Plc1p) was over-expressed in both wild-type and plc1Δ cells, and observed by 
fluorescence microscopy (native expression of GFP-Plc1p produces insufficient 
signal, NM Perera 2002, pers. comm.).  
 
Fluorescent proteins with different emission colours are valuable tools for in vivo 
multi-labelling experiments. DsRed is a 28 kDa red fluorescent protein (DsRed) 
cloned from coral of the Discoma genus (Baird et al. 2000). pUR34NLS, a construct 
that expresses DsRed as an amino-terminal fusion protein with an NLS1 (nuclear 
localisation signal) fragment of the simian virus 40 large T antigen, specifically 
targets the DsRed construct to the nucleus (Rodrigues et al. 2001). Nuclei were 
revealed by fluorescence microscopy (under a different excitation wavelength) by co-
transformation of the cells with a plasmid expressing a DsRed-NLS fusion protein 
(Fig 3.2).  
 
GFP-Plc1p was a stable construct (APPX. Fig A) and distributed in both nucleus and 
cytoplasm, but more concentrated in the nucleus (Fig 3.2). The distribution of GFP-
Plc1p was not significantly different in BY4742 wild-type and in a PLC1 knockout 
mutant. As a control, the expression of transfected GFP was seen as even fluorescence 
throughout the cells, except within the vacuole (Fig 3.3). Significantly more 
fluorescent signal was detected in the nucleus of GFP-Plc1p than of GFP in wild-type 
(P < 0.001, Fig 3.3), indicating the existence of some mechanism for concentrating 
Plc1p in the nucleus. I also observed that BY4742 plc1::KANMX4 cells grew more  
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Figure 3.2: Localisation of GFP-tagged Plc1p in wild-type and plc1Δ 
 
Genotype Fluorescence Ratio (Nuclear/Cytosolic) 
pUG36-PLC1 in WT 1.71 ± 0.04 
pUG36-PLC1 in plc1Δ 1.65 ± 0.04 
[There was no significant difference between the values in the two groups.] 
Fluorescence images of logarithmic phase cultures (5 x 106 – 1 x 107 cells/ml) of wild type BY4742 
(top) and plc1Δ (bottom) transformed with pUG36–PLC1 and pUR34NLS, respectively. The left-hand 
columns show low light DIC images. The left-mid columns show the localisation of the indicated GFP 
constructs. The right-mid columns show the localisation of nuclei as obtained by transformation of 
cells with a NLS construct, and the merged images are shown in the right-hand columns. These images 
are representative of three replicate cultures. The table shows ratios of fluorescence intensity between 
the nucleus and cytosol. Each value represents the mean ± S.E.M. of ten determinations. 
 
 
 
Figure 3.3: Localisation of GFP in wild-type cells 
                                   DIC                             GFP                        DsRed                       Merged   
                              
 
Genotype Fluorescence Ratio (Nuclear/Cytosolic) 
pUG36-PLC1 in WT 1.71 ± 0.04 
pUG36 in WT                                 1.19 ± 0.05*** 
[Significantly different from GFP-Plc1p in WT: ***P<0.001.] 
Fluorescence images of logarithmic phase cultures (5 x 106 – 1 x 107 cells/ml) of wild type BY4742 
transformed with pUG36, respectively. The left-hand columns show low light DIC images. The right 
columns show the localisation of the indicated GFP constructs. These images are representative of three 
replicate cultures. All strains were cultured in SC-Ura-Met + 2% glucose medium. The table shows 
ratios of fluorescence intensity between the nucleus and cytosol. Each value represents the mean ± 
S.E.M. of ten determinations. 
DsRed-NLS  
+ GFP in  
WT 
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slowly than wild-type even at the permissive temperature of 23 oC, indicating defects 
in PLC1 depleted cells. 
 
It is important to bear in mind that the readings of the fluorescence intensity collected 
in this study do not present the ‘true’ intensity. Each measurement in a set of 
fluorescence values will, in simple terms, represent the fluorescence emitted from the 
full depth of a chosen area of the imaged cell. Most of the fluorescence from the 
'cytoplasm' areas will be from cytoplasmic constituents, with a little from overlying 
and underlying plasma membrane. Fluorescence that contributed to 'nuclear' 
measurements will have come both from the nucleus and from the cytoplasm and 
plasma membrane that overlie and underlie it, with the nucleus occupying maybe one-
third of the depth of the cell.  As a result, any change in the nucleus/cytoplasm 
fluorescence ratio provide a valid indication of the direction of any change in 
fluorescent protein distribution, but it will understate the relative changes in protein 
concentrations in the two compartments - and particularly in changes within the quite 
small nuclear volume. 
 
3.4 Nucleo-cytoplasmic distribution of Plc1p and possible changes during cell 
cycle 
So, is Plc1p constantly resident in the nucleus or does it, like the mammalian PLC-δ1, 
undergo dynamic nucleo-cytoplasmic shuttling?  
 
Since Plc1p appeares to include a potential nuclear export signal (NES) (see later 
section 3.6.1) I decided to look for evidence of nucleo-cytoplasmic shuttling. The 
nuclear export receptor Xpo1p mediates the nuclear export of proteins with a leucine-
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rich NES, so I used a temperature-sensitive mutant xpo1-1 to test for such shuttling 
(Maurer et al. 2001). At elevated temperature, xpo1-1 is inactivated, allowing 
intranuclear proteins that contain a ‘classic’ NES to accumulate in the nucleus (e.g. 
Yrb1p) (Kunzler et al. 2000) (Figure 3.4). If Plc1p was undergoing this type of 
shuttling, then a larger proportion of GFP-Plc1p should be retained in the nucleus in 
the xpo1-1 mutant at 37ºC.  
 
Figure 3.4: Trafficking of NES-containing proteins through the temperature-
sensitive xpo1-1 mutant of the XPO1 nuclear exporter 
 
 
 
 
 
 
XPO1 and xpo1-1 cells were transformed with a plasmid expressing GFP-Plc1p and 
grown at the permissive temperatures (23oC) before they were shifted to 37oC for 2 
hours, followed by immediate microscopy. As the results in Fig 3.5 show, there was 
no obvious re-distribution of GFP-Plc1p observed in XPO1 cells after shift from 23oC 
to 37oC. However, GFP-Plc1p did become significantly more concentrated in the 
nucleus of the xpo1-1 strain after shift to 37oC (Fig 3.5). 
 
 
   Permissive temperature (23 oC)                        Restrictive temperature (37 oC) 
CYTOPLASM CYTOPLASM 
NUCLEUS
X NES-containing proteins 
NUCLEUS 
             NES-containing                     NES-containing            
              proteins                                  proteins                          
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Figure 3.5: Localization of GFP-Plc1p in XPO1 and xpo1-1 
  
                   
Fluorescence Ratio (Nuclear/Cytosolic) Genotype 
23 oC 37 oC 
pUG36-PLC1 in XPO1 1.62 ± 0.05 1.67 ± 0.06 
pUG36-PLC1 in xpo1-1   1.52 ± 0.03*     1.65 ± 0.05** 
[Significantly different from GFP-Plc1p in XPO1 at 23 oC: 0.01<*P<0.05.] 
[Significantly different from GFP-Plc1p in xpo1-1 at 23 oC: 0.001<**P<0.01.] 
Logarithmic phase cultures (5 x 106 – 1 x 107 cells/ml) were grown at 23oC then either left at this 
temperature or shifted to 37oC for 2h. The left-hand columns show low light DIC images. The right 
columns show the localisation of the indicated GFP constructs. These images are representative of 
three replicate cultures. All strains were cultured in SC-Ura-Met-His+2% glu medium. The table shows 
ratios of fluorescence intensity between the nucleus and cytosol. Each value represents the mean ± 
S.E.M. of ten determinations. 
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Several experimental observations have suggested that Plc1p might be involved in cell 
cycle control (DeLillo et al., 2003; Lin et al., 2000). Plc1p is likely to regulate cell 
stress responses via the C-type cyclin Ume3p (Cooper et al. 1999). Growth control by 
the cyclin-dependent protein kinase complex Pho80p/Pho85p is dependent on Plc1p 
(Flick and Thorner 1998). Also, more recently, Plc1p was found to accumulate at the 
centromeres during G2/M stage of cell cycle and to affect kinetochore function 
(DeLillo et al. 2003).  
 
I therefore examined Plc1p localisation at different stages of the cell cycle by 
arresting yeast cells at G1, M or S phase. Fig 3.6 shows the characteristic morphology 
of the budding yeast cell at different points in the cell cycle. Note, the nuclear 
envelope remains intact the whole time in S. cerevisiae. Rapamycin inhibits TOR 
kinase and arrests the cells at the G1 phase (Heitman et al. 1991). Nocodazole inhibits 
the polymerization of tubulin into microtubules and arrests cells at M phase, and 
hydroxyurea inhibits ribonucleotide reductase and arrests cells at S phase (Iwaki et al. 
2007). 
 
After these drug treatments, there was no marked change in the distribution of GFP-
Plc1p between nucleus and cytoplasm (Fig 3.7). However, quantitation and statistical 
analysis of the imaging data revealed a significant drop in the ratio of nuclear GFP-
Plc1p fluorescence intensity, relative to the cytoplasm in hydroxyurea treated cells 
compared with the distribution in untreated wild type cells (P < 0.01). No alterations 
in distribution were observed in any of the other drug-treated cells, even with longer 
treatments (data not shown). This indicates that cells tend to accumulate more 
cytosolic Plc1p during S phase, which is the preparation stage for mitosis, during  
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which the bud emerges and DNA synthesis takes place. Plc1p then appears to 
accumulate in the nucleus during the G2/M phase when nuclear division occurs. This 
is consistent with the idea that Plc1p may contribute to essential activities in the 
nucleus during this time. 
 
3.5 Plc1p localization during cell stresses 
3.5.1 Heat stress 
The Plc1p gene includes a presumptive binding site for heat shock transcription factor 
upstream of its TATA box (-156 to -169), and inactivation of Plc1p makes yeast more 
heat-sensitive (Flick and Thorner 1993). PLC1 cells grow normally at 37°C, but plc1Δ 
cells grow very slowly and are prone to lysis (Fig 3.8). The plc1Δ cells are still viable 
for a time, but they become enlarged, multibudded and unable to complete cytokinesis  
Figure 3.6: Shown below is a diagram illustrating the characteristic morphology of 
the budding yeast cell at various points in the cycle (Neumann FT A, 2005) 
 
The following criteria are characteristic of indicated stage:  
G1 phase: unbudded cells with round nuclei, or attached pairs of post-telophase cells that have two 
round, clearly separated nuclei; early S: with initial bud emergence, cells are in early S; mid-to-late S: 
cells with a bud big enough to form a ring at the bud neck, in which the nuclei are still round and 
centered in the mother cell; G2 phase: large budded cells (bud ≥ 2/3 size of mother cell) with the 
nucleus at the bud neck; mitosis (M): large budded cells in which the nucleus extends into the daughter 
cell due to spindle extension; telophase (T): two globular cells with two distinct nuclei that remain 
connected by residual nuclear structures.
 106
Figure 3.7: Localization of GFP-Plc1p at different stages of the cell cycle 
 
 
Fluorescence Ratio (Nuclear/Cytosolic) 
Genotype 
Untreated 
Rapamycin 
(G1) 
Nocodazole 
(M) 
Hydroxyurea 
(S) 
DMSO 
(control) 
pUG36-PLC1 in WT 1.71±0.04 1.79±0.06 1.62±0.07 1.54±0.01** 1.65±0.03 
[Significantly different from GFP-Plc1p in WT: 0.001<**P<0.01.] 
Low light DIC (left columns) and Fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of BY4742 + pUG36–PLC1 at 23°C after 200 ng/ml Rapamycin treatment for 
6 hours, 15μg/ml Nocodazole for 4 hours or 100mM Hydroxyurea for 4 hours. The bottom panel shows 
the untreated control cells in drug carrier DMSO (0.15% v:v). These images are representative of three 
replicate cultures. All strains were cultured in SC-Ura-Met +2% glu medium. The table shows ratios of 
fluorescence intensity between the nucleus and cytosol. Each value represents the mean ± S.E.M. of ten 
determinations. 
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 plc1Δ 
WT 
          37°C for 2 days  
(Flick and Thorner 1993). In mammalian cells, heat shock activates unidentified PLC 
isoenzymes, resulting in the synthesis of inositol polyphosphates (Calderwood and 
Stevenson 1993). Higher inositol phosphates also accumulate in S. cerevisiae cells 
incubated at 37ºC. After wild-type S. cerevisiae cultures were rapidly elevated from 
23oC to 37oC, an activation of PtdIns(4,5)P2 synthesis was detected, followed by 
PtdIns(4,5)P2 depletion and a corresponding accumulation of InsP6 that was sustained 
for at least ~1 hour. The increase in InsP6 was not seen in plc1Δ cells, indicating a 
possible activation of Plc1p in response to heat stress (Perera et al., 2004).  
 
Fig 3.8: Growth of wild-type and plc1Δ mutant at 37°C 
  
  
 
 
BY4742 wild-type and plc1Δ (plc1::KANMX4) cells were grown to exponential phase ( ~1 x 107 
cells/ml) in YPD + 2% glu media. A dilution assay was then carried out as described section 2.16. Cells 
were serially diluted five-fold then grown on YTD agar plates (2% glu) at 37 oC for 2 days. Data are 
representative of three independent experiments. 
 
I examined the distribution of GFP-Plc1p during heat stress. There was no detectable 
change in the localisation of Plc1p after growing at 37°C for 2 hours compared with 
the GFP distribution at the permissive temperature of 23°C, as in the data on XPO1 
cells grown at 23°C and 37°C that were discussed earlier. Also, no re-distribution was 
detected after a rapid shift from 23°C to 37°C (Fig 3.9). However, nearly half of the 
cells displayed punctate nuclear and cytoplasmic fluorescence, which may have 
influenced the intensity readings and might indicate an association of Plc1p with some 
kind of nuclear and membrane structures.  
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Fig 3.9: Localization of GFP-Plc1p in yeast growing at/after 37°C 
 
Fluorescence Ratio (Nuclear/Cytosolic) Genotype 37'C 2 hours 23'C (shifted from 37'C)  23'C (untreated) 
pUG36-PLC1 in WT 1.64 ± 0.07 1.74 ± 0.08 1.71 ± 0.04 
[There was no significant difference between any of the above values.] 
Low light DIC (left columns) and Fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of BY4742 + pUG36–PLC1, growing at 37°C for 2 hours and at 23°C 1 hour 
after shifted from 37°C. These images are representative of three replicate cultures. All strains were 
cultured in SC-Ura-Met +2% glu medium. The table shows ratios of fluorescence intensity between the 
nucleus and cytosol. Each value represents the mean ± S.E.M. of ten determinations. 
 
 
3.5.2 Osmotic stress  
Osmotic stresses are amongst the most common environmental changes that yeast 
cells experience throughout their life cycle. Despite the variety of the responses they 
trigger, the signalling mechanisms that control these responses are incompletely 
understood (Hohmann 2002). 
 
In yeast, the HOG (High Osmolarity Glycerol) pathway regulates many of the long-
term cellular responses to an increased external osmolarity (Brewster et al. 1993; 
Schuller et al. 1994). This pathway is defined by the PBS2 and HOG1 genes, which 
encode members of the MAPKK (MAP kinase kinase) and MAPK (mitogen-activated 
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protein kinase) families respectively (Brewster et al. 1993). Activation of this 
pathway initiates a phosphorylation cascade that leads to nuclear translocation of 
phosphorylated Hog1p. Nuclear Hog1p regulates gene expression, involving both 
repression and activation (Proft and Serrano 1999), that leads to an accumulation of 
intracellular glycerol (Larsson et al. 1993). Homologs of Hog1p have been found in 
other eukaryotic cells, indicating that the HOG pathway is likely conserved, though its 
functions are not always the same (Han et al. 1994). 
 
Flick and Thorner reported plc1Δ mutants were very sensitive to hypertonic stress 
(Flick and Thorner 1993). A double mutant of plc1Δhog1Δ was more osmosensitive 
and synthesized less glycerol than strains with single deletions. Plc1p and Hog1p 
therefore appear to function in independent pathways that regulate the response of 
yeast cells to increased extracellular osmolarity (Lin et al. 2002).  
 
Responses to hypotonic shock are mediated through the PKC1 signal transduction 
cascade (Davenport et al. 1995), PKC1 encodes a protein kinase C-like protein in 
yeast (Levin et al. 1990). Genetic approaches have identified other protein kinases in 
the Pkc1p pathway, and these form a linear cascade from Pkc1p to the MAPKKK 
(Bck1p) (Costigan et al. 1992), to two MAPKKs (Mkk1p and Mkk2p) (Irie et al. 
1993) and a MAPK (Mpk1p) (Lee et al. 1993). These enzymes are also conserved in 
mammalian cells (Lee et al. 1993). 
 
It has long been suggested that an ill-defined PLC activity is regulated by hypotonic 
shock in animal cells. In several cell types, hypo-osmotic treatment leads to rapid 
hydrolysis of phosphoinositides and generation of inositol phosphates. This hydrolysis 
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was inhibited by the PLC inhibitor U73122 (Einspahr et al. 1988; Bender et al. 1993). 
Earlier experiments in our laboratory showed that hypo-osmotic stress induces Plc1p 
activation: After wild-type cells were hypo-osmotically shocked for 2 minutes, InsP6 
levels were raised about 3-fold (Perera et al., 2004).  
 
In the terms of the localization of PLC during its activation, a previous study in 
MDCK cells found that PLC-δ1 was both activated and translocated from the plasma 
membrane to the perinuclear region after hypo-osmotic stress (Yagisawa et al. 2002). 
I therefore examined the localization of Plc1p before and after osmotic stresses.  
 
To visualize the localization of Plc1p during hyper-osmotic shock, exponential phase 
wild type cells expressing GFP-Plc1p were shifted to a synthetic complete medium 
(depleted of methionine and uracil) containing 0.6M NaCl. Images were taken at 2 
min, 15 min and 2 hours. The cell suspensions were then quickly diluted ten-fold in 
the same medium but without the extra NaCl. The localization of GFP-Plc1p was 
again examined at 2 min, 15 min and 2 hours to record what occurs during the 
resulting hypo-osmotic stress.  
 
Although there were no striking changes in the fluorescence distribution after either 
treatment (Fig 3.10), fluorescence quantitation and statistical analysis did detect a 
distinct decrease in the ratio of nuclear vs. cytosolic GFP-Plc1p resulting from the 
osmotic disturbances (Fig 3.10). A slight shift of Plc1p from the nucleus to the 
cytoplasm occurred within 2 minutes in response to the raised salt concentration and 
was gradually reversed (P > 0.05), and much the same happened when cells were 
diluted back into normal medium.  
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Figure 3.10:  Localization of GFP-Plc1p in wild-type cells  
during hype- and hypo-osmotic shock 
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Treatment Fluorescence Ratio (Nuclear/Cytosolic) 
time 2 min 15 min 2 Hrs 
Hyper-osmotic shocked 1.59 ± 0.04* 1.64 ± 0.04 1.63 ± 0.07 
Hypo-osmotic shocked 1.54 ± 0.05* 1.59 ± 0.03* 1.61 ± 0.04 
untreated 1.71 ± 0.04 
[Significantly different from the untreated: 0.01<*P<0.05.] 
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Logarithmic phase cultures (5 x 106 – 1 x 107 cells/ml) of BY4742 + pUG36–PLC1 at 25°C in SC-Ura-
Met +2% glu + 0.6M NaCl medium (hyper-) for 2 min, 15 min, and 2 hours, followed by a shift to a 10 
times diluted same media (hypo-) for another 2 min, 15 min, and 2 hours. These images are 
representative of three cultures. The table shows ratios of fluorescence intensity between the nucleus 
and cytosol. Each value represents the mean ± S.E.M. of ten determinations. 
 
 
The latter result is consistent with the observation of Dr Perera that Plc1p was 
stimulated upon hypo-osmotic shock for 2 minutes and that the loss of cellular 
PtdIns(4,5)P2 occurred at the plasma membrane (Perera et al., 2004). It seems that a 
sudden osmotic change to the growth environment in either direction results in a small 
proportion of the initially nuclear Plc1p moving to the cytoplasm.  How this occurs 
remains to be determined. 
 
Conclusively, I did not observe any change in Plc1p localisation after cells were 
subjected to raised temperature, but a small nuclear-to-cytoplasmic shift occurred 
after challenge in media of increased and decreased osmotic potential. Plc1p seems to 
undergo some rapid intracellular translocation in response to stresses. This then 
reverts to the ‘normal’ distribution fairly quickly.  
 
3.6 How does Plc1p get into the nucleus: nucleo-cytoplasmic signalling of Plc1p 
It has been suspected for a decade or so that some phosphoinositides reside in the 
nucleus, and that nuclear turnover might be regulated by mechanisms that are 
independent of the phosphoinositides in the plasma membrane and cytoplasmic 
membranes. Many of the key lipids and enzymes responsible for the metabolism of 
inositol lipids were also found in the nuclei (Irvine 2000). The yeast PLC distributes 
in both nucleus and cytoplasm throughout all stages of the cell cycle as well as during 
various stresses. Many of the postulated functions of Plc1p are nuclear functions, but 
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we wondered whether Plc1p might also have distinct functions in the cytoplasm, 
because much of the protein is present outside the nucleus. In order to address this 
question, I produced mutants of Plc1p that would be largely restricted to one 
compartment, so as to identify which phenotypes require nuclear or cytoplasmic 
Plc1p.  
 
Unlike small molecules which pass through the NPC (nuclear pore complex) freely by 
diffusion, proteins as large as Plc1p are specifically selected to translocate through the 
nuclear pores, relying on their own NLS (nuclear localization signals) and NES 
(nuclear export signals).  One of the goals of this study was to find two short amino-
acid sequences, which were likely to be the NLS and NES that mediate the entry and 
exit of Plc1p from the nucleus.  
 
3.6.1 Nuclear Export Signal in Plc1p 
The canonical NES is a short leucine-rich sequence motif (Kunzler et al. 2000). Such 
NES sequences have been found in the EF-hand of rat PLC-δ1, confering a 
predominantly cytosolic localisation upon this enzyme (Yamaga et al. 1999). 
Computer search of the amino-acid sequence of the open reading frame of PLC1 
revealed a putative NES-like motif in its PH domain, KLKALH (residues 189-194). 
Mutation of the leucines in the KLKALH motif proved critical for Plc1p nuclear 
export as a mutant Plc1p tagged with GFP in which these two leucines (Leu190 and 
Leu193) were replaced by alanines showed aberrant localisation. This Plc1pNES mutant 
(Plc1pL190A/L193A) was stable (APPX. Fig A) and displayed GFP fluorescence that was 
highly concentrated in the nucleus, suggesting an almost complete loss of NES 
function (Fig 3.11).  
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Figure 3.11:  Localization of GFP-Plc1pNES  
 
 
              
Genotype Fluorescence Ratio (Nuclear/Cytosolic) 
pUG36- PLC1NES in WT      2.27 ± 0.05***
pUG36-PLC1 in WT 1.71 ± 0.04
 [Significantly different from GFP-Plc1p in WT: ***P<0.001.] 
Low light DIC (left columns) and Fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of BY4742 + pUG36– PLC1NES (GFP-Plc1pL190A/L193A). These images are 
representative of three replicate cultures. All strains were cultured in SC-Ura-Met +2% glu medium. 
The table shows ratios of fluorescence intensity in nucleus and cytosol. Each value represents the mean 
± S.E.M. of ten determinations. 
 
This Plc1pNES is therefore a valuable reagent provided that the mutations I have 
introduced do not compromise the catalytic activity of Plc1p. This was tested by 
making an additional insertion mutation in addition to the NES which resulted in a 
mutant that no longer restricted in the nucleus though still bearing the L190A/L193A 
mutations, and the behavior of this mutant proved that these amino acid alterations in 
the NES mutant did not disrupt the catalytic function of Plc1p. This will be discussed 
in more detail in a later section (section 3.7). 
 
 
 
 
 115
3.6.2 Identification of the Nuclear Localization Signal (NLS) of Plc1p 
3.6.2.1 Delimiting the location of the NLS in truncations of PLC1  
The next step was to define the NLS of Plc1p. A typical NLS is generally a cluster or 
clusters of 5-10 basic amino acids in a distinct sequence pattern. For example, a basic 
amino acid cluster in the PH domain of PLC-δ4 is responsible for its nuclear 
localization (Liu et al. 1996), two lysine’s (K432 and K434) in the X-Y linker of 
PLC-δ1 play a role in its nuclear entry (Yagisawa et al. 2002), and that the NLS of 
PLC-β1 appears to be in its C-terminal region (Kim et al. 1996). It seems that PLC 
isozymes, even in the same family, can display a number of disparate ways of 
entering the nucleus using amino-acid motifs at a variety of positions in the protein.   
 
Our search began with truncations of the PLC1 gene. We expected that Plc1p might 
be similar to PLC-δ1, with an NLS situated between the X and Y domains of the 
catalytic β-barrel because of a NLS sequence match existing in this linker. However, 
mutation of the putative NLS sequence in the X-Y linker of Plc1p did not alter nuclear 
localisation at all (data not shown). In addition, I observed that a truncation mutant 
encoding only the first 333 amino-acids of Plc1p was nuclear when expressed as an 
N-terminal GFP fusion (Fig 3.12).   
 
This Plc1p1-333 construct was stable (APPX. Fig A) and displayed the same subcellular 
localization as the full length Plc1p, as determined by fluorescence quantitation and 
statistical analysis, despite encoding only the Plc1p-unique N-terminal domain, the 
PH domain and the EF hand. This suggested that the NLS sequence must reside in the 
N-terminal ~333 amino-acids of Plc1p in a position different from that of the NLSs of 
mammalian PLCs. 
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Figure 3.12:  Localization of GFP-Plc1p1-333 
 
 
 
                
Genotype Fluorescence Ratio (Nuclear/Cytosolic) 
pUG36- PLC11-333 in WT 1.72 ± 0.06
pUG36-PLC1 in WT 1.71 ± 0.04
 [There was no significant difference between the above values.] 
Low light DIC (left columns) and fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of BY4742 + pUG36–PLC11-333. These images are representative of three 
replicate cultures. All strains were cultured in SC-Ura-Met +2% glu medium. The table shows ratios of 
fluorescence intensity in nucleus and cytosol. Each value represents the mean ± S.E.M. of ten 
determinations. 
 
Further truncation mutants were constructed to define the region in which the Plc1p 
NLS resides more closely. All of these, including Plc1p1-333, were transformed into 
wild-type cells (containing their own untagged, full-length Plc1p) and into plc1Δ 
mutants. No difference was observed in the localization of our Plc1p truncated 
mutants in wild type or plc1Δ cells, so only images of wild-type cells are shown.  
 
None of the truncation mutants (GFP-Plc1p220-333, GFP-Plc1p1-220, GFP-Plc1p1-110 or 
GFP-Plc1p110-220) displayed marked nuclear fluorescence similar to that of full-length 
Plc1p, but there was a slight concentration of nuclear fluorescence in some cells. 
Statistical analysis revealed that the GFP-Plc1p-truncations did show some nuclear 
concentration but to a much lower degree than the full-length protein (P < 0.001) (Fig 
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3.13). That two of the non-overlapping constructs, Plc1p1-220 and Plc1p220-333, showed 
significant nuclear localisation. Since GFP itself cannot accumulate in the nucleus, the 
GFP-signal presumably derives from the Plc1p-truncations. This suggested that two 
weak NLSs might contribute to the nuclear localisation of Plc1p.  
 
Figure 3.13:  Localization of 
GFP-Plc1p220-333, GFP-Plc1p1-220, GFP-Plc1p1-110, GFP-Plc1p110-220 
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Genotype Fluorescence Ratio (Nuclear/Cytosolic) 
pUG36-PLC1220-333 in WT 1.32 ± 0.02***/+ 
pUG36-PLC11-220 in WT 1.38 ± 0.03***/++ 
pUG36-PLC11-110 in WT 1.19 ± 0.02*** 
pUG36-PLC1110-220 in WT 1.19 ± 0.02*** 
pUG36-PLC1 in WT                                1.71 ± 0.04 
[Significantly different from GFP-Plc1p in WT: ***P<0.001.] 
[Significantly different from GFP in WT: 0.01<+P<0.05, 0.001<++P<0.01] 
Low light DIC (left columns) and Fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of BY4742 transformed with indicated the truncation mutants, respectively. 
These images are representative of three replicate cultures. All strains were cultured in SC-Ura-Met 
+2% glu. The table shows the ratio of fluorescence intensity between nucleus and cytosol. Each value 
represents the mean ± S.E.M. of ten determinations.  
 
However, these four truncation constructs were not very stable (APPX. Fig A), so 
source of the observed fluorescence may have come from liberated GFP. Attempts to 
express smaller truncation (less than 220 amino-acids) mutants of Plc1p were not 
successful.  
 
In order to gain further insight into the nature of these sequences, I constructed N-
terminal GFP-linked truncations that lacked increasingly large portions of the N-
terminus of Plc1p: GFP-Plc1p110-end, GFP-Plc1p220-end and GFP-Plc1p333-end. I hoped 
that the N-terminal GFP fusions would protect the unnatural N-termini and so result in 
better stability. Two of these constructs, GFP-Plc1p110-end and GFP-Plc1p220-end, were 
stable (APPX. Fig A) and concentrated in the nucleus (Fig 3.14). This was not  
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Figure 3.14:  Localization of GFP-Plc1p110-end, GFP-Plc1p220-end, GFP-Plc1p333-end 
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Genotype Fluorescence Ratio (Nuclear/Cytosolic) 
pUG36-PLC1110-end in WT                              2.06 ± 0.04***/++ 
pUG36-PLC1220-end in WT                              2.10 ± 0.04***/++ 
pUG36-PLC1333-end in WT N/A 
pUG36-PLC1 in WT 1.71 ± 0.04 
pUG36-PLC1NES in WT 2.27 ± 0.05 
[Significantly different from GFP-Plc1p in WT: ***P<0.001.] 
[Significantly different from GFP-Plc1pNES in WT: 0.001<++P<0.01.] 
Low light DIC (left columns) and fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of BY4742 transformed with the indicated truncation mutants, respectively. 
These images are representative of three replicate cultures. All strains were cultured in SC-Ura-Met 
+2% glu. The table shows ratio of fluorescence intensity in nucleus and cytosol. Each value represents 
the mean ± S.E.M. of ten determinations.  
 
 
surprising, since the (220-end) construct is likely to lack a functional NES sequence 
and the (110-end) construct may have a disrupted NES, because the NES sequence is 
close to its end and may be obscured by the linker between GFP and the Plc1p 
sequence. The fluorescence of GFP-Plc1p333-end, which encodes the X and Y domains 
and the C2 domain of Plc1p, was very poor (Fig 3.14), probably because of its 
instability (APPX. Fig A).  
 
I had evidence from the C-terminal truncations that the first 333 amino-acids of Plc1p 
might include an NLS(s), and the N-terminal truncations suggested that there might be 
an NLS sequence between amino-acids 220 – 333 of Plc1p because the (220-end) 
construct is also nuclear. This lends weight to the idea that there is more than one 
means of achieving nuclear localisation in Plc1p with all the sequences required for 
both mechanisms residing in the first 333 amino-acids. Either or both of these 
sequences (1-220 and 220-333) may be a classical NLS sequences or may be protein-
protein interaction domain(s) that allow Plc1p to interact with other protein(s) that 
containing their own NLS sequences and could thus “piggy-back” Plc1p into the 
nucleus.  
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3.6.2.2 Mutagenesis of putative NLS sequences in PLC1  
Having located a possible NLS in the first 333 residues of Plc1p, I tried to define this 
NLS by site directed mutagenesis. I compared the N-terminal 333 amino-acids of 
PLC1 with the corresponding regions of PLC-δ1 and PLC-δ3, which do not include 
NLSs (Cheng et al. 1995). This amino-acid alignment highlighted a cluster of basic 
amino-acid residues (R111, R117, R120, R123) immediately N-terminal to the PH 
domain of Plc1p, but not present in rat PLC1-δ1. I therefore exchanged these four 
arginines in Plc1p with the corresponding amino acids in the rat PLC-δ1 sequence: 
R111L/R117S/R120S/R123E. The resulting construct, GFP-Plc1p4R (pUG36-
PLC1R111L/R117S/R120S/R123E), was stable (APPX. Fig A) and entered the nucleus less 
efficiently than wild-type GFP-Plc1p (Fig 3.15, P < 0.01).  
 
A search for classical NLSs within the first 333 amino-acids was also mounted using 
the NLS consensus determined by Corbett’s group (Leung et al. 2003). This 
comprises a loose consensus sequence of K(K/R)X(K/R), with a lysine in position 1, 
followed by basic residues in positions 2 and 4. This identified a KKLRK sequence 
(residues 94-98) and a KRLR sequence (residues 170-173).  
 
I then performed site-directed mutagenesis on the PLC1 possible NLSs, by converting 
the basic amino-acids in these two regions to neutral ones: K94A/K95A/R97A for 
KKLRK, and K170A/R171A/R173A for KRLR. These were ligated into pUG36 to 
create N-terminal GFP fusions, and transformed to BY4742 and BY4742 plc1Δ cells. 
Both mutants displayed decreased nuclear fluorescence, with GFP-Plc1pKKLRK 
(K94A/K95A/R97A) having the more profound effect (Fig 3.15). GFP-Plc1pKRLR 
(K170A/R171A/R173A) was stable but the K94A/K95A/R97A mutations yielded a 
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somewhat unstable construct (APPX. Fig A). Neither of these sequences on its own 
was sufficient to exclude Plc1p from the nucleus. 
 
Conclusively, mutations of three putative NLSs in the first 180 amino-acids of Plc1p 
attenuated the nuclear localization of Plc1p. However, the nuclear localization of 
Plc1p was not abolished by loss of any single putative NLS, therefore they may act 
together. Attempts to combine these mutations failed because of the instability of 
these multiple mutant constructs (data not shown). 
 
Figure 3.15:  Localization of GFP-Plc1p4R, GFP-Plc1pKKLRK and GFP-Plc1pKRLR 
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Genotype Fluorescence Ratio (Nuclear/Cytosolic) 
pUG36-PLC14R in WT                                    1.51 ± 0.04** 
pUG36-PLC1KKLRK in WT                                    1.47 ± 0.03*** 
pUG36-PLC1KRLR in WT                                    1.57 ± 0.05** 
pUG36-PLC1 in WT 1.71 ± 0.04 
[Significantly different from GFP-Plc1p in WT: ***P<0.001, 0.001<**P<0.01.] 
Low light DIC (left columns) and Fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of BY4742 transformed with the indicated PLC1 mutant constructs, 
respectively. These images are representative of three replicate cultures. All strains were cultured in 
SC-Ura-Met +2% glu medium. The table shows ratio of fluorescence intensity in nucleus and cytosol. 
Each value represents the mean ± S.E.M. of ten determinations.  
 
 
3.6.3 A plasma membrane localised Plc1p mutant – PLC1CAAX 
Difficulty in defining the NLS sequence of Plc1p made it hard to determine the 
phenotypes of cells expressing exclusively cytoplasmic or nuclear Plc1p. I therefore 
tried to create a cytoplasmic version of Plc1p that would overcome the influence of 
NLSs.  
 
The first strategy was to cause prenylation of Plc1p by adding a CAAX sequence to 
the C-terminus, in which C indicates a cysteine, A is an aliphatic amino acid (I used 
2× isoleucines), and X is any amino acid (serine). A prenylated GFP was first made, 
and its intracellular localization in wild-type (BY4742) cells was examined. As 
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expected, GFPCAAX was localised as a green fluorescent ring at the plasma membrane 
(Fig 3.16). Plc1pCAAX was expected to be located at the plasma membrane.  
 
Figure 3.16:  Localization of GFPCAAX and GFP-Plc1pCAAX 
 
 
 
Genotype Fluorescence Ratio (Plasma Membrane/Nuclear/Cytosolic) 
pUG36-CAAX in WT (1.40±0.02):(1.08±0.043):(1±0) 
pUG36-PLC1CAAX in WT [(1.14±0.03)+++:(1.14±0.04)***/+++]+:(1±0) 
pUG36-PLC1 in WT (N/A): (1.71 ± 0.04): (1±0) 
[Significantly different from GFP-Plc1p in WT: ***P<0.001.] 
[Significantly different from GFPCAAX in WT: +++P<0.001, 0.01<+P<0.05.] 
Fluorescence images of logarithmic phase cultures (5 x 106 – 1 x 107 cells/ml) of BY4742 transformed 
with the indicated constructs. The left-hand columns show low light DIC images. The left-mid columns 
show the localisation of the indicated GFP constructs. The right-mid columns show the localisation of 
nuclei as obtained by transformation of cells with a NLS construct, and the merged images are shown 
on the right-hand columns. These images are representative of three replicate cultures. All strains were 
cultured in SC-Ura-Met-His+2% glu medium. The table shows ratio of fluorescence intensity in PM 
(plasma membrane), nucleus and cytosol. Each value represents the mean ± S.E.M. of ten 
determinations.  
 
GFP-Plc1pCAAX was very stable construct (APPX. Fig A). A green fluorescent ring 
was detected on the yeast plasma membrane when Plc1pCAAX was expressed in cells 
as a C-terminal GFP fusion of Plc1p, indicating that GFP-Plc1pCAAX was indeed 
prenylated. However, there is still a small pool of Plc1pCAAX in the nucleus (Fig 3.16): 
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probably as a result of immediate nuclear translocation of nascent Plc1pCAAX after 
translation, before the prenyl transferases can get access to this mutant.  
 
3.6.4 Cytoplasmic Plc1p mutant – PLC1PKI 
In addition to the plasma membrane localised PLC1CAAX mutant, I decided to make a 
Plc1p that could be excluded from the nucleus by inserting into Plc1p two powerful 
NES from PKI.  
 
The NES from the protein kinase A inhibitor PKI (LALKLAGLDI) can redirect a 
variety of proteins from the nucleus to the cytoplasm (Miller and Cross 2000). I first 
attempted to add a carboxyl-terminal PKI NES, but this did not generate a stable 
mutant (data not shown). I then put a tandem PKI NES sequence at the amino-
terminus of Plc1p. This made a Plc1pPKI mutant which was excluded from the nucleus 
and was stable (APPX. Fig A). In these cells, there was a “hole” in the GFP signal in 
the area of the nucleus, as indicated by co-localization with a nuclear marker, 
pUR34NLS (DsRed, see material section) (Fig 3.17).  
 
3.7 The effects of the localisation of Plc1p on its functions 
3.7.1 Stress responses of over-expressed PLC1 mutants 
Once we had the cytoplasmic- and nuclear-restricted Plc1p, I phenotypically 
characterized cells expressing these mutant alleles as their only Plc1p to determine 
how the cytoplasmic and nuclear pools of Plc1p and hence of the liberated inositol 
polyphosphates contributed to Plc1p function.  
 
One concern was, the stress sensitivity of the Plc1pPKI and Plc1pNES mutants could 
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  Figure 3.17:  Localization of GFP-Plc1pPKI 
 
 
 
 
Genotype Fluorescence Ratio (Nuclear/Cytosolic) 
pUG36-PLC1PKI in WT                                      0.71 ± 0.02*** 
pUG36-PLC1 in WT 1.71 ± 0.04 
[Significantly different from GFP-Plc1p in WT: ***P<0.001.] 
Fluorescence images of logarithmic phase cultures (5 x 106 – 1 x 107 cells/ml) of BY4742 transformed 
with the indicated constructs. The left-hand columns show low light DIC images. The left-mid columns 
show the localisation of the indicated GFP constructs. The right-mid columns show the localisation of 
nuclei as obtained by transformation of cells with a NLS construct, and the merged images are shown 
on the right-hand columns. These images are representative of three replicate cultures. All strains were 
cultured in SC-Ura-Met-His+2% glu medium. The table shows ratio of fluorescence intensity in 
nucleus and cytosol. Each value represents the mean ± S.E.M. of ten determinations.  
 
 
 
have been due to the restricted localization of Plc1p or to some a loss of catalytic 
activity. In particular, the mutations in Plc1pNES map close to the PH domain of Plc1p, 
which is required for processive catalysis in animal cells (Cifuentes et al., 1993; 
Lomasney et al., 1996). This must be addressed in some fashion via a control that puts 
back the Plc1pNES mutant into the cytoplasm. If Plc1pNES is normally catalytically 
active, then restoration of some cytoplasmic enzyme should also restore growth etc. If 
it does not, then the suspicion would be that the enzyme does not rescue growth, not 
because it is primarily nuclear, but because it is inactive. 
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I therefore additionally tagged Plc1pNES, the mutant with a defective NES, with a 
CAAX prenylation signal to see whether the CAAX motif would prevent its 
accumulation in the nucleus. We had already observed the full growth of the 
Plc1pCAAX mutant under stresses and CAAX is a strong signal that results in a protein 
become firmly attached to the plasma membrane. I reasoned that if Plc1pNES/CAAX 
possessed a localisation similar to Plc1pCAAX and also appeared to be able to grow at 
37ºC and in 0.7M NaCl, this would ensure us that the original mutations made in the 
Plc1pNES didn’t compromise its activity.  
 
The construct including both the CAAX tag and the NES mutations was stable when 
expressed from pUG36 in yeast (APPX. Fig A). However, the CAAX tag did not 
localise Plc1pNES/CAAX mutant to the plasma membrane as we had hoped. Most of the 
GFP-Plc1pNES/CAAX was trapped in the nucleus, as confirmed by co-expression with 
the nuclear marker with some localized at the nuclear membrane (Fig 3.18).  
 
 
Figure 3.18:  Localization of GFP-Plc1pNES/CAAX 
 
Genotype Fluorescence Ratio (Nuclear/Cytosolic) 
pUG36-PLC1NES/CAAX in WT              1.73 ± 0.10***/+++ 
pUG36-PLC1 in WT     1.71 ± 0.04 
pUG36- PLC1NES in WT     2.27 ± 0.05 
pUG36-PLC1CAAX in WT     1.14 ± 0.04 
[Significantly different from GFP-Plc1pNES in WT: ***P<0.001.] 
[Significantly different from GFP-Plc1pCAAX in WT: +++P<0.001.] 
Fluorescence image of logarithmic phase cultures (5 x 106 – 1 x 107 cells/ml) of BY4742 transformed 
with pUG36-PLC1NES/CAAX. The left-hand columns show low light DIC images. The left-mid columns 
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show the localisation of the indicated GFP constructs. The right-mid columns show the localisation of 
nuclei as obtained by transformation of cells with a NLS construct, and the merged images are shown 
on the right-hand columns. These images are representative of three replicate cultures. All strains were 
cultured in SC-Ura-Met-His+2% glu medium. The table shows ratio of fluorescence intensity in 
nucleus and cytosol. Each value represents the mean ± S.E.M. of ten determinations.  
 
I then created PLC1 allele (Plc1pNES/PKI) that included both the inactivated NES and 
two copies of the PKI NES at its N-terminus. The resulting Plc1pNES/PKI mutant was 
stable (APPX. Fig A). As shown in Fig 3.19, the PKI NESs doesn’t direct all of the 
Plc1pNES/PKI out of the nucleus. Indeed, a nuclear marker of pUR34NLS co-localised 
with some GFP in the nucleus but nuclear localisation was no longer dominant -- 
cytoplasmic localisation is indeed restored in this mutant. 
 
Figure 3.19:  Localization of GFP-Plc1pNES/PKI 
 
 
Genotype Fluorescence Ratio (Nuclear/Cytosolic) 
pUG36-PLC1NES/PKI in WT 0.81 ± 0.02***/+++/### 
pUG36-PLC1 in WT 1.71 ± 0.04 
pUG36-PLC1NES in WT 2.27 ± 0.05 
pUG36-PLC1PKI in WT 0.71 ± 0.02 
[Significantly different from GFP-Plc1p in WT: ***P<0.001.] 
[Significantly different from GFP-Plc1pNES in WT: +++P<0.001.] 
[Significantly different from GFP-Plc1pPKI in WT: ###P<0.001.] 
Fluorescence image of logarithmic phase cultures (5 x 106 – 1 x 107 cells/ml) of BY4742 transformed 
with the indicated constructs. The left-hand columns show low light DIC images. The left-mid columns 
show the localisation of the indicated GFP constructs. The right-mid columns show the localisation of 
nuclei as obtained by transformation of cells with a NLS construct, and the merged images are shown 
on the right-hand columns. These images are representative of three replicate cultures. All strains were 
cultured in SC-Ura-Met-His+2% glu medium. The table shows ratio of fluorescence intensity in 
nucleus and cytosol. Each value represents the mean ± S.E.M. of ten determinations.  
 
 
 129
So, if the nuclear localisation was the reason for the failure of the Plc1pNES mutant to 
grow under stressful conditions, it was then hoped this double mutant, which now had 
most of the Plc1p translocated to the cytosol would show the same ability to grow at 
high temperature, and high salt as wild-type cells.  
 
I first over-expressed the various compartment restricted GFP-tagged Plc1p mutants  
from a single copy of the gene with a powerful promoter in plc1Δ background to test 
their phenotypes. This leads to an approximately ten-fold increase in the steady-state 
level of Plc1p from pMET over that found from endogenous expression, which could 
be partly suppressed by methionine (0.2g/L) in all media used to grow the cells, but I 
did not quantify expression levels in the experiments described below after repression.  
 
Wild-type GFP-Plc1p was functional, insofar as it corrected the slow growth of 
plc1Δ mutants at 23ºC (Fig 3.20). It also allowed these same mutant cells to grow at 
37ºC and on media containing 0.7M NaCl, as expected (Fig 3.20). The plasma 
membrane mutant, Plc1pCAAX appeared to be ‘wild-type’ in phenotype under either 
stress (Fig 3.20), possibly reflecting the fact that it is present in both nucleus and 
cytoplasm, at least when over-expressed. Both the over-expressed GFP-tagged 
Plc1pNES and Plc1pPKI mutants showed the same slow growth phenotype on salt media 
and the heat sensitivity as the plc1Δ strain (Fig 3.20), even when over-expressed. This 
might indicate that restricting Plc1p to either compartment is harmful to cells and that 
cells normally need Plc1p in both locales, or it could be that the mutations or 
insertions in some way inactivate the enzyme.  
 
The Plc1pNES/PKI double mutant grew normally when stressed (Fig 3.20), maybe  
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Fig 3.20: Growth of various pUG36-PLC1 mutants under Stress 
 
plc1Δ cells transformed with pUG36-PLC1 constructs were grown to exponential phase (~1 X 107 
cells/ml) in SC-Ura +2% glu media. Dilution assay was carried out as described in section 2.16. Cells 
were serially diluted five-fold then grown on an SC-Ura+Met (0.2g/L) +2% glu agar plate at 37 oC for 2 
days (till wild-type colonies were fully grown) or on the same plates supplemented with 0.7M NaCl at 
23 oC for 6 days (till wild type colonies were fully grown). The control plate was placed at 23 oC for 2 
days. These data are representative of three independent experiments. 
 
because it maintained pools of Plc1p in both compartments. This suggests that the 
mutations introduced into the natural NES of Plc1p did not impair catalytic function. 
Thus the different growth phenotypes of nuclear and cytoplasmic Plc1p mutants under 
stress seem to arise primarily from their distinct localisations. 
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3.7.2 Stress phenotypes of PLC1 mutants expressed at endogenous levels 
Earlier work showed that over-expression of PLC1 can lead to growth defects and 
perturb cell function (York et al. 1999) and it can be lethal when greatly over-
expressed from a powerful promoter (SK Dove and NM Perera 2002, pers. comm.). 
Expression of GFP-Plc1p from the pUG36 vector, under control of the MET promoter 
has been previously shown to restore hypo-osmotic stress mediated PtdIns(4,5)P2 
depletion and InsP6 accumulation in plc1Δ cells but the basal level of InsP6 is higher 
than wild-type (Perera 2002, p.114).  
 
I therefore sought to insert the PLC1 mutants as knock-ins. A construct was generated 
in which the LEU2 gene was inserted just 3’ of the PLC1 terminator as a selectable 
marker. Then, mutant PLC1 constructs were used to replace the coding region of the 
wild-type PLC1 gene, so as to achieve wild-type expression of these constructs from 
the endogenous promoter.  
 
Although I tried to make these knock-in mutants in several strain backgrounds, I 
could not isolate some of the attempted strains, for unknown reasons. The mutants in 
the BY4742 background are the ones I have successfully investigated so far. The 
effects of high temperature and high salt treatments on these knock-in constructs were 
examined (Fig 3.21). 
 
The Plc1pWT knock in construct appeared to grow faster than the “wild-type” (data not 
shown), probably as a result of acquisition of a functional LEU2 gene. The Plc1pCAAX 
grew normally, but the knock-in Plc1pNES and Plc1pPKI mutants displayed a much 
slower growth rate and were also much more stress sensitive (Fig 3.21).  
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Fig 3.21: Growth of various PLC1 mutants under Stress 
 
BY4742 cells with various PLC1 wild type or mutant gene knock-ins were grown to exponential phase 
till ~1 x 107 cells/ml in YPD +2% glu media. A dilution assay was carried out as described in the 
methodology section. Cells were serially diluted five-fold then grown on YTD+2% glu agar plate at 37 
oC (till wild type colonies were fully grown) for 2 days or on the same plates supplemented with 0.7M 
NaCl (till wild type colonies were fully grown) at 23 oC for 6 days. The control plate was placed at 23 
oC for 2 days. Data represents three independent experiments. 
 
Although such results suggest that restricting Plc1p to either the nucleus or cytoplasm 
during stress is deleterious to cell growth, the fact that Plc1pCAAX behaved normally 
under stresses seems to indicate that the presence of Plc1p only on the plasma 
membrane can adequately sustain cells. It is not clear how this is achieved, though it  
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is likely that cells expressing this mutant maintain a nuclear pool of Plc1p. 
 
These phenotypes have now been seen in more than five independent experiments, 
albeit with some variations. These data would seem to validate the hypothesis that is 
the cornerstone of this work: that Plc1p likely performs different roles in the nucleus 
and cytoplasm of cells.  
 
3.7.3 Fragmented vacuoles in plc1Δ and PLC1 mutants do not re-fuse   
Plc1Δ cells are enlarged and become multi-budded after they are shifted to 37°C 
(Flick and Thorner, 1993). For unknown reasons, vacuoles purified from plc1Δ strains 
still retain PtdIns(4,5)P2-directed PLC activity (Jun et al. 2004), but yeast cells 
lacking the PLC1 gene have defects in protein trafficking to the vacuole and in the 
fusion of vacuole elements: this explains the fragmented vacuole phenotype of plc1Δ 
cells (Seeley et al. 2002). I used FM4-64 staining to examine this abnormal vacuole 
morphology in plc1Δ cells. FM4-64 is a lipophillic vacuolar dye and vital stain for 
studying vacuole morphology. It is taken in via endocytosis and then trafficked to the 
vacuole (Vida and Emr 1995). It is also a marker for endocytic intermediates, but I 
exposed the cells to FM4-64 and incubated in FM4-64-free medium for 60 min, under 
which condition FM4-64 is exclusively on the vacuole membrane (see section 2.17).   
 
Wild-type cells normally have an average of 2-3 vacuole elements per cell, but 
plc1Δ cells have multiple and smaller highly fragmented vacuoles (Fig 3.22, 
untreated).  
 
Wild-type yeast vacuoles undergo rapid fission and re-fusion upon hyper- and then  
 134
hypo-osmotic stress. This was observed by treating wild type BY4742 cells with 
medium supplemented with 0.6M NaCl and followed by ten-times dilution of the cells 
with medium lacking the extra NaCl. Their vacuoles quickly fragmented to many 
small vacuoles in the salt medium (Fig 3.22, 0.6M NaCl 10min), and more than half 
of these small vacuoles re-fused into one or two large vacuole elements after dilution 
back into the unsupplemented medium for 60 min (Fig 3.22, 0.06M NaCl 1h). 
 
This re-fusion did not happen in plc1Δ cells: the vacuole fragmentation remained the 
same in the high salt medium (Fig 3.22, 0.6M NaCl 10min) but re-fusion to large 
vacuoles did not occur after dilution (Fig 3.22, 0.06M NaCl 60min). The abnormal 
vacuole morphology of plc1Δ  cells is therefore a consequence of a failure of the re-
fusion process.  
 
The PLC1 knock-in mutants were also examined for their vacuole morphology. 
Plc1pNES and Plc1pPKI cells both have highly fragmented vacuoles under normal 
conditions, with Plc1pNES vacuoles appearing more severely fragmented than those in 
plc1Δ (Fig 3.22). The Plc1pNES vacuoles did not re-fuse after hypo-osmotic treatment 
(Fig3.22), as in the PLC1 knockout cells. In contrast, vacuoles in Plc1pCAAX appear to 
be capable of undergoing the fission and re-fusion process, and they seem to undergo 
excessive fission and fusion in response to stress, when compared to wild-type 
(Fig3.22). 
 
Here, I observed that vacuole-function in the PLC1 mutants was in accord with their 
deficiencies noticed during stress responses. Hence, Plc1p activities seem essential to 
maintaining a functional vacuole even under normal non-stressed conditions. In 
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addition, I found both cytoplasmic and nuclear Plc1p are important to obtain normal 
vacuole morphology. 
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Figure 3.22: Vacuole morphology in wild-type and PLC1 mutant cells in response to salt stress 
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Low light DIC (left) and FM4-64 fluoresence images (right) of logarithmic phase cultures of wild-type and PLC1 mutant cells grown to 5 x 106 – 1 x 107 cells/ml at 23°C. Vacuoles were 
labeled with the fluorescent probe FM4-64 as described in section 2.17. Fields of cells were then photographed before, 10 min after a hyper-osmotic stress and 60 min after a hypo-osmotic 
stress. The number of vacuoles in each cell was quantified at each stage. These images are representative of three replicate cultures. The graphs show the percentage of cells containing the 
indicated number of vacuoles after hyper- and hypo- osmotic stresses. Error bars indicate mean ± SEM. Three independent experiments were conducted for each condition. 
1-2 vacuole(s)/cell 
3-4 vacuoles/cell 
5-8 vacuoles/cell 
≥ 9 vacuoles/cell
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3.8 Discussion 
3.8.1 Is the localisation of Plc1p critical to its functions? 
The “bedrock” hypothesis that I wanted to explore in this chapter of work, was 
whether Plc1p, and possibly PLC-δs in general, might generate compartment-specific 
signals that help cells adapt to external conditions. Some of these signals could be the 
inositol phosphates, but other “signals” could include protein-protein interactions. 
 
This hypothesis arises from the observation that Plc1p seems to be distributed 
between the nucleus and cytoplasm of normally dividing yeast cells. Tagging Plc1p 
with N-terminal GFP and expressing the GFP-Plc1p construct under a powerful 
MET25 promoter enhances Plc1p expression to about ten times the level found in wild 
type cells: others have shown that native expression of PLC1 is surprisingly low 
(Flick and Thorner, 1993; Fratti et al. 2004). It has proved difficult to detect Plc1p 
activity in cell lysates from S. cerevisiae, even though similar experiments with 
animal tissues yield a robust hydrolysis of PtdIns(4,5)P2 (SK Dove 2003, pers. 
Comm. and Fratti et al. 2004). GFP-Plc1p should be valuable for visualizing such 
endogenously low levels of expressed protein, provided that the localisation I observe 
with this construct faithfully reproduce the behaviour of the endogenous Plc1p. The 
early signs were favourable. The full length GFP-Plc1p construct is stable (APPX. Fig 
A). Our GFP-Plc1p expression system proved to not alter the cell phenotypically, nor 
did it result in aberrant inositol phosphate production in an earlier study, although 
there was some evidence that the basal pathway was more active (NM Perera and SK 
Dove 2002, per. comm.). I also saw localisation shifts with various Plc1p mutants, 
and these gave rise to mutant phenotypes even when there was a functional, native 
Plc1p in the cell. That I was able to observe this even despite the over-expression 
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suggests our system is in no-way ‘saturated’ with Plc1p and therefore is capable of 
reporting where this protein truly resides. 
 
My data suggest that wild-type GFP-Plc1p is distributed in a manner whereby its 
fluorescence in the nucleus exceeds that in the cytoplasm (Fig 3.2) by at least a factor 
of 1.6-1.7. However, they are not confocal microscope images. I was rather recording 
a ‘thin’ slice of whole-cell image. Therefore, the ‘nuclear’ fluorescence will be a sum 
of the nuclear fluorescence and some of the underlying and overlying fluorescence 
from the cytoplasm.  
 
This distribution is consistent with the proposed nucleo-cytoplasmic shuttling of 
Plc1p (York, 2006), with the nuclear Plc1p concentration maybe 3 times to the 
cytoplasmic concentration. Movement of Plc1p into and out of the nucleus must be a 
regulated event since the mass of GFP-Plc1p is ~130 kD and the molecular weight 
cutoff of the nuclear pore complex is only 30 kD. Our experiment using an xpo1-1 
mutant in which GFP-Plc1p became substantially more nuclear at restrictive 
temperature lends weight to the idea of regulated nuclear export of Plc1p (Fig 3.5), 
and that it uses this exportin to leave the nucleus. The relatively modest increase in 
nuclear GFP-Plc1p in this experiment may indicate that this enzyme can utilize other 
exportin pathways to leave the nucleus. In addition, I did not use heated microscope 
stage, so it is possible that Xpo1p activity might partially returned while I was 
recording images. 
 
If the steady-state localisation of Plc1p is compared to mammalian PLC-δ1 or PLC-δ4  
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then some differences are immediately apparent. For most of the time, PLC-δ1 is 
localized to the plasma membrane in animal cells during growth (Yagisawa et al., 
2002). In contrast, PLC-δ4 is present only in the nucleus of animal cells (D'Santos et 
al., 1998; Divecha et al., 1997; Liu et al., 1996; Martelli et al., 1992). The localization 
of Plc1p is intermediate between these localisation patterns.  
 
3.8.2 Plc1p localisation at different stages of the cell cycle and in response to 
stress 
Having a tool for tracking Plc1p made me want to determine if Plc1p might undergo 
the same regulated localisation changes that are observed for mammalian PLCs. Such 
shifts in location can provide clues to the regulation of a protein, though they alone 
are not a very reliable indicator.  
 
Cell cycle progression can alter the equilibrium between NES and NLS signals and 
cause the intracellular shuttling of PLC isoforms in animal cells. For example, the 
‘plasma membrane’ enzyme, PLC-δ1, can enter the nucleus at some stages of the cell 
cycle in mammalian cells (Yagisawa et al., 2002). The fact that PLC-β1 and PLC-γ1 
are associated with the nuclear matrix while PLC-δ1 binds to chromatin implies that 
PLCs might be associated with specific functions during the cell cycle (Crljen et al., 
2004). Genetic studies have revealed a link between Plc1p, the C-type cyclin Ume3p 
(Cooper et al. 1999) and the cyclin-dependent protein kinase complex Pho80p/Pho85p 
(Flick and Thorner 1998), so we were eager to determine if we could see any 
associated changes in Plc1p localisation. Plc1p has previously been found associated 
with chromosomes at the division site (DeLillo et al., 2003; Lin et al., 2000). 
Although this suggested there might be a cell cycle-regulated change of Plc1p 
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localisation within the nucleus. However, our attempt to observe this in cells treated 
with cell cycle modifying drugs was unsuccessful, I did see an efflux of Plc1p from 
the nucleus during S phase (Fig 3.7). This is when bud emergence occurs and when 
the cell prepares for mitosis and carries out DNA synthesis. Whether this event is 
specifically related to Plc1p or just reflects a general shift in nucleo-cytoplasmic 
shuttling at this time, remains to be determined. 
 
Strains lacking PLC1 grow slowly at raised temperatures (Flick and Thorner 1998). 
Synthesis of InsP6 downstream of Plc1p-catalysed InsP3 release is stimulated in yeast 
incubated at 37ºC and in mammalian cells subjected to heat stress (Calderwood and 
Stevenson 1993; Perera 2002, p.188). The presence of a heat shock binding consensus 
motif in the PLC1 promoter suggests that yeasts may require elevated levels of Plc1p 
to survive at higher temperatures, so I determined if heat stress would induce changes 
in Plc1p localization. To our surprise, the distribution of GFP-Plc1p remained largely 
unchanged after 2 hours at 37°C.  
 
There was, though, an obvious translocation of Plc1p after cells were exposed to 
osmotic challenge, with some GFP-Plc1p leaving the nucleus within 2 minutes, 
followed by a gradual restoration of its normal nuclear/cytoplasmic distribution (Fig 
3.10). An earlier study in our lab showed that InsP6 derived from Plc1p activity 
rapidly accumulates after hypo-osmotic shock, peaking at 2 minutes, and that much of 
the PtdIns(4,5)P2 hydrolysed by Plc1p was located at the plasma membrane (Perera et 
al., 2004).  
 
Why should the vacuole fusion that occurs after hypo-osmotic shock be inhibited in a  
 142
plc1 mutant? Recent data suggest a role for Plc1p in regulating Apl5p, a subunit of the 
AP-3 complex that is required for vacuolar trafficking (Saiardi et al., 2004), and 
Vps41p, a subunit of HOPS that mediates vacuole-vacuole fusion (K Dong and SK 
Dove 2009, pers. Comm.).  
 
Hyper-osmotic stress also seems to cause a translocation of Plc1p. Cells deleted for 
PLC1 are unable to grow in hyper-osmotic media, possibly because Plc1p functions in 
parallel to Hog1p in upregulation of glycerol synthesis. The two signaling pathways 
converge at Sgd1p, which resides in the nucleus and is a suppressor of the osmo-
sensitive phenotypes of both plc1 and hog1 deletions. It interacts with Plc1p 
physically, and this may be the mode of regulation instead of involving inositol 
phosphates, though this is unlikely to be the whole story since arg82 and kcs1 mutants 
also display a profound salt-sensitive phenotype (Dubois et al., 2002; El Alami et al., 
2003; and see Fig 4.31 in this work). 
 
One intriguing question arising from the above observations is to ask how both hyper 
and hypo osmotic stress can trigger the activation of Plc1p? Or heat stress for that 
matter? Previous studies suggest that Plc1p might be regulated in response to 
membrane stretching (Cooper et al., 1999). Since heat, hyper and hypo osmotic stress 
all produce an increase in plasma membrane flexing and bending, that might produce 
the signal that activates Plc1p.  
 
Another important question is why should all of these disparate stresses cause an 
activation of Plc1p, or in to ask this another way, what is Plc1p activation supposed to 
achieve? Since Plc1p has been shown to regulate expression of a number of the so-
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called general stress response genes, whose levels are up or down regulated in 
response to stresses, it might be anticipated that this is the major function of Plc1p 
during hypo, hyper and heat stress (Ansari et al., 1999; Cooper et al., 1999; Demczuk 
et al., 2008; Rebecchi and Pentyala, 2000; York, 2006).  
 
3.8.3 Nuclear localisation and export 
Having observed a potential nucleo-cytoplasmic shuttling of Plc1p during the cell 
cycle and under some stimulated conditions, the next question was to examine how 
Plc1p was entering and leaving the nucleus. As discussed in the Introduction, nucleo-
cytoplasmic shuttling usually relies upon signal sequences, known as nuclear 
localization and export sequences (NLS and NES) within the protein. 
 
The NES of Plc1p was easily found and is located in the PH domain of this protein 
close to the EF hand. It conforms to a canonical consensus sequence (Kunzler et al., 
2000), and its mutation led to an almost complete redistribution of Plc1p into the 
nucleus (Fig 3.11). A consequence of this relocation was that cells expressing the 
Plc1pNES mutant as their only Plc1p activity did not grow normally and behaved like 
cells lacking PLC1 (Fig 3.20 and Fig 3.21). That this was a consequence of the mis-
localisation of Plc1p was demonstrated when it was observed that adding an 
exogenous NES sequence from the protein PKI to Plc1pNES restored both its 
cytoplasmic localisation and all normal growth phenotypes  (Fig 3.20 and Fig 3.21). 
This strongly suggests that the NES I have identified is the sole NES in Plc1p, and 
that either that too much nuclear Plc1p is deleterious to cells or Plc1p is required in 
both compartments to fulfil. 
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Finding the NLS proved more challenging. Our first attempt focussed on the X-Y 
inter-domain linker since many mammalian PLCs have an NLS in this region, and 
Plc1p does have a highly basic cluster located there. However, the X-Y basic patch 
had no effect on nuclear localisation (data not shown). I therefore turned to a 
truncation strategy and discovered that a construct encoding only the first one-third of 
Plc1p displayed the same localisation as the full-length protein, suggesting that NLS 
and NES activities both reside in the N-terminal one third of Plc1p (Fig 3.12). The N-
terminus also seems important for nuclear export as the Plc1p110-end mutant displayed 
an increased ratio of nuclear/cytoplasmic fluorescence (Fig 3.14). The very nuclear 
mutant Plc1p220-end further indicates that an NLS exists in between amino-acids 220–
333 (Fig 3.14).  However, my data suggest that there could be more than one 
sequence mediating nuclear localization, as two further non-overlapping truncation 
mutants showed nuclear localization: Plc1p1-220 and Plc1p220-333 (Fig 3.13) although 
both were partially unstable (APPX. Fig A). However, despite creating two stable 
mutants, Plc1p4R and Plc1pKRLR, that have a number of potential basic sequences in 
this region of Plc1p mutated, neither of them abolished the nuclear localization of 
Plc1p completely (Fig 3.15). So I was unable to definitively identify these NLS 
motifs.  
 
3.8.4 Both nuclear and cytoplasmic pools of Plc1p are required for normal Plc1p 
function   
Having identified the NES sequence my attention turned to examining mutant forms 
of Plc1p that were tagged to the plasma-membrane (Plc1pCAAX), cytoplasm (Plc1pPKI) 
or nucleus (Plc1pNES), I investigated the consequences of restricting Plc1p to different 
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compartments. This was to determine if there are the compartment specific functions 
of Plc1p either because of the signaling cascade it controls or because of protein- 
protein interactions. 
 
Plc1pCAAX is concentrated on the plasma membrane but also has a detectable nuclear 
pool (Fig 3.16). The Plc1pPKI mutant however, is almost completely cytoplasmic: it 
appeared that the two virally derived NES sequences that were inserted into the N-
terminus were so effective that the nuclei of cells expressing this construct were 
almost devoid of fluorescence (Fig 3.17). The reverse is true of the Plc1pNES–
expressing cells, in which cytoplasmic fluorescence was very low. These constructs 
were stable (APPX. Fig A) and were suitable reagents to test the functions of the 
separate pools of Plc1p. 
 
Many of the known functions of Plc1p and inositol phosphates are nuclear functions 
(Irvine, 2003). However, my data make it clear that a functional, nucleus-restricted 
Plc1pNES is not sufficient to rescue the slow growth of salt- or heat-sensitive 
phenotypes of a plc1Δ cell even when over-expressed (Fig 3.20 and Fig 3.21). This is 
not a consequence of the GFP tag or of a loss of activity of this mutant because 
restoring Plc1pNES to the cytoplasm by adding extra NESs rescued the stress 
phenotypes in these cells (Fig 3.20).  
 
Two possible explanations are that Plc1p-derived inositol phosphates have to be 
locally generated in each compartment in order for cells to function normally, or that 
Plc1p protein is required in both compartments for some other reason. A catalytically 
dead Plc1p that combines either the PKI tag or the NES mutations would be useful to 
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distinguish between these two possibilities, such as Plc1pPKI/E425G and  Plc1pNES/E425G 
(regarding Plc1pE425G mutant, see section 4.7) Cells expressing pairs of Plc1p mutants, 
one catalytically dead and one active i.e. plc1Δ cells expressing Plc1pNES and 
Plc1pPKI/E425G and a separate set expressing Plc1pPKI and Plc1pNES/E425G. This would 
then allow us to tell where inositol phosphates are needed and where it is protein-
protein interactions only that are required for a normal phenotype. 
 
The phenotypes of the cytosol restricted Plc1pPKI mutant which does not rescue any of 
the stress phenotypes, reinforces the view that Plc1p is required in both 
compartments. It was unexpected to find that vacuoles from this mutant, like those of 
plc1Δ cells are abnormally fragmented (Fig 3.22), and thus that nuclear and 
cytoplasmic pools of Plc1p are both required for normal vacuolar homeostasis. As 
vacuole morphology is regulated by both Pho85p controlled gene expression and by 
the cell cycle, it is possible that these phenomena are indirect effects on the vacuole 
that arise that from primary defects in these two processes. However, there must also 
be a cytoplasmic component to Plc1p mediated control of vacuole morphology, or 
else the Plc1pNES mutant would have displayed normal vacuoles. 
 
Why should all these phenotypes require both nuclear and cytoplasmic Plc1p? This 
could reflect that fact that all of my assays are growth based and so are actually 
requiring the mutant cells to carry-out the complete life-cycle of S. cerevisiae in order 
to report the phenotype. Better assays would be those focused at the molecular level 
that would test for events happening over a shorter timescale, and so are more likely 
to show some discrimination between the two localisation restricted mutants.  
Alternatively, it could be that many of the phenotypes I have examined are actually 
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indirect consequences of the failure to export mRNA properly in plc1Δ mutants. If 
this is the case then it is possible that, as part of mRNA export, Plc1p itself must 
associate normally with the nuclear import and export machinery and my mutants 
prevent this from happening and so appear defective.  
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Chapter 4    Regulation of the plasma membrane  
association of Plc1p 
 
4.1 The intracellular distribution of the Ins(1,4,5)P3 kinase Arg82p is similar to 
that of Plc1p 
One hypothesis I examined in our attempts to determine why the NLS of Plc1p was so 
difficult to define was the idea that another protein might be taking Plc1p to the 
nucleus. Earlier work in our lab showed that when Plc1p was activated, InsP3 (InsP3) 
never accumulated to detectable levels: the ‘higher’ inositol phosphates appeared 
straightaway (Perera et al., 2004). This made us wonder whether Plc1p might be 
physically associated with one or more of the inositol phosphate kinases, facilitating 
the rapid synthesis of higher inositol phosphates. The first candidate I tested was the 
inositol phosphate kinase Arg82p. 
 
Arg82p is a dual function protein. It is the first kinase in the pathway of 
phosphorylation of InsP3, via inositol (1,4,5,6) tetrakisphosphate (InsP4) and inositol 
(1,3,4,5,6) pentakisphosphate (InsP5) to InsP6, InsP7 and InsP8, but it was discovered 
earlier as a regulator of arginine metabolism in yeast that stabilizes the Arg80-Arg81-
Mcm1 transcriptional complex (Bechet et al., 1970).  
 
To examine the localization of Arg82p, GFP-tagged Arg82p was expressed in wild-
type and arg82Δ cells, and its distribution compared with that of the nuclear marker 
pUR34NLS by fluorescence microscopy. GFP-Arg82p was distributed in a similar 
fashion to Plc1p under normal conditions: it was more concentrated in the nucleus 
than the cytoplasm (Fig 4.1).  Indeed the ratio of nuclear to cytoplasmic GFP-Arg82p  
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 Figure 4.1:  Localisation of GFP­Arg82p in wild type and arg82Δ cells 
 
      
Genotype Fluorescence Ratio (Nuclear/Cytosolic) 
pUG36-ARG82 in WT 1.64±0.04 
pUG36-ARG82 in arg82Δ 1.62±0.03 
pUG36-PLC1 in WT 1.70±0.08 
[There was no significantly difference between the corresponding values of GFP-Arg82p in WT 
and GFP-Arg82p in arg82Δ cells and no significantly difference between the corresponding values 
of GFP-Arg82p and GFP-Plc1p in WT cells.] 
Fluorescence images of logarithmic phase cultures (5 x 106 – 1 x 107 cells/ml) of wild type BY4742 
(top) and arg82Δ (bottom) transformed with pUG36–ARG82 and pUR34NLS, respectively. The left-
hand columns show low light DIC images. The left-mid columns show the localisation of the indicated 
GFP constructs. The right-mid columns show the localisation of nuclei, as reported by the DsRed-
tagged NLS construct, and the merged images are shown on the right-hand columns. These images are 
representative of three replicate cultures. All strains were cultured in SC-Ura-Met-His+2% glu 
medium. The table shows ratio of fluorescence intensity of plasma membrane (PM), nucleus and 
cytosol. Each value represents the mean ± S.E.M. of ten determinations. 
 
fluorescence was similar to the equivalent ratio for Plc1p (~1.6-1.7).  
 
4.2 GFP-Plc1p associates with plasma membrane in arg82Δ cells 
Accordingly I then tested whether Arg82p participated in the regulation of Plc1p 
localization. First, I examined the localization of Plc1p in cells depleted of Arg82p to 
see whether there would be ablation or the reduction of the nuclear localization of 
Plc1p. Unexpectedly, some GFP-Plc1p was now associated with cell periphery. It 
seems that the arg82Δ cells had a normal ratio of nuclear to cytosolic Plc1p, but some 
of the Plc1p was now concentrated on the plasma membrane (Fig 4.2).  
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This localisation has never before been observed in wild-type cells (Fig 4.2) which 
suggested that normally Arg82p somehow negatively regulates the association of 
Plc1p with the plasma membrane. Where I re-introduced wild-type Arg82p 
(pYCplac111-ARG82) into arg82Δ cells, Plc1p reverted to its normal 
nuclear/cytoplasmic distribution (Fig 4.2). Empty pYCplac111 vector had no effect on 
the localisation of Plc1p in arg82Δ cells (Fig 4.2).  
 
It is worth noting that the Arg82p constructs were transformed into both arg82Δ and 
arg82Δ plc1Δ cells, in case there was some interaction between our GFP tagged 
constructs and wild-type Plc1p. The same results were obtained in both cases, and 
only pictures of the arg82Δ cells are shown because expression of the constructs was 
always better in this strain. 
 
4.3 Plc1p is unlikely to form a complex with Arg82p  
I also examined the localisation of GFP-Arg82p in plc1Δ cells. Its distribution was the 
same as in wild-type cells (Fig 4.3), indicating that the absence of Plc1p did not 
change the localization of Arg82p.  
 
I then carried out a co-immunoprecipitation assay to detect if Plc1p and Arg82p were 
part of a common protein complex. Plc1p was tagged with three tandem copies of the 
HA epitope and Arg82p was tagged with nine copies of the Myc epitope. These 
constructs were expressed at wild-type levels in yeast cells as knock-ins at the normal 
chromosome locus (see section 2.15). A total protein lysate from cells expressing both 
tagged proteins was incubated with anti-Myc antibodies and Protein G sepharose, 
followed by incubation with anti-HA and anti-Myc antibodies, respectively (see  
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 Fig 4.2:  Localization of GFP-Plc1p in the absence or presence of Arg82p 
 
 
Fluorescence Ratio  Genotype 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
pUG36-PLC1 in arg82Δ 1.13± 0.02*** 1.74± 0.08 0.66±0.03*** 
pUG36-PLC1 in WT 0.74±0.01 1.70±0.08 0.44±0.02 
pUG36-PLC1 in arg82Δ + pYCplac111-ARG82 0.76± 0.04 1.56± 0.04 0.49±0.03 
pUG36-PLC1 in arg82Δ + pYCplac111 1.15± 0.01 1.67 ±0.06 0.70±0.03 
[Significantly different from GFP-Plc1p in WT and arg82Δ+pARG82 cells: ***P<0.001; There was no 
significant difference from arg82Δ with empty vector.] 
Logarithmic phase cultures (5 x 106 – 1 x 107 cells/ml) of arg82Δ+pUG36–PLC1 and BY4742 + 
pUG36–PLC1 in SC-Ura-Met+2%glu or arg82Δ + pUG36–PLC1 + pYCplac111-ARG82 and arg82Δ + 
pUG36–PLC1 + pYCplac111-ARG82 in SC-Ura-Met-Leu+2%glu, at 25°C. These images are 
representative of three replicate cultures. The table shows ratio of fluorescence intensity of plasma 
membrane (PM), nucleus and cytosol. Each value represents the mean ± S.E.M. of ten determinations.  
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 Fig 4.3: Localization of GFP-Arg82p in plc1Δ cells 
 
 
Fluorescence Ratio  Genotype 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
pUG36-ARG82 in plc1Δ 0.77±0.03 1.64±0.03 0.47±0.02 
pUG36-ARG82 in WT 0.73±0.02 1.64±0.04 0.45±0.02 
[There were no significant differences between the corresponding values of the two cell types.] 
Low light DIC (left columns) and Fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of plc1Δ + pUG36-ARG82 at 25°C in SC-Ura-Met+2% glu. These images are 
representative of three replicate cultures. The table shows the ratio of fluorescence intensity of plasma 
membrane (PM), nucleus and cytosol. Each value represents the mean ± S.E.M. of ten determinations.  
 
section 2.15). In the anti-Myc pull-down, Arg82p was visualized by anti-Myc, but no 
Plc1p-3HA was detected by anti-HA (Fig 4.4). The same negative result was obtained 
even after including the crosslinker such as DSP (Dithiobis (succinimidyl propionate), 
Pierce).  
 
Plc1p is present at very low levels (section 3.2), so it was possible that a small amount 
of Plc1p bound to Arg82p was not detected. I therefore used lysates from cells over-
expressing GFP-Plc1p from pUG36 in a similar experiment, probing the blots with 
anti-GFP. Again, no Plc1p was co-immunoprecipitated with Arg82p (Fig 4.5).  
 
These data suggest that Plc1p and Arg82p do not form a complex, though they do not 
eliminate the possibility of weak and/or transient association between the two 
proteins.   
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 Fig 4.4:  anti-Myc pull-down blot for detecting the putative binding of Plc1p and 
Arg82p anaylsed by Co-immunoprecipitation 
 
 
FY833 (PLC1::PLC1-3HA ARG82::ARG82-9Myc) and FY833(WT) culture (control)100ml each, were 
grown to OD600 ~0.7 (1x 107 /ml) in YEPD+2% glu media and lysates prepared (section 2.15). 5μl of 
anti-Myc and 100μl Protein G sepharose were together added to 500μl of total lysate, incubated for 2 
hours, and then supernatant and pellet were collected by centrifugation at 500g. The anti-Myc pull-downs 
were then analyzed by SDS-PAGE gel followed by Western-blotting for immunological analysis. 
Samples were electrophoretically transferred to a nitrocellulose filter followed by incubation with anti-
Myc or anti-HA(1:2000), respectively.  
                             
 
4.4 The kinase activity of Arg82p is required for negative regulation of the 
interaction of Plc1p with the plasma membrane 
The results above make it likely that one or more of the products of Arg82p may   
regulate Plc1p’s association with plasma membrane. 
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 Fig 4.5:  anti-Myc pull-down blot for detecting the putative binding of Plc1p and 
Arg82p analysed by Co-immunoprecipitation 
 
A 100ml culture of FY833 (ARG82::ARG82-9Myc, pUG36-PLC1) in SC-Ura-Met+2%glu was grown to 
OD600 ~0.7 (1x 107 /ml), with or without 5mM DSP added to each cell culture in 500μl of lysis buffer 
before cell breakage (section 2.15). 5μl of anti-Myc and 100μl Protein G sepharose were together added 
to 500μl total lysate, incubated for 2 hours, and then supernatant and pellet collected by centrifugation at 
500g. The anti-Myc pull-downs were then analyzed by SDS-PAGE gel followed by Western-blotting for 
immunological analysis. Samples were electrophoretically transferred to a nitrocellulose filter followed 
by incubation with anti-Myc (1:2000), or anti-GFP (1:1000), respectively.  
 
The inositol phosphate binding domain of Arg82p (residues 127 to 135), one of 
several well-conserved motifs found in InsP kinases, is required for its inositol kinase 
activity (Fig 4.6A). Mutations in such domains disrupt kinase activity but do not 
affect protein stability (Dubois et al., 2002). An aspartic acid to alanine amino-acid 
mutation at 131 (ARG82D131A) in the InsP binding domain eliminates kinase activity 
(Fig 4.6B). In contrast, the polyaspartate stretch close to the C-terminus (residues 282-
303) of Arg82p is involved in the regulation of arginine metabolism (Fig 4.6A), but 
not in kinase activity (Dubois et al., 2000). Removing the polyaspartate stretch  
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Fig 4.6: 
A. Schematic representation of Arg82p 
 
 
results in a mutant that does not regulate arginine metabolism but retains InsP3 kinase 
activity (Dubois et al., 2000) (Fig 4.6B).  
 
I obtained these two arg82 mutants, ARG82D131A and ARG82Δasp (ARG82Δ(282-303)), 
from Dr Evelyne Dubois (Brussels, Belgium) and cloned them into the pYCplac111 
vector. When I put the kinase-dead mutant, pARG82D131A, into cells lacking ARG82, 
Plc1p remained associated with the plasma membrane (Fig 4.7), but when I put the 
aspartate mutant pARG82Δasp into cells, they regained the Plc1p distribution 
characteristic of wild-type cells (Fig 4.7).  
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 Fig 4.7:  Localization of GFP-Plc1p in ARG82 mutants 
 
Fluorescence Ratio  Genotype 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
pUG36-PLC1 in arg82Δ + pYCplac111-ARG82D131A 1.16±0.04*** 1.86±0.09* 0.63±0.03** 
pUG36-PLC1 in arg82Δ + pYCplac111-ARG82Δasp 0.72±0.02+++ 1.61±0.03 0.45±0.02+++ 
pUG36-PLC1 in arg82Δ 1.13±0.02 1.74±0.08 0.66±0.03 
pUG36-PLC1 in arg82Δ + pYCplac111-ARG82 0.76±0.04 1.56±0.04 0.49±0.03 
[Significantly different from GFP-Plc1p in arg82Δ+pARG82: ***P<0.001, **0.001<P<0.01, 
*0.01<P<0.05, and not significantly different from GFP-Plc1p in arg82Δ.] 
 [Significantly different from GFP-Plc1p in arg82Δ: +++P<0.001, and not significantly different from 
GFP-Plc1p in arg82Δ+pARG82.] 
Low light DIC (left columns) and Fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of arg82Δ + pUG36-PLC1 transformed with pYCplac111-ARG82D131A or 
pYCplac111-ARG82Δasp, respectively, in SC-Ura-Met-Leu+2%glu at 25°C. These images are 
representative of three replicate cultures. The table shows ratio of fluorescence intensity of plasma 
membrane (PM), nucleus and cytosol. Each value represents the mean ± S.E.M. of ten determinations 
 
This suggests that the kinase activity of Arg82p is required for regulation of Plc1p 
distribution, and that inositol polyphosphates downstream of the kinase activity of 
Arg82p are likely to negatively regulate the interaction between Plc1p and plasma 
membrane. 
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4.5 GFP-ARG82pD131A is not on the plasma membrane in arg82Δ cells -- further 
confirming that Plc1p and Arg82p don’t physically associate 
Some Plc1p is redirected to the plasma membrane in cells lacking Arg82p or 
harbouring the kinase-dead Arg82pD131A, so what would be the distribution of 
Arg82pD131A if we linked it to GFP and expressed it in arg82Δ cells? 
 
The intracellular distribution of GFP-Arg82pD131A was the same as of wild-type GFP-
Arg82p: it showed no plasma membrane localisation in arg82Δ cells (Fig 4.8) despite 
the fact that some Plc1p was clearly on the plasma membrane in these cells (Fig 4.2). 
This reinforced our conclusion that Plc1p and Arg82p are unlikely to associate with 
each other directly. 
 
Fig 4.8: Localization of GFP-Arg82pD131A in arg82Δ cell 
 
Fluorescence Ratio  Genotype 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
pUG36-ARG82D131A in arg82Δ 0.74 ± 0.01 1.58 ± 0.01 0.47 ± 0.005 
pUG36-ARG82 in arg82Δ 0.72 ± 0.01 1.62 ± 0.03 0.45 ± 0.004 
[There were no significant differences between the corresponding values of the two cell populations.] 
Low light DIC (left columns) and fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of arg82Δ + pUG36-ARG82D131A were grown in SC-Ura-Met+2% glu at 25°C. 
These images are representative of three replicate cultures. The table shows ratio of fluorescence 
intensity of plasma membrane (PM), nucleus and cytosol. Each value represents the mean ± S.E.M. of 
ten determinations. 
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4.6 Inhibiting Plc1p activity by U73122 doesn’t result in the plasma membrane 
association of Plc1p 
If the interaction of Plc1p with the plasma membrane is inhibited by inositol 
polyphosphates, then blocking Plc1p activity should also have the same effect as 
deleting ARG82, because the InsP3 that Arg82p phosphorylates is all produced by 
Plc1p activity in S. cerevisiae. To examine this, I first tried to inhibit Plc1p by using 
U73122 (Sigma), an inhibitor of inositol lipid hydrolysis by phosphoinositidase C 
(Smith et al., 1990). In an earlier study by Dr. Perera, U73122 inhibited the Plc1p-
catalysed PtdIns(4,5)P2 hydrolysis in response to hypo-osmotic stress in a dose-
dependant manner, with a near-complete inhibition at ~5 μM, at which concentration 
most cells are still viable (Perera et al., 2004). However, U73122 did not inhibit the 
basal production of InsP6.  
 
I treated wild-type BY4742 cells transformed with pUG36-PLC1 with 5 μM U73122 
for an hour with gentle shaking at 23°C. There was no concentration of GFP-Plc1p 
fluorescence on the plasma membrane after treatment with U73122 or with 
0.26%(v/v) DMSO, in which it was added (Fig 4.9). However, before I ruled out that 
the association of Plc1p with plasma membrane was negatively regulated by the 
inositol phosphates, it was necessary to know if U73122’s inhibition on Plc1p activity 
could have any effect on the enzyme’s binding affinity to its substrate and the plasma 
membrane.  
 
I also examined the localization of Plc1p in arg82Δ cells treated with U73122. 
Unexpectedly, there was hardly any GFP-Plc1p fluorescence at the plasma membrane  
 
 159
 Fig 4.9: Localization of GFP-Plc1p in wild-type cells treated with U73122 
 
                                                                 
Fluorescence Ratio  pUG36-PLC1 in WT 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
5 μM U73122 1h 0.76±0.01 1.63±0.11 0.48±0.02 
0.26%(v:v) DMSO 1h 0.78±0.02 1.63±0.04 0.48±0.02 
untreated 0.74±0.01 1.70±0.08 0.44±0.02 
[There were no significant differences between the corresponding values of the untreated and the 
treated cell populations with U73122 or DMSO.] 
Low light DIC (left columns) and fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of BY4742 transformed with pUG36-PLC1 were grown in SC-Ura-Met+2% 
glu at 25°C and pre-treated for 1 hour with 5 μM U73122 or its vehicle 0.26%(v:v) DMSO. These 
images are representative of three replicate cultures. The table shows ratio of fluorescence intensity of 
plasma membrane (PM), nucleus and cytosol. Each value represents the mean ± S.E.M. of ten 
determinations. 
 
in the arg82Δ cells. Rather, fluorescence was concentrated at the nuclear envelope 
(Fig 4.10). The meaning of these U73122 results is not clear, but my data indicate that  
it was not acting solely as a PLC inhibitor and therefore that it was not an appropriate 
tool for these experiments. 
 
4.7 A catalytically dead PLC1E425G mutant associates with the plasma membrane 
stably 
Another way to determine whether these inositol phosphates might influence the    
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 Fig 4.10: Localization of GFP-Plc1p in arg82Δ cells treated with U73122 
 
 
Fluorescence Ratio  pUG36-PLC1 in arg82Δ 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
5 μM U73122 1h 0.82±0.02*** 1.66±0.05 0.50±0.02*** 
0.26%(v:v) DMSO 1h 1.16±0.02 1.61±0.07 0.73±0.03 
5 μM U73433 1h 1.14±0.02 1.60±0.06 0.73±0.03 
untreated 1.13±0.02 1.74±0.08 0.66±0.03 
[Significantly different from the untreated for each corresponding values: ***P<0.001; There were no 
significant differences between the corresponding values of the untreated with either DMSO or U73433 
treated.] 
Low light DIC (left columns) and fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of arg82Δ+pUG36-PLC1 in SC-Ura-Met+2%glu at 25°C and pre-treated for 1 
hour with 5 μM U73122 or its vehicle 0.26% DMSO or 5 μM its inactive analogue U73433. These 
images are representative of three replicate cultures. The table shows ratio of fluorescence intensity of 
plasma membrane (PM), nucleus and cytosol. Each value represents the mean ± S.E.M. of ten 
determinations. 
 
intracellular distribution of Plc1p was to make a catalytically inactive Plc1p mutant 
and express it in plc1Δ cells. A possible prediction would be that this mutant  might 
be at the plasma membrane, since it would not liberate any Plc1p derived inositol 
phosphates. Cheng et al. have previously made a variety of mutations in the X region 
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of human PLC-δ1. Amongst these, the Glu341 to Gly, or His 356 to Leu mutations 
abolished enzyme activity but yielded proteins that still bound to PtdIns(4,5)P2 with 
affinities similar to the wild-type enzyme and maintained a normal expression level 
(Cheng et al., 1995)(Fig 4.11 A). I located the corresponding Glu and His in Plc1p by 
aligning the highly conserved X region sequences of PLC isoforms from different 
species (Fig 4.11 B), and mutated the corresponding Glu425 to Gly (Plc1pE425G) and 
His439 to Leu (Plc1pH439L). 
 
Fig 4.11 
A. Characterization of human PLCδ1 mutants (Cheng et al., 1995) 
 
                       * The equivalent mutations in Plc1p were examined in this study. 
B: Comparison of the primary structures of the conserved regions of PLC 
isoenzymes (Cheng, et al., 1995) 
 
* 
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When I examined the distribution of these two mutants in arg82Δ cells, GFP-
Plc1pH439L distributed much like wild-type Plc1p does in wild-type cells: there was no 
obvious association with the plasma membrane (Fig 4.12). By contrast, GFP-
Plc1pE425G was clearly associated with the plasma membrane (Fig 4.12), in much the 
same pattern as Plc1pwt in arg82Δ cells.  
 
Fig 4.12:  Localization of GFP-Plc1pH439L and GFP-Plc1pE425G in arg82Δ cells 
 
 
Fluorescence Ratio  Genotype 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
pUG36-PLC1H439L in arg82Δ 0.87±0.02*** 1.92±0.08 0.46±0.02*** 
pUG36-PLC1E425G in arg82 Δ  1.16±0.01 1.70±0.09 0.71±0.05 
pUG36-PLC1 in arg82Δ 1.13±0.02 1.74±0.08 0.66±0.03 
[Significantly different from the corresponding values of GFP-Plc1p in arg82Δ: ***P<0.001; There 
were no significant differences between the corresponding values of GFP-Plc1pE425G to GFP-Plc1p in 
arg82Δ.] 
Low light DIC (left columns) and fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of arg82Δ transformed of the PLC1 mutant indicated above, in SC-Ura-
Met+2% glu at 25°C. These images are representative of three replicate cultures. The table shows ratio 
of fluorescence intensity of plasma membrane (PM), nucleus and cytosol. Each value represents the 
mean ± S.E.M. of ten determinations. 
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One possible explanation of the difference between these mutants is that the H439L 
mutation reduced the PtdIns(4,5)P2 affinity of this mutant, but the E425G mutation 
did not. I therefore decided to use only the Plc1pE425G for the remaining experiments.  
 
To simply test the activity of the Plc1pE425G mutant, I examined its effect on growth at 
elevated temperature. It hardly grew at 37°C, like plc1Δ, suggesting that the mutation 
probably abolished Plc1p activity (Fig 4.13).  
 
Fig 4.13: Heat stress to PLC1E425G mutant in plc1Δ cells 
 
Cells were grown to exponential phase till about ~1 x 107 cells/ml in SC-Ura-Met (2% glu) media. A 
dilution assay was then carried out as described in methodology section. Cells were serially diluted 
five-fold then grown on YTD agar plates (2% glu) at 37 oC (till wild type cells were fully grown) for 2 
days. A control plate was grown at 23oC for 2 days. Data represent three independent experiments. 
 
 
A lipid dot assay was also carried out to test its binding and catalytic properties. The 
strips were dotted with 1 nmole of PtdIns(3)P, PtdIns(3,5)P2 and PtdIns(4,5)P2, and 
then incubated with purified GST-Plc1p and GST-Plc1pE425G, respectively, followed 
by antibody detection of the GST tag. After the ECL chemiluminescence reaction, the 
binding of the proteins to the lipids was shown as black dots on the blot. No binding 
of wild-type GST-Plc1p was seen, presumably because it hydrolysed the 
PtdIns(4,5)P2 on the strip. Binding of Plc1pE425G to PtdIns(4,5)P2 was observed, 
showing that it bound and was catalytically inactive (Fig 4.14). PLC-δ1 PH has been 
long known to bind with PtdIns3P for unknown reasons and Plc1p appears to also do  
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 Fig 4.14: Lipid dot assay for detecting the binding of Plc1p or Plc1pE425G  
with phosphoinositides 
 
Hi-Bond C+ supported nitrocellulose strips were spotted with ~1μg of each of the following lipids: 
PtdIns3P, PtdIns(3,5)P2  and PtdIns(4,5)P2 and incubated with ~ 15μg of Gst-Plc1pwt and Gst-
Plc1pE425G, respectively, in 6 ml of TBST, for 2 hours at room temperature, followed up by anti-GST 
antibody detection.  
 
so (Ferguson et al., 2000). This served as a useful positive control to show the 
sensitivity of the assay.  
 
Having confirmed that Plc1pE425G associates with the plasma membrane and is 
probably catalytically inactive, I examined its distribution in plc1Δ cells. Again, it was 
associated with the plasma membrane (Fig 4.15), consistent with the idea that inositol 
polyphosphates are somehow responsible for preventing Plc1p from associating with 
the plasma membrane. This removes many of the trivial explanations for how Plc1p 
might be artificially associating since I have now demonstrated this interaction in two 
completely different ways.               
 
4.8 Distribution of GFP-Plc1p in cells devoid of the other inositol phosphate 
kinases 
Having evidence that inositol phosphates might regulate Plc1p’s interaction with the 
plasma membrane, I hoped to determine which inositol polyphosphate(s) are 
responsible for this effect by observing GFP-Plc1p localisation in cells depleted of the  
 
Gst-Plc1pE425G 
 PtdIns3P      PtdIns(3,5)P2       PtdIns(4,5)P2   PtdIns3P           PtdIns(3,5)P2              PtdIns(4,5)P2
Gst-Plc1pwt  
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 Fig 4.15: Localization of GFP-Plc1pE425G in plc1Δ cells. 
 
Fluorescence Ratio  Genotype 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
pUG36-PLC1E425G in plc1Δ 1.39±0.05***/+++ 1.74±0.09 0.81±0.03*** 
pUG36-PLC1 in plc1Δ 0.77±0.01 1.65±0.02 0.47±0.01 
pUG36-PLC1E425G in arg82 Δ 1.16±0.01 1.70±0.09 0.71±0.05 
[Significantly different from the corresponding values of GFP-Plc1p in plc1Δ: ***P<0.001, and of GFP-
Plc1pE425G in arg82Δ: +++P<0.001.] 
Low light DIC (left columns) and fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of BY4742plc1Δ transformed with pUG36-PLC1E425G in SC-Ura-Met+2% glu 
at 25°C. These images are representative of three replicate cultures. The table shows ratio of 
fluorescence intensity of plasma membrane (PM), nucleus and cytosol. Each value represents the mean 
± S.E.M. of ten determinations.  
 
other ‘higher’ inositol phosphates or inositol pyrophosphates that are phosphorylated 
via InsP5.  
 
The pathways by which S. cerevisiae converts Plc1p-generated InsP3 to InsP6 and then 
to inositol pyrophosphates have been established (Mulugu et al., 2007; Odom et al., 
2000; Zhang et al., 2001)(Fig 4.16).  
 
Hence, the localization of GFP-Plc1p was examined in ipk1Δ, kcs1Δ, vip1Δ and 
kcs1Δvip1Δ cells. GFP-Plc1p did not associate with the plasma membrane in any of 
these mutants (Fig 4.17). Arg82Δ cells are almost devoid of inositol phosphates 
possessing more than two phosphates. InsP5s (probably more than one isomer) are the 
only abundant InsPs in ipkΔ cells (Perera et al., 2004), and the inositol polyphosphate  
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profiles of the other mutants are dominated by InsP6. This being so, the simplest 
explanation of the presence of Plc1p at the plasma membrane only in arg82Δ cells is 
that this association only occurs when the cells do not contain a substantial 
concentration of any inositol polyphosphate with 5 or more phosphate groups.  
 
There was somewhat less GFP-Plc1p in the nucleus in kcs1Δ, vip1Δ, and 
vip1Δkcs1Δ cells than in the wild-type or arg82Δ cells (Fig 4.17). All of these mutants 
contain abnormally high levels of InsP6:  might this suppress nuclear Plc1p 
localization? 
 
4.9 The Ins(1,4,5,6)P4 kinase activity of Arg82p is responsible for destabilizing 
the Plc1p-plasma membrane interaction 
Arg82p is a dual InsP3 kinase: It first phosphorylates InsP3 at the D6 hydroxyl to form  
 PIP2   InsP3 
Arg82p 
 InsP4  InsP5 
 InsP6 
 InsP7 6-PP-InsP5   InsP7 5-PP-InsP5 
 InsP8 
  DAG
 
  
Plc1p 
Kcs1p 
Kcs1p 
(PP)2-InsP4
Arg82p 
Ipkp
1
Vip1p 
   
 
or Vip1p 
      Fig4.16: Pathways of InsP3 metabolism in S. cerevisiae 
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 Fig 4.17: Localization of GFP-Plc1p in ipk1Δ, kcs1Δ, vip1Δ and vip1Δkcs1Δcells 
 
Fluorescence Ratio  Genotype 
 PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
pUG36-PLC1 in ipk1Δ 0.77±0.02*** 1.59±0.06 0.49±0.02*** 
pUG36-PLC1 in kcs1Δ 0.71±0.01*** 1.46±0.05**/+ 0.49±0.02*** 
pUG36-PLC1 in vip1Δ 0.73±0.02*** 1.50±0.04*/+ 0.48±0.01*** 
pUG36-PLC1 in vip1Δkcs1Δ 0.72±0.02*** 1.50±0.04*/+ 0.49±0.01*** 
pUG36-PLC1 in WT 0.74±0.01 1.70±0.08 0.44±0.02 
pUG36-PLC1 in arg82Δ 1.13±0.02 1.74±0.08 0.66±0.03 
[Significantly different from the corresponding values of GFP-Plc1p in arg82Δ: ***P<0.001, 
0.001<**P<0.01, 0.01<*P<0.05; Significantly different from the corresponding values of GFP-Plc1p in 
WT: 0.01<+P<0.05.] 
Low light DIC (left columns) and fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of ipk1Δ (BY4742 ipk1::kanMX4), kcs1Δ (BY4742 kcs1::kanMX4), vip1Δ 
(BY4742 vip1::kanMX4), vip1Δkcs1Δ (BY4742 vip1::LEU2, kcs1::kanMX4), transformed of pUG36-
PLC1, respectively, was grown in SC-Ura-Met+2%glu at 25°C. These images are representative of 
three replicate cultures. The table shows ratio of fluorescence intensity of plasma membrane (PM), 
nucleus and cytosol. Each value represents the mean ± S.E.M. of ten determinations. 
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Ins(1,4,5,6)P4, then at D3, leading to the synthesis of Ins(1,3,4,5,6)P5 (see diagram 
below).  
 
 
To discover which of these inositol polyphosphates might have the dominant role in 
suppressing the Plc1p-plasma membrane interaction, I transformed a plasmid carrying 
an arg82 mutant ipk2-3 from Dr John York, which has a glycine at 344 converted to 
arginine, pUG34-ARG82G344R. This mutant makes only Ins(1,4,5,6)P4 (Chang et al., 
2002)(Fig 4.18).  
 
Fig 4.18: HPLC analysis of soluble inositol phosphates isolated from ARG82G344R 
(ipk2-3) strain grown in the presence of 30 µCi/ml [3H]inositol at 23 °C, which can 
synthesize InsP4. (Chang et al. 2002) 
 
 
 
 
 
 
  B. GFP-Plc1p in arg82Δ + pUG34-ARG82G344R  
 
 
When pARG82G344R was introduced into arg82Δ cells, GFP-Plc1p associated with the 
plasma membrane, as in cells devoid of Arg82p (Fig 4.19). Since Plc1p associated 
with the plasma membrane when cells could make Ins(1,4,5,6)P4 but not 
Ins(1,3,4,5,6)P5, it seems that Ins(1,3,4,5,6)P5 can inhibit the association of Plc1p with 
the plasma membrane. 
Ins(1,4,5)P3 
Arg82p 
Ins(1,4,5,6)P4 
Arg82p    
Ins(1,3,4,5,6)P5 
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 Fig 4.19: Localization of GFP-Plc1p is affected in ARG82G344R mutant 
 
 
Fluorescence Ratio  Genotype 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
pUG36-PLC1 in arg82Δ + pUG34-ARG82G344R 1.15±0.03 1.70±0.07 0.67±0.03 
pUG36-PLC1 in arg82Δ + pUG34-ARG82 0.71±0.02 1.56±0.06 0.46±0.019 
pUG36-PLC1 in arg82Δ + pUG34 1.16±0.02 1.84±0.09 0.64±0.02 
pUG36-PLC1 in arg82Δ 1.13±0.02 1.74±0.08 0.66±0.03 
pUG36-PLC1 in WT 0.74±0.01 1.70±0.08 0.44±0.02 
[There were no significant differences between the corresponding values of GFP-Plc1p in arg82Δ+ 
pARG82G344R and in arg82Δ,  GFP-Plc1p in arg82Δ+pARG82 and in WT, GFP-Plc1p in arg82Δ with 
empty vector and in arg82Δ.] 
Low light DIC (left columns) and Fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of arg82Δ+pUG36-PLC1 transformed with pARG82 and its mutant plasmid as 
indicated, respectively, were grown in SC-Ura-Met-His+2%glu at 25°C. These images are 
representative of three replicate cultures. The table shows ratio of fluorescence intensity of plasma 
membrane (PM), nucleus and cytosol. Each value represents the mean ± S.E.M. of ten determinations.  
 
One way to ask whether InsP5 can be sufficient to prevent Plc1p from associating 
with the plasma membrane is to determine whether Plc1p in arg82Δ cells could leave 
the plasma membrane if cells are loaded with exogenous InsP5.  
 170
I attempted to test this by incubating arg82Δ cells expressing wild-type GFP-Plc1p 
and plc1Δ cells expressing GFP-Plc1pE425G mutant with a membrane-permeant InsP5, 
2-O-Butyryl-Ins(1,3,4,5,6)P5/PM (100μM) (Echelon) (Rudolf et al., 1998; Yang et al., 
1999) (Fig 4.20 and Fig 4.21). Cells were treated for 2 hours in total, and examined 
after 15 min and 2 hours. After the treatment with membrane-permeant 
Ins(1,3,4,5,6)P5 for 15 min, there was a modest redistribution of GFP-Plc1p to the 
plasma membrane, which partially reversed after 2 hours. This was the opposite of 
what we had hoped might happen. 
 
This experiment was made difficult to interpret because I lacked a positive control and 
was also unsure if the InsP5 was actually taken into the cells because of the yeast cell 
wall. I did try spheroplasting the cells before adding the InsP5.  However, apart from 
ending up having diffused fluorescence that affected the microscopy results in most of 
the cells, I didn’t detect any changes in the localization of Plc1p on the plasma 
membrane (data not shown).  Hence these add-back experiments were inconclusive. 
 
However, it is unlikely that InsP5 itself destabilizes Plc1p’s association with plasma 
membrane in normal cells since previous work by Dr Perera showed there are no 
significant levels of InsP5 in wild type cells according to the [3H]inositol 
polyphosphate elution profiles from wild-type cells obtained by HPLC analysis 
(Perera et al., 2004). All InsP5 generated is rapidly phosphorylated, and only the InsP6 
level is substantial, at least in resting cells. At such an undetectable level, InsP5 would 
be unlikely to play a regulatory role on its own: though it is likely it can when it 
accumulates. It is therefore possible that InsP5, together with InsP6 and/or facilitated 
by the inositol pyrophosphates, are jointly responsible for directing Plc1p off from the 
 171
 
plasma membrane. At the moment, it is unsure if InsP5 alone is sufficient for de- 
stabilizing Plc1p from the plasma membrane.  
 
Fig 4.20:  Localization of GFP-Plc1p in arg82Δ incubated with Ins(1,3,4,5,6)P5/PM 
for indicated time course 
 
 
Fluorescence Ratio  
pUG36-PLC1 in arg82Δ 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
0.1% (v:v) DMSO 1.17±0.02 1.65±0.07 0.72±0.04 
100μM Ins(1,3,4,5,6)P5 15min 1.36±0.05*** 1.82±0.09 0.76±0.04* 
100μM Ins(1,3,4,5,6)P5 2hrs 1.29±0.04*** 1.80±0.05 0.72±0.02 
untreated 1.13±0.02 1.74±0.08 0.66±0.03 
[Significantly different from the corresponding values of the untreated: ***P<0.001, 0.01<*P<0.05. 
There were no significant differences between the corresponding values of the untreated with the 
DMSO treated, or between the treated for 15 min and for 2 hrs.] 
Low light DIC (left columns) and Fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of arg82Δ+pUG36-PLC1 were grown in SC-Ura-Met+2%glu at 25°C. 100μM 
of Ins(1,3,4,5,6)P5/PM were added and incubated for 15 min and 2 hours. Control was cells treated 
with drug carrier 0.1% (v:v) DMSO. These images are representative of three replicate cultures. The 
table shows ratio of fluorescence intensity of plasma membrane (PM), nucleus and cytosol. Each value 
represents the mean ± S.E.M. of ten determinations.  
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 Fig 4.21:  Localization of GFP-Plc1pE425G in plc1Δ incubated with 
Ins(1,3,4,5,6)P5/PM for indicated time course 
 
                    
Fluorescence Ratio  
pUG36-PLC1E425G in plc1Δ 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
0.1% (v:v) DMSO 1.39±0.02 1.67±0.08 0.85±0.03 
100μM Ins(1,3,4,5,6)P5 15min 1.38±0.04 1.57±0.05 0.89±0.01* 
100μM Ins(1,3,4,5,6)P5 2hrs 1.44±0.04 1.57±0.08 0.93±0.04** 
 untreated 1.39±0.05 1.74±0.09 0.81±0.03 
[Significantly different from the corresponding values of the untreated: 0.001<**P<0.01, 0.01<*P<0.05. 
There were no significant differences between the corresponding values of the untreated with the 
DMSO treated, or between the treated for 15 min and for 2 hrs.] 
Low light DIC (left columns) and fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of plc1Δ+pUG36-PLC1E425G were grown in SC-Ura-Met+2%glu at 25°C. 
100μM of Ins(1,3,4,5,6)P5/PM were added and incubated for 15 min and 2 hours. Control was cells 
treated with drug carrier 0.1% (v:v) DMSO. These images are representative of three replicate 
cultures. The table shows ratio of fluorescence intensity of plasma membrane (PM), nucleus and 
cytosol. Each value represents the mean ± S.E.M. of ten determinations. 
 
4.10 The PH domain of Plc1p is involved in its interaction with the plasma 
membrane 
The above experiments raised the question of how Plc1p associates with the plasma  
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membrane in cells lacking Arg82p and/or the downstream inositol polyphosphates. 
The PH domain of many PLC-δs is required for the processive hydrolysis of its 
substrate PtdIns(4,5)P2 at the plasma membrane, at least in animal cells. It is known 
that the high affinity binding of Ins(1,4,5)P3 to PLC-δ1 via its PH domain inhibits its 
binding to PtdIns(4,5)P2 (Cifuentes et al., 1994; Lemmon et al., 1995). In addition, a 
number of studies suggest that several inositol polyphosphates can inhibit interactions 
between various PH domains and phosphoinositides (Hirata et al., 1998). Hence we 
wondered if it was a PtdIns(4,5)P2-PH domain interaction in this case. 
 
I had made two stable mutants with mutations in or around the PH domain of Plc1p 
when I was seeking the nuclear localization signal: Plc1pR111L/R117S/R120S/R123E 
(Plc1p4R) and Plc1pK170A/R171A/R173A (Plc1pKRLR) (Section 3.6.2.2). Transformation into 
arg82Δ of GFP-Plc1pKRLR did not reduce the plasma membrane association of the 
protein in arg82Δ cells: nuclear localization was also affected as in wild-type cells 
(Fig 4.22 and Fig 3.15). The Plc1p4R mutant did not associate with the plasma 
membrane, and it was noticeably more concentrated in the nucleus in arg82Δ than in 
wild-type cells (Fig 4.22).  
 
The four arginines mutated in Plc1p4R are located at the start of the PH domain with 
the first arginine, R111, in the N-terminal extension before PH domain (see diagram 
below). This strongly suggests that some amino acid residues in the PH domain may 
be important for Plc1p’s interaction with plasma membrane.  
 
However, although these mutations alter the binding affinity of Plc1p for 
PtdIns(4,5)P2, they aren’t likely to affect Plc1p’s activities during stress responses, at  
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 Fig 4.22:  Localization of GFP-Plc1pKRLR and GFP-Plc1p4R in arg82Δ cells 
 
 
 
 
 
 
 
                
 
Fluorescence Ratio  Genotype 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
pUG36-PLC1KRLR in arg82Δ 1.16±0.02 1.49±0.04** 0.78±0.02** 
pUG36- PLC14R in arg82Δ 0.70±0.02*** 1.80±0.05 0.39±0.01*** 
pUG36-PLC1 in arg82Δ 1.13±0.02 1.74±0.08 0.66±0.03 
[Significantly different from the corresponding values of GFP-Plc1p in arg82Δ: ***P<0.001, 
0.001<**P<0.01.] 
Low light DIC (left columns) and fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of arg82Δ transformed with pUG36-PLC1KRLR or pUG36-PLC14R, 
respectively, were grown in SC-Ura-Met + 2%glu at 25°C. These images are representative of three 
replicate cultures. The table shows ratio of fluorescence intensity of plasma membrane (PM), nucleus 
and cytosol. Each value represents the mean ± S.E.M. of ten determinations.  
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least phenotypically – as this mutant grew as well as cells having wild type Plc1p 
transformed at elevated temperature (Fig 4.23).  
 
Fig 4.23: Heat stress response of the Plc1p4R mutant 
 
 
Cells were grown to exponential phase (about ~1 x 107 cells/ml) in SC-Ura-Met (2% glu) media. A 
dilution assay was then carried out as described in the methodology section. Cells were serially diluted 
five-fold then grown on YTD agar plate (2% glu) at 37 oC for 2 days (till wild type colonies were fully 
grown). 
 
 
I also mutated some of these arginine residues in pairs: Plc1pR117S/R120S (Plc1pR2/3), 
Plc1pR117S/R123E (Plc1pR2/4), and Plc1pR120S/R123E (Plc1pR3/4). None of these three 
mutants were disassociated as effectively from the plasma membrane as was Plc1p4R 
(Fig 4.24). Though the Plc1pR3/4 mutant does appear to have more effect on GFP-
Plc1p association with the plasma membrane than the Plc1pR2/3 and Plc1pR2/4 mutants 
both appeared to have only slight effects, and still displayed somewhat more plasma 
membrane associated GFP-Plc1p protein than the Plc1p4R mutant. 
 
I then looked at the single mutation of the first of these four arginines, GFP-Plc1pR1. 
The single R111L change decreased the association of GFP-Plc1p with the plasma 
membrane as effectively as the Plc1pR3/4 construct. The Plc1pR1 mutant also showed a 
high level of nuclear localization (Fig 4.24). 
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 Fig 4.24:  Localization of GFP-Plc1pR2/3, GFP- Plc1pR2/4, GFP- Plc1pR3/4 and 
GFP- Plc1pR1 in arg82Δ cells 
                     
Fluorescence Ratio  Genotype 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
pUG36-PLC1R2/3 in arg82Δ 1.02±0.03**/+++ 1.45±0.06**/+++ 0.71±0.03+++ 
pUG36-PLC1R2/4 in arg82Δ 1.13±0.02+++ 1.40±0.05**/+++ 0.82±0.03**/+++ 
pUG36-PLC1R3/4 in arg82Δ 0.84±0.04***/++ 1.47±0.06*/+++ 0.59±0.04+++ 
pUG36-PLC1R1 in arg82Δ 0.83±0.03***/++ 1.99±0.11* 0.43±0.03*** 
pUG36-PLC1 in arg82Δ 1.13±0.02 1.74±0.08 0.66±0.03 
pUG36- PLC14R in arg82Δ 0.70±0.02 1.80±0.05 0.39±0.01 
[Significantly different from the corresponding values of GFP-Plc1p in arg82Δ:  ***P<0.001, 
0.001<**P<0.01, 0.01<**P<0.05.]  
[Significantly different from the corresponding values of GFP-Plc1p4R in arg82Δ:  +++P<0.001, 
0.001<++P<0.01.] 
Low light DIC (left columns) and fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of arg82Δ transformed with various PLC1 mutant as indicated, respectively. 
Cells were grown in SC-Ura-Met+2%glu at 25°C. These images are representative of three replicate 
cultures. The table shows ratio of fluorescence intensity of plasma membrane (PM), nucleus and 
cytosol. Each value represents the mean ± S.E.M. of ten determinations.  
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These experiments didn’t isolate a single arginine that was responsible for the 
association of Plc1p and plasma membrane. R111 seems very effective, but it is 
possible that all of these arginine residues are important. 
 
4.11 GFP-Plc1p4R/E425G is not on the plasma membrane in plc1Δ 
A catalytically dead Plc1p mutant, GFP-Plc1pE425G was associated with the plasma 
membrane in plc1Δ cells, and mutations in or near the PH domain 
(R111L/R117S/R120S/R123E), disrupted this association. So how would the mutant 
that combines the R111L/R117S/R120S/R123E (4R) and E425G mutations 
behave? As expected, GFP-Plc1p4R/E425G was not associated with the plasma 
membrane in either plc1Δ or arg82Δ cells, presumably because of the mutations in the 
four arginines (Fig 4.25). However, this mutant had also lost much of its nuclear 
concentration. To test the reliability of these observations, I examined the stability of 
the various arginine mutants and Plc1pE425G. GFP-Plc1p4R/E425G are relatively stable, 
but some free GFP was also seen on the blot (APPX. Fig A).   
 
I am therefore confident that this construct does reliably represent the localisation of 
the catalytically inactive Plc1pE425G and that this mutant was truly no longer capable 
of binding with the plasma membrane when four arginines in its PH domain were 
disrupted. Therefore the PH domain does indeed appear to participate in the 
interaction of Plc1p with plasma membrane. 
 
4.12 Localisation of Plc1p truncation mutants in arg82Δ cells 
Having established that some mutations in the PH domain and the X-Y region appear 
to be important for Plc1p to interact with the plasma membrane, we wondered  
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 Fig 4.25: Localization of GFP-Plc1p4R/E425G in plc1Δ and arg82Δ cells 
 
 
Fluorescence Ratio  Genotype 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
pUG36-PLC14R/E425G in plc1Δ 0.77±0.02### 1.17±0.02***/+++/### 0.67±0.02***/+++/### 
pUG36-PLC14R/E425G in arg82Δ 0.79±0.02***/+++/### 1.16±0.03***/+++/### 0.69±0.02+++ 
pUG36-PLC1 in plc1Δ 0.77±0.01 1.65±0.02 0.47±0.01 
pUG36-PLC14R in plc1Δ 0.80±0.02 1.48±0.03 0.54±0.01 
pUG36-PLC1E425G in plc1Δ 1.39±0.05 1.74±0.09 0.81±0.03 
pUG36-PLC1 in arg82Δ 1.13±0.02 1.74±0.08 0.66±0.03 
pUG36-PLC14R in arg82Δ 0.70±0.02 1.80±0.05 0.39±0.01 
pUG36-PLC1E425G in arg82 Δ 1.16±0.01 1.70±0.09 0.71±0.05 
[Significantly different from the corresponding values of GFP-Plc1p in plc1Δ: ***P<0.001; of GFP-
Plc1p4R in plc1Δ: +++P<0.001; of GFP-Plc1pE425G in plc1Δ: ###P<0.001.] 
[Significantly different from the corresponding values of GFP-Plc1p in arg82Δ: ***P<0.001; of GFP-
Plc1p4R in arg82Δ: +++P<0.001; of GFP-Plc1pE425G in arg82Δ: ###P<0.001.] 
Fluorescence images of logarithmic phase cultures (5 x 106 – 1 x 107 cells/ml) of plc1Δ (top) and 
arg82Δ (bottom) transformed with pUG36–PLC14R/E425G and pUR34NLS, respectively. The left-hand 
columns show low light DIC images. The left-mid columns show the localisation of the indicated GFP 
constructs. The right-mid columns show the localisation of nuclei as obtained by transformation of 
cells with a NLS construct, and the merged images are shown on the right-hand columns. These images 
are representative of three replicate cultures. All strains were cultured in SC-Ura-Met-His+2% glu 
medium. The table shows ratio of fluorescence intensity of plasma membrane (PM), nucleus and 
cytosol. Each value represents the mean ± S.E.M. of ten determinations. 
 
whether other domains of Plc1p might also be required for the association with the 
plasma membrane. I tested this by examining the localization of the truncation 
mutants, Plc1p1-333, Plc1p220-end and Plc1p(1-333)+C2 in arg82Δ cells. GFP-Plc1p1-333 and 
GFP-Plc1p220-end are both stable (APPX. Fig A), and I also confirmed the stability of 
GFP-Plc1p(1-333)+C2 (APPX. Fig A). As shown in Fig 4.26, Plc1p1-333 includes the 
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entire PH domain, Plc1p220-end includes the XY and C2 domains, and the Plc1p(1-333)+C2 
mutant has the XY region deleted.  
 
Fig 4.26: Diagram of the Plc1p truncation mutants 
 
 
Thus, in arg82Δ, the GFP-Plc1p1-333 tests the requirement for the XY and C2 region 
for its association with plasma membrane. The localization of GFP-Plc1p220-end 
meanwhile, and GFP-Plc1p(1-333)+C2 were used to tell us if the PH domain and/or XY 
domain are indispensable for binding, respectively. 
 
None of these truncation mutant constructs associated with the plasma membrane in   
arg82Δ cells, and GFP-Plc1p220-end and GFP-Plc1p(1-333)+C2 were very concentrated in 
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the nucleus (Fig 4.27). Therefore, these latter two constructs were provided less useful 
insights into the association of Plc1p with the plasma membrane in arg82Δ cells. 
 
Fig 4.27: Localization of GFP-Plc1p1-333, GFP-Plc1p220-end and GFP-Plc1p(1-333)+C2 
in arg82Δ cells 
 
 
                                         
Fluorescence Ratio  Genotype 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
pUG36-PLC11-333 in arg82Δ  0.82±0.02*** 1.44±0.06** 0.58±0.03* 
pUG36-PLC1220-end in arg82Δ  0.79±0.02*** 2.83±0.30** 0.33±0.05*** 
pUG36-PLC1(1-333)+C2 in arg82Δ  0.78±0.01*** 2.17±0.14* 0.37±0.02*** 
pUG36-PLC1 in arg82Δ 1.13±0.02 1.74±0.08 0.66±0.03 
[Significantly different from the corresponding values of GFP-Plc1p in arg82Δ: ***P<0.001, 
0.001<**P<0.01, 0.01<*P<0.05.] 
Low light DIC (left columns) and fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of arg82Δ transformed with PLC1 mutants indicated, respectively. Cells were 
grown in SC-Ura-Met+2% glu at 25°C. These images are representative of three replicate cultures. The 
table show the ratio of fluorescence intensity of plasma membrane (PM), nucleus and cytosol. Each 
value represents the mean ± S.E.M. of ten determinations.  
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4.13 Plc1p associates with the plasma membrane in arg82Δvps41Δ cells which 
have a reduced complement of PtdIns(4,5)P2 
The catalytically dead and PH domain mutants of Plc1p no longer associate with the 
plasma membrane. We wondered whether PtdIns(4,5)P2 was involved in this binding 
of Plc1p with the plasma membrane.  
 
Vps41p is a vacuolar membrane protein that is a subunit of the homotypic vacuole 
fusion and vacuole protein sorting (HOPS) complex (Nakamura et al., 1997). 
Mutations in VPS41 cause many defects, including poor growth on low iron medium, 
altered vacuolar morphology, mis-sorting of membranous and soluble vacuolar 
proteins. One of our previous studies on Vps41p uncovered another defect: decreased 
levels of intracellular PtdIns(4,5)P2 in vps41Δ cells (SK Dove 2008, unpublished.). I 
therefore constructed a arg82Δvps41Δ double mutant, to observe GFP-Plc1p’s 
localization in the cells with a relatively low level of PtdIns(4,5)P2. 
 
arg82Δvps41Δ cells were very compromised, with slow growth and highly 
fragmented vacuoles. However, GFP-Plc1p was still on the plasma membrane, 
indicating that this localisation can be achieved despite a subnormal PtdIns(4,5)P2 
complement (Fig 4.28).  
 
4.14 Localisation of GFP-Plc1p in arg82Δ cells after hypo-osmotic shock 
activation 
Plc1p associates with the plasma membrane in unstressed arg82Δ cells. We were 
interested in knowing whether this association would change when cells were 
stressed. Dr Perera had earlier determined the phosphoinositide complements after  
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 Fig 4.28: Localization of GFP-Plc1p in arg82Δvps41Δ 
 
Fluorescence Ratio  Genotype 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
pUG36-PLC1 in arg82Δ vps41Δ 1.14±0.03 1.68±0.03 0.68±0.01 
pUG36-PLC1 in arg82Δ 1.13±0.02 1.74±0.08 0.66±0.03 
[There were no significant differences between the corresponding values of the two.] 
Low light DIC (left columns) and fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of arg82Δvps41Δ transformed with pUG36-PLC1 were grown in SC-Ura-
Met+2% glu at 25°C. These images are representative of three replicate cultures. The table shows the 
ratio of fluorescence intensity of plasma membrane (PM), nucleus and cytosol. Each value represents 
the mean ± S.E.M. of ten determinations.  
 
hypo-osmotic challenge of wild-type, plc1Δ and arg82Δ cells. After Plc1p was 
activated, the basal level of PtdIns(4,5)P2  was reduced by ~ 40% in wild-type and 
arg82Δ cells, but was unchanged in plc1Δ cells (Perera et al. 2004).  
 
I investigated whether the distribution of GFP-Plc1p in arg82Δ cells would change 
after hypo-osmotic shock. I grew cells in medium supplemented with 0.9M NaCl 
(through two steps: 0.5M NaCl and then 0.9M NaCl) into exponential phase, and then 
quickly diluted them into 10 volumes of the same medium lacking salt. After cells had 
been grown with a high concentration of salt for several generations, their plasma 
membrane GFP-Plc1p fluorescence increased, and there was less fluorescence in the 
nucleus. After hypo-osmotic shock, plasma membrane GFP-Plc1p declined somewhat 
and nuclear GFP-Plc1p gradually reverted to the normal levels.  30 minutes after the 
hypo-osmotic shock, Plc1p had regained its usual intracellular distribution in arg82Δ 
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cells (Fig 4.29). Although it is possible that the loss of PtdIns(4,5)P2 during Plc1p 
activation might have contributed to the dissociation of Plc1p from the plasma 
membrane upon  activation, it should be remembered that the PtdIns(4,5)P2 
complement of cells grown in high salt is, as far as we know, normal. 
 
Figure 4.29: Localization of GFP-Plc1p in arg82Δ during hypo-osmotic shock 
 
Fluorescence Ratio  
pUG36-PLC1 in arg82Δ  
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
untreated 1.13±0.02 1.74±0.08 0.66±0.03 
in 0.9M NaCl 1.30±0.03*** 1.28±0.04*** 1.03±0.05*** 
hypo-osmotic shocked - 0.09M NaCl 2 min 1.26±0.04** 1.44±0.06**/+ 0.88±0.04***/+ 
hypo-osmotic shocked - 0.09M NaCl 30 min 1.20±0.05 1.66±0.11 0.77±0.07 
[Significantly different from the corresponding values of the untreated: ***P<0.001, 0.001<**P<0.01; 
There were no significant differences between the untreated and the hypo-osmotic shocked for 30 min.] 
[Significantly different from the corresponding values of the cells grown in 0.9M NaCl: 0.01<+P<0.05; 
There were no significant differences from the hypo-osmotic shocked for 30 min.] 
Low light DIC (left columns) and fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of arg82Δ+ pUG36–PLC1 grown at 25°C in SC-Ura-Met + 2% glu + 0.9M 
NaCl media followed by a rapid shift to 10 volumes of medium lacking salt for 2 min and 30 min. 
These images are representative of three replicate cultures. The table shows ratio of fluorescence 
intensity of plasma membrane (PM), nucleus and cytosol. Each value represents the mean ± S.E.M. of 
ten determinations.  
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4.15 Plc1p’s localisation in gpr1Δ & gpr1Δarg82Δ cells   
The plasma membrane glucose response protein, Gpr1p, is coupled to a G-protein α-
subunit Gpa2p which regulates cAMP synthesis and PKA activity. Plc1p has been 
implicated in PKA signalling by affecting cAMP synthesis via an interaction with the 
Gpr1p/Gpa2p pathway (Ansari et al., 1999). Plc1p may physically interact with 
Gpr1p and Gpa2p, and Gpr1p may regulate Plc1p activity (Demczuk et al., 2008). I 
therefore determined whether deleting Gpr1p would influence the association between 
Plc1p and the plasma membrane. 
 
I examined the localization of GFP-Plc1p in gpr1Δ and gpr1Δ arg82Δ cells. Plc1p 
was distributed between the nucleus and cytoplasm in gpr1Δ, as in wild-type cells, 
and it still associated with the plasma membrane in cells devoid of both Gpr1p and 
Arg82p (Fig 4.30).  Therefore, Gpr1p seems to have no role in the association of 
Plc1p with the plasma membrane. 
 
4.16 Inositol polyphosphates are involved in stress responses 
PLC1 is not an essential gene, but cells devoid of Plc1p do not grow in stressed 
environments. Plc1p-mediated hydrolysis of PtdIns(4,5)P2 is the only pathway for 
InsP3 synthesis in S. cerevisiae (Odom et al., 2000; York et al., 1999), and the higher 
InsPs generated from InsP3 participate in multiple intracellular activities. Earlier, I 
presented evidence that correct intracellular localisation of Plc1p may be necessary 
for cells to maintain healthy growth under stress (section 3.7), and the fact that 
arg82Δ cells display increased transcription of Msn2p-dependent stress-responsive 
genes may indicate that synthesis of InsPs are required for normal PKA signalling 
(Demczuk et al., 2008). I tested this idea with arg82 mutants.  
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 Fig 4.30: Localization of GFP-Plc1p in gpr1Δ and gpr1Δ arg82Δ cells 
 
Fluorescence Ratio  Genotype 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
pUG36-PLC1 in gpr1Δ 0.71±0.02 1.64±0.06 0.44±0.02 
pUG36-PLC1 in gpr1Δ arg82Δ 1.17±0.06*** 1.77±0.08 0.68±0.05*** 
pUG36-PLC1 in WT 0.74±0.01 1.70±0.08 0.44±0.02 
pUG36-PLC1 in arg82Δ 1.13±0.02 1.74±0.08 0.66±0.03 
[Significantly different from the corresponding values of gpr1Δ: ***P<0.001. There were no significant 
differences between the corresponding values of GFP-Plc1p in WT and in gpr1Δ, in arg82Δ and in 
gpr1Δ arg82Δ.] 
Low light DIC (left columns) and fluorescence images (right columns) of logarithmic phase cultures (5 
x 106 – 1 x 107 cells/ml) of gpr1Δ and gpr1Δarg82Δ transformed with pUG36-PLC1, respectively, 
were grown in SC-Ura-Met+2% glu at 25°C. These images are representative of three replicate 
cultures. The table shows the ratio of fluorescence intensity of plasma membrane (PM), nucleus and 
cytosol. Each value represents the mean ± S.E.M. of ten determinations.  
 
Plasmids expressing ARG82D131A, ARG82Δasp and ARG82G344R were used here to 
investigate whether inositol polyphosphates downstream of Plc1p activation were 
essential to cell survival in stressed conditions. As shown in Fig 4.31, cells expressing 
ARG82D131A and ARG82G344R, which make no InsP5, both appeared sick at 37oC and in 
the presence of high salt (0.7M NaCl). In contrast, Arg82pΔasp, a kinase-active mutant 
with an ablated DNA binding domain, grew as well as the cells harbouring wild type 
Arg82p. This strengthens the evidence that Plc1p alleviates stress responses as a result 
of the synthesis of inositol polyphosphates.  
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 Fig 4.31: Growth of various ARG82 mutants under Stresses 
 
 
 
 
 
arg82Δ cells transformed with various plasmids as indicated were grown to exponential phase till about 
~1 x 107 cells/ml in YPD (for arg82Δ cells), SC-His + 2% glu (for pUG34 plasmids) or SC-Leu+2% 
glu (for pYcPlac111 plasmids). Dilution assay was carried out as described in methodology section. 
Cells were serially diluted five-fold then grown on YTD+2% glu agar plates at 37 oC (till wild-type was 
fully grown) for 2 days or on the same plate but with 0.7M NaCl (till wild-type was fully grown) for 6 
days. Control plate was grown at 23oC for 2 days. Data represents three independent experiments. 
 
4.17 Discussion 
4.17.1 Arg82p can negatively regulate the interaction between Plc1p and the 
plasma membrane 
In wild-type cells, GFP-Plc1p is distributed between the nucleus and the cytoplasm 
and displays no obvious interactions with any membranes. It was therefore 
unexpected to find GFP-Plc1p associated with the plasma membrane in arg82Δ cells 
(Fig 4.2). This is consistent with the idea that Plc1p has some kinship with PLC-δ1: 
both can associate with the plasma membrane and can enter the nucleus. To what 
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degree the plasma-membrane association of Plc1p ever occurs, even transiently, in 
wild-type cells remains uncertain. The functional consequences of this membrane 
binding by Plc1p are also unclear, as Plc1p activation in arg82Δ cells in response to 
hypo-osmotic shock seems normal (Perera et al., 2004).  
 
So, how does Arg82p influence membrane binding? I first confirmed that wild-type 
ARG82 restores wild-type Plc1p localisation to arg82Δ cells. This rules out the trivial 
possibility that the observed localisation shift was the result of an unlinked mutation 
(Fig 4.2).   
 
Arg82p was first discovered as a protein chaperon required to stabilize the Arg80p-
Mcm1p complex during the control of expression of arginine-responsive genes. This 
requires the Arg82p poly-aspartate domain (residues 282-303) but not the InsP kinase 
domain (residues 127-135) for Ins(1,3,4,5,6)P5 synthesis, although there is 
considerable controversy over this point (Odom et al., 2000; Dubois et al., 2000). The 
two domains and functions do indeed appear to be independent from each other in our 
hands, as was originally reported (Dubois et al., 2000). Indeed, the Arg82p kinase 
dead mutant is sensitive to stresses (Fig 4.31) in a manner similar to a PLC1 knock-
out strain, whereas the DNA binding function of Arg82p is not essential when 
growing in normal media under stresses as mutants deficient in arginine metabolism 
displayed a ‘wild type’ phenotype in response to stress (Fig 4.31).   
 
Various observations made us wonder whether Arg82p might physically interact with 
Plc1p and so facilitate the rapid metabolism of InsP3 to InsP6, an idea that became 
more attractive when it was observed that Arg82p and Plc1p sometimes show similar 
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intracellular distributions (Fig 4.1). However, Arg82p localisation did not change 
following deletion of PLC1 (Fig 4.3), and I obtained no evidence for a physical 
association between Plc1p and Arg82p by co-immunoprecipitation experiments (Fig 
4.4 and Fig 4.5) or by the observation that a catalytically inactive GFP-Arg82pD131A 
and Plc1p showed different distributions in arg82Δ cells (Fig 4.8).  
 
It therefore seemed likely that the products of Arg82p were preventing Plc1p from 
associating with the plasma membrane in normal cells. I tried to test this idea by 
inhibiting Plc1p activity and so removed all inositol phosphates, since they all derive 
from Plc1p mediated cleavage of PtdIns(4,5)P2. This method is an independent way to 
achieve an even greater loss of inositol phosphates than is the case in arg82Δ cells 
(York et al., 1999).  
 
I first attempted to use the PLC-inhibitor U73122 to arrest Plc1p activity. U73122 
partially inhibits Plc1p (Perera et al., 2004), but the mechanism of inhibition is ill-
defined. Plc1p was dissociated from the plasma membrane of arg82Δ cells by U73122 
treatment, maybe because of inhibition of active site binding to PtdIns(4,5)P2. This 
hypothesis was strengthened when I made several active site mutants of Plc1p. The 
catalytically inactive Plc1pH439L was also no longer able to associate with the plasma 
membrane of arg82Δ cells (Fig 4.12). This mutant contains only a single amino acid 
substitution in the active site, supporting the idea that substrate binding may be 
required for membrane association.  
 
A second Plc1p mutant, Plc1pE452G, was still plasma membrane bound in arg82Δ cells 
(Fig 4.12) but was also catalytically compromised, as indicated by the heat sensitivity 
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of strains expressing this construct as their sole Plc1p (Fig 4.13). This suggested that 
Plc1pE452G might also be plasma membrane-bound in plc1Δ cells, and this was indeed 
the case (Fig 4.15). These results are all consistent with a hypothesis that Plc1p binds 
to the plasma membrane via its active site and that inositol polyphosphates inhibit this 
association. 
 
The question now turned to which inositol phosphates might inhibit Plc1p membrane 
binding? To examine this question the localisation of GFP-Plc1p was examined in 
strains bearing deletions of the genes encoding the other known inositol phosphate 
kinases, Ipk1p, Kcs1p and Vip1p. As shown in Figure 4.17, inactivating these kinases 
did not cause a localisation shift of GFP-Plc1p to the plasma membrane. This 
refocused attention on Arg82p, and I analysed a mutant from Dr John York’s lab 
(Arg82pG344R) that can synthesize Ins(1,4,5,6)P4 but not Ins(1,3,4,5,6)P5. GFP-Plc1p 
remained associated with the plasma-membrane in this mutant (Fig 4.19), indicating 
that Ins(1,4,5,6)P4 does not dissociate Plc1p from the plasma membrane.  
 
To address the notion that Arg82p-generated Ins(1,3,4,5,6)P5 can dissociate Plc1p 
from the plasma membrane, I attempted to “add back” InsP5 to cells as a cell permeant 
2-O-Butyryl-Ins(1,3,4,5,6)P5 but was unsuccessful. This molecule can cross the 
plasma membrane of mammalian cells and becomes trapped when the butyryl ester is 
removed by esterases. This experiment failed to destablise GFP-Plc1p from the 
plasma membrane in arg82Δ cells (Fig 4.20) or of GFP-Plc1pE425G in plc1Δ cells (Fig 
4.21). Indeed, the reverse was true: there appeared to be more Plc1p on the membrane 
after treatment, though this might have been a consequence of a decrease in nuclear 
Plc1p. The reason for this decrease in nuclear Plc1p is not clear, but may be a result of 
 190
elevated inositol phosphates, since I also observed a similar reduction in nuclear Plc1p 
in kcs1Δ, vip1Δ and kcs1Δvip1Δ mutants (Fig 4.17), all of which exhibit abnormally 
high levels of certain higher inositol phosphates. Why exogenous InsP5 was not able 
to destablise Plc1p at the same time is not clear. However, knowing InsP5 is involved 
in such association does not rule out more phosphorylated inositol phosphates playing 
a role since the other kinases were intact in arg82Δ cells.  
 
The kinases involved in the InsPs synthesis pathway sequentially phosphorylate 
specific substrates and must work closely together as no isomer of InsP3, 
Ins(1,4,5,6)P4 or Ins(1,3,4,5,6,)P5 consistently accumulates in the control and 
stimulated wild-type cells (Perera et al., 2004). When depleted of a certain InsP 
kinase, yeast cells tend to accumulate the substrate of this kinase (or products of its 
degradation by an alternative route) (Perera et al., 2004), and these inositol 
phosphates are also subjected to increased dephosphorylation by specific phosphatase 
which results in a characteristic inositol polyphosphate profile that is distinct for each 
inositol phosphate kinase mutant. Various workers, including Dr Perera from our lab, 
have previously analyzed the inositol polyphosphate accumulation in cells lacking the 
inositol polyphosphate kinases Arg82p, Ipk1p and Kcs1p (Perera et al., 2004). Fig 
4.32 shows the inositol polyphosphates that accumulate in inositol polyphosphate 
kinase knock-out strains. Compared with the wild type, the major change in arg82Δ 
cells was a complete loss of higher inositol phosphates and a massive increase in the 
amount of Ins(1,4)P2 (InsP2) most likely resulting from an enhanced rate of InsP3 
dephosphorylation. In ipk1Δ cells, an accumulation of InsP5 and PP-InsP4 was seen 
and a huge peak of InsP6 plus some forms of InsP4 were found in kcs1Δ cells (Fig 
4.32). Since Dr Perera’s work, Vip1p was discovered as a second inositol 
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pyrophosphate synthase, with products that are structurally different from those 
produced by Kcs1p (Mulugu et al., 2007). vip1Δ cells would therefore be expected to 
have a profile of inositol polyphosphate accumulation largely similar to that of to 
kcs1Δ. 
 
 Fig 4.32: Composite HPLC chromatogram showing the combined elution profiles 
of [3H]labelled inositol polyphosphates in wild-type, arg82Δ, ipk1Δ, and kcs1Δ of 
BY4742 cells, respectively, after hypo-osmotic shock. Figure does not show the 
Ins(1,4)P2 that accumulated in arg82Δ cells. (Perera 2002, p.124) 
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The accumulation of Ins(1,4)P2 and the lack of InsP5/PP-InsP4 in arg82Δ indicates 
that either InsP5 or a pyrophosphorylated inositol phosphate generated from InsP5 
might regulate the association of Plc1p with the plasma membrane. 
 
Inositol pyrophosphates are now recognized as a group of important multi-functional 
molecules that regulate diverse cellular processes, including endocytic trafficking 
(Saiardi et al., 2002), DNA recombination (Luo et al., 2002) and are required for 
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vacuole morphogenesis (Saiardi et al., 2000b), cell wall integrity and resistance to salt 
stress (Dubois et al., 2002).  
 
Alternatively, it could be that any of the more highly phosphorylated inositol 
phosphate than InsP5 might be able to fulfil this role in cells. I favour this latter 
hypothesis because the only inositol phosphate to reach substantial levels in wild-type 
cells is InsP6 (Fig 4.31). Yet if only InsP6 were required, then GFP-Plc1p should be on 
the plasma membrane in ipk1Δ cells. Hence I suggest that InsP6 normally inhibits 
Plc1p associating with the membrane but that other inositol phosphates, such as InsP5 
and PP-InsP4, can also mediate this effect if their levels become elevated. Surely, the 
simplest explanation is that any InsPs with 5 or more phosphates keeps Plc1p off the 
plasma membrane. However, even some InsP2 could weakly interfere with Plc1p’s 
interaction with plasma membrane because it is notable that the GFP-Plc1pE425G gives 
a higher level of plasma membrane fluorescence in plcΔ than GFP-Plc1p does in 
arg82Δ cells: the former has no inositol phosphates whilst the latter has very high 
levels of InsP2.  
 
4.17.2 How does Plc1p interact the plasma membrane? 
Having defined as closely as possible that inositol polyphosphates, primarily InsP5 
and/or InsP6, prevent Plc1p from associating with the plasma membrane, I next tried 
to understand what features of the Plc1p molecule are involved in its interaction with 
the plasma membrane in arg82Δ cells that lack inositol polyphosphates.  
 
I already had evidence that PtdIns(4,5)P2 binding by the active site was probably 
needed, and I next tested if an intact PH domain was required. The PH domain and C2 
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domain are known as a membrane-targeting domain for most PLCs. The binding of 
Plcδ1 to PtdIns(4,5)P2 via its PH domain is important for processive hydrolysis in 
animal cells (Cifuentes et al., 1993; Lomasney et al., 1996), and the PH domain of 
PLC-δ1 is also known to bind to inositol polyphosphates. For example, InsP3 binds to 
PLC-δ1 via its PH domain with high affinity and competitively with PtdIns(4,5)P2 
(Cifuentes et al., 1994; Lemmon et al., 1995). Indeed, there is a substantial body of 
literature that suggests that inositol phosphates can inhibit the interactions between 
many PH domains and phosphoinositides (Hirata et al., 1998). This begged the 
question of whether the PH domain of Plc1p is the region that the inositol 
polyphosphates interact with in order to prevent membrane binding Plc1p? 
 
As shown in Fig 4.22, several basic residues in the PH domain are required for 
membrane binding, as the Plc1p4R mutant did not associate with the plasma membrane 
in arg82Δ cells. Oddly, this over-expressed mutant Plc1p did allow plc1Δ cells to 
grow at 37ºC (Fig 4.23), suggesting that growth at 37ºC does not need Plc1p to 
associate with the plasma membrane stable enough to be seen in our experiments.  
 
Unsurprisingly, the same 4R mutant also destabilized the plasma-membrane binding 
of the Plc1pE425G mutant in plc1Δ cells (Fig 4.25) as expected. The fluorescence 
looked rather diffuse though GFP-Plc1p4R/E425G was fairly a stable construct (APPX. 
Fig A), and it was intriguing that the nuclear fluorescence was dramatically decreased 
in the combined mutant while both GFP-Plc1p4R and GFP- Plc1pE425G were fairly 
nuclear. This might suggest that PtdIns(4,5)P2 binding may somehow contribute to 
nuclear localisation, since both of these domains are likely to interact with this lipid. 
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Much of the effect of the 4R mutant could derive from the loss of the R111 residue 
since a Plc1pR1 mutant had almost as little plasma-membrane binding as the Plc1p4R 
mutant (Fig 4.24). Therefore, sequence in the link of N-terminal extension and the PH 
domain are especially important. This was also confirmed by a truncation mutant 
Plc1p220-end which has no N-terminal 220 residue including the whole PH domain and 
failed to associate with plasma membrane in arg82Δ cells (Fig 4.27). 
 
That neither the truncation mutants of Plc1p (Plc1p1-333 and Plc1p(1-333)+C2) or 
Plc1pH439L associated with the plasma membrane in arg82Δ cells (Fig 4.27), suggested 
that domains other than the PH domain are also required for the plasma membrane 
interaction.  
 
The XY domain interacts with substrates, the membrane surface and the activating 
Ca2+. A ridge of hydrophobic residues surrounding the active site is important for the 
interaction with and insertion into the membrane (Rebecchi and Pentyala, 2000). 
However, what the PH and C2 domains of Plc1p are binding to is unclear (Flick and 
Thorner, 1993). Previous studies have demonstrated strong evidence that the C2 
domain in other proteins binds to lipids, usually either PtdSer and/or PtdIns(4,5)P2 
(Sutton et al., 1995; Rhee, 2001). The C2 domain of PLC-ζ was found interact with 
phosphoinositides, namely PtdIns3P or PtdIns5P, and this seemed to negatively 
regulate the PLC-ζ (Kouchi et al., 2005).  
 
That Plc1p can associate with the plasma membrane, even when it is over-expressed, 
suggests that at least some of its binding partners are reasonably abundant molecules, 
probably lipids. Which of these interactions is regulated by inositol phosphates is also 
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undefined, although the known propensity of PH domains to bind inositol phosphates 
is established and it would be surprising if this was not the site of lipid-inositol 
phosphate competition.    
 
In an attempt to define possible protein ligands for the various domains of Plc1p, I 
tried looking at GFP-Plc1p localisation in mutants that remove or reduce several 
known Plc1p-interactors. The first was Gpr1p, as Plc1p has recently been implicated 
as a possible component of the Gpr1p-Gpa2p signaling module, participating in PKA 
signalling by affecting cAMP synthesis (Ansari et al., 1999). The Plc1p/Grp1p/Gpa2p 
complex operates in a growth control pathway parallel to Ras2p (Demczuk et al., 
2008). The requirement for Plc1p in this pathway is unclear, as there is some 
suggestion that the protein merely acts as some sort of scaffold. Gpr1p is resident on 
the plasma membrane and was reported to enhance PtdIns(4,5)P2 hydrolysis by Plc1p 
through either a direct regulation of Plc1p or by mediating the recruitment of Plc1p to 
the plasma membrane and to PtdIns(4,5)P2 (Demczuk et al., 2008). However, deletion 
of GPR1 had no effect on GFP-Plc1p membrane interaction in a double gpr1Δ 
arg82Δ cells (Fig 4.30).  
 
Similarly, an attempt to reduce PtdIns(4,5)P2 levels by making a VPS41 deletion was 
also not successful in altering the binding of Plc1p to the cell surface (Fig 4.28). 
VPS41 encodes a vacuole membrane protein (Nakamura et al., 1997) and vps41Δ cells 
were found having relatively low level of membrane PtdIns(4,5)P2 (SK Dove 2008, 
pers. comm.). The reason the double mutant may still have displayed plasma 
membrane fluorescence could be because this strain still retains substantial 
PtdIns(4,5)P2 (about ¼ to ½ or normal SK Dove 2008, unpublished) or because the 
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levels of PtdIns(4,5)P2 are altered or restored in the arg82Δvps41Δ cells used in this 
experiment, as I did not measure this in the double mutant. This needs be further 
addressed by looking at GFP-Plc1p localisation in mss4-1, a mutant of the yeast 
PtdIns4P 5-kinase Mss4p, that have even lower levels of PtdIns(4,5)P2.  
 
Finally, I used the above system to see if plasma membrane localized Plc1p could be 
used as a tool to study activation of Plc1p. I tried using hyper-osmotic stress and 
demonstrated that changes in the localisation of Plc1p were detected during 
activation: a decrease in GFP tagged protein signal on the plasma membrane (Fig 
4.29). This would be expected if PtdIns(4,5)P2 hydrolysis was destabilizing Plc1p’s 
membrane association. It is a very interesting set of results because previously, Dr 
Perera demonstrated that when yeast cells are incubated at 37ºC, the complement of 
PtdIns(4,5)P2 increases by 2-4 fold, as do the levels of inositol phosphates (Perera et 
al., 2004). We wonder if the same is true of yeast exposed to salt for long periods 
because Plc1p is known to be required for growth under both these stressful 
conditions. If so, then this would explain why more Plc1p is on the plasma membrane 
immediately before dilution. These data also seem consistent with the idea that plasma 
membrane GFP-Plc1p could be used to monitor Plc1p activation in cells. 
 
4.17.3 Models 
Overall our data are consistent with a role for Arg82p derived inositol phosphates in 
the negative regulation of Plc1p-plasma membrane interaction and confirmed by the 
association of a catalytically inactive mutant GFP-Plc1pE425G with plasma membrane 
in plc1Δ cells.  
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The above study allows me to propose the following model: 
In cells devoid of Arg82p where the normal inositol phosphate profile consists of 
almost no InsP3 and mainly Ins(1,4)P2, Plc1p is associated with plasma membrane via 
binding with PtdIns(4,5)P2 through the concert effort of PH domain, XY region and 
C2 domain presumably. 
 
 
 
 
In wild-type cells where InsP6/Ins(1,3,4,5,6)P5 levels are substantial, Plc1p interacts 
with InsPs. This creates negative feedback and prevents the association of Plc1p with 
the plasma membrane. Exactly how this interaction inhibits binding is not clear but is 
likely to involve a competition with the PH domain. Despite the fact that a number of 
PH domain-inositol phosphate interactions are known, most of these interactions have 
only been found in vitro. There are in fact very few examples where inositol 
phosphates are actual physiological regulators of protein-lipid interactions and it is 
gratifying to have added another such phenomena to the overall picture. 
 
arg82Δ 
 198
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Wild-type 
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Chapter 5    Concluding remarks and future work 
 
5.1 Identification of the signals that direct nuclear localisation of Plc1p 
Further attempts to identify the NLS sequence(s) of Plc1p should focus on the region 
defined by amino-acid residues 220 to 333 using a random screen. The key to this 
type of approach is to find a protein that is deleterious when constitutively nuclear e.g. 
Pka3p. If time had allowed I would have first randomly mutagenised the 220-333 
amino-acids tract of DNA by error prone PCR. I would then have created a library of 
these mutant PLC1 truncation mutants fused to the PKA3 gene and tagged with GFP 
at the C-terminus. The whole library of constructs would have been placed under 
control of an inducible promoter (e.g GAL1 promoter that is repressed by growth in 
glucose containing media and is induced by galactose). The library would then have 
been  transformed into yeast and proteins bearing a non-functional Plc1p-NLS 
sequence isolated via growth on galactose (If the NLS is mutated, Pka3p will be 
cytoplasmic and unable to affect cell growth; hence cytoplasmic mutants will grow 
much faster on galactose medium). Mutants with in frame stop codons could be 
identified since they would not express any GFP: since GFP is at the C-terminus of 
the construct. Genuinely cytoplasmic proteins could then be identified using 
visualisation of the relevant fusion proteins by microscopy. The plasmids would then 
be isolated and sequenced to determine which residues are mutated and hence lead to 
disruption of the NLS, creating a Plc1pNLS mutant. 
 
The challenge to this type of screen would be the stability of the GFP tagged mutant 
and the activity of Pka3p as a fusion protein. Also, as several PH domain mutations 
can weaken the nuclear localisation signal of Plc1p but neither completely abolishes 
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the nuclear translocation, we are expecting that a structural-fold might direct nuclear 
localisation of Plc1p, rather than a simple sequence motif. 
 
Yeast two hybrid screens could also be utilized to find proteins that interact with 
Plc1p, and deletion mutants of each one of them examined for Plc1p-localisation: if 
any displayed a completely cytoplasmic Plc1p then this would be a good indication 
that it is not a true NLS that is directing Plc1p to the nucleus, but instead it is a 
protein-protein interaction. 
 
5.2 Inositol polyphosphates accumulation profile in PLC1 mutants 
Both Plc1pNES and Plc1pPKI failed to respond to stress, while Plc1pCAAX and 
Plc1pPKI/NES, which maintain Plc1p in both nucleus and cytoplasm, displayed full 
growth under these stresses. All these results strongly suggest that Plc1p function is 
localisation dependent and Plc1p is required in both cytoplasm and nucleus to exert 
control.  
 
Based on the fact that yeast has no InsP3 receptor and that the yeast PKC homolog 
doesn’t respond to DAG, most of the functions of Plc1p must be mediated via inositol 
polyphosphates. Plc1p regulated stress responses are at least partially through the 
inositol polyphosphates as indicated by the failure of growth under stresses of various 
Arg82p, and Kcs1p kinase disrupted mutants, as well as the catalytically inactive 
mutant I have described in this work. Water soluble inositol phosphates have been an 
area of active study in recent years and their diverse functions in multiple cellular 
processes have been revealed. It has been suggested that these inositol phosphates act 
as “second messengers”, yet the available evidence supports a different conclusion as 
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the concentration of these molecules is normally high, even in unstimulated cells. This 
implies a more fundamental ‘house-keeping’ role for these molecules, where changes 
in their concentration are not so important, though it does not rule out a second 
messenger role. 
 
A very important set of experiments would be to look at the generation of inositol 
phosphates in the knock-in constructs I have created, especially in response to heat, 
salt and hypo-osmotic stress, using a [3H]inositol labelling approach. Plc1p is 
activated under all these stress conditions and it will be interesting to determine to 
what extent this activation still happens in the nuclear versus cytoplasmically 
restricted Plc1p mutants. It will also be instructive to determine if the isomers of 
inositol phosphates produced change once Plc1p is restricted in one compartment or 
another. The answer to this question should give us an insight into whether the 
inositol phosphate kinases are physically associated with Plc1p: I have found no 
evidence for this so far but neither have I ruled it out. 
 
One important issue will be to learn where the “basal” pool of higher inositol 
phosphates is located and compare this with the location of the “stimulated” pool that 
appears during heat or salt or hypo-osmotic stress. Will this be the same compartment 
for all of these stresses or will it be different?  Higher inositol phosphates, with six or 
more phosphate groups, are soluble molecules and there are pores in the nuclear 
envelope that would seem to make restricting their subcellular localisation unlikely. 
However, higher inositol phosphates are not as mobile as might be expected. A large 
hydration shell of ordered water probably surrounds the highly charged inositides and 
this seems to result in a much slower and more restricted diffusion than might be 
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expected (Van der Kaay and Van Haastert, 1995). Higher inositol phosphates 
generated in one of the compartments could therefore conceivably be retained and 
unable to diffuse through the nuclear pores. What’s more, there are high 
concentrations of inositol phosphate phosphatases in the cytoplasm which could soak 
up any small leakage from the nucleus, rendering the cytoplasm inositol phosphate 
poor relative to the nucleus.  
 
The above assumptions are possible but have yet to be confirmed. Many of the 
functions of higher inositol phosphates elucidated so far appear to be nuclear 
functions that are essentially “house-keeping”, but the osmotic shock induced InsP6 
accumulation appears to be a cytoplasmic event (Perera et al., 2004). The Plc1pNES 
and Plc1pPKI constructs that are restricted to either the nucleus or the cytoplasm will 
help to test these hypotheses and to see if pools of spatially restricted higher inositol 
phosphates really occur in vivo.  
 
The next major question is how inositol phosphates actually function? One hypothesis 
is that the inositol pyrophosphates can pyrophosphorylate proteins that have already 
been “primed” with a serine phosphorylation by casein kinase I isoforms. However, 
some inositol pyrophosphates also seem to act as simple allosteric regulators, for 
example, InsP7 and Pho81p. Whatever the case, it is likely that additional effectors 
remain to be found and if time allowed I would have enjoyed making some high 
specific activity InsP7 and InsP8 and using them to probe for inositol phosphate 
binding proteins in yeast cell lysates. I would have followed this by FPLC mediated 
protein fractionation, to reduce the complexity of the mixture to distinct but resolved 
bands on an SDS-PAGE gel, and then used FT-ICR Mass spectrometry to determine 
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which proteins were in each band: an analysis of the phenotypes of deletion mutants 
for each identified protein should quickly expose any potential binding proteins. 
 
5.3 Upstream activator(s) for Plc1p 
The upstream activator of Plc1p remains undefined and this is an area I would have 
relished having time to dissect. An increase in Ca2+ concentration from entry of 
extracellular Ca2+ is proposed as a general mechanism of activation of Plc-δs (Das et 
al., 1993; Kim et al., 1999; Rebecchi and Pentyala, 2000; Rhee, 2001). Plc1p 
activation is regulated in response to a hypo-osmotic shock (Batiza et al., 1996) and 
Ca2+ influx is triggered by this stress, although Perera et al. (2004) observed no 
change in Plc1p activation when yeast cells were cultured in medium devoid of all 
divalent cations. I have noticed the hypo-osmotic shock induced localisation change 
of Plc1p which may indicate activation. Dr Nevin Perera noticed that several genes 
from the PKC1-MAP kinase pathway seemed to affect Plc1p activation when deleted: 
namely WSC1, WSC2, and WSC3 (for cell wall integrity and stress response 
component) (Perera 2002, p141). It seems unlikely that these are the direct upstream 
activators since these proteins are only found in ascomycete yeast, though they do 
have homology with some other protein families with a wider distribution. Since Plc-
δs are present in most eukaryotes, it seems likely that there will turn out to be some 
conservation in the way these enzymes are activated: perhaps one of the GTPases 
downstream of the WSC proteins will turn out to be this activator. I would therefore 
check regulation of Plc1p in deletion mutants of the entire Pkc1p MAPK pathway if 
time allowed. 
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5.4 What is the key factor that prevents Plc1p from associating with the plasma 
membrane in normal cells?  
Evidence has been presented in this work to suggest that inositol phosphates might be 
generating negative feedback: destabilizing Plc1p’s interaction with the plasma 
membrane and hence no plasma membrane localised GFP-Plc1p is seen in normally 
growing cells. However, the exact nature of this interaction remains ill-defined and 
needs further work. 
 
The [3H]inositol labelling assay would help to understand the inositol polyphosphates 
and PPIn accumulation in arg82Δ, ARG82G344R and PLC1E425G cells, and therefore 
might give clues to decipher the increased level of interaction of Plc1p with the 
plasma membrane in these mutants. 
 
Since  mutations that interrupt the PH domain of Plc1p result in a loss of interaction 
with plasma membrane, it seems reasonable to try and test if an increase in the levels 
of  PtdIns(4,5)P2 might be responsible for Plc1p binding to the plasma membrane in 
arg82Δ mutants. Most PtdIns(4,5)P2 is in the plasma membrane and regulates various 
cellular processes, many of which seem to occur constitutively, such as its role in the 
actin cytoskeleton and as an essential co-factor for a number of ion channels.   
 
An in vitro vesicle binding assay would be ideal to decide the potential negative 
feedback on Plc1p by inositol phosphates. Highly purified recombinant Plc1p and its 
catalytically dead form Plc1pE425G would be essential for this assay: this has been a 
serious impediment to setting up this experiment since Plc1p is not expressed well in 
E.coli. If I had had time to produced recombinant Plc1p via another expression system 
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then I would have liked to have tested whether InsP5, InsP6 and PP-InsP4 could affect 
the binding of Plc1p to PtdCho vesicles doped with 3 mol % PtdIns(4,5)P2. 
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Appendix A: Stability of GFP-Plc1p constructs described  
in this study 
 
It was important control to determine which of the mutant constructs generated in this 
work were stable to ensure that we are looking at the localisation of GFP-Plc1p 
constructs rather than of GFP. I examined extracts of these cells subjected to SDS-
PAGE, followed by western-blotting of an anti-GFP antibody. The extracts were 
prepared by brief alkali treatment of yeast cells followed by a standard 3 min boiling 
in the SDS-PAGE sample buffer (see section 2.13). This method is quick and reduces 
the potential of construct degradation by released vacuolar proteases as glass bead-
mediated disruption of yeast cells. 
 
In wild type cells, as in Fig A. the blot shows: GFP-Plc1p, GFP-Plc1pNES, GFP-
Plc1p1-333, GFP-Plc1p110-end, GFP-Plc1p220-end, GFP-Plc1p4R, GFP-Plc1pKRLR, GFP-
Plc1pCAAX, GFP-Plc1pPKI, GFP-Plc1pPKI/NES, GFP-Plc1pCAAX/NES, GFP-Plc1pE425G, 
GFP-Plc1pR1, GFP-Plc1pR2/3, GFP-Plc1pR2/4, GFP-Plc1p, GFP-Plc1p4R/E425G and GFP-
Plc1p(1-333)+C2 appeared to be largely stable under the extraction conditions employed.  
 
GFP-Plc1p220-333, GFP-Plc1p1-220, and GFP-Plc1p1-110 each showed evidence of 
degradation, with band around the size of GFP (~ 28 kD) in addition to a higher mass 
band corresponding to the un-degraded construct. 
 
For GFP-Plc1p110-220, GFP-Plc1p333-end and GFP-Plc1pKKLRK, only a ~30 kD band that 
is likely to be liberated GFP is obvious.  
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For GFP-Plc1p220-333, GFP-Plc1p1-220 and GFP-Plc1pKKLRK, however, we believe that 
the degradation is occurring after cell lysis, as these GFP-Plc1p constructs must be at 
least partially stabile because the expressed fluorescent protein were concentrated in 
the nucleus: GFP itself does not accumulate in the nucleus (Fig 3.3).  
 
However, the blot did help to explain the diffused fluorescence in GFP-Plc1p1-110, 
GFP-Plc1p110-220 and GFP-Plc1p333-end. I do not know why these truncations appeared 
to be more subject to proteolysis.  
 
Thus, these experiments are difficult to interpret and another more efficient method 
will have to be found to extract these proteins from cells avoiding post-lytic 
degradation. Experiments carried out as above but in strains deleted for the major 
vacuolar protease Pep4p, have not yielded better results (data not shown) suggesting 
that a non-vacuolar protease may be responsible for the observed degradation. Future 
studies must address this problem, possibly via a combination of protease deficient 
strains and higher concentrations of protease inhibitors. 
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Fig A: Stability of GFP-Plc1p mutant constructs by Western-blotting 
 
 
Samples were resolved by SDS-PAGE followed by Western-blotting: 5ml each cell culture (BY4742 cells transformed with each GFP-Plc1p mutant respectively) was grown 
to 1x107 /ml in SC-Ura-Met media+2% glucose. 32μl(~ 40%) of each total lysate was loaded into each well. Samples were electrophoretically transferred to a nitrocellulose 
filter followed by incubation with anti-GFP as described in section 2.13.  
 
 
 
150kDa ---- 
 
100kDa ---- 
50KDa  ---- 
 
37KDa  ---- 
GFP  ---- 
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Appendix B: Fluorescence instensity reading for GFP constructs    
B1: Constructs in Chapter 3          
[PM: plasma membrane fluorescence intensity;  N: nuclear fluorescence intensity;  C: cytosolic fluorescence intensity]  
Genotype       Mean SEM Ratio(N:C) MeanRatio SEMRatio 
pUG36 in WT          1.191 0.050 
1            N 147 149 120 100 103 114 122.167 8.693 0.915   
              C 135 152 130 137 122 125 133.500 4.372    
2            N 179 173 180 168 160 175 172.500 3.063 1.091   
              C 141 171 168 158 158 153 158.167 4.408    
3            N 228 217 227 211 201 217 216.833 4.135 1.178   
              C 195 159 175 185 198 192 184.000 6.022    
4            N 167 175 168 179 182 180 175.167 2.600 1.454   
              C 129 135 114 118 104 123 120.500 4.507    
5            N 200 199 203 202 199 195 199.667 1.145 1.334   
              C 165 140 147 150 146 150 149.667 3.412    
6            N 75 84 83 78 76 78 79.000 1.506 1.056   
              C 79 81 72 77 65 75 74.833 2.344    
7            N 76 66 72 74 77 73 73.000 1.592 1.203   
              C 72 62 46 50 63 71 60.667 4.364    
8            N 212 228 221 206 214 205 214.333 3.621 1.200   
              C 196 179 179 167 172 179 178.667 4.006    
9            N 168 173 164 170 175 150 166.667 3.685 1.133   
              C 157 141 138 155 145 147 147.167 3.081    
10          N 203 213 210 201 224 206 209.500 3.413 1.347   
              C 154 130 173 153 163 160 155.500 5.892    
pUG36 in plc1Δ          1.201 0.037 
1            N 149 130 132 131 145 134 136.833 3.301 1.039   
              C 132 138 121 138 124 137 131.667 3.062    
2            N 212 196 202 206 213 209 206.333 2.642 1.155   
              C 179 190 191 174 175 163 178.667 4.326    
3            N 179 181 179 181 195 184 183.167 2.482 1.191   
              C 160 165 141 153 157 147 153.833 3.582    
4            N 171 183 165 180 179 176 175.667 2.704 1.346   
              C 126 130 132 132 135 128 130.500 1.310    
5            N 214 218 228 205 217 221 217.167 3.114 1.179   
              C 193 195 171 186 185 175 184.167 3.902    
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6            N 196 194 193 202 193 196 195.667 1.382 1.421   
              C 124 153 138 134 146 131 137.667 4.279    
7            N 138 143 148 137 135 142 140.500 1.945 1.074   
              C 122 128 131 139 135 130 130.833 2.386    
8            N 158 162 161 170 154 147 158.667 3.180 1.266   
              C 119 123 130 132 127 121 125.333 2.108    
9            N 171 179 173 160 173 166 170.333 2.679 1.215   
              C 133 137 142 143 146 140 140.167 1.887    
10          N 167 170 168 152 167 169 165.500 2.742 1.121   
              C 136 164 142 149 144 151 147.667 3.921    
pUG36-PLC1 in WT         1.708 0.043 
1            N 174 157 152 164 168 173 164.667 3.593 2.016   
              C 74 80 86 84 79 87 81.667 2.011    
2            N 158 150 157 163 166 165 159.833 2.469 1.806   
              C 97 78 89 86 94 87 88.500 2.717    
3            N 228 220 229 207 235 205 220.667 5.038 1.738   
              C 116 135 111 145 135 120 127.000 5.410    
4            N 213 217 210 218 234 222 219.000 3.445 1.754   
              C 119 123 132 120 125 130 124.833 2.151    
5            N 135 134 137 140 145 139 138.333 1.626 1.660   
              C 88 80 80 82 87 83 83.333 1.406    
6            N 123 131 126 121 119 118 123.000 1.983 1.651   
              C 71 70 75 78 77 76 74.500 1.335    
7            N 142 145 131 136 140 135 138.167 2.088 1.579   
              C 88 92 91 73 87 94 87.500 3.085    
8            N 150 149 144 148 142 152 147.500 1.544 1.715   
              C 79 77 89 84 95 92 86.000 2.944    
9            N 91 88 109 96 89 99 95.333 3.232 1.521   
              C 59 53 77 66 61 60 62.667 3.333    
10          N 109 111 104 117 108 108 109.500 1.765 1.634   
              C 62 64 67 68 71 70 67.000 1.414    
pUG36-PLC1 in plc1Δ         1.654 0.042 
1            N 100 109 99 98 101 104 101.833 1.662 1.571   
              C 63 67 60 66 63 70 64.833 1.447    
2            N 81 84 83 81 80 76 80.833 1.138 1.492   
              C 57 54 56 50 50 58 54.167 1.424    
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3            N 176 173 171 178 174 188 176.667 2.472 1.584   
              C 124 113 114 97 115 106 111.500 3.731    
4            N 181 185 190 208 186 209 193.167 4.989 1.941   
              C 106 114 85 97 92 103 99.500 4.233    
5            N 106 105 103 97 102 104 102.833 1.302 1.615   
              C 66 73 60 72 54 57 63.667 3.232    
6            N 176 179 174 180 181 178 178.000 1.065 1.661   
              C 104 90 104 120 115 110 107.167 4.277    
7            N 196 175 186 197 182 200 189.333 4.030 1.618   
              C 113 123 121 106 110 129 117.000 3.568    
8            N 190 176 172 186 183 179 181.000 2.708 1.588   
              C 109 116 117 123 105 114 114.000 2.582    
9            N 197 190 201 196 202 196 197.000 1.751 1.830   
              C 119 110 108 101 107 101 107.667 2.728    
10          N 171 179 176 174 186 183 178.167 2.301 1.635   
              C 108 111 105 117 108 105 109.000 1.844    
pUG36-PLC1NES in WT         2.273 0.049 
1            N 95 98 100 98 96 102 98.167 1.046 2.464   
              C 35 33 37 45 41 48 39.833 2.400    
2            N 96 86 91 92 87 94 91.000 1.592 2.505   
              C 40 36 34 40 32 36 36.333 1.308    
3            N 87 91 84 81 91 86 86.667 1.606 2.464   
              C 32 39 37 31 32 40 35.167 1.621    
4            N 77 83 82 86 85 81 82.333 1.308 2.157   
              C 40 41 35 36 37 40 38.167 1.014    
5            N 186 192 190 180 176 180 184.000 2.582 2.300   
              C 84 69 75 88 86 78 80.000 2.978    
6            N 91 86 97 94 92 88 91.333 1.626 2.157   
              C 46 52 32 38 41 45 42.333 2.836    
7            N 86 84 82 78 73 81 80.667 1.892 2.180   
              C 39 37 41 37 36 32 37.000 1.238    
8            N 75 78 74 74 73 77 75.167 0.792 2.098   
              C 42 40 32 38 30 33 35.833 1.973    
9            N 81 84 76 83 76 72 78.667 1.926 2.117   
              C 33 44 41 35 32 38 37.167 1.922    
10          N 86 77 80 85 78 85 81.833 1.621 2.284   
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              C 35 40 37 38 34 31 35.833 1.302    
pUG36-PLC11-999nt in WT        1.718 0.055 
1            N 196 215 212 213 204 194 205.667 3.712 1.700   
              C 103 116 107 132 137 131 121.000 5.837    
2            N 215 212 216 228 227 223 220.167 2.750 1.543   
              C 135 136 165 127 149 144 142.667 5.445    
3            N 173 167 181 176 177 183 176.167 2.344 1.816   
              C 93 96 97 99 95 102 97.000 1.291    
4            N 94 86 88 96 91 87 90.333 1.647 1.477   
              C 67 65 64 59 54 58 61.167 2.023    
5            N 179 188 178 174 171 177 177.833 2.358 2.068   
              C 77 83 76 90 94 96 86.000 3.512    
6            N 117 119 116 115 120 110 116.167 1.447 1.864   
              C 55 62 65 67 60 65 62.333 1.783    
7            N 153 141 138 148 146 154 146.667 2.603 1.689   
              C 84 87 86 88 87 89 86.833 0.703    
8            N 156 158 173 170 155 160 162.000 3.109 1.591   
              C 102 107 103 105 96 98 101.833 1.701    
9            N 104 105 106 99 100 108 103.667 1.430 1.798   
              C 56 61 57 58 55 59 57.667 0.882    
10          N 89 96 82 85 87 99 89.667 2.679 1.635   
              C 52 51 52 53 58 63 54.833 1.922    
pUG36-PLC1660-999nt in WT        1.318 0.022 
1            N 164 169 173 174 166 165 168.500 1.727 1.231   
              C 134 114 136 132 157 148 136.833 6.013    
2            N 183 171 174 195 186 185 182.333 3.556 1.362   
              C 125 131 127 138 135 147 133.833 3.291    
3            N 158 154 155 157 158 150 155.333 1.256 1.324   
              C 116 112 119 121 124 112 117.333 1.994    
4            N 150 148 140 145 137 140 143.333 2.092 1.311   
              C 120 116 104 104 107 105 109.333 2.824    
5            N 131 126 138 137 136 128 132.667 2.060 1.266   
              C 94 119 113 111 101 91 104.833 4.578    
6            N 119 120 115 110 107 111 113.667 2.124 1.194   
              C 100 96 88 89 97 101 95.167 2.242    
7            N 145 146 141 149 156 150 147.833 2.088 1.386   
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              C 101 110 119 98 102 110 106.667 3.180    
8            N 140 139 134 147 138 131 138.167 2.242 1.370   
              C 105 104 93 94 109 100 100.833 2.600    
9            N 123 131 133 128 129 124 128.000 1.592 1.322   
              C 91 112 97 94 92 95 96.833 3.156    
10          N 146 151 148 158 146 156 150.833 2.104 1.416   
              C 104 108 97 116 109 105 106.500 2.566    
pUG36-PLC11-660nt in WT        1.383 0.035 
1            N 77 80 77 84 80 83 80.167 1.195 1.212   
              C 64 64 67 69 65 68 66.167 0.872    
2            N 83 84 81 85 90 82 84.167 1.302 1.358   
              C 56 64 65 64 57 66 62.000 1.770    
3            N 125 144 129 144 136 147 137.500 3.677 1.401   
              C 100 101 97 101 100 90 98.167 1.740    
4            N 125 128 124 129 135 142 130.500 2.790 1.362   
              C 103 96 94 100 90 92 95.833 2.007    
5            N 70 71 68 63 64 68 67.333 1.308 1.274   
              C 50 51 54 55 56 51 52.833 1.014    
6            N 67 68 63 68 71 68 67.500 1.057 1.387   
              C 49 51 54 47 44 47 48.667 1.430    
7            N 120 111 109 102 118 109 111.500 2.693 1.574   
              C 73 70 68 70 75 69 70.833 1.078    
8            N 129 130 114 127 129 123 125.333 2.486 1.301   
              C 104 86 91 105 97 95 96.333 3.007    
9            N 106 115 113 108 118 110 111.667 1.838 1.526   
              C 79 70 71 72 73 74 73.167 1.302    
10          N 112 107 118 110 109 111 111.167 1.537 1.441   
              C 74 71 77 84 73 84 77.167 2.301    
pUG36-PLC11-330nt in WT        1.195 0.025 
1            N 198 187 203 189 188 192 192.833 2.600 1.243   
              C 152 145 166 162 149 157 155.167 3.260    
2            N 137 138 132 131 133 136 134.500 1.176 1.180   
              C 118 120 108 115 107 116 114.000 2.176    
3            N 123 124 120 135 125 126 125.500 2.078 1.102   
              C 117 110 121 112 110 113 113.833 1.778    
4            N 116 128 133 123 130 129 126.500 2.487 1.159   
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              C 122 114 101 107 108 103 109.167 3.156    
5            N 151 148 155 150 146 152 150.333 1.282 1.116   
              C 126 145 138 131 135 133 134.667 2.642    
6            N 146 138 144 149 136 145 143.000 2.033 1.192   
              C 124 119 124 129 108 116 120.000 3.022    
7            N 118 125 123 121 116 118 120.167 1.400 1.214   
              C 99 98 94 104 100 99 99.000 1.317    
8            N 104 94 100 97 91 93 96.500 1.979 1.133   
              C 89 91 79 86 82 84 85.167 1.815    
9            N 174 167 172 173 172 178 172.667 1.453 1.244   
              C 148 155 125 131 132 142 138.833 4.672    
10          N 229 246 235 246 220 229 234.167 4.222 1.368   
              C 161 172 176 185 158 175 171.167 4.110    
pUG36-PLC1330-660nt in WT        1.190 0.019 
1            N 232 221 230 236 231 232 230.333 2.044 1.194   
              C 184 183 199 208 191 192 192.833 3.859    
2            N 225 224 212 224 221 223 221.500 1.979 1.154   
              C 189 182 196 199 209 177 192.000 4.789    
3            N 230 230 233 239 231 234 232.833 1.400 1.323   
              C 191 180 188 177 162 158 176.000 5.495    
4            N 111 119 122 111 115 112 115.000 1.880 1.150   
              C 103 101 93 100 106 97 100.000 1.862    
5            N 92 99 95 100 99 96 96.833 1.249 1.107   
              C 84 86 92 90 94 79 87.500 2.277    
6            N 84 92 79 84 87 93 86.500 2.172 1.215   
              C 65 68 79 74 75 66 71.167 2.301    
7            N 214 222 212 211 220 219 216.333 1.874 1.240   
              C 171 161 180 192 176 167 174.500 4.433    
8            N 141 140 134 136 135 138 137.333 1.145 1.208   
              C 105 103 118 114 124 118 113.667 3.333    
9            N 124 122 122 126 125 128 124.500 0.957 1.144   
              C 111 116 97 107 111 111 108.833 2.638    
10          N 130 127 120 124 133 128 127.000 1.862 1.169   
              C 105 105 101 110 117 114 108.667 2.486    
pUG36-PLC1330nt-end in WT        2.061 0.042 
1            N 122 130 122 119 132 116 123.500 2.553 2.099   
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              C 50 65 63 55 62 58 58.833 2.301    
2            N 76 75 72 79 78 78 76.333 1.054 1.775   
              C 43 43 46 41 47 38 43.000 1.342    
3            N 78 75 83 79 81 80 79.333 1.116 2.183   
              C 33 38 34 37 41 35 36.333 1.202    
4            N 97 103 101 103 99 101 100.667 0.955 2.083   
              C 43 45 58 51 48 45 48.333 2.246    
5            N 119 111 109 114 113 115 113.500 1.408 2.233   
              C 58 43 52 59 47 46 50.833 2.701    
6            N 118 127 87 111 107 126 112.667 6.070 2.146   
              C 56 53 50 53 54 49 52.500 1.057    
7            N 71 72 67 71 72 66 69.833 1.078 1.913   
              C 41 37 30 43 31 37 36.500 2.125    
8            N 124 118 114 111 123 121 118.500 2.110 2.079   
              C 60 54 55 56 55 62 57.000 1.317    
9            N 83 82 83 84 81 79 82.000 0.730 2.076   
              C 40 44 39 41 37 36 39.500 1.176    
10          N 67 67 69 73 68 70 69.000 0.931 2.020   
              C 35 32 34 35 34 35 34.167 0.477    
pUG36-PLC1660nt-end in WT        2.103 0.038 
1            N 213 212 211 195 219 212 210.333 3.283 1.927   
              C 122 93 99 123 108 110 109.167 4.909    
2            N 214 204 209 210 209 199 207.500 2.141 2.072   
              C 99 100 95 102 105 100 100.167 1.352    
3            N 198 189 188 202 194 200 195.167 2.372 2.209   
              C 85 87 93 88 97 80 88.333 2.445    
4            N 195 191 183 182 199 200 191.667 3.180 2.118   
              C 91 93 92 88 98 81 90.500 2.320    
5            N 110 103 106 100 116 108 107.167 2.286 2.248   
              C 46 56 43 40 48 53 47.667 2.459    
6            N 140 138 144 150 149 155 146.000 2.646 2.131   
              C 72 57 64 71 68 79 68.500 3.063    
7            N 185 188 189 190 176 178 184.333 2.431 2.127   
              C 85 82 88 90 95 80 86.667 2.246    
8            N 178 177 175 159 162 165 169.333 3.393 1.946   
              C 92 94 82 85 81 88 87.000 2.160    
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9            N 224 201 207 197 221 201 208.500 4.631 2.270   
              C 91 95 106 94 83 82 91.833 3.609    
10          N 111 106 101 109 110 111 108.000 1.592 1.982   
              C 54 54 57 58 50 54 54.500 1.147    
pUG36-PLC14R in WT         1.514 0.035 
1            N 211 218 212 214 222 220 216.167 1.833 1.595   
              C 139 141 129 126 142 136 135.500 2.693    
2            N 181 178 171 172 175 181 176.333 1.783 1.451   
              C 120 118 115 126 126 124 121.500 1.857    
3            N 205 199 207 209 202 213 205.833 2.040 1.542   
              C 131 122 131 139 140 138 133.500 2.814    
4            N 204 197 212 205 207 211 206.000 2.221 1.559   
              C 135 129 120 132 141 136 132.167 2.937    
5            N 104 97 97 90 89 94 95.167 2.242 1.366   
              C 68 63 73 72 74 68 69.667 1.687    
6            N 90 87 82 85 92 94 88.333 1.838 1.377   
              C 58 61 67 67 65 67 64.167 1.558    
7            N 152 154 148 153 158 146 151.833 1.759 1.393   
              C 114 111 116 108 106 99 109.000 2.503    
8            N 171 172 191 183 183 186 181.000 3.235 1.694   
              C 99 114 108 104 106 110 106.833 2.104    
9            N 190 183 197 191 187 196 190.667 2.171 1.591   
              C 133 120 112 120 113 121 119.833 3.070    
10          N 124 133 136 151 142 130 136.000 3.873 1.575   
              C 94 77 86 84 97 80 86.333 3.190    
pUG36-PLC1KKLRK in WT        1.468 0.030 
1            N 176 178 168 173 162 156 168.833 3.487 1.425   
              C 112 108 128 118 121 124 118.500 3.052    
2            N 181 171 165 164 179 185 174.167 3.582 1.401   
              C 111 128 118 122 128 139 124.333 3.938    
3            N 162 165 158 163 165 160 162.167 1.138 1.329   
              C 122 139 125 117 114 115 122.000 3.812    
4            N 151 155 144 151 153 156 151.667 1.745 1.550   
              C 108 96 104 104 81 94 97.833 4.003    
5            N 131 141 139 133 140 138 137.000 1.653 1.476   
              C 102 90 88 93 89 95 92.833 2.120    
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6            N 175 158 158 152 157 159 159.833 3.198 1.596   
              C 87 95 101 107 98 113 100.167 3.728    
7            N 125 115 121 119 125 125 121.667 1.687 1.440   
              C 82 81 82 81 93 88 84.500 2.012    
8            N 141 144 147 138 140 143 142.167 1.302 1.619   
              C 92 83 89 89 93 81 87.833 1.973    
9            N 147 138 140 151 145 146 144.500 1.945 1.474   
              C 92 99 95 96 104 102 98.000 1.844    
10          N 144 141 149 139 141 147 143.500 1.586 1.373   
              C 99 102 109 106 107 104 104.500 1.478    
pUG36-PLC1KRLR in WT         1.571 0.046 
1            N 201 196 190 195 200 207 198.167 2.386 1.556   
              C 123 119 125 138 128 131 127.333 2.716    
2            N 153 140 142 162 155 145 149.500 3.490 1.341   
              C 103 117 112 108 118 111 111.500 2.291    
3            N 202 192 197 194 202 205 198.667 2.092 1.624   
              C 121 119 114 124 126 130 122.333 2.290    
4            N 183 167 180 180 180 179 178.167 2.301 1.579   
              C 111 118 116 121 104 107 112.833 2.701    
5            N 133 122 128 122 122 126 125.500 1.821 1.543   
              C 77 80 74 86 85 86 81.333 2.092    
6            N 163 165 170 168 172 167 167.500 1.335 1.637   
              C 92 102 94 111 116 99 102.333 3.870    
7            N 180 175 176 184 185 188 181.333 2.124 1.835   
              C 96 87 106 97 108 99 98.833 3.092    
8            N 172 170 181 175 175 185 176.333 2.305 1.726   
              C 100 103 102 96 102 110 102.167 1.869    
9            N 215 204 202 210 211 208 208.333 1.944 1.450   
              C 142 159 141 141 145 134 143.667 3.403    
10          N 179 183 186 179 171 187 180.833 2.400 1.416   
              C 129 130 120 119 137 131 127.667 2.824    
pUG36-PLC1PKI in WT         0.710 0.017 
1            N 102 109 117 110 101 108 107.833 2.386 0.639   
              C 166 162 168 174 178 164 168.667 2.512    
2            N 151 158 162 149 158 153 155.167 2.023 0.655   
              C 249 230 223 238 240 242 237.000 3.759    
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3            N 153 153 154 161 163 144 154.667 2.765 0.762   
              C 215 202 200 205 195 201 203.000 2.745    
4            N 121 118 128 112 119 120 119.667 2.108 0.750   
              C 159 166 164 156 167 145 159.500 3.374    
5            N 115 111 123 118 114 110 115.167 1.956 0.757   
              C 154 150 158 148 155 148 152.167 1.682    
6            N 176 170 171 187 170 184 176.333 3.062 0.729   
              C 230 243 250 244 246 238 241.833 2.857    
7            N 188 185 182 180 195 188 186.333 2.171 0.769   
              C 239 237 240 250 240 248 242.333 2.171    
8            N 80 83 82 80 82 79 81.000 0.632 0.632   
              C 128 124 130 127 129 131 128.167 1.014    
9            N 164 171 166 168 162 169 166.667 1.358 0.699   
              C 250 242 211 243 245 240 238.500 5.673    
10          N 160 149 151 159 156 145 153.333 2.431 0.704   
              C 219 213 224 214 220 216 217.667 1.687    
pUG36-PLC1NES/PKI in WT        0.830 0.015 
1            N 150 158 160 152 159 166 157.500 2.363 0.773   
              C 203 201 196 201 211 210 203.667 2.362    
2            N 183 179 191 184 183 178 183.000 1.880 0.799   
              C 234 238 220 212 223 248 229.167 5.394    
3            N 175 180 188 169 179 171 177.000 2.817 0.837   
              C 201 214 212 208 211 223 211.500 2.952    
4            N 118 107 111 108 115 111 111.667 1.706 0.772   
              C 156 142 150 137 132 151 144.667 3.756    
5            N 139 133 145 135 143 144 139.833 2.040 0.850   
              C 165 163 174 170 148 167 164.500 3.658    
6            N 133 122 128 138 141 139 133.500 2.997 0.880   
              C 157 159 144 152 148 150 151.667 2.290    
7            N 132 124 135 138 140 131 133.333 2.333 0.901   
              C 142 140 137 166 154 149 148.000 4.405    
8            N 124 130 136 124 133 136 130.500 2.247 0.804   
              C 163 168 161 158 166 158 162.333 1.687    
9            N 104 95 90 88 92 101 95.000 2.582 0.793   
              C 120 114 126 118 123 118 119.833 1.721    
10          N 188 179 184 190 189 192 187.000 1.932 0.890   
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              C 202 214 201 212 210 222 210.167 3.208    
pUG36-PLC1NES/CAAX in WT         1.725 0.098 
1            N 80 81 75 79 80 84 79.833 1.195 1.497   
              C 50 58 52 46 59 55 53.333 2.028    
2            N 94 98 92 94 98 94 95.000 1.000 1.672   
              C 62 51 58 53 51 66 56.833 2.548    
3            N 73 70 71 73 73 80 73.333 1.430 1.447   
              C 51 52 49 54 44 54 50.667 1.542    
4            N 120 126 103 117 128 112 117.667 3.783 1.646   
              C 60 75 73 71 78 72 71.500 2.513    
5            N 120 114 118 110 121 118 116.833 1.682 1.565   
              C 77 66 74 77 71 83 74.667 2.376    
6            N 94 100 95 92 97 92 95.000 1.265 1.913   
              C 52 49 48 51 52 46 49.667 0.989    
7            N 86 89 87 94 86 92 89.000 1.366 1.723   
              C 54 51 48 55 53 49 51.667 1.145    
8            N 78 72 74 73 76 75 74.667 0.882 1.459   
              C 44 49 61 54 50 49 51.167 2.358    
9            N 187 179 187 181 179 182 182.500 1.500 2.483   
              C 71 67 69 73 71 90 73.500 3.403    
10          N 79 85 88 86 89 77 84.000 2.000 1.846   
              C 46 40 43 48 50 46 45.500 1.455    
pUG36-PLC1 in xpo1-1            
23'C          1.517 0.031 
1            N 93 86 87 88 86 96 89.333 1.706 1.501   
              C 60 62 55 60 61 59 59.500 0.992    
2            N 92 98 94 98 82 100 94.000 2.683 1.435   
              C 64 68 69 66 61 65 65.500 1.176    
3            N 80 77 76 83 75 81 78.667 1.282 1.489   
              C 55 53 46 52 53 58 52.833 1.621    
4            N 101 103 108 110 107 100 104.833 1.662 1.682   
              C 63 65 60 61 66 59 62.333 1.145    
5            N 101 106 105 99 107 93 101.833 2.167 1.579   
              C 60 72 69 62 59 65 64.500 2.110    
6            N 72 84 82 84 76 74 78.667 2.171 1.532   
              C 50 58 55 53 48 44 51.333 2.060    
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7            N 116 111 110 106 118 107 111.333 1.961 1.617   
              C 66 65 74 70 67 71 68.833 1.400    
8            N 88 83 87 82 80 79 83.167 1.493 1.324   
              C 57 66 60 67 65 62 62.833 1.579    
9            N 86 87 80 82 86 83 84.000 1.125 1.478   
              C 56 53 68 62 52 50 56.833 2.810    
10          N 81 84 77 76 75 72 77.500 1.765 1.530   
              C 53 51 49 53 50 48 50.667 0.843    
37'C          1.649 0.050 
1            N 107 114 130 118 120 108 116.167 3.487 1.602   
              C 74 70 74 71 69 77 72.500 1.232    
2            N 130 122 125 131 114 121 123.833 2.574 1.492   
              C 80 85 81 88 86 78 83.000 1.592    
3            N 105 112 114 105 109 101 107.667 1.994 1.780   
              C 63 71 59 61 52 57 60.500 2.604    
4            N 154 141 147 157 150 153 150.333 2.333 2.022   
              C 69 76 78 65 75 83 74.333 2.629    
5            N 101 96 94 98 90 97 96.000 1.528 1.582   
              C 65 61 60 55 64 59 60.667 1.476    
6            N 106 117 108 112 101 98 107.000 2.852 1.625   
              C 72 63 58 63 71 68 65.833 2.212    
7            N 141 133 130 122 138 135 133.167 2.725 1.627   
              C 86 79 76 86 84 80 81.833 1.682    
8            N 98 102 89 85 95 101 95.000 2.769 1.615   
              C 57 64 66 55 59 52 58.833 2.182    
9            N 99 85 92 90 88 89 90.500 1.945 1.686   
              C 49 64 57 50 47 55 53.667 2.578    
10          N 80 84 82 78 84 79 81.167 1.046 1.462   
              C 59 58 50 53 57 56 55.500 1.384    
pUG36-PLC1 in XPO1            
23'C          1.616 0.046 
1            N 72 67 71 69 73 70 70.333 0.882 1.695   
              C 38 40 43 49 39 40 41.500 1.648    
2            N 74 66 63 65 70 66 67.333 1.626 1.469   
              C 45 43 49 45 43 50 45.833 1.222    
3            N 83 79 74 76 77 76 77.500 1.285 1.609   
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              C 50 55 49 48 45 42 48.167 1.815    
4            N 126 131 127 123 125 119 125.167 1.641 1.873   
              C 66 63 76 63 66 67 66.833 1.956    
5            N 98 99 100 106 101 95 99.833 1.493 1.707   
              C 62 53 58 60 61 57 58.500 1.335    
6            N 81 86 85 82 78 87 83.167 1.400 1.631   
              C 50 43 53 48 54 58 51.000 2.129    
7            N 99 111 106 103 107 109 105.833 1.759 1.453   
              C 73 79 71 75 67 72 72.833 1.641    
8            N 90 97 94 84 93 79 89.500 2.766 1.384   
              C 65 70 58 64 62 69 64.667 1.820    
9            N 83 85 89 79 84 89 84.833 1.558 1.714   
              C 54 52 56 43 41 51 49.500 2.487    
10          N 89 87 96 101 103 95 95.167 2.587 1.627   
              C 60 57 59 54 58 63 58.500 1.232    
37'C          1.669 0.063 
1            N 109 106 100 105 96 102 103.000 1.897 1.666   
              C 66 58 57 54 70 66 61.833 2.587    
2            N 82 70 75 70 72 73 73.667 1.838 1.464   
              C 50 44 52 58 48 50 50.333 1.892    
3            N 90 86 91 82 92 84 87.500 1.668 1.683   
              C 60 61 49 45 50 47 52.000 2.781    
4            N 131 127 133 139 145 142 136.167 2.833 2.161   
              C 45 70 65 58 67 73 63.000 4.155    
5            N 113 123 126 118 120 117 119.500 1.875 1.719   
              C 70 81 74 62 61 69 69.500 3.063    
6            N 112 107 113 104 100 108 107.333 1.994 1.699   
              C 66 61 56 71 57 68 63.167 2.496    
7            N 83 85 81 91 89 85 85.667 1.520 1.440   
              C 53 58 52 68 65 61 59.500 2.617    
8            N 97 94 99 109 101 95 99.167 2.227 1.545   
              C 71 55 66 59 66 68 64.167 2.442    
9            N 82 86 83 89 78 80 83.000 1.633 1.633   
              C 51 45 50 56 54 49 50.833 1.579    
10          N 151 124 134 140 148 131 138.000 4.219 1.676   
              C 76 84 88 77 83 86 82.333 1.978    
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pUG36-PLC1 in WT             
37'C          1.637 0.072 
1            N 108 103 100 109 101 106 104.500 1.522 1.435   
              C 68 62 69 78 84 76 72.833 3.250    
2            N 91 89 83 89 91 88 88.500 1.204 1.553   
              C 53 57 58 60 53 61 57.000 1.390    
3            N 85 80 86 91 92 88 87.000 1.789 1.695   
              C 50 56 52 50 48 52 51.333 1.116    
4            N 161 146 161 171 170 152 160.167 4.012 1.945   
              C 85 78 78 89 86 78 82.333 2.011    
5            N 156 125 140 151 138 145 142.500 4.448 1.647   
              C 92 85 82 88 90 82 86.500 1.708    
6            N 79 75 72 80 73 75 75.667 1.308 1.549   
              C 51 46 52 52 45 47 48.833 1.302    
23'C (shifted from 37'C)           1.737 0.080 
1            N 156 166 151 160 153 166 158.667 2.629 2.021   
              C 76 76 79 82 78 80 78.500 0.957    
2            N 234 220 230 244 240 239 234.500 3.519 1.790   
              C 140 123 117 141 132 133 131.000 3.856    
3            N 249 240 249 235 224 250 241.167 4.222 1.762   
              C 136 145 123 130 144 143 136.833 3.628    
4            N 187 174 176 183 179 174 178.833 2.151 1.720   
              C 101 92 112 116 103 100 104.000 3.550    
5            N 94 96 95 97 91 96 94.833 0.872 1.714   
              C 54 58 52 47 57 64 55.333 2.362    
6            N 72 77 74 75 78 82 76.333 1.430 1.414   
              C 55 56 52 55 56 50 54.000 1.000    
pUG36-PLC1 in WT Hypo-osmotic shock         
2min          1.543 0.051 
1            N 124 111 117 119 115 125 118.500 2.187 1.431   
              C 78 81 76 85 87 90 82.833 2.212    
2            N 169 165 159 162 161 155 161.833 1.973 1.671   
              C 87 92 110 105 92 95 96.833 3.591    
3            N 70 71 63 67 68 65 67.333 1.229 1.597   
              C 39 40 46 47 43 38 42.167 1.537    
4            N 81 86 92 94 92 91 89.333 1.994 1.901   
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              C 48 41 48 44 48 53 47.000 1.673    
5            N 176 170 160 161 166 159 165.333 2.728 1.565   
              C 104 101 110 102 109 108 105.667 1.563    
6            N 217 203 203 216 198 211 208.000 3.183 1.361   
              C 161 153 151 159 145 148 152.833 2.535    
7            N 68 63 70 72 67 70 68.333 1.282 1.530   
              C 45 44 43 39 51 46 44.667 1.606    
8            N 62 65 59 65 61 66 63.000 1.125 1.562   
              C 42 39 38 38 43 42 40.333 0.919    
9            N 65 56 57 59 61 66 60.667 1.687 1.411   
              C 43 39 41 45 46 44 43.000 1.065    
10          N 254 240 252 254 250 239 248.167 2.810 1.405   
              C 167 163 194 176 169 191 176.667 5.308    
15min          1.592 0.026 
1            N 175 186 180 185 187 192 184.167 2.414 1.563   
              C 126 116 122 119 111 113 117.833 2.301    
2            N 167 165 169 163 156 164 164.000 1.826 1.509   
              C 109 101 104 110 115 113 108.667 2.171    
3            N 83 77 74 72 83 77 77.667 1.856 1.612   
              C 49 52 51 44 45 48 48.167 1.302    
4            N 72 77 75 73 71 75 73.833 0.910 1.629   
              C 42 45 49 54 44 38 45.333 2.275    
5            N 244 250 236 251 241 248 245.000 2.366 1.771   
              C 133 140 143 140 136 138 138.333 1.430    
6            N 221 212 218 232 225 227 222.500 2.884 1.524   
              C 140 143 150 141 152 150 146.000 2.145    
7            N 191 193 200 198 188 196 194.333 1.838 1.548   
              C 131 120 135 112 122 133 125.500 3.658    
8            N 171 168 164 173 166 167 168.167 1.352 1.651   
              C 98 110 104 101 92 106 101.833 2.587    
9            N 221 229 216 223 215 216 220.000 2.221 1.495   
              C 141 121 159 158 148 156 147.167 5.941    
10          N 83 77 74 72 83 77 77.667 1.856 1.612   
              C 49 52 51 44 45 48 48.167 1.302    
2hrs          1.612 0.041 
1            N 92 86 82 87 86 88 86.833 1.327 1.644   
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              C 57 56 51 47 54 52 52.833 1.493    
2            N 240 249 233 247 250 232 241.833 3.280 1.539   
              C 152 148 156 168 178 141 157.167 5.552    
3            N 134 118 123 129 131 116 125.167 2.982 1.784   
              C 70 69 66 84 61 71 70.167 3.135    
4            N 124 121 112 115 109 110 115.167 2.496 1.592   
              C 81 73 65 74 70 71 72.333 2.155    
5            N 129 116 127 118 124 115 121.500 2.432 1.841   
              C 71 64 61 66 60 74 66.000 2.266    
6            N 181 180 188 186 177 168 180.000 2.910 1.581   
              C 108 104 114 117 123 117 113.833 2.798    
7            N 191 196 189 196 192 195 193.167 1.195 1.547   
              C 112 129 126 135 128 119 124.833 3.321    
8            N 113 115 108 116 119 107 113.000 1.915 1.455   
              C 77 74 68 88 84 75 77.667 2.951    
9            N 104 106 110 119 101 115 109.167 2.798 1.688   
              C 60 78 67 58 61 64 64.667 2.963    
10          N 124 117 121 118 123 118 120.167 1.195 1.451   
              C 90 84 75 82 76 90 82.833 2.664    
pUG36-PLC1 in WT Hyper-osmotic shock         
2min          1.589 0.044 
1            N 199 195 200 198 199 211 200.333 2.246 1.565   
              C 128 126 132 130 132 120 128.000 1.862    
2            N 182 186 183 169 182 175 179.500 2.566 1.440   
              C 139 130 122 115 119 123 124.667 3.509    
3            N 161 168 165 176 169 163 167.000 2.176 1.556   
              C 106 100 113 118 96 111 107.333 3.383    
4            N 168 163 157 159 167 168 163.667 1.961 1.945   
              C 84 83 84 89 78 87 84.167 1.537    
5            N 210 199 200 193 195 202 199.833 2.442 1.543   
              C 130 139 134 127 123 124 129.500 2.513    
6            N 211 217 206 212 211 203 210.000 2.000 1.607   
              C 124 127 136 127 137 133 130.667 2.201    
7            N 58 64 63 59 57 65 61.000 1.390 1.612   
              C 41 40 37 39 32 38 37.833 1.302    
8            N 67 61 65 56 62 66 62.833 1.662 1.467   
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              C 42 40 43 41 44 47 42.833 1.014    
9            N 60 59 58 59 63 60 59.833 0.703 1.617   
              C 41 30 35 36 38 42 37.000 1.789    
10          N 120 101 111 102 122 112 111.333 3.575 1.536   
              C 73 74 70 69 76 73 72.500 1.057    
15min          1.638 0.036 
1            N 113 123 132 123 119 128 123.000 2.720 1.732   
              C 66 75 72 67 74 72 71.000 1.506    
2            N 90 105 106 93 100 103 99.500 2.693 1.668   
              C 57 63 52 61 59 66 59.667 1.994    
3            N 115 121 121 130 114 124 120.833 2.414 1.510   
              C 75 78 86 82 82 77 80.000 1.653    
4            N 130 134 132 135 143 130 134.000 1.983 1.564   
              C 73 86 90 85 88 92 85.667 2.741    
5            N 62 56 61 69 69 65 63.667 2.060 1.744   
              C 41 37 38 35 36 32 36.500 1.232    
6            N 70 78 76 74 75 78 75.167 1.222 1.469   
              C 46 52 54 50 54 51 51.167 1.222    
7            N 136 133 131 126 128 126 130.000 1.653 1.848   
              C 74 65 72 69 72 70 70.333 1.282    
8            N 100 96 98 84 93 99 95.000 2.422 1.624   
              C 54 57 55 59 66 60 58.500 1.765    
9            N 142 126 133 128 130 122 130.167 2.810 1.624   
              C 78 76 75 87 86 79 80.167 2.088    
10          N 116 106 101 110 109 107 108.167 2.023 1.595   
              C 78 73 53 65 67 71 67.833 3.506    
2hrs          1.626 0.067 
1            N 104 95 103 96 115 99 102.000 2.989 1.360   
              C 72 75 74 73 79 77 75.000 1.065    
2            N 104 102 103 106 107 102 104.000 0.856 1.526   
              C 65 66 61 71 72 74 68.167 2.023    
3            N 242 237 235 209 240 234 232.833 4.922 2.013   
              C 115 116 115 111 120 117 115.667 1.202    
4            N 204 180 193 185 176 191 188.167 4.110 1.470   
              C 135 131 139 117 113 133 128.000 4.282    
5            N 141 132 124 131 137 135 133.333 2.376 1.646   
              C 80 84 78 85 81 78 81.000 1.211    
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6            N 145 134 150 146 140 131 141.000 3.011 1.963   
              C 68 80 75 69 67 72 71.833 2.023    
7            N 116 111 106 107 118 114 112.000 1.983 1.680   
              C 63 64 71 72 64 66 66.667 1.585    
8            N 115 111 113 104 108 111 110.333 1.585 1.505   
              C 71 79 73 78 69 70 73.333 1.726    
9            N 60 63 57 68 62 58 61.333 1.626 1.540   
              C 40 44 39 42 41 33 39.833 1.537    
10          N 76 70 71 74 75 70 72.667 1.085 1.557   
              C 49 47 46 43 45 50 46.667 1.054    
pUG36-PLC1 in WT Rapamycine treated       1.787 0.060 
1            N 115 110 101 107 110 106 108.167 1.922 2.003   
              C 50 49 55 53 56 61 54.000 1.789    
2            N 73 66 68 63 68 66 67.333 1.358 1.629   
              C 43 46 37 37 40 45 41.333 1.606    
3            N 165 151 154 161 158 161 158.333 2.092 1.915   
              C 81 78 83 87 83 84 82.667 1.229    
4            N 114 110 124 119 122 115 117.333 2.155 1.626   
              C 74 77 69 70 68 75 72.167 1.493    
5            N 212 206 205 210 207 204 207.333 1.256 2.126   
              C 99 95 92 101 93 105 97.500 2.062    
6            N 130 129 141 137 136 138 135.167 1.922 1.886   
              C 71 67 73 72 72 75 71.667 1.085    
7            N 127 126 121 123 129 121 124.500 1.360 1.653   
              C 78 67 68 76 84 79 75.333 2.704    
8            N 113 107 110 108 111 107 109.333 0.989 1.526   
              C 71 78 74 69 64 74 71.667 1.978    
9            N 134 142 136 141 140 135 138.000 1.390 1.747   
              C 75 83 82 77 80 77 79.000 1.291    
10          N 143 151 146 136 145 150 145.167 2.212 1.763   
              C 83 92 79 80 76 84 82.333 2.261    
pUG36-PLC1 in WT Nocodazole treated       1.622 0.066 
1            N 225 228 240 219 223 215 225.000 3.531 1.767   
              C 126 119 127 129 139 124 127.333 2.716    
2            N 208 204 206 214 208 202 207.000 1.693 2.013   
              C 105 107 114 92 103 96 102.833 3.219    
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3            N 145 147 142 140 142 150 144.333 1.520 1.485   
              C 92 104 101 91 91 104 97.167 2.651    
4            N 113 115 110 115 119 121 115.500 1.628 1.843   
              C 69 61 57 60 61 68 62.667 1.944    
5            N 156 150 152 155 149 160 153.667 1.687 1.532   
              C 97 96 93 123 102 91 100.333 4.787    
6            N 134 136 123 137 127 134 131.833 2.272 1.548   
              C 78 90 87 88 85 83 85.167 1.740    
7            N 155 136 140 144 131 139 140.833 3.341 1.749   
              C 79 84 74 83 81 82 80.500 1.478    
8            N 116 122 107 118 114 118 115.833 2.072 1.460   
              C 84 81 84 77 74 76 79.333 1.745    
9            N 107 120 116 109 110 117 113.167 2.120 1.439   
              C 80 76 72 81 77 86 78.667 1.961    
10          N 80 79 82 88 84 86 83.167 1.424 1.382   
              C 62 60 55 63 61 60 60.167 1.138    
pUG36-PLC1 in WT Hydroxyurea treated       1.537 0.013 
1            N 88 82 95 96 90 94 90.833 2.167 1.531   
              C 60 62 57 55 57 65 59.333 1.520    
2            N 95 90 85 80 83 87 86.667 2.171 1.490   
              C 57 60 62 55 54 61 58.167 1.352    
3            N 180 188 184 187 184 195 186.333 2.076 1.544   
              C 118 118 119 126 120 123 120.667 1.308    
4            N 182 195 188 193 192 185 189.167 2.056 1.563   
              C 122 127 119 125 120 113 121.000 2.017    
5            N 122 124 112 121 126 119 120.667 1.994 1.557   
              C 78 71 86 81 71 78 77.500 2.377    
6            N 122 120 121 117 125 128 122.167 1.579 1.566   
              C 83 80 78 70 84 73 78.000 2.266    
7            N 110 106 107 105 108 116 108.667 1.626 1.452   
              C 73 78 70 73 78 77 74.833 1.352    
8            N 211 220 209 223 215 210 214.667 2.348 1.567   
              C 135 143 136 138 140 130 137.000 1.826    
9            N 174 183 179 193 190 184 183.833 2.845 1.587   
              C 125 123 121 116 110 100 115.833 3.859    
10          N 95 97 87 96 90 105 95.000 2.543 1.508   
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              C 65 60 68 62 53 70 63.000 2.503    
pUG36-PLC1  DMSO treated(control)       1.649 0.026 
1            N 249 236 250 245 251 245 246.000 2.251 1.689   
              C 145 155 142 146 140 146 145.667 2.108    
2            N 126 122 126 132 125 130 126.833 1.470 1.605   
              C 72 82 89 81 73 77 79.000 2.595    
3            N 169 163 166 158 161 159 162.667 1.726 1.814   
              C 87 94 83 86 96 92 89.667 2.076    
4            N 133 128 130 132 136 131 131.667 1.116 1.583   
              C 75 83 85 77 84 95 83.167 2.880    
5            N 254 242 240 246 243 244 244.833 2.007 1.563   
              C 159 146 148 158 163 166 156.667 3.283    
6            N 75 70 75 74 78 69 73.500 1.384 1.683   
              C 43 37 44 42 47 49 43.667 1.706    
7            N 76 80 73 78 69 78 75.667 1.647 1.566   
              C 51 48 51 42 55 43 48.333 2.060    
8            N 63 60 65 66 62 69 64.167 1.302 1.704   
              C 41 39 32 38 36 40 37.667 1.333    
9            N 55 62 56 57 58 60 58.000 1.065 1.575   
              C 37 38 35 39 37 35 36.833 0.654    
10          N 74 70 71 79 75 78 74.500 1.478 1.706   
              C 48 43 44 40 42 45 43.667 1.116    
Genotype       Mean SEM Ratio(PM:N:C) MeanRatio SEMRatio 
pUG36-PLC1CAAX in WT          1.139 0.031 
 1           PM 205 211 214 205 207 213 209.167 1.641 1.153 1.144 0.043 
              N 194 189 183 184 194 198 190.333 2.459 1.050 1.000 0.000 
              C 190 175 188 171 180 184 181.333 3.029 1.000   
 2           PM 198 184 171 199 211 168 188.500 6.961 1.281   
              N 170 162 160 171 154 164 163.500 2.604 1.111   
              C 143 141 140 150 158 151 147.167 2.868 1.000   
 3           PM 66 65 71 66 70 66 67.333 1.022 1.251   
              N 61 62 57 60 61 64 60.833 0.946 1.130   
              C 60 54 50 48 52 59 53.833 1.973 1.000   
 4           PM 112 123 131 113 116 132 121.167 3.628 1.247   
              N 126 128 122 137 128 125 127.667 2.076 1.314   
              C 93 100 97 96 96 101 97.167 1.195 1.000   
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 5           PM 138 143 129 126 120 133 131.500 3.394 1.075   
              N 168 176 172 159 183 175 172.167 3.321 1.407   
              C 125 121 126 120 116 126 122.333 1.647 1.000   
 6           PM 125 127 118 112 121 126 121.500 2.349 1.070   
              N 133 134 127 136 150 149 138.167 3.790 1.217   
              C 119 110 113 115 118 106 113.500 2.012 1.000   
 7           PM 127 125 131 125 148 135 131.833 3.600 1.106   
              N 136 132 134 137 124 143 134.333 2.565 1.127   
              C 122 119 115 114 125 120 119.167 1.701 1.000   
 8           PM 113 114 125 131 125 130 123.000 3.173 1.010   
              N 122 121 121 116 118 121 119.833 0.946 0.984   
              C 121 132 117 118 126 117 121.833 2.469 1.000   
 9           PM 108 111 102 109 104 118 108.667 2.305 1.028   
              N 103 99 106 103 103 108 103.667 1.256 0.981   
              C 111 105 104 105 112 97 105.667 2.216 1.000   
 10         PM 88 89 90 86 91 93 89.500 0.992 1.167   
              N 85 86 84 87 85 87 85.667 0.494 1.117   
              C 75 78 80 77 73 77 76.667 0.989 1.000   
pUG36-CAAX in WT          1.396 0.022 
 1           PM 119 113 120 117 130 124 120.500 2.405 1.351 1.079 0.043 
              N 90 97 97 86 95 91 92.667 1.801 1.039 1.000 0.000 
              C 95 90 89 88 92 81 89.167 1.922 1.000   
 2           PM 131 119 120 122 120 134 124.333 2.642 1.429   
              N 88 87 86 83 81 82 84.500 1.176 0.971   
              C 91 93 84 83 85 86 87.000 1.653 1.000   
 3           PM 137 139 135 141 147 136 139.167 1.797 1.535   
              N 83 81 85 87 85 90 85.167 1.276 0.939   
              C 81 86 94 98 103 82 90.667 3.685 1.000   
 4           PM 153 143 138 142 144 137 142.833 2.330 1.382   
              N 112 107 99 102 103 101 104.000 1.932 1.006   
              C 100 103 101 108 100 108 103.333 1.542 1.000   
 5           PM 171 157 152 166 149 160 159.167 3.400 1.404   
              N 120 118 115 117 123 118 118.500 1.118 1.046   
              C 110 111 119 109 115 116 113.333 1.606 1.000   
 6           PM 180 174 185 178 187 181 180.833 1.922 1.405   
              N 127 125 127 119 134 130 127.000 2.049 0.987   
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              C 131 124 125 132 128 132 128.667 1.453 1.000   
 7           PM 237 234 246 230 237 234 236.333 2.201 1.418   
              N 231 235 223 220 226 231 227.667 2.305 1.366   
              C 154 158 167 174 170 177 166.667 3.685 1.000   
 8           PM 136 134 124 135 133 161 137.167 5.082 1.434   
              N 108 123 132 128 110 123 120.667 3.947 1.261   
              C 97 98 104 88 95 92 95.667 2.231 1.000   
 9           PM 106 109 132 115 113 108 113.833 3.877 1.331   
              N 86 90 98 93 102 97 94.333 2.376 1.103   
              C 86 90 82 85 79 91 85.500 1.875 1.000   
 10         PM 133 130 137 127 134 138 133.167 1.701 1.270   
              N 122 115 111 108 112 105 112.167 2.414 1.070   
              C 106 101 105 110 107 100 104.833 1.537 1.000   
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Vacuole morphology under salt stress:    
WT  1-2/cell 3-4/cell 5-8/cell ≥9/cell 
Untreated Exp I 4 6 4 0 
 % 0.286 0.429 0.286 0.000 
 Exp II 7 6 1 0 
 % 0.500 0.429 0.071 0.000 
 Exp III 8 4 1 0 
 % 0.615 0.308 0.077 0.000 
 Mean(%) 0.467 0.388 0.145 0.000 
 SEM 0.097 0.040 0.071 0.000 
hyper-osmotic shock  Exp I 3 7 3 10 
(0.6M NaCl 10min) % 0.130 0.304 0.130 0.435 
 Exp II 2 3 5 6 
 % 0.125 0.188 0.313 0.375 
 Exp III 2 3 5 10 
 % 0.100 0.150 0.250 0.500 
 Mean(%) 0.118 0.214 0.231 0.437 
 SEM 0.009 0.046 0.053 0.036 
hyper-osmotic shock Exp I 8 11 3 0 
(0.06M NaCl 60min) % 0.364 0.500 0.136 0.000 
 Exp II 8 5 1 0 
 % 0.571 0.357 0.071 0.000 
 Exp III 12 4 1 0 
 % 0.706 0.235 0.059 0.000 
 Mean(%) 0.547 0.364 0.089 0.000 
 SEM 0.100 0.076 0.024 0.000 
plc1Δ  1-2/cell 3-4/cell 5-8/cell ≥9/cell 
Untreated Exp I 2 1 3 6 
 % 0.167 0.083 0.250 0.500 
 Exp II 1 1 3 7 
 % 0.083 0.083 0.250 0.583 
 Exp III 1 2 2 4 
 % 0.111 0.222 0.222 0.444 
 Mean(%) 0.120 0.130 0.241 0.509 
 SEM 0.025 0.046 0.009 0.040 
hyper-osmotic shock  Exp I 1 1 2 8 
(0.6M NaCl 10min) % 0.083 0.083 0.167 0.667 
 Exp II 3 4 3 14 
 % 0.125 0.167 0.125 0.583 
 Exp III 3 3 2 10 
 % 0.167 0.167 0.111 0.556 
 Mean(%) 0.125 0.139 0.134 0.602 
 SEM 0.024 0.028 0.017 0.033 
hyper-osmotic shock Exp I 1 1 2 8 
(0.06M NaCl 60min) % 0.083 0.083 0.167 0.667 
 Exp II 2 2 3 12 
 % 0.105 0.105 0.158 0.632 
 Exp III 1 3 3 9 
 % 0.063 0.188 0.188 0.563 
 Mean(%) 0.084 0.125 0.171 0.620 
 SEM 0.012 0.032 0.009 0.031 
PLC1NES  1-2/cell 3-4/cell 5-8/cell ≥9/cell 
Untreated Exp I 0 0 1 11 
 % 0.000 0.000 0.083 0.917 
 Exp II 0 1 1 8 
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 % 0.000 0.100 0.100 0.800 
 Exp III 0 0 2 12 
 % 0.000 0.000 0.143 0.857 
 Mean(%) 0.000 0.033 0.109 0.858 
 SEM 0.000 0.033 0.018 0.034 
hyper-osmotic shock  Exp I 0 0 0 10 
(0.6M NaCl 10min) % 0.000 0.000 0.000 1.000 
 Exp II 0 0 2 15 
 % 0.000 0.000 0.118 0.882 
 Exp III 0 0 0 9 
 % 0.000 0.000 0.000 1.000 
 Mean(%) 0.000 0.000 0.039 0.961 
 SEM 0.000 0.000 0.039 0.039 
hyper-osmotic shock Exp I 0 2 3 10 
(0.06M NaCl 60min) % 0.000 0.133 0.200 0.667 
 Exp II 0 1 3 11 
 % 0.000 0.067 0.200 0.733 
 Exp III 0 1 2 10 
 % 0.000 0.077 0.154 0.769 
 Mean(%) 0.000 0.092 0.185 0.723 
 SEM 0.000 0.021 0.015 0.030 
PLC1CAAX  1-2/cell 3-4/cell 5-8/cell ≥9/cell 
Untreated Exp I 5 3 1 0 
 % 0.556 0.333 0.111 0.000 
 Exp II 11 5 1 0 
 % 0.647 0.294 0.059 0.000 
 Exp III 13 9 1 0 
 % 0.565 0.391 0.044 0.000 
 Mean(%) 0.589 0.340 0.071 0.000 
 SEM 0.029 0.028 0.020 0.000 
hyper-osmotic shock  Exp I 0 1 1 9 
(0.6M NaCl 10min) % 0.000 0.091 0.091 0.818 
 Exp II 0 1 2 11 
 % 0.000 0.071 0.143 0.786 
 Exp III 0 2 1 15 
 % 0.000 0.111 0.056 0.833 
 Mean(%) 0.000 0.091 0.096 0.812 
 SEM 0.000 0.011 0.025 0.014 
hyper-osmotic shock Exp I 18 3 0 0 
(0.06M NaCl 60min) % 0.857 0.143 0.000 0.000 
 Exp II 11 1 0 0 
 % 0.917 0.083 0.000 0.000 
 Exp III 17 0 0 0 
 % 1.000 0.000 0.000 0.000 
 Mean(%) 0.925 0.075 0.000 0.000 
 SEM 0.041 0.041 0.000 0.000 
PLC1PKI  1-2/cell 3-4/cell 5-8/cell ≥9/cell 
Untreated Exp I 2 1 2 7 
 % 0.167 0.083 0.167 0.583 
 Exp II 2 1 2 8 
 % 0.154 0.077 0.154 0.615 
 Exp III 0 1 1 9 
 % 0.000 0.091 0.091 0.818 
 Mean(%) 0.107 0.084 0.137 0.672 
 SEM 0.054 0.004 0.023 0.074 
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hyper-osmotic shock  Exp I 0 0 0 7 
(0.6M NaCl 10min) % 0.000 0.000 0.000 1.000 
 Exp II 0 1 1 5 
 % 0.000 0.143 0.143 0.714 
 Exp III 0 0 0 9 
 % 0.000 0.000 0.000 1.000 
 Mean(%) 0.000 0.048 0.048 0.905 
 SEM 0.000 0.048 0.048 0.095 
hyper-osmotic shock Exp I 2 0 0 7 
(0.06M NaCl 60min) % 0.222 0.000 0.000 0.778 
 Exp II 0 0 1 3 
 % 0.000 0.000 0.250 0.750 
 Exp III 0 1 2 9 
 % 0.000 0.083 0.167 0.750 
 Mean(%) 0.074 0.028 0.139 0.759 
 SEM 0.074 0.028 0.073 0.009 
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B2: Constructs in Chapter 
4 
           
[PM: plasma membrane fluorescence intensity;  N: nuclear fluorescence intensity;  C: cytosolic fluorescence intensity]    
Genotype       Mean SEM Ratio(PM:C) Ratio(N:C) Ratio(PM:N) MeanRatio(PM:C) MeanRatio(N:C) MeanRatio(PM:N) 
pUG36-PLC1 in 
WT 
          SEMRatio(PM:C) SEMRatio(N:C) SEMRatio(PM:N) 
 1     PM 35 35 37 38 41 39 37.500 0.957 0.843 1.491 0.565 0.742 1.703 0.444 
        N 64 68 65 67 64 70 66.333 0.989    0.013 0.078 0.021 
        C 47 48 41 44 39 48 44.500 1.565       
 2     PM 63 57 62 56 50 52 56.667 2.124 0.759 2.270 0.334    
        N 169 174 168 168 178 160 169.500 2.500       
        C 75 69 63 78 82 81 74.667 3.018       
 3     PM 66 58 70 64 63 75 66.000 2.408 0.719 1.800 0.399    
        N 158 162 167 162 174 169 165.333 2.362       
        C 98 90 95 88 86 94 91.833 1.869       
 4     PM 48 44 58 51 55 60 52.667 2.499 0.744 1.565 0.475    
        N 100 99 126 106 124 110 110.833 4.778       
        C 72 75 70 71 69 68 70.833 1.014       
 5     PM 48 52 49 51 48 51 49.833 0.703 0.757 1.458 0.519    
        N 95 93 93 96 98 101 96.000 1.265       
        C 71 68 65 60 62 69 65.833 1.740       
 6     PM 102 114 87 104 88 90 97.500 4.440 0.687 1.629 0.422    
        N 227 229 236 232 234 228 231.000 1.461       
        C 132 137 140 150 148 144 141.833 2.786       
 7     PM 89 101 88 94 90 96 93.000 2.033 0.738 1.772 0.416    
        N 208 227 234 218 228 225 223.333 3.721       
        C 137 133 120 117 123 126 126.000 3.141       
 8     PM 62 56 60 53 64 69 60.667 2.333 0.751 1.967 0.382    
        N 148 164 159 169 165 149 159.000 3.568       
        C 79 82 76 75 84 89 80.833 2.151       
 9     PM 56 60 54 56 71 65 60.333 2.667 0.708 1.648 0.430    
        N 136 151 147 129 139 140 140.333 3.201       
        C 96 88 86 74 83 84 85.167 2.926       
 10   PM 52 58 51 40 52 43 49.333 2.704 0.715 1.425 0.502    
        N 96 101 99 103 97 94 98.333 1.358       
        C 67 66 71 67 69 74 69.000 1.238       
pUG36-PLC1 in plc1Δ             
 1     PM 76 62 75 72 60 73 69.667 2.813 0.771 1.708 0.451 0.770 1.649 0.468 
        N 156 157 162 153 148 150 154.333 2.076    0.014 0.025 0.011 
        C 89 88 80 90 92 103 90.333 3.040       
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 2     PM 46 48 38 45 36 44 42.833 1.939 0.714 1.736 0.411    
        N 101 110 93 99 120 102 104.167 3.877       
        C 67 65 62 55 52 59 60.000 2.366       
 3     PM 57 55 62 59 63 63 59.833 1.376 0.827 1.717 0.482    
        N 128 112 120 125 133 127 124.167 2.982       
        C 68 71 70 78 75 72 72.333 1.476       
 4     PM 61 64 62 58 60 59 60.667 0.882 0.751 1.592 0.472    
        N 135 120 121 133 124 139 128.667 3.273       
        C 81 80 74 83 77 90 80.833 2.242       
 5     PM 90 89 88 94 102 91 92.333 2.108 0.778 1.642 0.474    
        N 196 187 189 202 200 195 194.833 2.414       
        C 119 114 115 121 127 116 118.667 1.978       
 6     PM 63 73 83 74 70 79 73.667 2.848 0.747 1.454 0.513    
        N 142 149 145 141 139 145 143.500 1.455       
        C 97 102 108 86 101 98 98.667 2.985       
 7     PM 40 41 44 46 40 43 42.333 0.989 0.833 1.616 0.515    
        N 75 78 82 78 92 88 82.167 2.688       
        C 52 50 53 51 50 49 50.833 0.601       
 8     PM 36 35 37 32 39 38 36.167 1.014 0.702 1.693 0.415    
        N 88 92 89 87 80 87 87.167 1.621       
        C 54 58 52 49 45 51 51.500 1.803       
 9     PM 86 92 93 84 83 90 88.000 1.732 0.760 1.650 0.460    
        N 185 207 192 204 172 187 191.167 5.288       
        C 111 119 122 108 112 123 115.833 2.574       
 10   PM 61 65 66 64 63 62 63.500 0.764 0.818 1.680 0.487    
        N 130 131 137 125 127 133 130.500 1.746       
        C 73 81 70 87 71 84 77.667 2.963       
pUG36-ARG82 in WT             
 1     PM 62 62 72 70 68 72 67.667 1.892 0.712 1.742 0.409 0.728 1.642 0.446 
        N 158 165 164 169 171 166 165.500 1.839    0.022 0.037 0.018 
        C 94 92 90 102 95 97 95.000 1.713       
 2     PM 29 28 31 33 27 31 29.833 0.910 0.886 1.535 0.577    
        N 50 55 48 54 50 53 51.667 1.116       
        C 34 35 30 35 38 30 33.667 1.282       
 3     PM 51 58 52 42 54 56 52.167 2.286 0.647 1.676 0.386    
        N 137 135 143 129 134 133 135.167 1.905       
        C 85 84 80 78 77 80 80.667 1.308       
 4     PM 65 78 69 63 54 65 65.667 3.201 0.722 1.498 0.482    
        N 139 140 134 129 135 141 136.333 1.856       
        C 94 83 98 94 85 92 91.000 2.366       
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 5     PM 65 52 60 60 56 61 59.000 1.826 0.664 1.657 0.401    
        N 148 144 152 156 138 145 147.167 2.587       
        C 89 84 96 81 93 90 88.833 2.272       
 6     PM 75 71 59 60 62 63 65.000 2.646 0.649 1.624 0.400    
        N 161 161 159 162 167 166 162.667 1.282       
        C 108 90 102 108 92 101 100.167 3.146       
 7     PM 95 105 98 82 87 90 92.833 3.361 0.737 1.837 0.401    
        N 210 234 242 237 231 235 231.500 4.552       
        C 131 127 122 126 130 120 126.000 1.770       
 8     PM 100 108 99 80 82 89 93.000 4.531 0.785 1.633 0.481    
        N 187 192 197 203 197 185 193.500 2.778       
        C 110 126 122 117 111 125 118.500 2.837       
 9     PM 85 84 79 76 72 89 80.833 2.574 0.700 1.450 0.483    
        N 167 169 159 172 168 170 167.500 1.839       
        C 110 116 114 123 121 109 115.500 2.320       
 10   PM 32 35 30 34 33 47 35.167 2.469 0.779 1.771 0.440    
        N 76 82 83 87 79 73 80.000 2.066       
        C 45 47 45 43 48 43 45.167 0.833       
pUG36-ARG82 in arg82Δ             
 1     PM 78 73 74 74 75 77 75.167 0.792 0.708 1.637 0.432 0.725 1.623 0.447 
        N 177 169 179 173 167 178 173.833 2.040    0.006 0.027 0.004 
        C 110 111 105 102 101 108 106.167 1.701       
 2     PM 90 83 75 74 85 84 81.833 2.522 0.739 1.631 0.453    
        N 217 22 197 208 211 228 180.500 31.974       
        C 120 121 118 119 111 112 116.833 1.740       
 3     PM 45 42 40 39 44 42 42.000 0.931 0.733 1.672 0.438    
        N 98 93 96 92 96 100 95.833 1.222       
        C 55 53 50 58 63 65 57.333 2.376       
 4     PM 96 98 106 103 97 101 100.167 1.579 0.764 1.817 0.420    
        N 241 240 236 242 233 238 238.333 1.382       
        C 130 133 129 134 133 128 131.167 1.014       
 5     PM 109 112 107 110 101 105 107.333 1.606 0.751 1.669 0.450    
        N 229 250 238 243 231 239 238.333 3.159       
        C 140 141 134 153 154 135 142.833 3.554       
 6     PM 82 95 93 91 91 96 91.333 2.044 0.718 1.567 0.458    
        N 199 207 195 201 195 199 199.333 1.820       
        C 137 118 112 123 139 134 127.167 4.527       
 7     PM 77 76 82 71 80 83 78.167 1.815 0.710 1.566 0.453    
        N 168 177 170 168 174 178 172.500 1.821       
        C 99 111 126 100 109 116 110.167 4.143       
 257
 8     PM 79 80 70 78 75 78 76.667 1.498 0.715 1.616 0.443    
        N 167 176 171 169 177 179 173.167 1.973       
        C 106 120 101 100 110 106 107.167 2.971       
 9     PM 101 95 94 98 89 90 94.500 1.875 0.707 1.571 0.450    
        N 210 215 208 212 211 204 210.000 1.528       
        C 133 120 145 126 138 140 133.667 3.801       
 10   PM 100 91 89 94 95 91 93.333 1.606 0.703 1.483 0.474    
        N 199 198 191 194 201 199 197.000 1.528       
        C 131 132 127 133 141 133 132.833 1.869       
pUG36-ARG82 in plc1Δ             
 1     PM 97 91 89 78 99 94 91.333 3.062 0.744 1.811 0.410 0.771 1.640 0.471 
        N 219 216 235 222 225 218 222.500 2.814    0.027 0.028 0.015 
        C 115 127 120 132 110 133 122.833 3.825       
 2     PM 91 103 106 88 87 80 92.500 4.089 0.823 1.604 0.513    
        N 188 180 189 173 171 180 180.167 3.027       
        C 109 105 126 111 122 101 112.333 3.981       
 3     PM 105 98 102 92 95 88 96.667 2.578 0.801 1.546 0.518    
        N 186 199 180 193 170 191 186.500 4.217       
        C 123 133 116 119 126 107 120.667 3.639       
 4     PM 83 87 90 75 70 75 80.000 3.204 0.889 1.733 0.513    
        N 155 160 152 162 158 149 156.000 2.017       
        C 85 95 90 90 92 88 90.000 1.390       
 5     PM 118 95 115 111 97 90 104.333 4.800 0.696 1.630 0.427    
        N 250 253 243 238 250 233 244.500 3.212       
        C 145 153 131 145 159 167 150.000 5.132       
 6     PM 86 91 94 81 92 96 90.000 2.266 0.610 1.554 0.393    
        N 236 221 214 242 217 245 229.167 5.498       
        C 150 153 129 144 161 148 147.500 4.372       
 7     PM 103 102 91 88 99 98 96.833 2.469 0.702 1.656 0.424    
        N 217 220 237 228 233 236 228.500 3.433       
        C 143 145 137 122 138 143 138.000 3.445       
 8     PM 98 83 90 86 84 79 86.667 2.704 0.837 1.663 0.503    
        N 164 176 169 175 170 179 172.167 2.242       
        C 109 105 99 101 107 100 103.500 1.668       
 9     PM 90 98 92 88 72 80 86.667 3.783 0.726 1.499 0.485    
        N 193 187 181 164 168 180 178.833 4.512       
        C 121 123 128 115 121 108 119.333 2.836       
 10   PM 50 53 54 61 63 51 55.333 2.201 0.885 1.704 0.520    
        N 108 101 113 105 110 102 106.500 1.910       
        C 60 61 72 62 64 56 62.500 2.187       
 258
pUG36-PLC1 in arg82Δ             
 1     PM 116 125 122 102 115 123 117.167 3.439 1.182 1.461 0.809 1.128 1.736 0.662 
        N 140 136 145 141 159 148 144.833 3.301    0.017 0.078 0.030 
        C 92 100 92 104 111 96 99.167 3.038       
 2     PM 122 135 145 120 114 117 125.500 4.890 1.162 1.662 0.699    
        N 177 182 186 184 178 170 179.500 2.363       
        C 106 115 111 102 114 100 108.000 2.569       
 3     PM 115 116 103 120 111 117 113.667 2.445 1.021 1.554 0.657    
        N 184 171 179 160 178 166 173.000 3.670       
        C 112 111 115 107 109 114 111.333 1.229       
 4     PM 125 127 140 124 130 137 130.500 2.693 1.135 1.909 0.595    
        N 219 221 207 237 215 218 219.500 4.031       
        C 113 108 116 121 107 125 115.000 2.910       
 5     PM 102 97 110 94 102 112 102.833 2.880 1.062 2.088 0.509    
        N 201 208 200 215 197 192 202.167 3.341       
        C 99 93 88 108 95 98 96.833 2.750       
 6     PM 101 93 85 89 88 87 90.500 2.363 1.170 2.216 0.528    
        N 176 171 175 165 174 167 171.333 1.838       
        C 87 77 78 67 75 80 77.333 2.667       
 7     PM 95 76 78 99 92 97 89.500 4.072 1.126 1.444 0.779    
        N 112 119 115 120 114 109 114.833 1.701       
        C 86 81 74 83 76 77 79.500 1.875       
 8     PM 183 180 167 153 169 148 166.667 5.731 1.135 1.672 0.679    
        N 239 242 252 250 241 249 245.500 2.232       
        C 141 140 160 152 155 133 146.833 4.238       
 9     PM 172 156 143 139 152 153 152.500 4.710 1.092 1.758 0.621    
        N 250 247 248 254 244 230 245.500 3.384       
        C 134 135 139 141 149 140 139.667 2.186       
 10   PM 101 91 95 82 98 107 95.667 3.518 1.193 1.599 0.746    
        N 121 126 136 124 132 130 128.167 2.257       
        C 74 87 82 76 77 85 80.167 2.151       
pUG36-PLC1 + pYCplac111-ARG82 in arg82Δ           
 1     PM 65 71 70 74 61 67 68.000 1.897 0.824 1.479 0.557 0.755 1.563 0.487 
        N 120 125 121 136 114 116 122.000 3.215    0.037 0.043 0.027 
        C 88 83 77 92 77 78 82.500 2.592       
 2     PM 66 74 89 87 74 63 75.500 4.342 0.983 1.646 0.597    
        N 121 126 131 122 124 135 126.500 2.232       
        C 75 66 63 70 93 94 76.833 5.522       
 3     PM 38 57 42 51 46 52 47.667 2.860 0.765 1.693 0.452    
        N 112 108 119 102 91 101 105.500 3.973       
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        C 58 59 59 62 69 67 62.333 1.892       
 4     PM 42 35 52 43 38 39 41.500 2.405 0.856 1.550 0.552    
        N 77 79 73 69 75 78 75.167 1.515       
        C 45 42 56 61 41 46 48.500 3.314       
 5     PM 81 88 69 80 75 74 77.833 2.701 0.663 1.825 0.363    
        N 221 230 218 211 197 208 214.167 4.672       
        C 126 114 123 119 103 119 117.333 3.313       
 6     PM 77 67 63 81 84 79 75.167 3.390 0.727 1.487 0.489    
        N 160 158 151 147 155 151 153.667 1.994       
        C 114 112 77 93 113 111 103.333 6.168       
 7     PM 59 49 52 53 46 45 50.667 2.108 0.788 1.609 0.490    
        N 98 105 101 109 108 100 103.500 1.839       
        C 70 61 68 59 58 70 64.333 2.290       
 8     PM 86 91 92 90 76 82 86.167 2.535 0.593 1.475 0.402    
        N 217 209 218 219 211 212 214.333 1.706       
        C 128 149 144 152 148 151 145.333 3.648       
 9     PM 76 94 80 77 71 72 78.333 3.412 0.574 1.565 0.367    
        N 214 225 204 202 230 207 213.667 4.723       
        C 134 143 127 149 136 130 136.500 3.354       
 10   PM 63 59 62 59 61 67 61.833 1.222 0.779 1.296 0.601    
        N 106 110 98 99 104 100 102.833 1.905       
        C 81 80 79 76 83 77 79.333 1.054       
pUG36-PLC1 + pYCplac111 in arg82Δ            
 1     PM 59 60 69 63 54 61 61.000 2.017 1.137 1.798 0.632 1.152 1.674 0.699 
        N 99 102 86 95 97 100 96.500 2.320    0.007 0.063 0.028 
        C 56 55 54 56 48 53 53.667 1.229       
 2     PM 198 212 188 190 219 198 200.833 5.009 1.170 1.454 0.804    
        N 240 250 252 253 249 254 249.667 2.076       
        C 163 170 179 180 169 169 171.667 2.679       
 3     PM 100 117 94 103 99 95 101.333 3.412 1.128 2.052 0.550    
        N 187 192 183 178 184 182 184.333 1.944       
        C 98 78 93 97 85 88 89.833 3.135       
 4     PM 114 104 105 108 122 111 110.667 2.728 1.155 1.910 0.605    
        N 181 180 179 188 184 186 183.000 1.461       
        C 107 89 89 91 97 102 95.833 3.060       
 5     PM 116 127 128 121 110 128 121.667 3.040 1.157 1.550 0.746    
        N 164 167 161 170 165 151 163.000 2.696       
        C 115 109 102 99 101 105 105.167 2.428       
 6     PM 169 162 155 150 166 160 160.333 2.860 1.163 1.543 0.754    
        N 214 217 211 206 210 218 212.667 1.856       
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        C 145 141 139 138 134 130 137.833 2.151       
 7     PM 110 115 101 113 116 104 109.833 2.496 1.119 1.720 0.651    
        N 164 168 172 162 175 172 168.833 2.072       
        C 102 107 101 93 89 97 98.167 2.664       
 8     PM 98 107 104 99 95 94 99.500 2.078 1.159 1.711 0.678    
        N 148 154 155 136 146 142 146.833 2.949       
        C 89 98 70 92 88 78 85.833 4.135       
 9     PM 83 86 88 88 96 104 90.833 3.167 1.140 1.354 0.842    
        N 108 105 109 110 107 108 107.833 0.703       
        C 86 78 82 79 73 80 79.667 1.764       
 10   PM 200 180 182 170 179 178 181.500 4.064 1.194 1.645 0.726    
        N 245 250 252 249 254 250 250.000 1.238       
        C 158 155 157 150 148 144 152.000 2.266       
pUG36-PLC1 + pUG34-ARG82D131A in arg82Δ           
 1     PM 101 105 99 107 104 96 102.000 1.673 1.032 1.653 0.624 1.163 1.862 0.634 
        N 165 172 168 166 150 159 163.333 3.180    0.044 0.092 0.028 
        C 92 100 93 99 100 109 98.833 2.496       
 2     PM 118 113 123 114 100 119 114.500 3.253 1.130 1.849 0.611    
        N 196 179 188 195 186 180 187.333 2.940       
        C 101 98 99 106 103 101 101.333 1.174       
 3     PM 84 90 98 111 96 97 96.000 3.697 1.095 1.546 0.708    
        N 134 145 142 133 129 130 135.500 2.668       
        C 83 97 85 90 89 82 87.667 2.275       
 4     PM 112 106 111 107 109 116 110.167 1.493 1.168 2.366 0.494    
        N 235 237 209 234 210 214 223.167 5.498       
        C 91 86 82 98 105 104 94.333 3.887       
 5     PM 159 172 163 172 139 155 160.000 5.046 1.529 1.984 0.770    
        N 215 206 208 219 197 201 207.667 3.383       
        C 108 108 102 100 109 101 104.667 1.667       
 6     PM 171 170 194 193 200 189 186.167 5.160 1.183 1.555 0.761    
        N 240 244 250 234 246 254 244.667 2.906       
        C 153 170 172 159 147 143 157.333 4.863       
 7     PM 92 89 97 95 83 98 92.333 2.305 1.099 1.599 0.687    
        N 136 133 136 132 125 144 134.333 2.539       
        C 83 80 88 84 82 87 84.000 1.238       
 8     PM 98 81 77 73 92 100 86.833 4.643 1.271 2.388 0.532    
        N 162 157 163 181 153 163 163.167 3.919       
        C 65 68 65 58 70 84 68.333 3.547       
 9     PM 81 79 77 75 87 79 79.667 1.687 1.072 1.812 0.592    
        N 133 134 127 134 136 144 134.667 2.246       
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        C 77 74 69 69 77 80 74.333 1.856       
 10   PM 109 103 101 110 108 122 108.833 3.005 1.050 1.873 0.561    
        N 188 198 195 201 193 190 194.167 1.990       
        C 103 106 106 107 101 99 103.667 1.308       
pUG36-PLC1 + pUG34-ARG82Δasp in arg82Δ           
 1     PM 91 94 90 96 102 104 96.167 2.344 0.733 1.559 0.470 0.723 1.608 0.451 
        N 211 205 188 213 211 199 204.500 3.914    0.022 0.027 0.016 
        C 122 129 137 130 145 124 131.167 3.497       
 2     PM 72 98 103 82 101 90 91.000 4.953 0.677 1.551 0.436    
        N 194 207 216 214 205 216 208.667 3.499       
        C 139 131 129 124 140 144 134.500 3.128       
 3     PM 44 37 33 45 42 43 40.667 1.909 0.850 1.568 0.542    
        N 80 75 74 76 72 73 75.000 1.155       
        C 51 48 47 50 47 44 47.833 1.014       
 4     PM 73 68 87 77 88 82 79.167 3.240 0.749 1.711 0.438    
        N 183 182 177 186 173 184 180.833 1.990       
        C 101 98 112 101 109 113 105.667 2.629       
 5     PM 83 94 75 77 79 85 82.167 2.810 0.700 1.753 0.400    
        N 214 202 205 197 207 209 205.667 2.390       
        C 136 126 117 103 109 113 117.333 4.890       
 6     PM 102 98 85 87 93 112 96.167 4.110 0.745 1.601 0.465    
        N 202 208 210 208 210 203 206.833 1.424       
        C 116 121 117 126 153 142 129.167 6.140       
 7     PM 103 121 107 88 95 88 100.333 5.200 0.694 1.433 0.485    
        N 203 205 212 209 194 219 207.000 3.474       
        C 141 139 132 149 161 145 144.500 4.048       
 8     PM 92 80 83 88 93 96 88.667 2.525 0.734 1.657 0.443    
        N 209 201 182 210 200 199 200.167 4.110       
        C 112 114 112 136 130 121 120.833 4.151       
 9     PM 116 124 101 108 99 120 111.333 4.193 0.782 1.607 0.487    
        N 226 231 218 227 237 233 228.667 2.692       
        C 141 134 131 141 157 150 142.333 3.981       
 10   PM 91 83 70 82 85 90 83.500 3.085 0.568 1.639 0.346    
        N 251 234 245 248 232 236 241.000 3.266       
        C 138 146 150 132 141 175 147.000 6.154       
pUG36-PLC1 in WT             
U73122 1h               
 1     PM 51 58 55 54 50 52 53.333 1.202 0.691 1.585 0.436 0.762 1.627 0.483 
        N 118 127 126 124 123 116 122.333 1.801    0.011 0.110 0.023 
        C 88 79 75 80 65 76 77.167 3.070       
 262
 2     PM 54 66 72 60 72 66 65.000 2.864 0.791 1.584 0.499    
        N 129 140 121 133 122 136 130.167 3.114       
        C 77 80 81 81 89 85 82.167 1.721       
 3     PM 42 46 43 41 40 46 43.000 1.033 0.766 1.513 0.506    
        N 81 89 86 84 82 88 85.000 1.317       
        C 57 53 63 54 54 56 56.167 1.493       
 4     PM 45 47 43 40 41 44 43.333 1.054 0.747 1.351 0.553    
        N 78 74 81 78 82 77 78.333 1.174       
        C 63 55 57 59 54 60 58.000 1.366       
 5     PM 33 31 32 33 30 34 32.167 0.601 0.751 1.650 0.455    
        N 68 66 79 74 69 68 70.667 1.994       
        C 41 42 40 38 49 47 42.833 1.740       
 6     PM 40 42 43 39 44 41 41.500 0.764 0.761 1.428 0.533    
        N 78 81 74 75 79 80 77.833 1.138       
        C 52 58 54 53 51 59 54.500 1.335       
 7     PM 50 49 48 51 49 51 49.667 0.494 0.786 1.612 0.488    
        N 102 105 97 100 105 102 101.833 1.249       
        C 61 66 64 68 61 59 63.167 1.400       
 8     PM 53 42 55 47 51 53 50.167 1.973 0.816 1.618 0.504    
        N 94 93 103 97 104 106 99.500 2.262       
        C 54 66 63 65 60 61 61.500 1.765       
 9     PM 52 48 49 50 51 50 50.000 0.577 0.726 1.312 0.554    
        N 94 88 90 88 92 90 90.333 0.955       
        C 70 72 67 71 66 67 68.833 1.014       
 10   PM 72 66 58 57 60 61 62.333 2.319 0.781 2.618 0.298    
        N 203 213 210 207 214 207 209.000 1.693       
        C 82 76 99 71 76 75 79.833 4.094       
 DMSO 1h               
 1     PM 65 59 60 78 65 66 65.500 2.766 0.756 1.790 0.422 0.778 1.634 0.481 
        N 155 159 159 154 151 153 155.167 1.327    0.019 0.041 0.020 
        C 85 98 81 84 89 83 86.667 2.512       
 2     PM 66 59 61 55 56 62 59.833 1.662 0.708 1.562 0.453    
        N 129 130 132 132 134 135 132.000 0.931       
        C 85 89 82 88 81 82 84.500 1.384       
 3     PM 66 61 66 56 55 50 59.000 2.633 0.761 1.548 0.492    
        N 124 128 112 123 118 115 120.000 2.463       
        C 74 79 81 72 76 83 77.500 1.727       
 4     PM 50 53 51 57 54 50 52.500 1.118 0.765 1.563 0.489    
        N 105 108 111 106 105 109 107.333 0.989       
        C 71 66 74 65 70 66 68.667 1.453       
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 5     PM 51 45 46 53 52 50 49.500 1.335 0.712 1.722 0.414    
        N 120 118 116 119 120 125 119.667 1.229       
        C 71 68 74 63 71 70 69.500 1.522       
 6     PM 48 47 42 47 49 45 46.333 1.022 0.869 1.681 0.517    
        N 88 92 97 87 94 80 89.667 2.459       
        C 52 51 49 56 54 58 53.333 1.358       
 7     PM 47 50 50 51 57 50 50.833 1.352 0.843 1.591 0.530    
        N 100 90 101 93 98 94 96.000 1.770       
        C 56 70 64 61 51 60 60.333 2.667       
 8     PM 68 63 69 55 56 69 63.333 2.642 0.705 1.887 0.374    
        N 175 163 173 169 169 168 169.500 1.708       
        C 100 85 86 78 96 94 89.833 3.351       
 9     PM 58 62 62 57 61 55 59.167 1.195 0.803 1.579 0.509    
        N 110 123 120 118 113 114 116.333 1.978       
        C 71 72 70 78 77 74 73.667 1.333       
 10   PM 56 59 60 52 63 61 58.500 1.607 0.862 1.418 0.608    
        N 99 89 98 100 97 94 96.167 1.662       
        C 71 69 72 61 68 66 67.833 1.621       
pUG36-PLC1 in arg82Δ             
U73122 1h               
 1     PM 46 57 63 56 62 55 56.500 2.487 0.706 1.760 0.401 0.819 1.658 0.499 
        N 146 132 143 145 128 151 140.833 3.628    0.020 0.047 0.021 
        C 75 85 69 90 82 79 80.000 3.033       
 2     PM 54 55 52 51 49 45 51.000 1.483 0.725 1.571 0.462    
        N 114 107 113 104 107 118 110.500 2.172       
        C 72 76 58 74 74 68 70.333 2.704       
 3     PM 46 49 50 50 55 52 50.333 1.229 0.795 1.708 0.465    
        N 101 123 100 122 109 94 108.167 4.936       
        C 60 62 75 63 59 61 63.333 2.404       
 4     PM 55 50 46 49 46 53 49.833 1.493 0.923 1.775 0.520    
        N 94 95 106 97 90 93 95.833 2.242       
        C 59 49 57 49 56 54 54.000 1.713       
 5     PM 53 56 51 50 41 43 49.000 2.380 0.776 1.916 0.405    
        N 133 112 108 131 116 126 121.000 4.258       
        C 62 61 67 59 58 72 63.167 2.182       
 6     PM 37 43 48 43 40 38 41.500 1.648 0.838 1.545 0.542    
        N 78 72 76 79 75 79 76.500 1.118       
        C 47 52 50 48 48 52 49.500 0.885       
 7     PM 46 40 46 47 51 47 46.167 1.447 0.871 1.538 0.566    
        N 89 78 80 82 83 77 81.500 1.765       
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        C 53 59 58 54 48 46 53.000 2.129       
 8     PM 60 55 54 53 51 54 54.500 1.232 0.847 1.531 0.553    
        N 104 98 97 104 95 93 98.500 1.875       
        C 56 71 70 60 62 67 64.333 2.431       
 9     PM 56 55 56 55 52 62 56.000 1.342 0.866 1.423 0.609    
        N 96 93 88 87 90 98 92.000 1.807       
        C 74 63 65 57 58 71 64.667 2.789       
 10   PM 47 54 50 42 45 44 47.000 1.789 0.847 1.814 0.467    
        N 106 94 98 103 101 102 100.667 1.706       
        C 55 58 52 59 58 51 55.500 1.384       
DMSO 1h               
 1     PM 60 56 60 66 66 54 60.333 2.028 1.191 1.658 0.718 1.161 1.610 0.734 
        N 85 84 77 88 81 89 84.000 1.826    0.016 0.071 0.032 
        C 50 54 55 54 44 47 50.667 1.820       
 2     PM 66 67 64 71 65 71 67.333 1.229 1.232 1.500 0.821    
        N 78 85 76 82 83 88 82.000 1.807       
        C 53 58 57 52 50 58 54.667 1.406       
 3     PM 121 107 111 118 113 106 112.667 2.431 1.045 1.856 0.563    
        N 199 203 190 200 211 198 200.167 2.798       
        C 101 111 112 111 100 112 107.833 2.330       
 4     PM 108 110 105 112 111 102 108.000 1.571 1.178 1.465 0.804    
        N 138 139 135 129 130 135 134.333 1.667       
        C 99 94 88 90 85 94 91.667 2.044       
 5     PM 118 137 145 115 110 121 124.333 5.572 1.166 2.163 0.539    
        N 230 221 230 238 240 225 230.667 2.985       
        C 94 93 116 121 98 118 106.667 5.302       
 6     PM 168 185 181 182 160 164 173.333 4.333 1.149 1.475 0.779    
        N 230 225 218 225 217 220 222.500 2.045       
        C 141 139 151 145 171 158 150.833 4.929       
 7     PM 191 183 201 189 208 194 194.333 3.648 1.181 1.378 0.857    
        N 240 228 212 229 227 224 226.667 3.685       
        C 170 168 161 159 171 158 164.500 2.377       
 8     PM 170 182 167 171 184 179 175.500 2.884 1.174 1.501 0.782    
        N 221 225 220 230 222 228 224.333 1.647       
        C 146 155 157 145 142 152 149.500 2.460       
 9     PM 79 85 81 87 88 80 83.333 1.563 1.104 1.459 0.756    
        N 109 115 105 104 117 111 110.167 2.136       
        C 77 75 64 82 75 80 75.500 2.566       
 10   PM 83 71 86 78 84 81 80.500 2.202 1.187 1.644 0.722    
        N 108 115 107 110 113 116 111.500 1.522       
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        C 65 68 78 72 61 63 67.833 2.574       
U73244 1h               
 1     PM 139 144 142 126 132 148 138.500 3.324 1.118 1.977 0.566 1.145 1.599 0.727 
        N 229 250 238 254 252 246 244.833 3.919    0.017 0.063 0.029 
        C 130 124 128 113 125 123 123.833 2.414       
 2     PM 136 128 133 138 132 139 134.333 1.687 1.065 1.976 0.539    
        N 255 242 247 248 254 250 249.333 1.961       
        C 117 127 126 129 123 135 126.167 2.455       
 3     PM 183 142 139 128 156 162 151.667 8.003 1.110 1.563 0.710    
        N 202 210 218 205 229 218 213.667 4.072       
        C 130 150 129 139 135 137 136.667 3.106       
 4     PM 113 117 129 116 110 114 116.500 2.693 1.097 1.507 0.728    
        N 153 160 159 166 158 164 160.000 1.880       
        C 117 110 108 101 98 103 106.167 2.822       
 5     PM 132 139 124 120 132 121 128.000 3.066 1.157 1.437 0.805    
        N 153 166 156 162 157 160 159.000 1.897       
        C 106 120 113 111 109 105 110.667 2.231       
 6     PM 142 109 112 125 123 117 121.333 4.835 1.178 1.521 0.774    
        N 160 157 152 155 153 163 156.667 1.726       
        C 106 101 110 108 103 90 103.000 2.921       
 7     PM 123 116 113 117 112 115 116.000 1.592 1.184 1.524 0.777    
        N 145 158 138 147 149 159 149.333 3.273       
        C 112 97 90 100 96 93 98.000 3.130       
 8     PM 115 102 101 112 110 105 107.500 2.320 1.267 1.627 0.779    
        N 129 140 146 142 131 140 138.000 2.696       
        C 71 81 85 95 93 84 84.833 3.544       
 9     PM 109 107 104 102 101 98 103.500 1.648 1.167 1.455 0.802    
        N 117 137 125 136 134 125 129.000 3.235       
        C 75 82 71 99 100 105 88.667 5.903       
 10   PM 89 84 92 89 95 90 89.833 1.493 1.105 1.406 0.786    
        N 112 111 121 117 115 110 114.333 1.706       
        C 78 91 75 82 76 86 81.333 2.552       
pUG36-PLC1H439L in arg82Δ             
 1     PM 57 54 51 49 47 52 51.667 1.453 0.787 2.193 0.359 0.870 1.925 0.459 
        N 129 157 138 144 136 160 144.000 5.000    0.025 0.077 0.022 
        C 73 66 65 67 61 62 65.667 1.745       
 2     PM 45 55 52 60 53 59 54.000 2.221 0.905 2.106 0.430    
        N 126 130 131 109 136 122 125.667 3.853       
        C 64 66 56 59 57 56 59.667 1.764       
 3     PM 58 53 73 66 59 50 59.833 3.458 0.913 2.369 0.386    
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        N 150 160 183 144 142 152 155.167 6.145       
        C 69 58 73 64 64 65 65.500 2.078       
 4     PM 48 56 58 60 50 51 53.833 1.973 0.852 1.850 0.461    
        N 124 107 120 118 121 111 116.833 2.651       
        C 55 63 69 70 58 64 63.167 2.414       
 5     PM 50 45 57 55 49 50 51.000 1.770 0.781 1.811 0.431    
        N 110 122 115 118 121 124 118.333 2.108       
        C 62 65 65 73 58 69 65.333 2.140       
 6     PM 60 55 52 51 58 59 55.833 1.537 0.786 1.725 0.456    
        N 117 115 129 122 124 128 122.500 2.320       
        C 71 80 66 68 72 69 71.000 2.000       
 7     PM 98 100 106 104 108 111 104.500 1.996 0.858 1.947 0.441    
        N 242 249 250 238 230 214 237.167 5.528       
        C 123 113 135 119 123 118 121.833 3.038       
 8     PM 120 121 105 99 121 115 113.500 3.828 0.915 1.996 0.459    
        N 250 246 231 255 253 250 247.500 3.528       
        C 120 123 112 118 143 128 124.000 4.374       
 9     PM 124 148 151 134 137 176 145.000 7.376 1.051 1.791 0.587    
        N 250 242 237 254 252 248 247.167 2.638       
        C 130 142 150 124 131 151 138.000 4.612       
 10   PM 113 97 95 98 122 113 106.333 4.544 0.852 1.459 0.584    
        N 180 183 180 173 195 182 182.167 2.937       
        C 114 125 134 123 116 137 124.833 3.790       
pUG36-PLC1E425G in arg82Δ             
 1     PM 181 175 164 174 173 169 172.667 2.348 1.223 1.129 1.084 1.159 1.696 0.707 
        N 162 150 170 154 165 155 159.333 3.095    0.013 0.093 0.047 
        C 140 138 143 144 137 145 141.167 1.352       
 2     PM 124 144 134 173 142 151 144.667 6.810 1.097 1.702 0.645    
        N 234 220 231 233 209 219 224.333 4.063       
        C 124 142 133 132 129 131 131.833 2.414       
 3     PM 152 152 141 143 155 140 147.167 2.676 1.153 1.742 0.662    
        N 240 235 219 220 209 211 222.333 5.149       
        C 125 127 125 129 126 134 127.667 1.406       
 4     PM 131 143 130 135 139 133 135.167 2.040 1.174 1.821 0.645    
        N 201 211 202 218 217 209 209.667 2.940       
        C 112 108 130 108 115 118 115.167 3.371       
 5     PM 150 140 148 130 138 170 146.000 5.633 1.086 1.644 0.660    
        N 230 210 224 229 231 203 221.167 4.826       
        C 133 159 120 115 154 126 134.500 7.406       
 6     PM 125 118 111 113 134 108 118.167 3.995 1.164 2.294 0.508    
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        N 240 237 211 252 240 217 232.833 6.364       
        C 101 107 110 104 95 92 101.500 2.837       
 7     PM 107 97 124 119 109 114 111.667 3.896 1.149 1.942 0.592    
        N 190 193 186 182 196 185 188.667 2.155       
        C 92 101 98 95 94 103 97.167 1.740       
 8     PM 115 106 104 95 112 116 108.000 3.256 1.137 1.474 0.771    
        N 141 139 136 142 139 143 140.000 1.033       
        C 95 105 98 100 85 87 95.000 3.152       
 9     PM 105 98 97 102 102 100 100.667 1.202 1.194 1.466 0.814    
        N 115 120 144 124 122 117 123.667 4.279       
        C 84 86 90 79 85 82 84.333 1.520       
 10   PM 141 128 121 127 109 120 124.333 4.333 1.209 1.749 0.691    
        N 184 172 182 179 180 182 179.833 1.721       
        C 100 101 104 102 104 106 102.833 0.910       
pUG36-PLC1E425G in plc1Δ             
 1     PM 110 105 85 90 93 110 98.833 4.438 1.392 1.763 0.790 1.388 1.741 0.808 
        N 132 124 119 127 122 127 125.167 1.851    0.046 0.091 0.027 
        C 65 75 65 74 68 79 71.000 2.380       
 2     PM 111 113 117 132 120 110 117.167 3.341 1.535 1.583 0.970    
        N 108 126 118 124 120 129 120.833 3.038       
        C 74 84 71 72 74 83 76.333 2.319       
 3     PM 95 89 84 79 95 90 88.667 2.565 1.337 1.814 0.737    
        N 113 124 122 117 125 121 120.333 1.856       
        C 72 66 70 58 67 65 66.333 1.978       
 4     PM 88 85 83 87 79 83 84.167 1.327 1.238 1.517 0.816    
        N 89 117 115 101 105 92 103.167 4.708       
        C 63 69 68 66 70 72 68.000 1.291       
 5     PM 87 75 110 96 82 90 90.000 4.946 1.406 1.917 0.734    
        N 116 129 123 121 117 130 122.667 2.404       
        C 66 60 73 64 60 61 64.000 2.049       
 6     PM 82 103 123 80 105 101 99.000 6.537 1.588 1.963 0.809    
        N 118 115 123 124 130 124 122.333 2.140       
        C 66 61 59 65 64 59 62.333 1.256       
 7     PM 61 59 80 67 72 71 68.333 3.159 1.344 1.826 0.736    
        N 90 93 99 98 92 85 92.833 2.120       
        C 52 50 46 55 53 49 50.833 1.302       
 8     PM 56 54 59 48 51 56 54.000 1.612 1.174 1.380 0.850    
        N 60 65 63 65 67 61 63.500 1.088       
        C 51 50 42 47 45 41 46.000 1.673       
 9     PM 119 121 108 115 110 120 115.500 2.232 1.240 1.322 0.938    
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        N 121 123 116 137 125 117 123.167 3.103       
        C 93 99 90 94 87 96 93.167 1.740       
 10   PM 145 131 108 81 82 91 106.333 10.917 1.628 2.329 0.699    
        N 163 130 165 151 150 154 152.167 5.108       
        C 66 62 63 66 65 70 65.333 1.145       
pUG36-PLC1 in ipk1Δ              
 1     PM 76 82 80 57 60 58 68.833 4.778 0.677 1.456 0.465 0.772 1.585 0.495 
        N 155 148 150 142 152 141 148.000 2.266    0.021 0.060 0.024 
        C 94 108 99 98 93 118 101.667 3.921       
 2     PM 63 70 67 65 70 67 67.000 1.125 0.773 1.462 0.529    
        N 127 123 126 125 130 129 126.667 1.054       
        C 84 81 91 82 87 95 86.667 2.231       
 3     PM 60 65 71 61 64 60 63.500 1.727 0.819 1.667 0.492    
        N 126 122 128 131 133 135 129.167 1.956       
        C 76 72 86 74 72 85 77.500 2.604       
 4     PM 65 76 61 72 80 78 72.000 3.088 0.780 1.599 0.488    
        N 153 149 140 146 148 150 147.667 1.801       
        C 95 89 82 98 93 97 92.333 2.445       
 5     PM 60 65 61 44 53 50 55.500 3.212 0.742 1.312 0.565    
        N 91 96 98 100 103 101 98.167 1.740       
        C 75 72 67 77 78 80 74.833 1.922       
 6     PM 55 58 63 76 60 53 60.833 3.361 0.787 1.573 0.500    
        N 123 116 121 124 126 120 121.667 1.430       
        C 82 80 79 69 87 67 77.333 3.169       
 7     PM 75 72 60 50 49 52 59.667 4.667 0.923 1.415 0.652    
        N 99 94 98 90 87 81 91.500 2.814       
        C 59 62 70 60 66 71 64.667 2.092       
 8     PM 49 53 51 50 50 57 51.667 1.202 0.728 1.620 0.449    
        N 105 109 120 115 124 117 115.000 2.864       
        C 74 73 70 67 68 74 71.000 1.265       
 9     PM 73 68 58 62 67 75 67.167 2.626 0.694 2.031 0.342    
        N 195 188 192 200 198 207 196.667 2.704       
        C 96 100 102 99 94 90 96.833 1.797       
 10   PM 59 64 80 71 78 66 69.667 3.353 0.798 1.719 0.464    
        N 139 154 149 159 143 157 150.167 3.250       
        C 87 90 96 86 82 83 87.333 2.092       
pUG36-PLC1 in kcs1Δ              
 1     PM 44 42 40 37 43 45 41.833 1.195 0.721 1.443 0.500 0.712 1.464 0.493 
        N 86 90 81 85 82 78 83.667 1.726    0.013 0.050 0.020 
        C 61 55 56 56 58 62 58.000 1.183       
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 2     PM 61 56 60 51 52 55 55.833 1.662 0.756 1.415 0.534    
        N 106 96 99 105 107 114 104.500 2.592       
        C 82 74 65 84 68 70 73.833 3.146       
 3     PM 56 65 62 54 63 62 60.333 1.764 0.713 1.305 0.546    
        N 110 107 114 112 107 113 110.500 1.232       
        C 80 94 85 84 90 75 84.667 2.777       
 4     PM 66 69 64 59 56 61 62.500 1.945 0.724 1.297 0.558    
        N 119 112 111 109 108 113 112.000 1.592       
        C 82 90 85 91 76 94 86.333 2.716       
 5     PM 60 72 73 76 75 63 69.833 2.725 0.727 1.542 0.472    
        N 139 154 146 143 158 148 148.000 2.864       
        C 102 96 104 99 85 90 96.000 2.978       
 6     PM 77 74 68 60 70 85 72.333 3.471 0.628 1.742 0.360    
        N 205 179 225 187 213 195 200.667 6.955       
        C 106 117 118 112 120 118 115.167 2.136       
 7     PM 51 43 47 40 50 37 44.667 2.290 0.759 1.453 0.522    
        N 94 78 85 82 90 84 85.500 2.335       
        C 62 60 58 62 56 55 58.833 1.222       
 8     PM 99 88 80 77 86 92 87.000 3.266 0.708 1.746 0.406    
        N 221 203 218 212 218 215 214.500 2.617       
        C 123 128 120 130 116 120 122.833 2.167       
 9     PM 67 67 61 73 79 79 71.000 2.966 0.743 1.351 0.550    
        N 133 136 112 122 134 137 129.000 4.050       
        C 83 99 97 101 99 94 95.500 2.680       
 10   PM 65 59 62 66 68 74 65.667 2.108 0.641 1.341 0.478    
        N 132 135 141 133 145 139 137.500 2.062       
        C 110 102 99 89 98 117 102.500 4.006       
pUG36-PLC1 in kcs1Δvip1Δ            
 1     PM 78 71 56 69 78 77 71.500 3.471 0.668 1.396 0.479 0.722 1.503 0.481 
        N 142 149 155 158 144 148 149.333 2.525    0.016 0.037 0.009 
        C 100 104 102 111 115 110 107.000 2.394       
 2     PM 76 81 77 84 52 65 72.500 4.877 0.721 1.454 0.496    
        N 147 146 143 148 144 149 146.167 0.946       
        C 113 103 118 88 96 85 100.500 5.433       
 3     PM 56 54 63 51 72 71 61.167 3.646 0.681 1.434 0.475    
        N 133 138 122 118 128 134 128.833 3.124       
        C 90 86 90 96 89 88 89.833 1.376       
 4     PM 73 76 70 68 65 57 68.167 2.725 0.740 1.770 0.418    
        N 153 148 158 184 154 182 163.167 6.410       
        C 106 101 91 80 92 83 92.167 4.094       
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 5     PM 72 62 77 60 48 66 64.167 4.135 0.635 1.389 0.457    
        N 146 137 140 136 152 131 140.333 3.084       
        C 100 96 112 106 105 87 101.000 3.578       
 6     PM 60 57 52 77 73 70 64.833 4.045 0.828 1.647 0.503    
        N 132 124 118 139 133 128 129.000 3.011       
        C 74 84 90 68 84 70 78.333 3.630       
 7     PM 133 127 140 140 142 113 132.500 4.522 0.773 1.434 0.539    
        N 247 252 250 238 246 241 245.667 2.171       
        C 173 185 162 169 158 181 171.333 4.295       
 8     PM 123 134 106 117 102 126 118.000 4.987 0.722 1.473 0.490    
        N 241 239 244 250 232 238 240.667 2.472       
        C 159 169 166 170 162 154 163.333 2.525       
 9     PM 73 75 84 80 81 82 79.167 1.740 0.745 1.569 0.475    
        N 169 163 166 161 172 170 166.833 1.740       
        C 109 112 99 100 111 107 106.333 2.275       
 10   PM 80 87 102 73 89 94 87.500 4.169 0.707 1.466 0.482    
        N 188 186 178 175 177 185 181.500 2.232       
        C 126 133 121 125 117 121 123.833 2.257       
pUG36-PLC1 in vip1Δ             
 1     PM 102 99 90 86 84 72 88.833 4.445 0.756 1.450 0.522 0.731 1.495 0.490 
        N 176 166 165 177 167 171 170.333 2.124    0.019 0.037 0.014 
        C 118 120 124 126 121 96 117.500 4.455       
 2     PM 72 74 64 69 59 74 68.667 2.472 0.659 1.406 0.469    
        N 148 144 149 142 146 150 146.500 1.258       
        C 104 97 107 104 112 101 104.167 2.088       
 3     PM 82 78 71 73 78 68 75.000 2.129 0.743 1.611 0.461    
        N 166 170 155 156 168 161 162.667 2.578       
        C 103 97 108 97 101 100 101.000 1.693       
 4     PM 76 79 72 76 76 87 77.667 2.076 0.805 1.428 0.563    
        N 133 140 135 137 144 138 137.833 1.579       
        C 86 90 96 106 101 100 96.500 3.030       
 5     PM 97 97 99 107 100 96 99.333 1.647 0.601 1.359 0.442    
        N 230 227 232 224 225 209 224.500 3.334       
        C 161 150 184 164 158 174 165.167 4.942       
 6     PM 78 84 74 77 83 91 81.167 2.496 0.802 1.502 0.534    
        N 155 158 159 147 142 151 152.000 2.708       
        C 108 90 105 99 101 104 101.167 2.574       
 7     PM 66 84 72 78 83 77 76.667 2.777 0.741 1.491 0.497    
        N 159 143 148 164 154 158 154.333 3.148       
        C 97 92 101 104 115 112 103.500 3.585       
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 8     PM 73 79 74 88 80 77 78.500 2.202 0.700 1.584 0.442    
        N 168 171 183 186 182 176 177.667 2.929       
        C 113 109 116 130 97 108 112.167 4.438       
 9     PM 83 86 106 83 78 72 84.667 4.716 0.732 1.372 0.534    
        N 160 167 149 159 161 156 158.667 2.431       
        C 120 115 129 110 120 100 115.667 4.055       
 10   PM 45 38 39 46 44 52 44.000 2.082 0.772 1.751 0.441    
        N 100 104 92 98 110 95 99.833 2.638       
        C 47 60 52 61 59 63 57.000 2.517       
pUG36-PLC1 + pUG34-ARG82G344R in arg82Δ           
 1     PM 187 155 146 134 121 118 143.500 10.452 1.255 1.988 0.631 1.154 1.770 0.665 
        N 250 236 210 225 222 221 227.333 5.667    0.026 0.075 0.035 
        C 108 109 120 113 128 108 114.333 3.313       
 2     PM 171 125 159 151 145 144 149.167 6.337 1.206 1.788 0.674    
        N 226 214 223 229 211 224 221.167 2.892       
        C 115 129 127 132 123 116 123.667 2.848       
 3     PM 128 126 125 122 146 164 135.167 6.735 1.157 1.679 0.689    
        N 188 191 202 211 196 189 196.167 3.646       
        C 106 113 119 120 119 124 116.833 2.600       
 4     PM 175 163 183 162 148 194 170.833 6.740 1.281 1.503 0.853    
        N 219 198 195 201 213 176 200.333 6.152       
        C 129 133 140 128 136 134 133.333 1.820       
 5     PM 109 103 123 120 115 106 112.667 3.252 1.050 1.635 0.642    
        N 206 205 21 212 200 209 175.500 30.944       
        C 101 96 112 113 110 112 107.333 2.894       
 6     PM 150 107 143 123 120 112 125.833 6.992 1.075 2.130 0.505    
        N 249 250 254 242 249 251 249.167 1.621       
        C 98 119 112 124 120 129 117.000 4.442       
 7     PM 140 139 149 155 133 129 140.833 3.970 1.199 1.949 0.615    
        N 225 223 232 230 237 227 229.000 2.082       
        C 126 121 114 112 109 123 117.500 2.766       
 8     PM 119 121 123 116 123 145 124.500 4.241 1.184 1.868 0.634    
        N 205 185 218 187 175 209 196.500 6.771       
        C 108 101 98 103 109 112 105.167 2.182       
 9     PM 114 124 111 137 119 134 123.167 4.316 1.025 1.872 0.547    
        N 218 228 231 223 232 218 225.000 2.556       
        C 120 121 114 123 124 119 120.167 1.447       
 10   PM 173 162 165 170 143 150 160.500 4.780 1.109 1.287 0.862    
        N 196 189 180 179 190 183 186.167 2.701       
        C 151 134 145 138 153 147 144.667 3.018       
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pUG36-PLC1 + pUG34-ARG82 in arg82Δ            
 1     PM 86 97 109 94 93 99 96.333 3.116 0.666 1.403 0.475 0.705 1.564 0.456 
        N 196 210 206 204 208 194 203.000 2.671    0.023 0.065 0.019 
        C 147 152 150 149 141 129 144.667 3.490       
 2     PM 89 88 77 71 96 85 84.333 3.667 0.597 1.495 0.399    
        N 213 204 222 225 207 197 211.333 4.402       
        C 154 152 137 150 124 131 141.333 5.084       
 3     PM 91 84 86 78 74 76 81.500 2.680 0.679 2.031 0.334    
        N 240 248 245 249 253 227 243.667 3.774       
        C 120 110 126 108 106 150 120.000 6.772       
 4     PM 114 96 101 113 122 119 110.833 4.175 0.591 1.234 0.479    
        N 245 150 247 245 254 247 231.333 16.323       
        C 205 197 166 183 197 177 187.500 5.999       
 5     PM 97 93 95 81 92 95 92.167 2.344 0.720 1.539 0.468    
        N 190 188 199 198 200 207 197.000 2.852       
        C 113 141 139 118 127 130 128.000 4.546       
 6     PM 87 96 85 91 78 89 87.667 2.472 0.755 1.636 0.461    
        N 192 196 187 192 185 188 190.000 1.653       
        C 114 125 112 112 116 118 116.167 2.007       
 7     PM 100 86 89 78 82 81 86.000 3.215 0.747 1.443 0.518    
        N 166 159 166 151 182 173 166.167 4.393       
        C 122 118 125 110 107 109 115.167 3.070       
 8     PM 73 81 84 93 81 82 82.333 2.629 0.847 1.532 0.553    
        N 157 148 155 149 154 130 148.833 4.028       
        C 105 102 84 90 97 105 97.167 3.516       
 9     PM 87 81 90 84 88 90 86.667 1.453 0.723 1.769 0.409    
        N 216 209 204 201 217 225 212.000 3.670       
        C 123 125 121 117 112 121 119.833 1.905       
 10   PM 106 105 91 92 102 92 98.000 2.887 0.730 1.557 0.469    
        N 206 218 209 204 219 199 209.167 3.240       
        C 136 139 136 151 124 120 134.333 4.536       
pUG36-PLC1 + pUG34 in arg82Δ             
 1     PM 135 153 140 136 125 134 137.167 3.754 1.288 2.352 0.548 1.160 1.837 0.642 
        N 249 250 255 247 252 250 250.500 1.118    0.023 0.087 0.025 
        C 101 103 102 107 114 112 106.500 2.232       
 2     PM 160 118 108 109 111 149 125.833 9.286 1.154 1.856 0.622    
        N 196 211 217 211 192 187 202.333 4.991       
        C 96 114 111 112 107 114 109.000 2.805       
 3     PM 119 110 105 105 108 116 110.500 2.377 1.017 1.561 0.651    
        N 162 160 173 180 172 171 169.667 3.040       
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        C 110 101 95 116 112 118 108.667 3.648       
 4     PM 111 109 106 100 114 105 107.500 2.012 1.215 2.164 0.561    
        N 201 193 184 186 189 196 191.500 2.617       
        C 111 98 75 84 80 83 88.500 5.482       
 5     PM 83 91 84 100 96 105 93.167 3.591 1.090 2.101 0.519    
        N 175 182 176 188 177 180 179.667 1.978       
        C 85 88 78 83 89 90 85.500 1.839       
 6     PM 112 109 99 110 116 123 111.500 3.253 1.182 1.733 0.682    
        N 163 167 162 167 168 154 163.500 2.141       
        C 104 98 87 89 91 97 94.333 2.629       
 7     PM 170 180 176 159 148 154 164.500 5.214 1.191 1.685 0.707    
        N 233 244 230 230 216 244 232.833 4.277       
        C 133 147 142 129 135 143 138.167 2.810       
 8     PM 159 123 150 157 159 122 145.000 7.243 1.155 1.817 0.636    
        N 220 225 229 231 229 234 228.000 2.000       
        C 140 128 116 125 121 123 125.500 3.334       
 9     PM 120 115 109 122 119 111 116.000 2.129 1.206 1.685 0.716    
        N 160 157 158 166 163 168 162.000 1.807       
        C 99 97 100 88 98 95 96.167 1.778       
 10   PM 86 95 88 94 92 87 90.333 1.563 1.099 1.418 0.775    
        N 118 120 124 114 113 110 116.500 2.094       
        C 78 88 80 83 86 78 82.167 1.721       
pUG36-PLC1 in arg82Δ             
DMSO 2hrs              
 1     PM 66 59 69 67 68 60 64.833 1.740 1.063 1.992 0.534 1.166 1.654 0.719 
        N 127 115 123 119 128 117 121.500 2.187    0.021 0.073 0.035 
        C 57 61 63 63 60 62 61.000 0.931       
 2     PM 98 80 89 78 77 79 83.500 3.394 1.222 1.359 0.899    
        N 91 96 96 88 91 95 92.833 1.352       
        C 67 75 73 65 66 64 68.333 1.856       
 3     PM 100 85 90 105 100 104 97.333 3.283 1.180 1.691 0.698    
        N 135 142 140 141 136 143 139.500 1.335       
        C 80 81 78 84 90 82 82.500 1.708       
 4     PM 92 88 98 90 96 89 92.167 1.641 1.229 2.118 0.580    
        N 165 168 161 150 161 148 158.833 3.301       
        C 80 72 68 70 83 77 75.000 2.422       
 5     PM 90 86 89 89 85 81 86.667 1.382 1.169 1.409 0.829    
        N 110 104 98 108 104 103 104.500 1.708       
        C 74 72 70 70 81 78 74.167 1.833       
 6     PM 124 120 111 116 105 114 115.000 2.733 1.065 1.590 0.670    
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        N 175 187 168 171 170 159 171.667 3.756       
        C 119 111 102 97 110 109 108.000 3.120       
 7     PM 135 132 117 126 118 129 126.167 3.005 1.188 1.449 0.820    
        N 163 160 157 140 147 156 153.833 3.535       
        C 109 101 106 102 112 107 106.167 1.701       
 8     PM 74 70 73 74 70 76 72.833 0.980 1.278 1.596 0.800    
        N 91 90 100 92 87 86 91.000 2.033       
        C 57 55 62 50 64 54 57.000 2.129       
 9     PM 73 75 67 76 76 69 72.667 1.563 1.141 1.599 0.714    
        N 104 109 98 95 101 104 101.833 2.023       
        C 64 61 59 66 70 62 63.667 1.606       
 10   PM 82 79 78 82 84 85 81.667 1.116 1.124 1.741 0.646    
        N 129 122 131 125 129 123 126.500 1.500       
        C 76 66 75 79 78 62 72.667 2.848       
InsP5 15min              
 1     PM 130 162 160 135 117 106 135.000 9.209 1.500 1.609 0.932 1.357 1.820 0.761 
        N 147 144 139 149 148 142 144.833 1.579    0.048 0.087 0.039 
        C 88 95 85 87 92 93 90.000 1.592       
 2     PM 93 100 142 88 121 131 112.500 8.984 1.403 1.603 0.875    
        N 132 127 129 122 134 127 128.500 1.727       
        C 77 90 78 81 80 75 80.167 2.151       
 3     PM 164 180 153 147 150 188 163.667 6.922 1.409 1.884 0.748    
        N 218 230 229 204 215 217 218.833 3.945       
        C 110 99 114 126 132 116 116.167 4.778       
 4     PM 119 124 110 102 139 115 118.167 5.186 1.393 1.737 0.802    
        N 143 140 152 143 157 149 147.333 2.642       
        C 90 83 81 85 78 92 84.833 2.182       
 5     PM 159 145 152 150 149 153 151.333 1.909 1.417 1.847 0.767    
        N 199 195 201 192 199 198 197.333 1.333       
        C 95 118 105 108 99 116 106.833 3.719       
 6     PM 70 88 81 79 82 74 79.000 2.582 1.148 2.535 0.453    
        N 180 182 179 176 161 169 174.500 3.274       
        C 67 64 71 78 70 63 68.833 2.242       
 7     PM 112 116 103 101 110 109 108.500 2.291 1.247 1.632 0.764    
        N 142 146 136 152 144 132 142.000 2.921       
        C 84 82 90 89 85 92 87.000 1.592       
 8     PM 65 68 59 63 69 61 64.167 1.600 1.271 1.888 0.673    
        N 100 93 98 89 91 101 95.333 2.044       
        C 51 45 49 53 54 51 50.500 1.310       
 9     PM 91 87 90 94 96 100 93.000 1.897 1.646 1.947 0.845    
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        N 112 107 110 106 118 107 110.000 1.844       
        C 59 56 51 54 60 59 56.500 1.432       
 10   PM 83 80 78 86 91 77 82.500 2.172 1.135 1.523 0.745    
        N 109 104 110 115 114 112 110.667 1.626       
        C 74 68 75 69 72 78 72.667 1.542       
InsP5 2hrs               
 1     PM 52 57 54 56 57 57 55.500 0.847 1.189 1.500 0.793 1.294 1.799 0.721 
        N 75 65 65 71 69 75 70.000 1.844    0.036 0.048 0.016 
        C 41 47 47 52 47 46 46.667 1.430       
 2     PM 64 67 62 49 56 53 58.500 2.837 1.258 1.896 0.664    
        N 92 90 84 88 86 89 88.167 1.167       
        C 43 50 45 46 47 48 46.500 0.992       
 3     PM 61 56 53 60 56 55 56.833 1.249 1.348 1.921 0.702    
        N 76 85 87 81 77 80 81.000 1.770       
        C 38 40 41 45 37 52 42.167 2.272       
 4     PM 65 57 53 55 52 58 56.667 1.909 1.232 1.822 0.676    
        N 83 80 89 88 73 90 83.833 2.676       
        C 52 42 44 43 45 50 46.000 1.653       
 5     PM 98 73 77 80 116 110 92.333 7.451 1.556 1.947 0.799    
        N 118 112 120 122 112 109 115.500 2.125       
        C 64 62 61 60 55 54 59.333 1.626       
 6     PM 96 94 88 107 89 109 97.167 3.646 1.207 1.718 0.702    
        N 144 125 142 130 139 150 138.333 3.783       
        C 90 81 85 71 79 77 80.500 2.680       
 7     PM 52 56 57 55 60 59 56.500 1.176 1.246 1.577 0.790    
        N 77 74 65 70 69 74 71.500 1.765       
        C 45 47 56 41 43 40 45.333 2.376       
 8     PM 77 59 58 52 66 60 62.000 3.512 1.174 1.744 0.673    
        N 90 87 98 99 84 95 92.167 2.496       
        C 51 58 55 51 50 52 52.833 1.249       
 9     PM 65 77 74 57 60 68 66.833 3.177 1.298 1.900 0.683    
        N 92 90 100 104 100 101 97.833 2.257       
        C 51 53 56 54 47 48 51.500 1.432       
 10   PM 88 87 89 88 91 83 87.667 1.085 1.433 1.965 0.730    
        N 122 110 119 124 121 125 120.167 2.212       
        C 61 59 63 65 63 56 61.167 1.327       
pUG36-PLC1E425G in plc1Δ             
DMSO 2hrs              
 1     PM 75 65 68 66 69 71 69.000 1.483 1.423 2.292 0.621 1.392 1.668 0.851 
        N 108 112 113 111 105 118 111.167 1.815    0.018 0.084 0.034 
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        C 53 50 49 48 46 45 48.500 1.176       
 2     PM 119 111 108 114 110 118 113.333 1.820 1.456 1.925 0.756    
        N 147 146 160 153 145 148 149.833 2.330       
        C 92 80 74 75 78 68 77.833 3.291       
 3     PM 101 100 98 96 97 102 99.000 0.966 1.338 1.649 0.811    
        N 114 112 119 132 137 118 122.000 4.139       
        C 71 76 69 78 79 71 74.000 1.713       
 4     PM 115 97 94 100 101 104 101.833 2.982 1.462 1.624 0.900    
        N 116 114 118 112 110 109 113.167 1.424       
        C 70 68 68 63 72 77 69.667 1.909       
 5     PM 60 48 55 61 57 51 55.333 2.076 1.425 1.494 0.954    
        N 55 57 62 54 58 62 58.000 1.390       
        C 37 36 39 39 42 40 38.833 0.872       
 6     PM 55 58 49 45 55 52 52.333 1.926 1.276 1.350 0.946    
        N 56 52 59 60 52 53 55.333 1.453       
        C 45 39 43 40 41 38 41.000 1.065       
 7     PM 101 107 98 105 102 99 102.000 1.414 1.360 1.818 0.748    
        N 142 138 133 132 130 143 136.333 2.231       
        C 73 68 77 76 74 82 75.000 1.897       
 8     PM 123 124 122 130 120 133 125.333 2.060 1.340 1.483 0.904    
        N 139 133 144 142 138 136 138.667 1.626       
        C 98 92 88 92 93 98 93.500 1.586       
 9     PM 112 128 137 132 129 149 131.167 4.949 1.388 1.444 0.961    
        N 132 130 138 142 136 141 136.500 1.962       
        C 88 90 92 99 101 97 94.500 2.141       
 10   PM 129 135 128 121 131 123 127.833 2.104 1.447 1.600 0.904    
        N 139 142 146 142 141 138 141.333 1.145       
        C 96 81 84 97 89 83 88.333 2.801       
InsP5 15min              
 1     PM 209 156 149 189 170 182 175.833 9.053 1.509 1.784 0.846 1.382 1.566 0.885 
        N 209 215 204 185 219 215 207.833 5.049    0.037 0.054 0.013 
        C 120 105 108 118 121 127 116.500 3.413       
 2     PM 160 155 163 159 162 162 160.167 1.195 1.255 1.441 0.870    
        N 219 166 191 172 186 170 184.000 8.046       
        C 129 113 128 131 126 139 127.667 3.461       
 3     PM 141 123 171 112 113 126 131.000 9.081 1.406 1.555 0.904    
        N 153 140 143 144 148 141 144.833 1.990       
        C 109 94 88 91 90 87 93.167 3.321       
 4     PM 120 122 127 126 130 121 124.333 1.606 1.463 1.606 0.911    
        N 126 135 140 139 137 142 136.500 2.320       
 277
        C 94 87 81 77 84 87 85.000 2.380       
 5     PM 48 49 50 43 44 44 46.333 1.229 1.343 1.488 0.903    
        N 53 47 48 56 50 54 51.333 1.453       
        C 32 30 32 35 40 38 34.500 1.586       
 6     PM 45 41 48 46 42 45 44.500 1.057 1.296 1.471 0.881    
        N 53 45 48 52 56 49 50.500 1.607       
        C 33 35 28 37 33 40 34.333 1.667       
 7     PM 202 199 195 204 198 200 199.667 1.282 1.383 1.415 0.978    
        N 196 204 199 229 194 203 204.167 5.212       
        C 132 166 148 144 140 136 144.333 4.910       
 8     PM 197 170 154 173 194 196 180.667 7.219 1.604 1.942 0.826    
        N 206 197 202 234 235 239 218.833 7.795       
        C 113 112 118 120 102 111 112.667 2.578       
 9     PM 95 90 87 94 88 93 91.167 1.352 1.181 1.359 0.870    
        N 98 97 118 107 99 110 104.833 3.400       
        C 72 73 76 82 83 77 77.167 1.851       
 10   PM 86 91 105 107 99 94 97.000 3.337 1.379 1.600 0.862    
        N 113 111 109 114 110 118 112.500 1.335       
        C 69 67 68 72 74 72 70.333 1.116       
InsP5 2hrs               
 1     PM 149 155 137 142 139 145 144.500 2.729 1.412 2.254 0.626 1.441 1.569 0.933 
        N 234 222 199 237 248 244 230.667 7.320    0.041 0.076 0.037 
        C 100 108 97 103 101 105 102.333 1.585       
 2     PM 72 78 71 65 71 66 70.500 1.910 1.391 1.520 0.916    
        N 70 72 78 75 84 83 77.000 2.338       
        C 51 52 49 50 54 48 50.667 0.882       
 3     PM 67 68 72 63 129 114 85.500 11.607 1.618 1.562 1.036    
        N 85 87 85 76 80 82 82.500 1.648       
        C 47 59 49 52 56 54 52.833 1.815       
 4     PM 70 74 75 68 74 69 71.667 1.229 1.433 1.573 0.911    
        N 75 80 65 83 84 85 78.667 3.106       
        C 49 50 51 49 47 54 50.000 0.966       
 5     PM 95 92 97 82 87 91 90.667 2.231 1.451 1.533 0.946    
        N 101 88 100 99 89 98 95.833 2.358       
        C 61 62 67 61 66 58 62.500 1.384       
 6     PM 61 69 67 78 71 70 69.333 2.261 1.224 1.376 0.889    
        N 80 76 81 78 75 78 78.000 0.931       
        C 56 55 60 52 56 61 56.667 1.358       
 7     PM 181 158 168 157 153 160 162.833 4.159 1.494 1.479 1.010    
        N 175 158 161 159 154 160 161.167 2.937       
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        C 106 112 107 109 114 106 109.000 1.366       
 8     PM 78 82 74 69 68 70 73.500 2.277 1.441 1.386 1.040    
        N 75 78 66 71 70 64 70.667 2.155       
        C 57 52 51 50 53 43 51.000 1.880       
 9     PM 75 63 76 69 74 67 70.667 2.108 1.676 1.601 1.047    
        N 62 65 69 69 68 72 67.500 1.432       
        C 44 45 39 40 42 43 42.167 0.946       
 10   PM 64 63 65 82 70 72 69.333 2.917 1.272 1.404 0.906    
        N 84 78 66 70 83 78 76.500 2.918       
        C 53 54 54 53 60 53 54.500 1.118       
pUG36-PLC1KRLR in arg82Δ             
 1     PM 177 175 169 170 186 192 178.167 3.719 1.118 1.542 0.725 1.162 1.492 0.784 
        N 238 250 239 243 254 250 245.667 2.692    0.015 0.040 0.021 
        C 160 162 160 155 162 157 159.333 1.145       
 2     PM 149 135 182 189 177 180 168.667 8.774 1.212 1.744 0.695    
        N 239 241 245 242 239 250 242.667 1.726       
        C 142 137 160 134 134 128 139.167 4.564       
 3     PM 98 107 102 100 105 110 103.667 1.838 1.187 1.410 0.842    
        N 122 117 128 125 128 119 123.167 1.887       
        C 81 72 78 100 88 105 87.333 5.277       
 4     PM 87 72 75 79 88 85 81.000 2.720 1.133 1.305 0.868    
        N 95 87 98 100 96 84 93.333 2.603       
        C 67 71 69 66 75 81 71.500 2.306       
 5     PM 108 110 114 111 110 104 109.500 1.360 1.237 1.429 0.866    
        N 128 118 132 122 130 129 126.500 2.187       
        C 92 84 94 96 84 81 88.500 2.553       
 6     PM 150 146 159 161 174 201 165.167 8.195 1.089 1.531 0.711    
        N 228 227 234 250 222 232 232.167 3.953       
        C 146 150 148 154 151 161 151.667 2.171       
 7     PM 157 159 150 161 148 166 156.833 2.774 1.200 1.611 0.745    
        N 202 215 213 218 202 213 210.500 2.790       
        C 111 117 138 142 143 133 130.667 5.518       
 8     PM 119 118 124 127 130 122 123.333 1.892 1.121 1.364 0.822    
        N 145 154 146 153 158 144 150.000 2.352       
        C 109 110 115 107 113 106 110.000 1.414       
 9     PM 74 71 69 70 72 73 71.500 0.764 1.195 1.407 0.850    
        N 76 83 85 82 90 89 84.167 2.088       
        C 60 62 65 59 56 57 59.833 1.352       
 10   PM 119 129 118 128 120 125 123.167 1.956 1.125 1.574 0.715    
        N 181 162 171 168 177 175 172.333 2.777       
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        C 112 102 108 114 104 117 109.500 2.391       
pUG36-PLC14R in arg82Δ             
 1     PM 68 79 78 78 68 74 74.167 2.072 0.689 1.650 0.417 0.697 1.804 0.389 
        N 177 178 168 179 179 185 177.667 2.246    0.022 0.053 0.015 
        C 115 88 96 108 120 119 107.667 5.346       
 2     PM 69 70 65 73 66 70 68.833 1.195 0.678 2.039 0.333    
        N 200 215 212 203 211 201 207.000 2.620       
        C 105 108 98 94 104 100 101.500 2.094       
 3     PM 73 85 84 74 65 64 74.167 3.664 0.705 1.623 0.435    
        N 167 180 171 163 170 173 170.667 2.348       
        C 119 105 100 95 104 108 105.167 3.321       
 4     PM 85 74 62 66 93 80 76.667 4.773 0.667 1.809 0.369    
        N 211 203 216 205 207 206 208.000 1.932       
        C 123 122 120 110 109 106 115.000 3.055       
 5     PM 48 50 47 51 56 60 52.000 2.049 0.774 2.010 0.385    
        N 125 138 136 140 131 140 135.000 2.422       
        C 68 73 65 66 70 61 67.167 1.701       
 6     PM 61 60 65 60 56 55 59.500 1.478 0.687 1.671 0.411    
        N 150 142 144 130 147 156 144.833 3.582       
        C 90 93 85 90 75 87 86.667 2.591       
 7     PM 48 44 40 46 40 36 42.333 1.820 0.767 1.861 0.412    
        N 104 101 93 104 109 105 102.667 2.201       
        C 50 57 56 53 59 56 55.167 1.302       
 8     PM 38 40 37 32 41 37 37.500 1.285 0.771 1.637 0.471    
        N 78 82 78 79 77 84 79.667 1.116       
        C 45 49 51 52 50 45 48.667 1.229       
 9     PM 45 46 41 38 47 50 44.500 1.765 0.527 1.679 0.314    
        N 144 139 145 130 148 145 141.833 2.651       
        C 91 87 78 89 86 76 84.500 2.487       
 10   PM 74 58 60 57 58 66 62.167 2.713 0.706 2.057 0.343    
        N 175 180 192 182 174 183 181.000 2.658       
        C 81 80 90 86 99 92 88.000 2.933       
pUG36-PLC1R2/3 in arg82Δ             
 1     PM 176 166 174 158 170 164 168.000 2.733 1.069 1.165 0.917 1.023 1.451 0.713 
        N 177 184 181 189 182 186 183.167 1.701    0.028 0.056 0.029 
        C 172 150 149 171 159 142 157.167 5.043       
 2     PM 156 131 156 129 182 166 153.333 8.341 0.973 1.496 0.650    
        N 242 238 241 230 218 246 235.833 4.183       
        C 158 159 168 154 147 160 157.667 2.836       
 3     PM 63 65 77 61 91 93 75.000 5.842 1.175 1.661 0.708    
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        N 101 104 107 116 105 103 106.000 2.160       
        C 58 59 63 66 72 65 63.833 2.088       
 4     PM 91 101 98 93 108 114 100.833 3.609 0.904 1.356 0.667    
        N 146 152 158 152 151 148 151.167 1.682       
        C 106 114 116 108 121 104 111.500 2.680       
 5     PM 79 101 103 90 77 81 88.500 4.646 0.894 1.305 0.685    
        N 136 127 119 130 131 132 129.167 2.358       
        C 102 105 100 92 95 100 99.000 1.932       
 6     PM 94 74 86 83 80 82 83.167 2.713 1.102 1.296 0.850    
        N 111 97 86 96 98 99 97.833 3.260       
        C 70 76 72 85 77 73 75.500 2.172       
 7     PM 143 158 166 98 106 99 128.333 12.640 1.108 1.666 0.665    
        N 190 198 189 194 192 195 193.000 1.366       
        C 118 107 126 103 109 132 115.833 4.686       
 8     PM 120 117 107 113 118 152 121.167 6.447 0.997 1.342 0.743    
        N 166 173 159 151 162 167 163.000 3.088       
        C 111 118 117 129 130 124 121.500 3.041       
 9     PM 58 61 70 74 71 75 68.167 2.868 1.062 1.701 0.624    
        N 116 104 108 115 104 108 109.167 2.136       
        C 65 63 61 70 62 64 64.167 1.302       
 10   PM 73 72 65 72 69 74 70.833 1.352 0.951 1.526 0.623    
        N 119 116 106 107 118 116 113.667 2.319       
        C 72 68 80 75 78 74 74.500 1.746       
pUG36-PLC1R2/4 in arg82Δ             
 1     PM 106 100 101 99 112 111 104.833 2.330 1.111 1.412 0.787 1.127 1.396 0.819 
        N 131 140 143 133 125 127 133.167 2.903    0.015 0.054 0.032 
        C 90 91 96 94 98 97 94.333 1.333       
 2     PM 104 97 92 100 102 107 100.333 2.171 1.144 1.622 0.706    
        N 142 136 144 146 145 140 142.167 1.515       
        C 87 84 86 92 95 82 87.667 2.011       
 3     PM 105 108 140 114 146 141 125.667 7.592 1.144 1.754 0.652    
        N 198 193 181 195 185 204 192.667 3.451       
        C 118 113 116 101 104 107 109.833 2.798       
 4     PM 208 135 122 146 129 201 156.833 15.439 1.160 1.432 0.811    
        N 179 197 187 195 204 199 193.500 3.686       
        C 148 142 125 129 134 133 135.167 3.458       
 5     PM 176 179 158 140 166 168 164.500 5.772 1.053 1.439 0.732    
        N 218 223 234 227 230 216 224.667 2.848       
        C 160 163 149 146 153 166 156.167 3.280       
 6     PM 208 199 189 207 166 152 186.833 9.407 1.128 1.251 0.902    
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        N 201 210 207 203 206 216 207.167 2.182       
        C 156 168 174 179 154 163 165.667 4.039       
 7     PM 152 146 149 156 165 171 156.500 3.956 1.078 1.217 0.886    
        N 182 173 182 183 165 175 176.667 2.883       
        C 140 139 144 146 152 150 145.167 2.136       
 8     PM 147 138 143 128 130 134 136.667 3.029 1.105 1.388 0.796    
        N 164 168 179 176 171 172 171.667 2.201       
        C 111 124 132 127 118 130 123.667 3.232       
 9     PM 157 187 168 165 162 153 165.333 4.863 1.107 1.213 0.913    
        N 183 182 172 191 182 177 181.167 2.600       
        C 145 141 153 149 156 152 149.333 2.261       
 10   PM 166 179 213 185 215 188 191.000 7.904 1.238 1.233 1.004    
        N 193 188 183 191 195 192 190.333 1.745       
        C 145 152 153 158 151 167 154.333 3.051       
pUG36-PLC1R3/4 in arg82Δ             
 1     PM 89 93 103 90 91 96 93.667 2.124 1.029 1.443 0.713 0.845 1.467 0.586 
        N 131 128 132 130 137 130 131.333 1.256    0.044 0.064 0.040 
        C 91 87 81 100 94 93 91.000 2.646       
 2     PM 88 111 110 105 148 112 112.333 8.011 1.017 1.195 0.851    
        N 138 128 131 134 127 134 132.000 1.693       
        C 113 107 115 110 106 112 110.500 1.432       
 3     PM 88 79 75 82 89 93 84.333 2.777 0.932 1.455 0.641    
        N 122 129 130 134 142 133 131.667 2.692       
        C 87 93 95 88 97 83 90.500 2.187       
 4     PM 89 78 90 91 110 133 98.500 8.086 0.793 1.478 0.537    
        N 174 183 193 180 183 188 183.500 2.668       
        C 103 118 112 138 141 133 124.167 6.290       
 5     PM 81 75 77 83 102 92 85.000 4.171 0.651 1.310 0.497    
        N 178 174 168 164 168 175 171.167 2.167       
        C 137 134 132 128 133 120 130.667 2.445       
 6     PM 127 121 118 102 126 115 118.167 3.736 0.859 1.497 0.574    
        N 209 201 200 220 213 192 205.833 4.126       
        C 132 134 142 150 135 132 137.500 2.918       
 7     PM 73 67 69 70 65 68 68.667 1.116 0.843 1.716 0.491    
        N 143 142 137 136 147 134 139.833 2.023       
        C 82 77 85 90 77 78 81.500 2.141       
 8     PM 100 93 87 78 70 77 84.167 4.571 0.737 1.899 0.388    
        N 210 212 231 224 219 205 216.833 3.945       
        C 101 118 107 122 113 124 114.167 3.646       
 9     PM 71 67 73 68 66 68 68.833 1.078 0.616 1.218 0.506    
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        N 142 138 138 134 129 135 136.000 1.807       
        C 115 124 120 112 100 99 111.667 4.201       
 10   PM 100 86 89 77 96 114 93.667 5.220 0.971 1.463 0.664    
        N 148 132 139 144 142 142 141.167 2.197       
        C 94 99 102 104 84 96 96.500 2.918       
pUG36-PLC1R1 in arg82Δ             
 1     PM 67 63 67 73 57 51 63.000 3.225 0.758 2.098 0.361 0.831 1.987 0.431 
        N 163 159 176 179 187 183 174.500 4.559    0.035 0.110 0.029 
        C 91 83 84 80 87 74 83.167 2.386       
 2     PM 56 52 61 60 71 69 61.500 2.997 0.913 2.312 0.395    
        N 157 151 152 157 155 162 155.667 1.626       
        C 76 62 67 70 63 66 67.333 2.092       
 3     PM 51 46 45 44 45 50 46.833 1.195 0.719 2.765 0.260    
        N 176 172 179 178 186 190 180.167 2.713       
        C 75 71 72 67 60 46 65.167 4.377       
 4     PM 57 65 64 61 66 73 64.333 2.186 0.744 1.832 0.406    
        N 163 165 169 142 170 142 158.500 5.321       
        C 81 93 86 94 78 87 86.500 2.592       
 5     PM 77 82 88 87 115 88 89.500 5.396 0.901 2.059 0.438    
        N 198 219 201 205 195 209 204.500 3.538       
        C 105 101 95 100 94 101 99.333 1.687       
 6     PM 50 54 69 56 64 58 58.500 2.825 1.104 1.871 0.590    
        N 97 95 92 95 103 113 99.167 3.146       
        C 46 47 52 50 61 62 53.000 2.828       
 7     PM 41 43 39 40 38 42 40.500 0.764 0.781 1.582 0.494    
        N 83 86 72 88 79 84 82.000 2.352       
        C 57 49 51 48 53 53 51.833 1.327       
 8     PM 41 42 38 42 40 40 40.500 0.619 0.815 1.470 0.555    
        N 75 74 73 76 73 67 73.000 1.291       
        C 54 57 45 43 52 47 49.667 2.246       
 9     PM 48 44 39 32 36 43 40.333 2.376 0.747 1.938 0.385    
        N 108 109 96 107 103 105 104.667 1.944       
        C 60 53 55 51 49 56 54.000 1.592       
 10   PM 42 42 40 41 42 47 42.333 0.989 0.825 1.942 0.425    
        N 99 95 101 95 106 102 99.667 1.745       
        C 53 50 49 51 48 57 51.333 1.333       
pUG36-PLC14R/E425G in arg82Δ            
 1     PM 59 61 62 61 58 65 61.000 1.000 0.799 1.168 0.684 0.794 1.160 0.687 
        N 98 82 89 88 86 92 89.167 2.227    0.017 0.025 0.017 
        C 74 79 70 82 77 76 76.333 1.687       
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 2     PM 65 57 62 57 61 53 59.167 1.759 0.814 1.128 0.722    
        N 82 87 85 77 79 82 82.000 1.506       
        C 79 68 74 75 69 71 72.667 1.687       
 3     PM 62 69 62 63 67 59 63.667 1.498 0.736 1.183 0.622    
        N 95 113 102 101 103 100 102.333 2.418       
        C 85 80 91 83 88 92 86.500 1.910       
 4     PM 68 78 69 71 55 65 67.667 3.095 0.717 1.067 0.672    
        N 100 107 105 94 98 100 100.667 1.926       
        C 91 92 94 100 96 93 94.333 1.333       
 5     PM 42 41 42 37 44 40 41.000 0.966 0.879 1.300 0.676    
        N 54 55 68 63 65 59 60.667 2.290       
        C 44 43 46 50 44 53 46.667 1.626       
 6     PM 32 40 37 35 31 38 35.500 1.432 0.822 1.278 0.644    
        N 60 54 53 50 58 56 55.167 1.470       
        C 44 44 43 45 42 41 43.167 0.601       
 7     PM 78 67 67 64 81 72 71.500 2.766 0.737 1.129 0.653    
        N 112 106 100 111 116 112 109.500 2.306       
        C 102 92 90 104 96 98 97.000 2.236       
 8     PM 88 89 85 78 82 73 82.500 2.513 0.843 1.027 0.821    
        N 102 110 95 96 105 95 100.500 2.540       
        C 99 93 105 101 94 95 97.833 1.905       
 9     PM 62 64 61 77 52 71 64.500 3.528 0.740 1.128 0.656    
        N 101 103 93 102 97 94 98.333 1.745       
        C 87 86 85 87 91 87 87.167 0.833       
 10   PM 65 52 51 61 52 58 56.500 2.349 0.856 1.192 0.718    
        N 76 79 80 81 79 77 78.667 0.760       
        C 65 70 68 64 61 68 66.000 1.342       
pUG36-PLC14R/E425G in plc1Δ             
 1     PM 65 70 64 57 50 60 61.000 2.852 0.812 1.047 0.775 0.775 1.169 0.666 
        N 70 75 78 84 80 85 78.667 2.305    0.016 0.025 0.021 
        C 75 76 80 75 74 71 75.167 1.195       
 2     PM 58 62 55 48 53 50 54.333 2.108 0.731 1.175 0.622    
        N 88 87 86 90 88 85 87.333 0.715       
        C 79 73 70 71 74 79 74.333 1.585       
 3     PM 51 50 45 57 52 50 50.833 1.579 0.792 1.291 0.614    
        N 80 83 87 78 85 84 82.833 1.352       
        C 63 65 65 69 59 64 64.167 1.327       
 4     PM 48 44 41 45 49 45 45.333 1.174 0.834 1.160 0.720    
        N 61 65 67 57 66 62 63.000 1.528       
        C 57 54 55 53 55 52 54.333 0.715       
 284
 5     PM 115 129 123 114 110 116 117.833 2.822 0.758 1.137 0.666    
        N 177 174 181 171 176 182 176.833 1.701       
        C 145 160 149 157 166 156 155.500 3.085       
 6     PM 111 88 93 98 97 127 102.333 5.840 0.754 1.189 0.634    
        N 160 163 159 160 169 157 161.333 1.726       
        C 143 131 128 138 132 142 135.667 2.539       
 7     PM 114 105 111 101 116 114 110.167 2.414 0.676 1.130 0.598    
        N 180 178 189 196 177 185 184.167 3.005       
        C 153 172 172 167 155 159 163.000 3.454       
 8     PM 78 84 80 78 81 66 77.833 2.535 0.767 1.110 0.691    
        N 109 108 116 109 122 112 112.667 2.216       
        C 93 102 108 103 104 99 101.500 2.078       
 9     PM 70 87 85 82 77 88 81.500 2.814 0.864 1.129 0.765    
        N 105 104 103 111 112 104 106.500 1.607       
        C 92 93 101 94 95 91 94.333 1.453       
 10   PM 49 60 48 55 53 43 51.333 2.431 0.760 1.321 0.576    
        N 94 81 87 97 93 83 89.167 2.638       
        C 68 71 65 68 62 71 67.500 1.432       
pUG36-PLC14R in plc1Δ              
 1     PM 90 96 105 104 105 107 101.167 2.725 0.706 1.422 0.496 0.798 1.477 0.540 
        N 205 210 197 199 207 205 203.833 2.007    0.022 0.025 0.010 
        C 152 141 145 135 142 145 143.333 2.290       
 2     PM 110 109 110 106 111 105 108.500 0.992 0.787 1.522 0.517    
        N 210 204 211 208 212 214 209.833 1.424       
        C 130 132 140 142 144 139 137.833 2.286       
 3     PM 122 112 130 128 115 133 123.333 3.461 0.777 1.492 0.521    
        N 240 225 235 245 230 245 236.667 3.333       
        C 162 157 154 163 164 152 158.667 2.060       
 4     PM 117 128 130 129 110 122 122.667 3.242 0.735 1.344 0.547    
        N 224 229 219 229 218 226 224.167 1.956       
        C 181 172 156 168 158 166 166.833 3.763       
 5     PM 110 109 84 93 89 105 98.333 4.529 0.774 1.430 0.541    
        N 175 189 174 188 179 185 181.667 2.679       
        C 122 130 121 128 131 130 127.000 1.789       
 6     PM 74 71 75 67 68 76 71.833 1.537 0.860 1.461 0.589    
        N 118 115 119 128 127 125 122.000 2.191       
        C 88 86 87 82 78 80 83.500 1.668       
 7     PM 67 57 54 52 58 70 59.667 2.951 0.856 1.593 0.538    
        N 108 110 112 113 107 116 111.000 1.366       
        C 74 65 62 75 70 72 69.667 2.108       
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 8     PM 63 69 62 55 49 56 59.000 2.887 0.715 1.446 0.494    
        N 121 128 115 114 118 120 119.333 2.060       
        C 90 82 81 76 78 88 82.500 2.247       
 9     PM 77 74 72 70 56 67 69.333 3.007 0.827 1.435 0.576    
        N 120 122 119 121 123 117 120.333 0.882       
        C 78 85 87 83 80 90 83.833 1.815       
 10   PM 50 43 46 51 53 48 48.500 1.478 0.942 1.628 0.579    
        N 85 89 88 81 78 82 83.833 1.740       
        C 49 50 51 55 54 50 51.500 0.992       
pUG36-PLC11-999nt in arg82Δ             
 1     PM 71 70 74 72 75 67 71.500 1.176 0.800 2.011 0.398 0.818 1.439 0.580 
        N 181 183 179 182 178 175 179.667 1.202    0.020 0.065 0.030 
        C 88 89 87 91 89 92 89.333 0.760       
 2     PM 53 54 57 60 52 54 55.000 1.211 0.838 1.282 0.653    
        N 85 89 79 84 82 86 84.167 1.400       
        C 62 66 70 65 67 64 65.667 1.116       
 3     PM 50 49 52 48 52 50 50.167 0.654 0.858 1.336 0.642    
        N 78 79 78 79 75 80 78.167 0.703       
        C 58 61 55 56 58 63 58.500 1.232       
 4     PM 57 45 55 47 50 55 51.500 1.996 0.925 1.243 0.745    
        N 69 70 71 66 72 67 69.167 0.946       
        C 59 52 58 60 51 54 55.667 1.563       
 5     PM 58 54 58 52 57 56 55.833 0.980 0.838 1.458 0.575    
        N 101 99 96 95 100 92 97.167 1.400       
        C 70 65 62 64 73 66 66.667 1.667       
 6     PM 56 55 60 45 54 47 52.833 2.330 0.832 1.360 0.612    
        N 91 88 81 87 83 88 86.333 1.498       
        C 70 58 68 62 63 60 63.500 1.893       
 7     PM 40 47 48 43 49 46 45.500 1.384 0.667 1.501 0.445    
        N 101 95 97 110 106 105 102.333 2.333       
        C 68 65 63 75 73 65 68.167 1.973       
 8     PM 42 44 35 39 44 37 40.167 1.537 0.806 1.408 0.572    
        N 70 75 69 73 65 69 70.167 1.424       
        C 53 49 54 45 48 50 49.833 1.352       
 9     PM 46 36 41 42 38 37 40.000 1.528 0.825 1.443 0.571    
        N 71 70 74 66 71 68 70.000 1.125       
        C 42 49 48 51 49 52 48.500 1.432       
 10   PM 31 32 40 33 34 38 34.667 1.453 0.788 1.348 0.584    
        N 60 58 65 56 58 59 59.333 1.256       
        C 44 48 45 44 42 41 44.000 1.000       
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pUG36-PLC1660nt-end in arg82Δ            
 1     PM 24 25 29 23 32 30 27.167 1.493 0.787 2.826 0.279 0.786 2.832 0.326 
        N 99 93 100 103 92 98 97.500 1.727    0.021 0.295 0.048 
        C 30 31 39 36 38 33 34.500 1.522       
 2     PM 32 30 31 29 29 25 29.333 0.989 0.834 2.697 0.309    
        N 103 91 95 99 93 88 94.833 2.227       
        C 42 32 36 29 35 37 35.167 1.815       
 3     PM 37 37 39 41 33 35 37.000 1.155 0.716 3.123 0.229    
        N 157 164 168 164 161 154 161.333 2.092       
        C 48 49 52 54 55 52 51.667 1.116       
 4     PM 35 36 40 39 33 34 36.167 1.138 0.751 3.578 0.210    
        N 157 164 174 175 180 184 172.333 4.120       
        C 47 53 44 53 50 42 48.167 1.887       
 5     PM 27 24 26 25 27 20 24.833 1.078 0.756 3.178 0.238    
        N 107 111 103 100 99 106 104.333 1.856       
        C 33 34 30 30 35 35 32.833 0.946       
 6     PM 38 38 35 34 36 39 36.667 0.803 0.685 4.343 0.158    
        N 231 226 216 240 233 248 232.333 4.522       
        C 55 44 54 65 46 57 53.500 3.128       
 7     PM 40 33 35 37 36 37 36.333 0.955 0.739 3.807 0.194    
        N 176 190 179 199 196 183 187.167 3.807       
        C 49 58 52 42 49 45 49.167 2.272       
 8     PM 47 48 50 45 47 48 47.500 0.671 0.893 1.505 0.594    
        N 77 82 79 81 80 81 80.000 0.730       
        C 50 49 55 50 61 54 53.167 1.851       
 9     PM 49 44 42 43 40 41 43.167 1.302 0.814 1.440 0.566    
        N 77 80 79 75 74 73 76.333 1.145       
        C 54 53 52 54 50 55 53.000 0.730       
 10   PM 52 46 52 49 55 49 50.500 1.285 0.881 1.828 0.482    
        N 104 105 98 110 104 108 104.833 1.682       
        C 59 56 55 57 58 59 57.333 0.667       
pUG36-PLC11-999nt+C2 in arg82Δ            
 1     PM 43 37 36 35 40 35 37.667 1.308 0.846 3.404 0.249 0.777 2.166 0.371 
        N 156 144 149 150 148 162 151.500 2.630    0.010 0.145 0.020 
        C 44 43 42 47 46 45 44.500 0.764       
 2     PM 32 38 30 40 31 36 34.500 1.668 0.772 1.944 0.397    
        N 87 89 91 84 86 84 86.833 1.138       
        C 45 46 40 49 43 45 44.667 1.229       
 3     PM 30 36 34 38 33 36 34.500 1.147 0.796 1.696 0.469    
        N 72 75 74 73 76 71 73.500 0.764       
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        C 48 45 36 42 48 41 43.333 1.892       
 4     PM 35 39 29 30 32 36 33.500 1.565 0.814 1.781 0.457    
        N 76 67 70 70 77 80 73.333 2.060       
        C 38 37 39 44 47 42 41.167 1.579       
 5     PM 28 23 27 30 36 26 28.333 1.801 0.766 1.896 0.404    
        N 67 66 68 70 78 72 70.167 1.797       
        C 38 37 33 35 39 40 37.000 1.065       
 6     PM 41 50 50 51 44 46 47.000 1.633 0.766 2.043 0.375    
        N 117 129 131 124 121 130 125.333 2.290       
        C 65 57 59 64 61 62 61.333 1.229       
 7     PM 44 56 46 41 45 41 45.500 2.262 0.780 2.111 0.369    
        N 117 121 119 132 127 123 123.167 2.257       
        C 59 55 53 61 63 59 58.333 1.520       
 8     PM 40 48 40 50 45 39 43.667 1.909 0.724 2.365 0.306    
        N 150 145 131 139 153 138 142.667 3.353       
        C 67 62 58 59 56 60 60.333 1.563       
 9     PM 40 39 41 38 44 42 40.667 0.882 0.748 2.160 0.347    
        N 110 122 119 118 113 122 117.333 1.994       
        C 48 56 51 64 50 57 54.333 2.404       
 10   PM 36 34 40 38 43 42 38.833 1.424 0.759 2.254 0.337    
        N 118 119 113 126 101 115 115.333 3.393       
        C 56 47 54 45 52 53 51.167 1.740       
pUG36-PLC1 in arg82Δvps41Δ             
 1     PM 158 160 161 179 159 155 162.000 3.502 0.991 1.488 0.666 1.140 1.681 0.679 
        N 238 233 254 245 250 240 243.333 3.201    0.025 0.032 0.011 
        C 167 156 160 155 168 175 163.500 3.191       
 2     PM 161 180 183 178 170 173 174.167 3.260 1.114 1.575 0.708    
        N 244 250 245 238 252 248 246.167 2.040       
        C 145 148 155 160 167 163 156.333 3.518       
 3     PM 65 57 60 55 70 66 62.167 2.358 1.215 1.674 0.726    
        N 80 84 92 90 80 88 85.667 2.092       
        C 53 50 48 48 52 56 51.167 1.276       
 4     PM 78 90 88 95 96 87 89.000 2.658 1.203 1.631 0.738    
        N 123 120 118 118 123 122 120.667 0.955       
        C 83 70 72 72 70 77 74.000 2.082       
 5     PM 86 72 78 87 74 71 78.000 2.864 1.164 1.744 0.668    
        N 113 120 124 109 120 115 116.833 2.242       
        C 70 59 64 71 68 70 67.000 1.897       
 6     PM 76 73 77 88 84 99 82.833 3.945 1.206 1.859 0.649    
        N 131 128 124 133 122 128 127.667 1.687       
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        C 69 75 74 63 70 61 68.667 2.319       
 7     PM 89 100 92 102 101 99 97.167 2.182 1.187 1.692 0.702    
        N 134 150 143 139 125 140 138.500 3.452       
        C 86 87 81 78 80 79 81.833 1.537       
 8     PM 125 143 108 124 120 114 122.333 4.890 1.154 1.748 0.660    
        N 193 196 172 183 178 190 185.333 3.792       
        C 100 105 112 101 110 108 106.000 1.983       
 9     PM 84 78 76 78 82 89 81.167 1.973 1.171 1.776 0.659    
        N 120 127 120 126 118 128 123.167 1.759       
        C 73 78 72 64 62 67 69.333 2.472       
 10   PM 67 64 80 85 81 75 75.333 3.393 0.993 1.618 0.614    
        N 118 117 126 119 133 123 122.667 2.486       
        C 88 78 72 77 80 60 75.833 3.816       
pUG36-PLC1 in arg82Δ              
0.9M NaCl               
 1     PM 193 182 194 177 188 193 187.833 2.845 1.345 1.150 1.169 1.296 1.281 1.026 
        N 157 156 148 151 155 197 160.667 7.397    0.030 0.043 0.047 
        C 143 145 138 133 144 135 139.667 2.060       
 2     PM 135 123 128 142 140 160 138.000 5.285 1.202 1.380 0.871    
        N 160 163 156 150 160 162 158.500 1.962       
        C 107 112 109 126 122 113 114.833 3.070       
 3     PM 93 97 92 88 73 89 88.667 3.393 1.415 1.465 0.966    
        N 92 87 88 99 95 90 91.833 1.851       
        C 65 67 62 61 64 57 62.667 1.430       
 4     PM 110 102 109 115 112 109 109.500 1.765 1.341 1.096 1.223    
        N 85 95 88 90 92 87 89.500 1.478       
        C 83 80 78 86 80 83 81.667 1.174       
 5     PM 94 87 84 88 83 87 87.167 1.579 1.144 1.407 0.813    
        N 110 117 98 101 110 107 107.167 2.798       
        C 77 79 76 73 78 74 76.167 0.946       
 6     PM 91 95 92 105 118 104 100.833 4.206 1.375 1.323 1.040    
        N 95 93 92 105 95 102 97.000 2.145       
        C 76 75 70 74 72 73 73.333 0.882       
 7     PM 154 145 143 130 144 109 137.500 6.505 1.329 1.296 1.025    
        N 129 136 130 139 138 133 134.167 1.701       
        C 97 99 107 102 104 112 103.500 2.232       
 8     PM 118 119 102 112 106 97 109.000 3.615 1.164 1.429 0.814    
        N 138 127 129 133 136 140 133.833 2.088       
        C 94 93 98 96 97 84 93.667 2.076       
 9     PM 120 119 108 133 124 118 120.333 3.333 1.407 1.201 1.172    
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        N 99 107 112 104 101 93 102.667 2.692       
        C 84 85 90 92 85 77 85.500 2.141       
 10   PM 107 94 96 135 105 122 109.833 6.467 1.239 1.066 1.162    
        N 102 99 87 91 90 98 94.500 2.432       
        C 92 84 87 94 85 90 88.667 1.626       
hypo-osmotic shock (0.09M NaCl) 2min           
 1     PM 84 95 86 101 92 91 91.500 2.513 1.207 1.662 0.726 1.255 1.445 0.882 
        N 128 125 123 131 121 128 126.000 1.506    0.040 0.056 0.044 
        C 71 74 80 76 73 81 75.833 1.621       
 2     PM 99 104 98 97 102 112 102.000 2.266 1.163 1.333 0.873    
        N 122 111 118 109 121 120 116.833 2.242       
        C 90 83 85 87 93 88 87.667 1.453       
 3     PM 98 88 90 100 91 95 93.667 1.944 1.322 1.198 1.104    
        N 86 91 82 83 80 87 84.833 1.621       
        C 74 77 71 67 66 70 70.833 1.701       
 4     PM 136 128 137 133 132 134 133.333 1.308 1.325 1.276 1.038    
        N 127 134 122 128 125 135 128.500 2.078       
        C 101 105 100 96 100 102 100.667 1.202       
 5     PM 109 110 114 108 123 113 112.833 2.242 1.073 1.418 0.756    
        N 146 152 150 157 144 146 149.167 1.973       
        C 104 101 106 110 109 101 105.167 1.579       
 6     PM 117 108 104 98 117 106 108.333 3.062 1.069 1.541 0.694    
        N 150 159 156 154 158 160 156.167 1.515       
        C 105 94 96 107 104 102 101.333 2.124       
 7     PM 79 86 101 104 124 124 103.000 7.642 1.290 1.743 0.740    
        N 139 131 142 148 135 140 139.167 2.386       
        C 72 71 78 84 83 91 79.833 3.135       
 8     PM 142 135 81 134 89 140 120.167 11.235 1.484 1.562 0.950    
        N 133 126 116 133 132 119 126.500 3.063       
        C 89 84 78 82 77 76 81.000 2.033       
 9     PM 122 128 113 85 122 89 109.833 7.499 1.227 1.225 1.002    
        N 106 111 112 104 115 110 109.667 1.647       
        C 88 96 86 99 93 75 89.500 3.510       
 10   PM 85 81 82 78 76 77 79.833 1.400 1.392 1.488 0.936    
        N 82 81 76 89 91 93 85.333 2.716       
        C 54 62 57 53 58 60 57.333 1.406       
hypo-osmotic shock (0.09M NaCl) 30min           
 1     PM 97 98 110 180 185 141 135.167 16.329 0.930 1.635 0.569 1.205 1.658 0.766 
        N 231 232 244 250 240 229 237.667 3.412    0.053 0.106 0.069 
        C 141 156 139 144 152 140 145.333 2.871       
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 2     PM 180 152 108 121 112 140 135.500 11.242 1.120 1.928 0.581    
        N 233 232 224 236 228 247 233.333 3.221       
        C 121 118 113 108 148 118 121.000 5.715       
 3     PM 85 114 93 90 140 131 108.833 9.421 1.223 2.185 0.560    
        N 197 196 202 195 193 184 194.500 2.432       
        C 80 87 82 95 93 97 89.000 2.887       
 4     PM 125 113 124 110 120 123 119.167 2.548 1.058 2.071 0.511    
        N 227 243 238 234 216 242 233.333 4.208       
        C 122 98 107 120 116 113 112.667 3.648       
 5     PM 93 98 97 86 100 96 95.000 2.033 1.140 1.936 0.589    
        N 167 160 158 153 167 163 161.333 2.231       
        C 92 84 80 81 81 82 83.333 1.820       
 6     PM 89 90 86 84 92 96 89.500 1.746 1.370 1.625 0.843    
        N 107 108 102 112 105 103 106.167 1.493       
        C 61 67 65 71 70 58 65.333 2.076       
 7     PM 154 167 158 165 154 160 159.667 2.231 1.219 1.249 0.976    
        N 170 153 158 168 163 170 163.667 2.860       
        C 134 133 127 134 128 130 131.000 1.265       
 8     PM 132 133 158 161 145 146 145.833 4.949 1.173 1.340 0.875    
        N 158 166 168 170 171 167 166.667 1.892       
        C 136 131 121 118 126 114 124.333 3.373       
 9     PM 62 66 52 54 64 59 59.500 2.277 1.240 1.222 1.014    
        N 58 59 55 60 62 58 58.667 0.955       
        C 47 49 48 50 45 49 48.000 0.730       
 10   PM 58 57 52 57 49 52 54.167 1.493 1.578 1.383 1.140    
        N 48 47 46 50 45 49 47.500 0.764       
        C 33 36 32 29 37 39 34.333 1.498       
pUG36-ARG82D131A in arg82Δ             
 1     PM 63 66 53 52 45 51 55.000 3.235 0.721 1.592 0.453 0.738 1.581 0.467 
        N 118 123 124 128 117 119 121.500 1.727    0.006 0.008 0.005 
        C 72 74 75 79 78 80 76.333 1.282       
 2     PM 48 46 63 59 64 61 56.833 3.198 0.751 1.632 0.460    
        N 132 129 122 124 116 118 123.500 2.527       
        C 82 80 75 75 64 78 75.667 2.591       
 3     PM 40 42 41 44 39 42 41.333 0.715 0.754 1.541 0.489    
        N 80 89 82 85 84 87 84.500 1.335       
        C 54 50 53 58 50 64 54.833 2.197       
 4     PM 53 49 53 40 44 42 46.833 2.301 0.749 1.603 0.468    
        N 102 101 110 95 98 95 100.167 2.301       
        C 59 63 68 65 62 58 62.500 1.522       
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 5     PM 80 88 81 63 62 58 72.000 5.092 0.702 1.571 0.447    
        N 161 157 159 164 160 165 161.000 1.238       
        C 110 108 105 92 98 102 102.500 2.729       
 6     PM 78 72 70 81 78 75 75.667 1.687 0.760 1.554 0.489    
        N 160 153 150 158 152 155 154.667 1.542       
        C 105 107 100 93 97 95 99.500 2.277       
 7     PM 85 90 78 79 64 68 77.333 4.030 0.746 1.580 0.472    
        N 160 161 169 162 168 163 163.833 1.537       
        C 108 103 100 114 96 101 103.667 2.616       
 8     PM 62 70 56 52 75 67 63.667 3.547 0.706 1.560 0.453    
        N 137 140 142 148 142 135 140.667 1.856       
        C 95 78 80 87 104 97 90.167 4.175       
 9     PM 71 72 70 61 59 67 66.667 2.231 0.750 1.570 0.478    
        N 148 147 140 127 136 139 139.500 3.149       
        C 88 92 91 80 93 89 88.833 1.922       
 10   PM 60 54 63 59 68 64 61.333 1.961 0.740 1.610 0.460    
        N 133 135 129 138 130 135 133.333 1.382       
        C 83 72 90 75 89 88 82.833 3.135       
pUG36-PLC1 in gpr1Δ              
 1     PM 59 55 49 52 51 54 53.333 1.430 0.764 1.473 0.519 0.715 1.641 0.442 
        N 108 104 106 96 100 103 102.833 1.759    0.019 0.062 0.021 
        C 64 70 79 66 69 71 69.833 2.120       
 2     PM 37 48 41 49 42 45 43.667 1.856 0.749 1.683 0.445    
        N 100 96 106 98 96 93 98.167 1.833       
        C 56 58 60 57 58 61 58.333 0.760       
 3     PM 55 48 47 44 42 49 47.500 1.839 0.652 1.403 0.465    
        N 105 97 104 100 102 105 102.167 1.302       
        C 74 77 79 65 74 68 72.833 2.182       
 4     PM 49 47 44 45 48 49 47.000 0.856 0.801 1.690 0.474    
        N 96 105 98 94 100 102 99.167 1.641       
        C 62 60 55 60 57 58 58.667 1.022       
 5     PM 33 29 36 30 34 37 33.167 1.302 0.819 1.494 0.548    
        N 65 59 63 57 58 61 60.500 1.258       
        C 40 42 41 40 39 41 40.500 0.428       
 6     PM 99 97 70 77 81 73 82.833 5.036 0.680 1.933 0.352    
        N 234 241 226 230 238 244 235.500 2.778       
        C 104 111 118 133 128 137 121.833 5.300       
 7     PM 81 88 84 79 74 80 81.000 1.932 0.669 1.985 0.337    
        N 223 232 252 250 238 248 240.500 4.703       
        C 128 117 120 115 125 122 121.167 1.990       
 292
 8     PM 83 89 105 90 92 86 90.833 3.114 0.660 1.729 0.382    
        N 241 233 230 244 241 239 238.000 2.191       
        C 154 138 132 130 129 143 137.667 3.921       
 9     PM 85 90 81 88 89 83 86.000 1.461 0.695 1.637 0.425    
        N 202 216 198 206 195 198 202.500 3.117       
        C 122 111 141 130 108 130 123.667 5.129       
 10   PM 77 97 102 97 89 85 91.167 3.781 0.659 1.386 0.476    
        N 197 200 179 184 195 195 191.667 3.363       
        C 156 138 126 127 150 133 138.333 5.024       
pUG36-PLC1 in arg82Δgpr1Δ             
 1     PM 143 154 146 147 134 122 141.000 4.633 0.980 1.696 0.578 1.173 1.769 0.681 
        N 254 248 230 234 250 248 244.000 3.933    0.057 0.083 0.050 
        C 148 147 141 132 144 151 143.833 2.750       
 2     PM 108 161 89 125 117 111 118.500 9.811 1.207 1.691 0.714    
        N 172 151 159 163 172 179 166.000 4.179       
        C 108 94 97 118 87 85 98.167 5.186       
 3     PM 108 113 99 95 102 113 105.000 3.066 1.079 1.909 0.565    
        N 170 173 192 197 195 188 185.833 4.715       
        C 99 101 90 94 98 102 97.333 1.856       
 4     PM 75 67 78 82 99 101 83.667 5.548 1.290 2.249 0.574    
        N 110 153 136 160 156 160 145.833 8.035       
        C 71 58 60 61 66 73 64.833 2.522       
 5     PM 147 137 139 134 121 143 136.833 3.673 0.962 1.748 0.551    
        N 250 246 252 238 251 254 248.500 2.363       
        C 149 138 141 139 134 152 142.167 2.822       
 6     PM 117 112 106 94 93 121 107.167 4.785 0.946 2.124 0.445    
        N 234 242 245 252 243 228 240.667 3.461       
        C 116 108 97 101 124 134 113.333 5.760       
 7     PM 57 59 52 56 54 59 56.167 1.138 1.387 1.819 0.762    
        N 72 73 79 74 66 78 73.667 1.909       
        C 39 41 40 38 43 42 40.500 0.764       
 8     PM 41 39 35 39 40 36 38.333 0.955 1.100 1.464 0.752    
        N 53 56 52 47 49 49 51.000 1.342       
        C 36 38 34 30 32 39 34.833 1.424       
 9     PM 150 149 146 142 153 153 148.833 1.740 1.287 1.326 0.971    
        N 153 149 143 155 160 160 153.333 2.692       
        C 119 117 114 112 114 118 115.667 1.116       
 10   PM 102 97 96 89 107 111 100.333 3.263 1.494 1.660 0.900    
        N 114 107 104 107 118 119 111.500 2.592       
        C 64 73 64 66 74 62 67.167 2.072       
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Appendix C: P-value tables 
 
[***P < 0.001;  0.001 <**P < 0.01;  0.01 <*P < 0.05;  n.s.: not significant] 
 
C1: for Chapter 3 
 
P-value (Nuclear/Cytosolic) GFP-Plc1p in WT 
GFP-Plc1p in plc1Δ n.s. 
 
P-value (Nuclear/Cytosolic) GFP-Plc1p in WT 
GFP in WT *** 
 
P-value (Nuclear/Cytosolic) GFP-Plc1p in XPO1   23°C GFP-Plc1p in xpo1-1  37°C 
GFP-Plc1p in XPO1   37°C n.s. n.s. 
GFP-Plc1p in xpo1-1  23°C * ** 
 
P-value (Nuclear/Cytosolic) WT untreat 
DMSO n.s. 
rapamycin n.s. 
nocodazle n.s. 
hydroxyurea ** 
 
P-value (Nuclear/Cytosolic) 23°C (untreat) 23°C (shifted from 37°C) 
 37°C n.s. n.s. 
 23°C (shifted from 37°C) n.s. 
 
P-value (Nuclear/Cytosolic) hyper 2 min  hyper 15 min hyper 2 h 
untreated * n.s. n.s. 
 
P-value (Nuclear/Cytosolic) hypo 2 min hypo 15 min hypo 2 h 
untreated * * n.s. 
 
P-value (Nuclear/Cytosolic) hypo 2 min hypo 15 min hypo 2 h 
hyper 2 h n.s. n.s. n.s. 
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P-value (Nuclear/Cytosolic) GFP-Plc1p 
GFP-Plc1pNES *** 
 
P-value (Nuclear/Cytosolic) GFP-Plc1p 
GFP-Plc1p1-333 n.s. 
 
P-value (Nuclear/Cytosolic) GFP-Plc1p GFP 
GFP-Plc1p1-333 *** * 
GFP-Plc1p 1-220 *** ** 
GFP-Plc1p 1-110 *** n.s. 
GFP-Plc1p 110-220 *** n.s. 
 
P-value (Nuclear/Cytosolic) GFP-Plc1p GFP-Plc1pNES GFP-Plc1p220-end 
GFP-Plc1p110-end *** ** n.s. 
GFP-Plc1p220-end *** ** 
 
P-value (Nuclear/Cytosolic) GFP-Plc1p 
GFP-Plc1p4R in WT ** 
GFP-Plc1pKKLRK in WT *** 
GFP-Plc1pKRLR in WT ** 
 
P-value (Nuclear/Cytosolic) GFP-Plc1p 
GFP-Plc1pCAAX *** 
 
GFP-CAAX P-value 
PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1pCAAX *** *** * 
 
P-value (Nuclear/Cytosolic) GFP-Plc1p 
GFP-Plc1pPKI *** 
 
P-value (Nuclear/Cytosolic) GFP-Plc1p GFP-Plc1pNES GFP-Plc1pCAAX 
GFP-Plc1pNES/CAAX n.s. *** *** 
 
P-value (Nuclear/Cytosolic) GFP-Plc1p GFP-Plc1pNES GFP-Plc1pPKI 
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GFP-Plc1pNES/PKI *** *** *** 
 
Vacuole morphology under salt stress: 
WT vs. plc1Δ 1-2/cells 3-4/cells 5-8/cells ≥ 9/cells  
untreated * ** n.s. ** 
Hyper-osmotic shocked n.s. n.s. n.s. * 
Hypo-osmotic shocked * * * ** 
 
WT vs. PLC1CAAX 1-2/cells 3-4/cells 5-8/cells ≥ 9/cells  
untreated n.s. n.s. n.s. n.s. 
Hyper-osmotic shocked ** n.s. n.s. ** 
Hypo-osmotic shocked * * * n.s. 
 
plc1Δ vs. PLC1CAAX 1-2/cells 3-4/cells 5-8/cells ≥ 9/cells  
untreated *** * ** ** 
Hyper-osmotic shocked * n.s. n.s. ** 
Hypo-osmotic shocked *** n.s. ** ** 
 
plc1Δ vs. PLC1NES 1-2/cells 3-4/cells 5-8/cells ≥ 9/cells  
untreated * n.s. ** ** 
Hyper-osmotic shocked * * n.s. ** 
Hypo-osmotic shocked * n.s. n.s. * 
 
plc1Δ vs. PLC1PKI 1-2/cells 3-4/cells 5-8/cells ≥ 9/cells  
untreated n.s. n.s. * * 
Hyper-osmotic shocked * n.s. n.s. * 
Hypo-osmotic shocked n.s. * n.s. * 
 
PLC1NES vs. PLC1PKI 1-2/cells 3-4/cells 5-8/cells ≥ 9/cells  
untreated n.s. n.s. n.s. n.s. 
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Hyper-osmotic shocked / n.s. n.s. n.s. 
Hypo-osmotic shocked n.s. n.s. n.s. n.s. 
 
C2: for Chapter 4 
 
P-value Nuclear/Cytosolic 
GFP-Arg82p in WT vs. GFP-Arg82p in arg82Δ n.s. 
GFP-Arg82p in WT vs. GFP-Plc1p in WT n.s. 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1p in arg82Δ 
vs. 
GFP-Plc1p in WT 
*** n.s. *** 
GFP-Plc1p in WT 
vs. 
GFP-Plc1p in arg82Δ + pYCplac111-ARG82 
n.s. n.s. n.s. 
GFP-Plc1p in arg82Δ + pYCplac111 
vs. 
GFP-Plc1p in arg82Δ 
n.s. n.s. n.s. 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GPF-Arg82p in plc1Δ 
vs. 
GPF-Arg82p in WT 
n.s. n.s. n.s. 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1p in arg82Δ+ pYCplac111-ARG82D131A 
vs. 
GFP-Plc1p in arg82Δ 
n.s. n.s. n.s. 
GFP-Plc1p in arg82Δ+ pYCplac111-ARG82D131A 
vs. 
GFP-Plc1p in arg82Δ+ pYCplac111-ARG82 
*** * ** 
GFP-Plc1p in arg82Δ+ pYCplac111-ARG82Δasp   
vs. 
GFP-Plc1p in arg82Δ 
*** n.s. *** 
GFP-Plc1p in arg82Δ+ pYCplac111-ARG82Δasp  
 vs. 
GFP-Plc1p in arg82Δ+ pYCplac111-ARG82 
n.s. n.s. n.s. 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-ARG82pD131A in arg82Δ  
vs. 
GFP-ARG82p in arg82Δ 
n.s. n.s. n.s. 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1p in WT 5 μM U73122 1h  
vs. n.s. n.s. n.s. 
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GFP-Plc1p in WT 
GFP-Plc1p in WT 0.26% DMSO 1h  
vs. 
GFP-Plc1p in WT 
n.s. n.s. n.s. 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1p in arg82Δ 5 μM U73122 1h  
vs. 
GFP-Plc1p in arg82Δ  
*** n.s. *** 
GFP-Plc1p in arg82Δ 0.26% DMSO 1h  
vs. 
GFP-Plc1p in arg82Δ 
n.s. n.s. n.s. 
GFP-Plc1p in arg82Δ 5 μM U73433 1h  
vs. 
GFP-Plc1p in arg82Δ 
n.s. n.s. n.s. 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1pH439L in arg82Δ 
vs. 
GFP-Plc1p in arg82Δ  
*** n.s. *** 
GFP-Plc1pE425G in arg82 Δ  
vs. 
GFP-Plc1p in arg82Δ 
n.s. n.s. n.s. 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1pE425G in plc1Δ 
vs. 
GFP-Plc1p in plc1Δ  
*** n.s. *** 
GFP-Plc1pE425G in plc1Δ 
vs. 
GFP-Plc1pE425G in arg82Δ  
*** n.s. n.s. 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1p in ipk1Δ vs. GFP-Plc1p in WT n.s. n.s. n.s. 
GFP-Plc1p in ipk1Δ vs. GFP-Plc1p in arg82Δ  *** n.s. *** 
GFP-Plc1p in kcs1Δ vs. GFP-Plc1p in WT n.s. * n.s. 
GFP-Plc1p in kcs1Δ vs. GFP-Plc1p in arg8 2 Δ *** ** *** 
GFP-Plc1p in vip1Δ vs. GFP-Plc1p in WT n.s. * n.s. 
GFP-Plc1p in vip1Δ vs. GFP-Plc1p in arg82Δ *** * *** 
GFP-Plc1p in vip1Δkcs1Δ vs. GFP-Plc1p in WT n.s. * n.s. 
GFP-Plc1p in vip1Δkcs1Δ vs. GFP-Plc1p in arg82 Δ *** * *** 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1p in arg82Δ + pUG34-ARG82G344R 
vs. 
 GFP-Plc1p in arg82Δ  
n.s. n.s. n.s. 
GFP-Plc1p in arg82Δ + pUG34-ARG82 
vs. 
 GFP-Plc1p in WT 
n.s. n.s. n.s. 
GFP-Plc1p in arg82Δ + pUG34 
vs. 
 GFP-Plc1p in arg82Δ  
n.s. n.s. n.s. 
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P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1p in arg82Δ 0.1% (v:v) DMSO  
vs. 
 GFP-Plc1p in arg82Δ  
n.s. n.s. n.s. 
GFP-Plc1p in arg82Δ 100mM InsP5 15min 
vs. 
GFP-Plc1p in arg82Δ  
*** n.s. * 
GFP-Plc1p in arg82Δ 100mM InsP5 2hrs 
vs. 
 GFP-Plc1p in arg82Δ  
*** n.s. n.s. 
GFP-Plc1p in arg82Δ 100mM InsP5 15min 
vs. 
GFP-Plc1p in arg82Δ 100mM InsP5 2hrs 
n.s. n.s. n.s. 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1pE425G in plc1Δ 0.1% (v:v) DMSO  
vs. 
 GFP-Plc1pE425G in plc1Δ 
n.s. n.s. n.s. 
GFP-Plc1pE425G in plc1Δ 100μM InsP5 15min 
vs. 
GFP-Plc1pE425G in plc1Δ 
n.s. n.s. * 
GFP-Plc1pE425G in plc1Δ 100μM InsP5 2hrs  
vs. 
 GFP-Plc1pE425G in plc1Δ 
n.s. n.s. ** 
GFP-Plc1pE425G in plc1Δ 100μM InsP5 15min 
vs. 
GFP-Plc1pE425G in plc1Δ 100μM InsP5 2hrs  
n.s. n.s. n.s. 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1pKRLR in arg82Δ  
vs. 
 GFP-Plc1p in arg82Δ 
n.s. ** ** 
GFP-Plc1p4R in arg82Δ  
vs. 
 GFP-Plc1p in arg82Δ 
*** n.s. *** 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1pR2/3 in arg82Δ 
vs. 
 GFP-Plc1p in arg82Δ 
** ** n.s. 
GFP-Plc1pR2/3 in arg82Δ  
vs. 
GFP-Plc1p4R in arg82Δ  
*** *** *** 
GFP-Plc1pR2/4 in arg82Δ 
vs. 
 pUG36-PLC1 in arg82Δ 
n.s. ** ** 
GFP-Plc1pR2/4 in arg82Δ  
vs. 
GFP-Plc1p4R in arg82Δ 
*** *** *** 
GFP-Plc1pR3/4 in arg82Δ  
vs. 
 pUG36-PLC1 in arg82Δ 
*** * n.s. 
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GFP-Plc1pR3/4 in arg82Δ  
vs. 
GFP-Plc1p4R in arg82Δ 
** *** *** 
GFP-Plc1pR1 in arg82Δ  
vs. 
GFP-Plc1p in arg82Δ 
*** * *** 
GFP-Plc1pR1 in arg82Δ  
vs. 
GFP-Plc1p4R in arg82Δ 
** n.s. n.s. 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1p4R/E425G in plc1Δ  
vs. 
GFP-Plc1p in plc1Δ 
n.s. *** *** 
GFP-Plc1p4R/E425G in plc1Δ  
vs. 
GFP-Plc1p4R in plc1Δ 
n.s. *** *** 
GFP-Plc1p4R/E425G in plc1Δ  
vs. 
GFP-Plc1pE425G in plc1Δ 
*** *** *** 
GFP-Plc1p4R/E425G in arg82Δ  
vs. 
GFP-Plc1p in arg82Δ 
*** *** n.s. 
GFP-Plc1p4R/E425G in arg82Δ  
vs. 
GFP-Plc1p4R in arg82Δ 
*** *** *** 
GFP-Plc1p4R/E425G in arg82Δ  
vs. 
GFP-Plc1pE425G in arg82 Δ 
*** *** n.s. 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1p1-333 in arg82Δ  
vs. 
GFP-Plc1p in arg82Δ 
*** ** * 
GFP-Plc1p220-end in arg82Δ  
vs. 
GFP-Plc1p in arg82Δ 
*** ** *** 
GFP-Plc1p(1-333)+C2 in arg82Δ  
vs. 
GFP-Plc1p in arg82Δ 
*** * *** 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1p in arg82Δ vps41Δ 
vs. 
GFP-Plc1p in arg82Δ 
n.s. n.s. n.s. 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1p in arg82Δ 0.9M NaCl  
vs. 
GFP-Plc1p in arg82Δ 
*** *** *** 
GFP-Plc1p in arg82Δ 0.9M NaCl  
vs. n.s. * * 
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GFP-Plc1p in arg82Δ  10 × 0.9M NaCl 2 min  
GFP-Plc1p in arg82Δ  10 × 0.9M NaCl 2 min  
vs. 
GFP-Plc1p in arg82Δ 
** ** *** 
GFP-Plc1p in arg82Δ  10 × 0.9M NaCl 30 min  
vs. 
GFP-Plc1p in arg82Δ 
n.s. n.s. n.s. 
GFP-Plc1p in arg82Δ  10 × 0.9M NaCl 2 min  
vs. 
GFP-Plc1p in arg82Δ  10 × 0.9M NaCl 30 min 
n.s. n.s. n.s. 
 
P-value PM/Cytosolic Nuclear/Cytosolic PM/Nuclear 
GFP-Plc1p in gpr1Δ  
vs. 
GFP-Plc1p in WT 
n.s. n.s. n.s. 
GFP-Plc1p in gpr1Δ  
vs. 
GFP-Plc1p in gpr1Δ arg82Δ 
*** n.s. *** 
GFP-Plc1p in gpr1Δ arg82Δ 
vs. 
GFP-Plc1p in arg82Δ 
n.s. n.s. n.s. 
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